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SUMMARY
Mechanical debridement of supragingival but predominantly 
subgingival bacterial plaque and calculus has been the 
mainstay of traditional treatment for periodontal disease. 
Practical difficulties and occasionally lack of response 
or recurrence of disease in some patients have made
investigators search for more effective alternative or
adjunctive methods of therapy. In this thesis, two modern 
approaches, local antimicrobial delivery systems, as 
adjuncts to scaling and root planing, and the Nd:YAG
laser, as an alternative to scaling and root planing, were 
investigated.
The study designed to investigate subgingival
antimicrobial systems was of randomised parallel design 
and sought to evaluate the efficacy of 3 locally delivered 
antimicrobial systems as adjuncts to scaling and root 
planing in the treatment of sites with persistent 
periodontal lesions. Fifty-four patients with 4 pockets > 
5 mm and bleeding on probing (BOP) and/or suppuration were 
randomised in 4 treatment groups including: scaling and
root planing either alone (S) or plus application of 25% 
tetracycline fibre (S&T) or 2% minocycline gel (S&Mi) or 
25% metronidazole gel (S&Me). All treatments resulted in 
significant improvement in pocket depth (PD), attachment 
level (AL) , BOP and the Modified Gingival Index (MGI)
XXV
scores which were maintained until the end of the 6-month 
follow-up period, although some rebound towards baseline 
occurred in all groups at the 6-month visit. The 
improvements in clinical parameters were greater in the 
S&T group than other groups at any time point. At the 6- 
week visit, the pocket depth reduction (APD) was 
significantly greater in the S&T group than in the S group 
(p=0.002). There was no significant difference between 
groups in APD at 3 and 6-month visits. The difference 
between groups in improvement of AL (AAL) or BOP was not 
significant at any time point. The frequency of sites with 
suppuration reached zero only in the S&T group at the 6- 
week and 3-month visits. No serious adverse effects were 
observed or reported in any of the treatment groups. The 
S&T was the most time-consuming treatment. While all 3 
locally applied antimicrobial systems appear to offer some 
benefit over scaling and root planing alone, S&T treatment 
demonstrated the greatest advantage in the treatment of 
persistent periodontal lesions, particularly at 
suppurating sites.
A further aim of the study was to evaluate the effect of 
smoking on the outcome of periodontal therapy. Regardless 
of the type of treatment, APD and AAL were consistently 
greater in non-smoker subjects than smokers. The General 
Linear Model analysis was used for APD and AAL to take 
into account, variations in the treatments, number of 
smokers per group and baseline pocket depth. There was
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consistently a significant interaction between the 
'smoking' and the 'baseline PD'. Further analysis using 
linear regression indicated that while there was a 
significant relationship between the baseline PD and the 
APD or AAL among the non-smokers, a weak and insignificant 
relationship existed among the smoker subjects. These 
results strongly suggest that smoking is a factor to 
consider|in the determination of prognosis of periodontal 
treatment, particularly in deep pockets.
The aim of the first laser study was to evaluate the 
effects of Nd:YAG laser treatment on sub-gingival 
calculus, cementum and dentine, in vitro at different
power settings and durations. Eight different laser 
treatment settings were tested on subgingival calculus,
cementum and dentine specimens and were assessed using 
scanning electron microscopy (SEM). Micrographs were 
taken from each treated site at xlOO and x750 
magnifications. An arbitrary scale (from 0 to 3) was used 
to score the degree of damage caused by the laser. 
Generally, the laser caused greater damage on calculus 
than either cementum or dentine specimens, although in 
cases of complete ablation of calculus, the underlying 
cementum was ablated too. This may limit selective 
calculus removal without damaging the underlying dental 
tissues. Three-way analysis of variance showed that for
calculus, the power setting, pulse repetition, and the
duration of exposure, contributed independently to the
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mean damage score in an additive way. The results also 
showed that there was variability in susceptibility of 
different teeth and different parts of each tooth, which 
was true for calculus, cementum and dentine. This 
variability may preclude the safe and predictable removal 
of calculus by specific laser settings.
The aim of the second laser study was to determine whether 
the Nd:YAG laser energies of 50 and 80mJ at lOpps were 
capable of improving the clinical parameters associated 
with periodontal disease. These energy settings were 
chosen as previous reports indicated that higher values 
would damage root surfaces and that 80mJ had an in vitro 
bactericidal effect. Eighty periodontally affected sites 
in teeth scheduled for extraction from 11 patients with 
adult periodontitis were randomly placed in one of the 
following 4 treatment groups: 1) laser treatment at 50mJ, 
lOpps for 3 minutes; 2) laser treatment at 80mJ, lOpps for 
3 minutes; 3) scaling and 4) untreated control. After 6 
weeks, only the scaling group showed a significant 
reduction in pocket depth and BOP (p<0.001). The 
microbial samples taken immediately after scaling and 80mJ 
laser treatments showed a significant reduction in total 
anaerobic colony forming units compared to baseline 
(p<0.01), which was sustained only in the scaling group 
until week 6. SEM did not reveal any heat damage on the 
root surfaces. This study demonstrated that application 
of Nd:YAG laser pulses of 50mJ and 80mJ failed to improve
xxviii
the clinical and microbiological parameters of periodontal 
disease.
While subgingivally delivered antimicrobial systems, may 
be useful adjuncts to root planing in selected sites with 
persistent pocketing, the Nd:YAG laser, despite the 
manufacturer's claims, was not found to be a useful 
alternative to root planing. At the lower energy settings 
no clinical benefit was noted, and at the higher energy 
settings the results suggested that the laser is 
potentially damaging to the root cementum and dentine.
Further research should be directed towards the 
development of resorbable antimicrobial delivery systems 
with improved substantivity and more convenient and less 
time-consuming insertion methods. Such a system, may 
reduce the duration and number of required visits, and 
thus will improve the patient compliance and acceptance. 
Laser research should be directed towards the development 
and clinical testing of laser wavelengths with selective 
absorption for bacteria and calculus and minimal 
absorption in the dental tissues.
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CHAPTER I
INTRODUCTION
1.1 General introduction
Periodontal disease is among the most widely distributed 
diseases of mankind. Much effort has been expended to 
increase the knowledge of the pathogenesis of the disease. 
In spite of the rapidly expanding knowledge of the 
aetiological factors and pathways which interact with 
disease progression, a full understanding of the disease 
process has not yet been achieved. With an increase in 
the average life span, and a decrease in the prevalence of 
tooth loss due to caries, more teeth are now at risk of 
developing periodontal disease, and the need for skilful 
and knowledgeable prevention and therapy is increasing. 
Along with the development of new diagnostic tools, the 
ability of clinicians to diagnose and plan preventive and 
treatment strategies is improving. As the understanding of 
the pathogenesis of periodontal disease has evolved, these 
strategies have been developed and modified. While some 
of these strategies are no longer universally accepted, 
some others are still in the process of early development.
This thesis attempts to evaluate some of the recent 
therapeutic techniques developed for the treatment of 
periodontal disease. These new therapies may be adjuncts 
or alternatives to the established practice of root 
planing. These include local drug delivery systems and 
laser therapy, both of which have been suggested to act 
mainly by an antimicrobial action. The following 
literature review initially deals with definitions of
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basic aspects of periodontology. Then basic concepts of 
periodontal treatment will be considered. Special
consideration will be given to background research on 
local antimicrobial therapy and laser therapy. Finally, 
the clinical methods for assessing the outcome of 
periodontal treatment will be critically reviewed.
1.2 Definitions
1.2.1 The 'normal' periodontium: Clinical and
histological appearance
Supporting structures of the teeth, known as the 
periodontium, are comprised of the alveolar bone, the 
periodontal ligament, the root cementum and the gingivae 
which together form a functional unit (Lindhe, 1989) . The 
normal periodontium is clinically pale pink in colour, has 
a scalloped outline and a firm texture. It does not bleed 
on gentle probing, and fills the entire space between 
adjacent teeth (Wennstrom, 1988). In health, the depth of 
gingival sulcus is minimal. Histologically, no
inflammatory infiltrate is present and only a few 
polymorphonuclear leucocytes can be seen within the 
connective tissue and junctional epithelium. In a normal 
periodontium the alveolar bone is located 1mm apical to 
the cementoenamel junction, but a clinically healthy 
periodontium may show tissue recession and reduced height 
of the alveolar bone. Furthermore, the classical 
microscopic picture of the 'normal' periodontium has 
recently been an issue of debate. Investigators have found
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that an inflammatory infiltrate, comprising of both 
polymorphonuclear leucocytes and small round mononuclear 
cells is always present in gingival biopsies from 
clinically healthy gingivae (Seymour, Powell and Aitken, 
1983; Brecx et al., 1987). Therefore, the term
'clinically healthy1 compared to 'normal' periodontium is 
preferable (Wennstrom, 1988).
1.2.2 Diseased periodontium: Clinical features and 
epidemiology
Gingivitis refers to pathological inflammatory changes 
which are limited to the gingivae, and are clinically 
manifested by a change in colour (redness) , texture and 
appearance (swelling) of the gingivae, together with an 
increased tendency to bleeding on gentle probing. 
Periodontitis affects the deeper structures of the 
periodontium (bone, periodontal ligament and cementum), 
resulting in loss of periodontal support. It is 
frequently associated with the presence of periodontal 
pockets and bleeding on probing. Bone loss is the
pathognomonic feature.
The world workshop in clinical periodontology (1989) 
classified different forms of periodontal disease as 
follows: 1) Adult periodontitis; 2) Early-onset
periodontitis including: a) Prepubertal periodontitis
(localized and generalized), b) Juvenile periodontitis 
(localized and generalized), and c) Rapidly progressive
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periodontitis; 3) Periodontitis associated with systemic 
disease; 4) Necrotizing ulcerative periodontitis; and 5) 
Refractory periodontitis. However, there is considerable 
overlapping within the classification defined above. For 
example, the presence of a systemic disease such as 
diabetes may contribute to the development of a non- 
responsive so-called refractory periodontitis. HIV- 
associated periodontitis could be classified as 
periodontitis associated with systemic disease, although 
it is usually manifested by features of necrotizing 
ulcerative periodontitis. Furthermore, separation of the 
generalized form of juvenile periodontitis from rapidly 
progressive periodontitis adds confusion. Finally, the 
age of onset is sometimes difficult to determine 
retrospectively because quite often the patients are not 
aware of the presence of the disease until informed by 
their dentist. Periodontitis is a multifactorial, complex 
and chronic disease. Clearly, a better understanding of 
histopathological and epidemiological characteristics of 
the disease is needed before more clear-cut and well- 
defined classifications become available.
Early reports on the prevalence of periodontitis indicated 
that destructive periodontal disease affected a majority 
of the adult population above the age of 35-40 (Belting et 
al., 1953; Sandler and Stahl, 1954; Marshal-Day et al., 
1955; Bossert and Marks, 1956; Russel, 1957; Schei et al., 
1959) . Furthermore, from the above studies it was
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concluded that the inevitable fate of an untreated 
gingivitis was the development of periodontitis (Schrep,
1964). During the 1980's a new epidemiological concept 
emerged, as a result of new surveys, using more well- 
defined criteria in screening the patients. The new 
findings were not consistent with the old concepts. 
Generally, it was found that a small percentage of the 
population over the age of 40 were affected by periodontal 
disease (Baelum, Fejereskov and Manji, 1988; Jenkins and 
Kinane, 1989; Youneyama et al., 1988; Brown, Oliver and 
Loe, 1990; Hugoson, Laurell and Lundgren, 1992). 
Moreover, longitudinal studies on periodontitis 
populations revealed that a very small fraction of sites 
undergo attachment loss if left untreated (Lindhe, 
Haffajee and Socransky, 1983; Haffajee, Socransky and 
Goodson, 1983a; Jenkins, MacFarlane and Gilmour, 1988; 
Lindhe et al., 1989). Papapanou et al. (1988) reported 
that over a 10 year period, only 7% of subjects over 25 
years of age showed >3 mm attachment loss. Loe et al. 
(1986) conducted a 15 year study on a population who never 
practised oral hygiene measures. It was found that rapid 
progression of periodontal disease occurred in 8% of the 
total population. Collectively, the recent studies 
indicate that a subfraction not exceeding 10-20% of the 
whole populations show evidence of extensive periodontal 
disease.
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Realisation of the fact that certain individuals, and even 
certain sites in general, are more susceptible to 
periodontal disease than others, has made investigators 
focus on risk factors and markers of this disease. Over 
the years many risk factors have been proposed. These 
include host factors and environmental factors. Host 
factors could either be local (e.g. anatomic and plaque
retentive factors) or systemic factors. A variety of
immunologic and endocrine disorders are associated with 
impaired host response and thus, may be associated with 
increased susceptibility to plaque _ induced periodontal 
break-down (reviewed by Kinane and Davies, 1990). 
Although it has been documented that with increasing age, 
the prevalence of periodontal disease increases (Marshall- 
Day et al., 1955), the age per se may represent a past 
history of exposure to the disease rather than an actual 
current susceptibility. Moreover, the increased 
progression of periodontal disease in the elderly may be 
due to the association of ageing with cumulative 
attachment loss (Haffajee et al., 1991) or recession 
(which results in exposed roots with greater tendency for 
plaque retention) (Kinane and Davies, 1990). Stress may
affect the host response by increasing the level of 
corticosteroids. Furthermore, it may also affect the
patients oral hygiene habits and therefore may be a risk 
factor. Among the environmental factors the presence of 
some micro-organisms have been reported to have strong 
associations with periodontal disease (reviewed by
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Haffajee and Socransky, 1994). Finally, smoking has been 
shown to affect various aspects of host immune response. 
Smoking may have an adverse effect on fibroblast function 
(Raulin et al., 1988), chemotaxis and phagocytosis by 
neutrophils (Kenny et al., 1977; Kraal et al., 1977),
immunoglobulin production (Holt, 1987; Johnson et al., 
1990) and induction of peripheral vasoconstriction 
(Clarke, Shephard and Hirsch, 1981). Epidemiologic 
evidence indicates that cigarette smoking is a stronger 
risk indicator for the presence of periodontal disease 
than any of the 5 most suspected periodontal pathogens 
i.e. Actinobacillus actinomycetemcomi tans (A.a.), 
Porphyromonas gingivalis (P.g.), Prevotella intermedia 
(P.i.), Eikenella corrodens and Fusobacterium nucleatum 
(Stoltenberg et al., 1993).
1.2.3 Diseased periodontium: Aetiology and
pathogenesis
Periodontal disease is a disease of the supporting tissues 
of the teeth. Evidence indicates that periodontal disease 
is the result of interactions between bacterial plaque and 
the host response. If the pathological alteration is 
limited to the gingiva, it is called gingivitis, and if it 
leads to destruction of the supporting connective tissue 
and apical migration of the junctional epithelium, it is 
referred to as periodontitis.
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1.2.3.1 Gingivitis
Gingivitis refers to inflammatory lesions that are
confined to the gingiva. The main aetiological factor in 
gingivitis is dental plaque (Loe, Theilade and Jensen,
1965) . In fact, other factors have only a secondary role 
by either enhancing plaque accumulation or increasing host 
susceptibility to the plaque. Page & Schroeder (1976) 
described consecutive histopathological features of 
gingivitis under the titles of initial, early,
established, and advanced lesions.
The initial lesion: The initial lesion, develops within 1-
2 days of cessation of plaque control. It is an acute
inflammatory reaction and is characterised by the 
migration of neutrophils and monocytes from surrounding 
nearby vessels into the connective tissue, junctional 
epithelium, and gingival sulcus. A proportion of 
perivascular collagen fibres may disappear and gingival 
fluid flow is increased as a result of enhanced 
permeability of the gingival vessels.
The early lesion: The early lesion is seen 4-7 days after 
plaque accumulation. It features infiltration by lymphoid 
cells which are mainly T cells. The number of PMNs and 
monocytes also continues to rise. Some fibroblasts may 
show early signs of degeneration. Further loss of the 
collagen fibre network supporting the marginal gingivae is
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observed. The basal cells of the junctional epithelium 
begin to proliferate.
The established lesion: Although the original model of
Page and Schroeder suggested that the established lesion 
occurs 2-3 weeks after plaque accumulation, more recent 
evidence indicates that the time taken for the established 
lesion to develop is uncertain (Brecx et al., 1988). It is 
characterised by a cellular infiltrate dominated by plasma 
cells and B lymphocytes, continuing loss of connective 
tissue substance noted in the early lesion, and 
proliferation and lateral extension of the junctional 
epithelium. Gingivitis at this stage is still reversible 
if oral hygiene is re-instituted, otherwise, it may either 
remain unaltered for extended periods of time or progress 
to an advanced lesion, i.e., periodontitis.
1.2.3 .2 Periodontitis
Periodontitis is an inflammatory disease of the attachment 
apparatus. Its features are characterised by dominant 
plasma cell infiltration, bone resorption, destruction of 
periodontal ligament fibres and apical migration of the 
junctional epithelium. Progression of periodontitis may 
ultimately result in tooth loss. Interactions between the 
host defense system and the pathogenic microflora are 
generally considered to be the key features of the 
pathogenesis of the periodontitis.
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1.2.3.3 Bacterial plaque
Bacterial plaque may be defined as an aggregation of 
bacteria colonizing the tooth surface (Kelstrup and 
Theilade, 1974). The bacteria are attached together or to 
the tooth surface either directly or via a matrix of 
carbohydrates and proteins, called the inter-microbial 
matrix. A few minutes after exposure of the cleaned tooth 
surface to saliva, an acellullar and homogenous pellicle 
of salivary glycoproteins called "acquired pellicle" is 
formed which glues the bacteria to the tooth surface. 
Early plaque is dominated by Gram positive coccal 
organisms and short rods. Gradually the number of Gram 
negative coccal organisms and rods increases and after a 
few days filamentous micro-organisms appear followed by 
spirilla and spirochetes (Theilade et al., 1966). If the 
plaque remains undisturbed, as it becomes thicker, the 
environment shifts to one which is more hospitable to 
anaerobic micro-organisms especially in the deeper layers 
next to the tooth surface (Ritz, 1969). In advanced 
periodontitis, the cultivable flora is comprised mainly of 
anaerobic micro-organisms and the proportion of 
spirochetes increases with increasing pocket depth 
(Listgarten and Levin, 1981).
1.3 The role of bacteria in the aetiology of
periodontal disease
The relationship between plaque and periodontal disease is 
now universally accepted. Loe, Theilade and Jensen
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(1965), Theilade et al. (1966), and Jensen et al. (1968) 
showed that after refraining from oral hygiene measures, 
dental plaque developls ., closely followed by inflammation 
of the gingiva. They observed that after plaque removal 
the gingivitis disappeared within a few days.
There are many mechanisms by which the bacteria may 
contribute, directly, or indirectly to the tissue 
destruction. It has been suggested that the bacteria may 
invade the marginal periodontal tissues (Frank, 1980; 
Saglie et al., 1982a,b; Gillett and Johnston, 1982; 
Saglie, Carranza and Newman, 1985; Christersson et al., 
1987; Saglie et al., 1988; Lamont, 1992; Duncan et al., 
1993). However, scepticism has emerged because of the 
possibility of artefacts during the preparation of tissues 
(Liakoni, Barber and Newman 1987). Nevertheless, it 
appears from the results of controlled in vitro studies 
(Sandros, Papapanou and Dahlen, 1993; Sandros et al., 
1994; Papapanou et al., 1994) that some bacteria have the 
ability to invade host cells. The bacteria may also 
induce damage through release of their toxic products. 
Sulphides, thiols, ammonia, and indole are some toxic 
metabolites of the inhabitants of the pocket flora. 
Bacteria may also release products which adversely affect 
the homeostasis of the periodontium either by suppressing 
the host response or by inducing immunologic reactions 
beyond the protective role of the host which could result 
in tissue destruction. Some bacteria can degrade IgA and
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IgG (Kilian, 1981). Some Bacteroides may secrete a surface 
coating which makes them resistant to phagocytosis 
(Sundqvist et al., 1982). Proteinases may be released by 
bacteria (Fujimura and Nakamura, 1981). A.a. produces a 
leukotoxin which kills human PMNs and monocytes (Tsai et 
al., 1979; Baehni et al., 1979). Van Dyke et al. (1982)
suggested that several species release peptides that can 
bind to and block the receptors for chemoattractant 
molecules, found on the surface of phagocytic cells. 
Lipopolysacharide (LPS) of Gram negative bacteria can 
induce bone resorption and activate the complement 
cascade, in addition to its inhibitory effect on 
fibroblasts.
1.4 Host mediated tissue damage
The discovery of several specific regulatory mediators was 
a breakthrough in the understanding of host response 
mechanisms. Cytokines, chemokines, growth factors, 
prostaglandins, leukotrienes, thromboxanes,
anaphylatoxins, kinins, and biologically active amines all 
play roles in the induction, amplification, persistence, 
control and resolution of localized inflammatory immune 
responses. The stimulation by the bacteria and their 
products, of host cells which release cytokines, 
particularly interleukin-1 and tumour necrosis factor- 
alpha, may trigger the activation of tissue destructive 
mechanisms by the host. There are at least 4 distinct 
mechanisms which are involved in the remodelling of the
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tissue stromal architecture. These are the osteoclast 
pathway, the matrix metalloproteinase pathway, the 
plasminogen-dependent pathway, and the intracellular 
lysosomal dependent phagocytic pathway (Birkedal-Hansen, 
1993). While the first pathway is involved in the 
degradation of the mineralised matrices, the matrix 
component of the connective tissue is the target of the 
second and third pathways and finally the fourth pathway 
is responsible for the intra-cellular digestion and 
disposition of larger fragments such as collagen fibrils 
(Meikle, Heath and Reynolds, 1986).
1.5 The clinical assessment of periodontium
1.5.1 Plaque index
Plaque index is an expression of plaque accumulation on 
the tooth surface. The choice of plaque index for a 
clinical trial should be made with regard to the objective 
of the trial. Currently, plaque indices estimate plaque 
accumulation by measuring either the tooth surface area 
covered or the thickness of plaque in the area. One of 
the earliest plaque indices for the assessment of debris 
was introduced by Ramfjord (1959) as part of his 
periodontal index and was modified by Shick and Ash (1961) 
and is based on the surface area covered by plaque on 6 
Ramfjord teeth. This index, having a range from 0 to 3, 
measures the plaque on the lingual and buccal surfaces and 
the plaque status on the proximal surfaces has only a 
minor contribution to the score. The simplified oral
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hygiene index (OHI-S) of Greene and Vermillion (1964) 
assesses the debris accumulation based on the tooth 
surface area using a scale ranging from 0 to 3. The 
plaque index of Quigley and Hein (1962) scores the area 
covered by plaque from 0 to 5. Until the early 60's, most 
plaque indices assessed mainly the buccal and lingual 
surfaces. Furthermore, these plaque indices tended to 
overscore the incisal portion of the tooth at the expense 
of the cervical portion. When plaque is evaluated in 
trials of periodontal disease, the amount of plaque in 
close contact with the gingivae is of greater importance. 
Taking this into consideration, Silness and Loe introduced 
their plaque index in 1964. The index was described in 
more detail by Loe (1967) . It is still one of the most 
widely used plaque indices in clinical studies of 
gingivitis and periodontitis. The index scores the 
thickness of plaque on the gingival area of each of the 4 
surfaces of the tooth. However, because this index is 
disruptive (when discriminating between score 0 and 1 
using the probe) , the evaluation of the inter- and intra­
examiner variability prior to a study is not possible. 
For this reason and because of the relative subjectivity 
of the index, only one examiner should be fully trained 
and used throughout the study period. The Navy Plaque 
Index (Elliot et al., 1972), divides the tooth surface 
into 9 parts 6 of which are located in the gingival third. 
This index and its modification (Fischman, 1986), although
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putting more emphasis on the gingival part, seem to be 
difficult for the examiner to learn and remember.
The use of a plaque index in a clinical trial evaluating 
the efficacy of clinical modalities for the treatment of 
periodontal disease can provide some evidence of the 
effectiveness of patients' plaque control. Obviously, the 
quality of patients' home care will affect the response to 
the therapy and should be monitored and kept at a high 
standard during the study period and more importantly
should be balanced between the treatment groups. However, 
since brushing by the patients shortly before the clinical 
measurements may invalidate the plaque score data, to draw 
conclusions about the performance of patients in their 
plaque control, plaque index should be supplemented with a 
gingival index or a bleeding index. These latter indices 
could fairly, at least in gingivitis with little 
periodontal destruction, act as evidence of recent plaque 
exposure.
1.5.2 Gingival index
Once gingivitis and periodontitis were thought to be
different stages of the same disease. Naturally, the
indices designed to assess the disease covered both 
entities in their scales. Among these were the PMA 
(P:papillary, Mrmarginal & A:attached) Index (Schour and 
Massler, 1947), Russell's Periodontal Index (Russell,
1956), the Periodontal Disease Index (Ramfjord, 1959), the
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Gingiva-Bone Count Index (Dunning and Leach, 1960) and the 
Navy Periodontal Disease Index (Elliot et al., 1972). 
Most of these indices were developed for epidemiological 
studies and the tooth rather than the site was the unit of 
examination and for each subject one value would be 
calculated based on the score obtained from all or some 
teeth. However, concurrent with the evolving of the 
knowledge of periodontal disease and the increasing 
interest in the aetiology and pathogenesis of periodontal 
destruction, the following changes occurred in more recent 
gingival indices.
1) By differentiating gingivitis from periodontitis, most 
authors used gingival indices as a means of assessing the 
inflammation in the gingivae alone. The severity of 
periodontal destruction was assessed by measuring pocket 
depth and bone loss.
2) The gingival unit was defined as a localized area of 
the gingiva adjacent to a certain aspect of the tooth 
(e.g. mesiobuccal or buccal site) rather than the entire 
gingiva surrounding the tooth. As a result, more emphasis 
was put on the severity of the gingival inflammation at a 
site rather than its superficial extent and location. The 
gingival index of Loe and Silness (1963) was able to 
measure the severity of gingival inflammation at a site on 
the basis of both visual examination and bleeding on 
probing. The scores ranged from 0 to 3. Among the other
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gingival indices were: the Sulcular Bleeding Index
(Muhlemann and Mazor, 1958; Muhlemann and Son, 1971), the 
Gingival Bleeding Index (Ainamo and Bay, 1975) and the 
papillary bleeding index (Muhlemann, 1977; Barnett, 
Ciancio and Mather, 1980).
3) Up until the mid 80's, most indices used the bleeding 
on probing as a part of or the entire criteria of scoring 
the gingival inflammation. With growing interest in the 
assessment of crevicular fluid components, it became 
necessary to develop indices which would allow the 
assessment of gingival inflammation without inducing any 
trauma to the gingival tissue. The stimulation of the 
gingival tissue by the probe could transiently produce an 
increased flow of GCF and obscure the profile of various 
biochemical components. Therefore, the modification of 
previous indices was introduced so that the gingival 
examination could be assessed by mere visual examination. 
The gingival index of Loe and Silness (1963) was modified 
by Lobene et al. (1986) . In addition to elimination of 
the bleeding component, an additional score was 
incorporated in the index and the criteria for mild and 
moderate inflammation was redefined. Relying only on the 
visual signs of inflammation does not reduce the ability 
of an index to detect gingivitis. Morphometric studies 
indicated that the presence of visual signs of gingivitis 
alone significantly correlated with the presence of
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inflammatory infiltrate in the gingival connective tissue 
(Greenstein, Caton and Poison, 1981) .
1.5.3 Gingival crevicular fluid (GCF) flow
The volume of Gingival crevicular fluid has been shown to 
correlate with the degree of inflammation in the gingival 
tissue (Brill, 1960; Mann, 1963; Egelberg, 1964; Loe and 
Holm-Pedersen, 1965; Egelberg and Attstrom, 1973; Borden, 
Golub and Kleinberg, 1977) . One non-invasive method of 
collection of GCF includes the insertion of filter paper 
strips at the orifice of the pocket. The Periotron 6000 
measures the conductivity of the wetted paper strip which 
is in turn a function of the volume of fluid absorbed onto 
the paper. This method, originally developed to
differentiate healthy gingiva, gingivitis and 
periodontitis, has been reported to correlate with other 
clinical methods of measuring the gingival inflammation 
(Suppipat, Johansen and Gjermo, 1977; Garnick, Pearson and 
Harrel, 1979).
1.5.4 Bleeding on probing
In the evaluation of periodontal destruction, the Modified 
Gingival Index alone is of limited value because it tells 
little about the inflammatory status of the deeper 
portions of the periodontium. Hence, the use of a 
bleeding index in addition to the Modified Gingival Index 
has been recommended (Lobene et al., 1989). A number of 
bleeding indices were cited in section 1.5.2. Some
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bleeding indices rely on stimulation of the superficial 
portion of the periodontium. Among these is the Bleeding 
Points Index (Lenox and Kopczyk, 1973). These indices 
were introduced to monitor the gingival health and oral 
hygiene performance of the patient and are of limited 
value in the assessment of periodontal destruction. 
Hence, in the evaluation of periodontitis, the probe 
should be aimed at the base of the pocket. Bleeding on 
probing may be attributed to alteration of blood vessel 
walls, weakening and ulceration of pocket epithelium, and 
reduction in the collagen fibres around the blood vessels 
(Greenstein, 1984). However, the occurrence of bleeding
after probing into the base of the pocket is not 
necessarily indicative of inflammation in this area.
Preferably a standardised probing force should be used 
when probing to assess bleeding since the tendency towards 
bleeding increases with increasing probing force (Freed, 
Gapper and Kalkwarf, 1983; van der Velden, 1980; Caton, 
Proyne and Poison, 1982; Proye, Caton and Poison, 1982; 
Lang et al., 1991). The Periodontal Pocket Bleeding Index 
(van der Velden, 1979) uses a constant force of 0.75 N and 
dichotomised scores are given to each site if it shows
bleeding within 30sec of probing. 30 seconds seems a 
sufficient length of time to allow the micro-haemorrhage 
which occurs at the base of the pocket to show itself at
the orifice of the pocket. Lang et al. (1991) and
Karayiannis et al. (1992) studied the effect of varying
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probing forces on bleeding scores in healthy gingiva and 
observed that with a probe tip diameter of 0.40 mm, 
minimal bleeding was found using a probing force of 0.25 N 
(about 24 g) . It seems that bleeding provoked by forces 
higher than 0.25 N may be caused by trauma to healthy 
blood vessels rather than the rupture of fragile vessels 
in inflamed tissues. If probing forces above 0.25 N are 
preferred, bleeding scores of clinically healthy gingiva 
may not approach 0%. In addition, the reduction of 
bleeding on probing scores after treatment, relative to 
baseline scores, have been found greatest for the lower 
probing forces (van der Velden, 1980; Caton et al., 1982; 
Proye et al., 1982).
There has been debate in the literature regarding the 
value of bleeding on probing. Janssen, Faber and van 
Palenstein Helderman (1986) reported limited
reproducibility for bleeding on probing. For clinical 
purposes, therefore, bleeding on probing alone may not be 
reliable on an individual site basis and should be 
interpreted with caution. Nevertheless, despite these 
limitations changes of bleeding scores for pooled sites in 
a patient seem to be an indicator of improvement in 
periodontal condition as a result of the treatment. 
Gingivae that do not bleed on probing have been shown to 
contain a smaller inflammatory infiltrate and denser 
collagenous connective tissue, than those that bleed 
(Poison, Greenstein and Caton, 1981; Cooper, Caton and
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Poison, 1983; Davenport, Simpson and Hassell, 1982; 
Greenstein, Caton and Poison, 1981; Engelberger, Heftji and 
Kallenberger, 1983). These studies indicated that
bleeding on probing demonstrate a substantial deviation 
from health. Generally, the absence of bleeding on 
probing in a site that previously bled may be interpreted 
as improvement in periodontal health and an absence of 
disease (Greenstein, 1984; Lang et al., 1990).
1.5.5 Probing depth and probing attachment level
Periodontal probing has been one of the most fundamental 
methods of periodontal examination. The simplicity of 
this method has allowed clinicians to evaluate the
presence of a pathologically deepened sulcus. The
reliability of periodontal probing has been extensively 
studied. All published studies on evaluation of
periodontal probing have dealt with one or more measures 
of the quality of this diagnostic tool; resolution or 
precision, validity or accuracy, and repeatability 
(Jeffcoat and Reddy, 1991a). Resolution is related to the 
smallest increment which the probe can measure and is 
dependent on the design of the probe. Higher resolution 
per se is not necessarily synonymous with higher
reproducibility. However, if an examiner could perform 
highly reproducible probings, the higher resolution would 
play a role by resulting in both more precise measurements 
and improved variability. Accuracy is closeness of the 
probe reading to the parameter which the probe is meant to
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measure i.e. the distance from the gingival margin or 
cemento-enamel junction (CEJ) to the most coronal 
transeptal connective tissue fibres. This may depend on 
factors related to probe design such as probing force and 
the probe tip diameter, as well as factors related to the 
status of the periodontal tissues such as degree of 
inflammation. The last factor i.e. reproducibility is 
related to a great extent to the operator skill and 
careful characterisation of the site to be probed. 
Furthermore, the factors related to the probe design and 
the tissue status play a role in the reproducibility of 
the measurements. It has been consistently reported that 
a significant relationship exists between the degree of 
inflammation and the level of probe penetration (Armitage, 
Svanberg and Loe, 1977; Robinson and Vitek, 1979; Jansen, 
Pilot and Corba, 1981; Magnusson and Listgarten, 1980; 
Caton et al., 1981; Fowler et al., 1982; Garnick et al. 
1989).
The measurement of true connective tissue attachment is a 
critical factor when evaluating the outcome of
regenerative procedures from which a coronal re-growth of
connective tissue attachment is expected. Moreover in
monitoring the disease progression in periodontitis sites, 
the major interest is focused on the apical displacement 
of connective tissue attachment levels in relation to a 
reference point such as CEJ. However, after standard 
procedures such as root planing or any procedure which
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results in the resolution of inflammation, the relative 
attachment change over a time period is mainly a 
reflection of increase in density of connective tissue 
fibres and formation of a long junctional epithelium 
(clinical attachment gain). While the observed changes in 
probing attachment may be substantial, the true 
regeneration of transeptal fibres is usually small. Even 
if a probing technique is capable of predictably measuring 
the connective tissue attachment levels before treatment, 
it will underestimate the attachment levels after therapy. 
Therefore, the consistent and accurate estimation of true 
connective tissue attachment during the assessment of 
procedures which result in clinical attachment gain with 
little true attachment gain, is neither achievable nor 
practically important and reflective of treatment success.
In addition to the degree of inflammation, there are a 
number of factors which play a role in the reproducibility 
of the probing. These variables include diameter of the 
probe tip (Keagle et al., 1989), angulation of the probe 
to the root surface (Karim, Birek & McCulloch, 1990; 
Watts, 1989), accuracy of probe markings (van der Velden, 
1978; Winter, 1979; van der Zee, Davies and Newman, 1991), 
and the identification of a reference point such as CEJ in 
the case of attachment level measurements. The CEJ has 
been reported to be masked by its subgingival location or 
by the presence of restoration margins or by the presence 
of calculus in 17% of the sites (Clark et al., 1987) . In
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an attempt to reduce errors in the identification of the 
CEJ as well as errors in the placement of the probe, 
occlusal stents have been used and reported to be useful 
(Isidor, Karring and Attstrom, 1984a; Badersten et al., 
1984a; Clark et al., 1987). Probing force has also been 
shown to be an important factor in the degree of probe 
penetration (van der Velden, 1979; van der Velden and 
Jansen, 1981; Chamberlain et al., 1985 and Gamick et al., 
1989). Since the late 70's many investigators have used 
controlled force probes to improve the reliability of the 
probing measurements (van der Velden and de Vries, 1978; 
Caton et al., 1982; Proye et al., 1982). While the 
superiority of pressure controlled probes over manual 
probing is not universally accepted (van der Velden and de 
Vries, 1980; Badersten, et al., 1984a; Simons and Watts, 
1987), most data indicates that these probes are useful 
instruments in reducing the measurement error. Freed et 
al. (1983) reported that the force of probing may vary 
from 5 to 125 g among clinicians. Similar findings were 
reported by Hassel, Germann and Saxer (1973). Moreover, 
it was reported that distal sites and posterior teeth are 
probed at higher forces than mesial sites and anterior 
teeth, when conventional probes are used. van der Velden 
(1979) evaluated the position of the probe tip in relation 
to the true connective tissue attachment level at 
different probing forces. It was reported that with 
increasing probing force, the probe penetration increased 
and using a probe tip of 0.63 mm diameter, the probing
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force of 0.75 N produced the best indication of true 
attachment levels. However, in van der Velden's study the 
probing was performed on treated periodontitis sites. 
Since the diseased sites are of the most interest to 
clinicians, it would be more realistic if the diseased 
sites had been evaluated for optimal probing force. Walsh 
and Saxby (1989) reported 100% agreement within 1 
millimetre between pairs of measurements when a pressure 
sensitive probe with a force of 0.25 N was used. The 
corresponding value for the manual probe was 96%. They 
also reported that the use of a constant force probe 
improved the inter-examiner variability but only one of 
the examiners benefited from the pressure probe in 
improving the intra-examiner variability. Similar
findings indicative of a lack of benefit of pressure 
probes on the intra-examiner variability were reported by 
Abbas et al. (1982) . These data indicate that some 
operators can probe more reproducibly than others and that 
operator skill is an important source of variation. van 
der Velden and de Vries (1980) reported no advantage for 
the pressure probe using a force of 0.75 N in terms of 
variability. Mombelli, Mukle and Frigg (1992) reported 
that while the amount of measured attachment gain after 
therapy is higher at low-force probings, the higher force 
probings were more reproducible. These 2 factors i.e., 
the mean difference between pre- and post-therapy and 
measurement error are 2 major determinants which dictate 
whether a treatment outcome is statistically significant
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or not. It appears that at each probing force, one of 
these factors could be improved at the expense of the 
other one. In this context, it is worth mentioning the 
study of Proye et al. (1982), who reported that controlled 
force probing using 25 g or 50 g was capable of detecting 
a significant attachment gain at 3 and 4 weeks post- 
therapy, whereas manual probing at the same sites failed 
to detect the attachment gain at the 4 week time point.
Deeper measurements by the conventional probes as compared 
to pressure sensitive probes have been reported by many 
investigators (Proye et al. 1982, Caton et al. 1982, 
Osborn et al. 1990)
1.5.5.1 Electronic pressure sensitive probes
A pressure sensitive probe which automatically detects the 
CEJ was described by Jeff coat and Reddy. Using this probe 
a standard deviation of less than 0.2 mm was found for 
individual sites (Jeffcoat and Reddy, 1991b). An 
electronic pressure sensitive probe, the Florida Probe, 
which measures pocket depth and attachment level to the 
nearest 0.1 to 0.2 mm was developed by Gibbs et al. (1988) 
and has a reported reproducibility of 0.58 mm and 0.28 mm 
for probing depth and attachment level (Stent probe) 
respectively (Gibbs et al., 1988; Clark, Yang and 
Magnusson, 1992). The Florida Probe is equipped with 
different handpieces which allow pocket depth measurement 
as well as the measurement of attachment level both from a
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custom-made stent and the occlusal surface (Magnusson et 
al., 1988a; Osborn et al., 1990). Magnusson et al., 
(1988a) reported that both intra-examiner and inter­
examiner variability of probing depth measurements were 
significantly reduced when the controlled force Florida 
Probe was used instead of a conventional probe. The 
standard deviation of duplicate measurements of attachment 
levels decreased when the Florida Probe was used 
(Magnusson et al. 1988b) as compared to manual probes. 
This resulted in a subject threshold as low as 0.60 mm for 
severe periodontitis sites. It was concluded that the 
changes in attachment levels could be detected earlier if 
the Florida Probe is used instead of manual probes. 
Osborn et al., (1990) compared the reproducibility of the 
conventional probe with the Florida probe with a force of 
20 g. It was reported that intra- and inter-examiner 
variability of measurements of probing depth and 
attachment levels using a single pass of the Florida probe 
did not offer any advantage over conventional probing. 
However, duplicate measurements using the Florida probe 
showed less variability compared to the single measurement 
by conventional probes. This was especially true for 
attachment level measurements. Although the improvement 
in the reliability of probing as a result of duplicate 
measurements is a statistical phenomenon, it could be 
particularly useful when blind measurements are obtained. 
The standard deviation of differences in 2 consecutive 
measurements is reduced by a factor of the square root of
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2 if duplicate rather than single measurements are taken. 
However, obtaining duplicate measurements using 
conventional probing can not be relied upon unless 2 
separate visits are used to take the readings. Since the 
examiner reads the measurement, he/she probably remembers 
the first reading, when the second measurement is being 
obtained. This will result in a bias in the second 
reading making it artificially close or equal to the first 
reading. This problem is overcome when obtaining 
measurements using the Florida probe, since the reading 
appears on a computer screen and recorded by an assistant 
and no graduation exists on the probe tip, the examiner 
remains blind to the actual reading and the possibility of 
bias in the probing is eliminated. Marks et al. (1991) 
reported a higher reproducibility for the *Stent Florida 
Probe* as compared to the 'Disk Florida Probe1. However, 
only sites with minimal periodontal disease were included 
in the study. Another electronic pressure sensitive 
probe, the Toronto Probe, was first described by Birek, 
McCulloch and Hardy (1987) and later modified by Karim, et 
al. (1990). It measures attachment level to the nearest 
0.1 mm under controlled angulation with a reported 
reproducibility of 0.46 mm. An electronic pressure 
sensitive probe, Inter-probe, uses disposable flexible 
plastic tips at a force of 15 g, has a resolution of 0.5 
mm and measures only the pocket depth. The
reproducibility of this probe was reported to be 0.8 mm 
(Goodson and Kondon, 1988) and did not offer any advantage
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over the manual probes (Wang et al., 1995). Possibly, the 
flexibility of the tip and excessively low force of 
probing are responsible for the poor reproducibility of 
this probe. It is worth mentioning that the
reproducibility of manual probing for attachment levels 
has been reported as 0.84 mm (Haffajee, Socransky and 
Goodson, 1983b). The quoted reproducibility of the 
mentioned probes was dependent on figures reported by 
investigators in separate studies, which are obviously not 
comparable because different operators and patients were 
used for each study.
In conclusion, it appears that: a) most pressure sensitive 
probes offer advantages over manual probes; b) due to 
large operator-dependent measurement variations, a single 
operator should be trained and used throughout 
longitudinal studies if possible; c) careful localisation 
of the sites, through exact characterisation and possibly 
the use of occlusal stents are essential for reduction of 
measurement errors; and d) duplicate recordings may be 
useful in further reducing the variability. Despite all 
the factors which limit the interpretation of probing 
data, probing pocket depth and probing attachment level, 
still comprise the major outcome variables and the 
periodontal probe still remains one of the most reliable 
tools in the hands of therapists.
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1.6 Treatment strategies in periodontal therapy
The methods of treating periodontal disease can be 
categorised into 4 basic groups; 1) resective therapy, 2) 
mechanical therapy, 3) regenerative therapy, and 4) 
antimicrobial therapy.
1.6.1 Resective therapy
Briefly, resective therapy includes the surgical 
elimination of the periodontal pocket. The proponents of 
this approach believe that the total elimination of the 
periodontal pocket and establishment of a normal anatomy, 
but at a reduced height is the only means of arresting the 
progression of the disease. In this approach, the 
marginal bone may be resected to re-establish normal 
contour (Page, 1993). The pocket wall is eliminated 
either by excision or apical re-positioning of the flap.
1.6.2 Mechanical therapy
This approach includes the non-specific elimination of 
bacterial plaque, calculus and other plaque retentive 
factors from the pocket by means of mechanical disruption. 
A surgical flap may be reflected only to aid visual access 
(Ramf jord and Nissle, 1974) . In this strategy the gold 
standard is not zero pocket depth but rather conversion of 
infected pockets to healthy pockets, maintained free of 
pathogenic bacteria. Since the late 1970's many
longitudinal studies have been conducted to compare the 
ability of mechanical therapy to other treatment
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modalities. The work of several investigators has 
demonstrated that while pocket elimination may favour a 
reduction in pocket depth, scaling and root planing or 
modified Widman surgery favour a gain in clinical 
attachment levels (Ramfjord et al., 1975; Knowles et al., 
1979; Knowles et al., 1980). In a 5 year clinical study, 
Hill et al. (1981) and Ramfjord et al. (1987) showed that 
scaling and root planing and curettage produced more 
attachment gain than pocket elimination surgery in 
moderately deep pockets while no difference was found 
between treatments in very deep pockets. Moreover, in the 
shallow sites the surgical elimination technique resulted 
in the largest attachment loss. Kaldahl et al. (1988) 
reported that clinical attachment gain is more favourable 
after the modified Widman flap procedure or scaling and 
root planing when compared to pocket elimination surgery 
or supragingival scaling. The results of studies by 
Isidor, Karring and Attstrom (1984b), Lindhe et al.
(1984), and Isidor and Karring (1986) indicated that there 
was no difference between scaling and root planing and the 
modified Widman technique. In summary, longitudinal 
trials demonstrated that scaling and root planing and 
surgical procedures were equally effective in arresting 
the progression of periodontal disease. It appears that 
the major determinant of the periodontal therapy is
i
thorough root debridement land good oral hygiene.
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1.6.2.1 The practical limitation of the traditional 
mechanical therapy
Having mentioned the efficacy of mechanical therapy, it 
should be stated that there are some factors which 
sometimes limit the practicality of traditional mechanical 
therapy. Scaling and root planing is very time consuming. 
In the study of Ramfjord et al. (1987) scaling and root 
planing amounted to 5 to 8 hours by a hygienist for the 
whole mouth plus 1.5 hours per quadrant by a periodontist. 
In other studies the root planing required 6 to 8 hours 
per patient (Pihlstrom, Ortiz-Campos and McHugh 1981; 
Lindhe et al., 1984). The other limiting obstacle is the 
skill of the operator. There is a considerable 
variability among clinicians in their ability to perform 
root debridement effectively. (Badersten, Nilveus and 
Egelberg, 1985; Eaton, Kieser and Davies, 1985; Brayer et 
al., 1989). A thorough root debridement can be painful 
for patients. Dentinal sensitivity may occur which is 
often exacerbated by structural wear of the tooth due to 
long term maintenance therapy with root planing at 3 
monthly intervals. If the root debridement necessitates 
flap reflection, then the complications encountered during 
or after the procedure should also be added to the list of 
limitations of mechanical therapy. Finally, some sites 
respond less favourably than others to mechanical therapy 
(Hirschfeld and Wasserman, 1978; Loos et al., 1989). 
However, it is not clear whether the failure of the 
treatment is due to incomplete root debridement and/or
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inadequate home care or a deficient host response, or
whether a peculiarly persistent micro-organism(s) is 
responsible. Whatever the aetiology of persistent 
periodontitis, the occasional lack of a predictable 
response to treatment, the time obstacle, the variation in
operator skills, and the short term and long term patient
discomfort, have encouraged the clinical scientists to 
seek other treatment approaches to establish periodontal 
health.
1.6.3 Alternatives or adjuncts to root planing
1.6.3.1 Regenerative therapy
Since Nyman et al. (1982a,b) demonstrated the possibility 
of regeneration of periodontal tissues on previously 
diseased surfaces using a physical barrier, there have
been many efforts to develop practical and predictable 
techniques and materials to achieve this goal. It is not 
the scope of this thesis to review the studies on the 
regeneration potential of bone and periodontal ligament 
using different graft materials, membrane placement, 
surgical techniques or chemical modification of the root 
surface. While much research is going on and some 
advances have been made, it seems that a practical,
predictable and cost-effective regenerative technique is
yet to be developed.
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1.6.3.2 Antimicrobial therapy
Shortly after bacterial plaque was discovered as the major 
aetiological factor in periodontal disease (Loe et al., 
1965), antimicrobial agents were demonstrated to produce 
qualitative and quantitative changes in plaque (Loe et 
al., 1967, Jensen et al., 1968). Since then, the debate 
has been opened as to whether the antimicrobials could be 
used as an adjunctive/sole treatment for periodontal 
disease and several investigators tested the efficacy of 
antibiotics for this purpose (reviewed by Slots and Rams 
1990, Gordon and Walker 1993, Greenstein 1993, Kornman 
1993, Seymour and Heasman 1995a,b).
1.7 A review of systemic antibacterial therapy for
the treatment of periodontal disease
1.7.1 Introduction
A single micro-organism or groups of micro-organisms have 
been reported as having a strong association with 
periodontal disease. If a micro-organism is proved to be 
both a periodontal pathogen and exogenous, then its 
specific elimination from the pocket is necessary. As yet 
no such direct causative relationship has been recognised. 
In addition, of the suspected periodontal pathogenic 
bacteria, no single species has been linked with diseased 
sites which is not also commonly isolated in non-diseased 
sites. Non-selective cultures have revealed that the 
subgingival ecosystem, is comprised of more than 300 
species, and has a complex and variable nature. Until the
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many ongoing efforts elucidate this problem, the non­
specific elimination of the whole mass of the microbial 
plaque by means of mechanical instrumentation remains the 
main tool in the hands of the therapist. Nevertheless, 
the increasing evidence for the association of specific
species with some forms of periodontal disease, has 
increased the interest in the use of antibacterial drugs 
for elimination of these organisms. Many systemic and 
local forms of antimicrobial agents were developed to 
eliminate suspected pathogens from the subgingival 
ecosystem. Many studies have been conducted by clinical 
researchers to examine whether these agents could be 
effective in arresting the progression of periodontal 
disease either as the sole treatment or as an adjunct to 
mechanical therapy. In the following sections, the 
background information concerning the use of antibacterial 
agents in the treatment of periodontal disease will be
reviewed and discussed.
1.7.2 Tetracyclines
To date, tetracyclines are the only antibiotics that 
following systemic administration achieve gingival fluid 
levels higher than serum levels. Multiple oral doses of 
tetracycline, doxycycline and minocycline produce GCF 
concentrations of 2-5 times serum levels (Gordon et al.,
1981; Ciancio, Mather and McMullen 1980; Ciancio et al.,
1982; Pascale et al., 1986). Dental tissues can act as a 
reservoir which prolong the substantivity of the drug
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(Baker et al., 1983; Bjorvatn, Skaug and Selvig, 1985). 
Most micro-organisms considered periodontal pathogens are 
susceptible to the tetracycline concentration in GCF after 
systemic administration (Walker et al. 1981a; Walker, 
Gordon and Socransky 1983; Walker et al., 1985; Baker et 
al., 1985). Lindhe and Liljenberg (1984) reported that a 
combination of surgery and 1 g/day tetracycline for 2 
weeks was successful in the treatment of localized
juvenile periodontitis (LJP) and adult periodontitis 
patients. Slots and Rosling (1983) reported that whilst 
scaling and root planing was ineffective in eliminating 
A.atinomycetemcomitans (A.a.) from periodontal pockets of 
patients with LJP, tetracycline administered in 250 mg 
doses 4 times a day for 14 days was successful in
eliminating A.a. from half of the treated sites, until 38 
weeks post-therapy. The authors concluded that the
tetracycline should be continued for 3 weeks. Kornman and 
Robertson (1985) reported that in patients with LJP, 
scaling plus tetracycline given in 250 mg doses of 4 times 
a day for 4 weeks, was more successful than scaling alone 
in sites in which A.a. was detected. Mandell et al., 
(1986) used 100 mg doxycycline a day for 2 weeks. It was 
reported that until 10 months after therapy the
combination of doxycycline and scaling was more 
successfull in arresting the attachment loss than 
doxycycline alone. Mandell and Socransky (1988) reported 
that the combination of surgery and doxycycline therapy of 
100 mg daily for 14 days was successful in elimination of
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A. a. from the sites of 6 out of 8 patients with LJP after 
1 year. Although these studies suggest a beneficial role 
for tetracyclines in the treatment of LJP, there are 
reports in the literature that indicate that mechanical 
therapy alone is successful in treating LJP lesions 
(Waerhaug, 1977; Christersson et al., 1985; Saxen et al., 
1986) .
There are a number of reports indicative of the efficacy 
of the tetracycline family as adjuncts to mechanical 
therapy for adult periodontitis (Lindhe, Liljenberg and 
Adielsson, 1983; Haffajee, Dzink and Socransky, 1988; 
Papli and Lewis, 1989). Furthermore, some investigators 
reported success after the use of tetracyclines for 
refractory periodontitis (Slots et al., 1979; Rams and 
Keys, 1983; Rams et al., 1985; McCulloch et al., 1990). 
On the other hand, Listgarten, Lindhe and Hellden (1978), 
Hellden, Listgarten and Lindhe (1979) and Scopp et al. 
(1980) found no advantage in using adjunctive tetracycline 
or tetracycline alone. Ciancio et al. (1982) found that 
adjunctive minocycline brought no advantage over scaling 
alone in reducing the pocket depth although the gingival 
inflammation was improved more favourably after the 
combination therapy. In a series of animal studies, 
Williams et al. (1981a), and Williams, Jeffcoat and 
Goldhaber (1982) reported that long-term treatment with 
low dosage tetracycline reduced the rate of bone loss in 
the experimental group, although their data indicated that
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18 months after the start of treatment, a trend towards 
baseline was observed in the rate of bone loss. Kornman 
and Karl (1982) reported that 250 mg tetracycline per day 
was effective in treating refractory periodontitis 
lesions. The tetracycline reduced the suspected 
periodontal pathogens, although the levels of tetracycline 
resistant bacteria were increased. However, following the 
cessation of tetracycline the disease recurred. Lindhe, 
Liljenberg and Adielsson (1983) reported that long term 
tetracycline was more beneficial than scaling alone in 
reducing pocket depth, attachment loss, and bleeding on 
probing. Tetracycline at a dosage of 250 mg 4 times a day 
was given for 2 weeks, followed by 250 mg once a day for 
the rest of the 12 month period of the study. While the 
published data regarding the effect of long term and low 
dose tetracycline is not yet sufficient to prove its 
efficacy with certainty, this approach should be looked at 
with great care because of the risk of bacterial 
resistance which is relevant to the long-term and low- 
dosage use of wide spectrum antibiotics such as the 
tetracyclines. Animal studies indicated that long-term 
use of tetracycline changed the subgingival microflora to 
one more resistant to tetracycline (Williams et al., 1979; 
Williams et al., 1981b). Although currently,
tetracyclines are not usually used in medicine for 
dangerous and life threatening infections and therefore 
tetracycline resistance would not be as important, the 
plasmid associated bacterial resistance, if developed to
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one antibiotic e.g. tetracycline, will usually also 
promote resistance to a large number of similar
antibiotics. In periodontal pocket, antibiotic resistance 
may occur in A.a. and C.consicus upon continued exposure 
to subinhibitory concentrations of the antibiotic 
(O'Connor, Newman and Wilson, 1990). When a systemic 
antibiotic such as tetracycline is used, theoretically, a 
systemic serum level, effective against susceptible
strains is achieved at the site of infection. However, it 
could be argued that some bacteria from the pocket (such 
as Eikenella Corrodens, and Selenomonas Sputigena) may not 
be entirely inhibited by systemic levels of tetracycline, 
and may develop and transmit tetracycline resistance to 
other species.
On the other hand, if a local antibiotic is used, it could 
be assumed that the periphery of the treated area may 
receive an antibiotic concentrations below the effective 
levels. Unless the topical treatment can provide a high 
concentration of antibiotic, which covers the entire 
infected area, the chance of development of antibiotic 
resistance exists. In case of periodontal therapy using 
topical agents, this may occur if the topical agent fails 
to reach the most apical plaque front or it reaches there 
only at sublethal concentrations. Furthermore, if the
topical treatment is going to be repeated, the 
substantivity of the system should sustain an antibiotic 
level above the inhibitory levels during the interval
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between two applications. It has been reported that both 
locally delivered and systemically administered 
minocycline in periodontal tissues, produce a transient 
increase in the proportion of minocycline resistant 
bacteria. However, for both types of treatment, after a 
few weeks these proportions returned to pre-treatment 
values (Preus et al. 1995).
Some important side effects of tetracycline include 
discoloration of developing teeth in children, nausea, 
vomiting, diarrhoea, erythema, dizziness and vertigo 
(minocycline) , headache and visual disturbances (may be 
indicative of benign intracranial hypertension), severe 
exfoliative rashes (minocycline), liver damage, 
photosensitivity and pseudomembranous colitis. 
Tetracyclines should not be prescribed for children under 
12 years of age because of the risk of tetracycline 
staining of the teeth. Other contra-indications include 
severe renal impairment (only tetracycline), pregnancy and 
systemic lupus erythematous and porphyria (doxycycline). 
In the case of breast-feeding, hepatic and severe renal 
impairment, tetracycline should be administered cautiously 
(British National Formulary, 1994). The absorption of 
tetracyclines is inhibited by a number of drugs such as 
antacids, angiotensin-converting enzyme inhibitors, ulcer 
healing drugs, zinc salts and iron salts. In the presence 
of tetracyclines the effect of cyclosporins and 
anticoagulants are increased. On the other hand, the
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efficacy of oral contraceptives and antiepileptic drugs 
are reduced if used concurrently with tetracyclines 
(British National Formulary, 1994).
1.7.3 Metronidazole
Metronidazole achieves a gingival crevicular fluid 
concentration of 14 pg/ml following multiple oral doses 
Giedrys-Leeper, Selipsky and Williams (1985). This level 
has been reported to be inhibitory for anaerobic 
periodontal micro-organisms in vitro (Sutter, Jones and 
Ghoniem, 1983; Baker et al., 1985; Walker et al., 1985; 
Newman et al., 1979). Hydroxy metabolites of
metronidazole have been reported to increase its efficacy 
against facultative organisms in vivo (Jousimies-Somer et 
al., 1988). However, the presence of Fusobacterium 
nucleatum was reported to protect other micro-organisms 
against this antibiotic (Lacroix and Mayrand, 1989). The 
inhibition of A.a. and Capnocytophaga spp. and Eubacterium 
spp. and Eikenella corrodens by metronidazole requires 
higher concentrations than those achieved in GCF. 
Metronidazole has been reported to be successful in the 
treatment of acute ulcerative gingivitis (Duckworth et 
al., 1966). However, the reports regarding its efficacy 
on adult periodontitis |ar  ^ equivocal. Combination of 
surgery with metronidazole (| 2 00 mg 4 times a day, for 7 
days) was reported to have no clinical and microbiological 
benefit over surgery alone (Mahmood and Dolby, 1987). 
Despite a short lived benefit, there was no long lasting
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advantage of using systemic metronidazole in periodontal 
patients (Joyston-Bechal, Smales and Duckworth, 1984 and 
1986). Clark et al., (1983) found no advantage in the use 
of adjunctive metronidazole in the treatment of mentally 
retarded periodontal patients. Sterry, Langeroudi and 
Dolby (1985), Giedrys-Leeper, Selipsky and Williams
(1985), Jenkins et al. (1989) and Walsh et al. (1986) also 
reported similar negative results. On the other hand, 
some authors reported that systemic metronidazole could be 
beneficial as an adjunct (Loesche et al., 1981; Lundstrom, 
Johansson and Hamp, 1984; Loesche et al., 1984) or the 
sole treatment (Watts, Palmer and Floyd 1986; van Oosten, 
Mikx and Renggli, 1987) of periodontal disease. The 
combination of metronidazole with spiramycin has been 
reported as an effective adjunct to root planing (Chin 
Quee et al., 1987).
Important side effects of metronidazole include nausea, 
vomiting, unpleasant taste, gastero-intestinal
disturbances, rashes, urticaria and angioedema, drowsiness 
(rarely), headache, dizziness, ataxia, darkening of urine, 
peripheral neuropathy (in prolonged and intensive 
treatment), transient epileptiform seizures and leucopenia 
(British National Formulary, 1994). During pregnancy and 
breast-feeding it should be prescribed with caution. 
Disulfiram-like reactions may occur if it is used with 
alcohol (British National Formulary, 1994) . Other drug 
interactions include enhancement of the effect of
42
anticoagulants, increased serum concentration of 
phenytoin, fluorouracil and lithium by metronidazole and 
decreased metronidazole serum concentration by cimetidine 
and phenobarbitone (British National Formulary, 1994).
1.7.4 Other antibiotics
Penicillin^, due to the presence of beta-lactamase
producing micro-organisms in the subgingival flora
(Kinder, Holt and Kornman, 1986; Valdes, Lobbins and 
Slots, 1982) are not effective against periodontal micro­
organisms in vivo (Walker et al., 1987). In vitro,
penicillins are effective against most subgingival 
bacteria but A.a. (Slots et al., 1980). The combination 
of clavulanic acid and amoxicillin i.e. augmentin has been 
reported to have some efficacy (Magnusson et al., 1989). 
Clavulanic acid has a beta-lactam ring which competitively 
binds to beta-lactamase and inactivates it. A combination 
of amoxycillin with metronidazole has been reported to be 
beneficial in the treatment of periodontal lesions and the 
eradication of A.a. in patients who did not respond to the 
adjunctive treatment by tetracycline (van Winkelhoff et 
al., 1989; van Winkelhoff, Tijhof and de Graaff, 1992; 
Pavicic et al., 1994) or minocycline (Goene et al., 1990).
Clindamycin (150 mg tablets, 4 times a day) was used 
successfully as an adjunct in refractory periodontitis 
patients who had subgingival flora susceptible to 
clindamycin (Gordon et al., 1985; Gordon et al., 1990;
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Walker and Gordon, 1990). This antibiotic should be used 
very cautiously since it may lead to the complex side 
effect of pseudomembranous colitis (British National 
Formulary, 1994).
1.7.5 Concluding remarks from the systemic antibiotic 
therapy
In considering the efficacy of a systemic antibiotic for 
periodontal lesions, 2 factors should be considered; the 
concentration of the antibiotic in the gingival crevicular 
fluid and the MIC90 of the antibiotic for suspected 
periodontal pathogens. When a local, drug delivery system 
is to be used, an additional factor should be taken into 
account; substantivity. The GCF concentration of most 
antibiotics following systemic administration has been 
determined (Ciancio et al., 1980; Walker et al., 1981b;
Gordon et al., 1981; Ciancio et al., 1982; Giedrys-Leppers 
et al., 1985; Britt and Pohlod, 1986; Pascale et al., 
1986; van Oosten, Notten and Mikx, 1986) . The MIC90 of 
most antibiotics against suspected periodontal pathogens 
in vitro has also been measured (Slots et al., 1980;
Sutter, Jones and Ghoniem, 1983; Walker et al., 1985;
Baker et al., 1985; Miyake et al., 1988). These studies 
indicate that most antibiotics appear in the GCF at higher 
levels than the MIC90 values for P. gingivalis and W. recta 
and Capnocytophaga; however, none of them are effective
against E. Corrodens at these levels. Interestingly, even 
the use of a commonly used combination of 2 antibiotics,
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metronidazole and amoxlycillin, does not seem to inhibit
this micro-organism. Only metronidazole can inhibit 
Peptostreptococcus. Metronidazole and to some extent 
clindamycin are effective against Selenomonas sputigena. 
Fusobacterium is susceptible to tetracycline, doxycycline, 
clindamycin and metronidazole. P. intermedia is
susceptible to most of the commonly used antibiotics with 
the exception of erythromycin. Finally, the tetracycline 
family are the only antibiotics which inhibit A .
actinomycetemcomitans, although the combination of 
metronidazole and amoxycillin has also been used 
successfully against this micro-organism (van Winkelhof et 
al., 1992). It has been suggested that to inhibit a 
pathogen only antibiotics which achieve in vivo 
concentrations of at least 4 times their MIC values for
that micro-organism should be selected (Bryan, 1982). It
appears that no single antibiotic or combination of 2 
antibiotics are effective against all suspected
periodontal pathogens if used systemically.
1.8 Locally delivered antimicrobial systems
1.8.1 Introduction
The concept of delivering drugs directly to the site of 
action has attracted continuous attention from 
investigators in pharmaceutical research. Controlled
local drug delivery systems are advantageous compared with 
systemic administration in a number of ways: 1) The
patient's compliance plays a minor role in the treatment
45
outcome, if the drug is administered professionally to the 
site of action. 2) The total amount of the drug taken is 
usually reduced by several times, reducing the risk of 
systemic adverse effects. 3) Oral systemic drugs are 
absorbed in the gastrointestinal tract and the rate of 
absorption of some drugs may be influenced by the quality 
of foods taken at the time of drug administration. This 
may result in variations in the amount of drug uptake 
between and within individuals because of dietary habits. 
This problem can be eliminated if the drug is delivered 
locally to the site of action.
On the other hand, local drug delivery systems may have 
some potential disadvantages and limitations: 1) If the
drug is carried in a polymer substance, the polymer should 
be neither toxic nor allergic to the host tissues. 
Moreover, biodegradable matrices will be transformed to 
one or more by-products. The biocompatibility of such by­
products is a precondition for the use of any local drug 
system. Nevertheless, allergic reactions may occur. 2) 
The placement of drug release systems usually needs 
professional intervention and may be painful for patients 
and require other procedures such as local anaesthesia.
3) A number of systems such as some of those for the 
treatment of periodontal disease may need special care and 
attention by the patient, for their in situ retention 
during the treatment period. In such cases, as with
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systemic drug therapy, the patient compliance is important 
for the achievement of therapeutic goals.
1.8.2 Terminology
The term 'local delivery1 implies that the drug is used 
locally, but this does not necessarily mean that the drug 
is retained and released in a sustained manner by a 
controlled mechanism. Without such a mechanism, the drug 
would be washed rapidly out of the pocket or any specific 
site of action. The term 'controlled delivery' (also 
called 'controlled release', 'sustained release', 'timed 
release' and 'slow release') implies that a controlled 
mechanism exists to increase the bio-availability and 
substantivity of the drug. These systems are not 
necessarily applied locally. Controlled release 
formulations delivered systemically may be used in order 
to cause delay until the drug has reached the appropriate 
site (e.g., coated enteric aspirins formulated to dissolve 
in the small intestine, preventing gastric erosion), or to 
prolong the duration of action of a short acting drug such 
as nifedipine (Grahame-Smith and Aronson, 1992). The term 
'topical' is normally used to describe the application of 
the drug to an 'exposed area' of the body, with an example 
being fluoride therapy in the supragingival environment 
(Kornman, 1993).
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1.8.3 Classification
Some local delivery systems used in periodontal pockets 
may be a simple solution or a gel whose only task is to 
carry the drug into the pocket. There is no reservoir in 
these systems to increase the substantivity of the drug. 
Therefore, the drug diffuses into the tissues by its 
concentration gradient alone and is then cleared away. In 
some systems, a substance usually a polymer, may be used 
to act as a reservoir. Kornman (1993) classified the 
delivery systems used to release the drug in a sustained 
mode as: 1) monolithic devices; 2) polymer membranes; 3) 
erodible polymeric matrices, and 4) drug particles with 
erodible coating. In monolithic devices the drug is 
dispersed in a solid polymer such as acrylic resin. In 
membrane (reservoir) systems a core of drug is surrounded 
by a polymer film, e.g. dialysis tubing. In bio-erodible 
systems the drug is distributed in an erodible polymer 
which is amenable to enzymatic or hydrolytic cleavage, and 
as a result, the drug is released. Delivery of coated 
particles involves the coating of drug granules with a 
lipid in varying thickness. The coat thickness of each 
granule dictates its solution rate. Therefore a mixture 
of granules with coatings of varying thickness will act as 
a sustained release system. Similar classifications have 
been suggested by Langer and Peppas (1981), Brook and van 
Noort (1984), Needleman (1991) and Fiorellini and Paquette 
(1992) .
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1.8.4 Kinetics of the release
In membrane devices, the rate of release is determined by 
the Fick's law (Langer and Peppas, 1981; Parker, 1983) and 
is a function of the permeability of the membrane to the 
drug, the difference between the concentration of the drug 
in the receiving fluid and saturation concentration of the 
drug inside the membrane. As long as the drug is
maintained at a saturated concentration in the device, the 
delivery follows zero-order kinetics, that is, the
concentration of the drug is independent of the amount of 
the drug under process. As the core becomes unsaturated, 
the release falls exponentially and follows first-order 
kinetics. In first-order delivery, the speed of release 
at any given time (release rate) is dependent on the 
concentration of the drug inside the membrane at that
time. While in zero-order delivery, the plot of the 
concentration in the receiving fluid against time is
linear, in first-order release, the plot of the logarithm 
of the drug concentration against time is linear i.e., the 
higher the concentration inside the membrane, the faster 
it falls (Grahame-Smith and Aronson, 1992) .
In matrix controlled systems (e.g., monolithic devices), 
the amount of drug released per unit area of exposed 
surface of the matrix after a given time depends on the 
diffusibility of the drug in the GCF, the solubility of 
the drug in the GCF, the porosity of the matrix, the
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initial concentration of the drug in the matrix, and the 
tortuosity of the matrix (Higuchi, 1963).
In drug suspensions within an ointment base, the rate of 
release from the base is dependant on the concentration of 
the drug in the base, the solubility of the drug in the 
base, the diffusibility of the drug molecules in the base 
and the time of exposure (Higuchi, 1961). The final drug 
release will depend, in addition to the above factors, on 
the clearance of the ointment vehicle.
1.8.5 A literature review of local drug delivery
systems in the treatment of periodontal disease
1.8.5.1 Hollow fibres
Goodson, Haffajee and Socransky (1979) developed a drug 
delivery system which consisted of hollow fibres made of 
cellulose acetate and filled with tetracycline. Each 
centimetre of fibre had a volume of 0.3 |im3 which was 
filled with a 20% solution of tetracycline. When the 
fibres were placed in periodontal pockets for 24 hours, 
the half life of drug levels measured by spectrophotometry 
in the GCF was found to be 30 mins. In other words 95% of 
the drug was released over the first 2 hours. However, 
there was still a concentration of 15 |ig/ml detectable 
after 24 hours. Lindhe et al. (1979) compared the 
efficacy of the system as the sole treatment with both a 
positive root planing alone control and a negative or 
untreated control. Both treatments were repeated at day
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28. At each treatment the fibres were left for 2 days. 
The reduction in pocket depth at day 37 was 2.3 mm for 
root planed sites compared to 1.3 mm in fibre treated 
sites. A significant reduction in the proportion of
motile rods and spirochetes was reported in the test 
group. Hollow fibres have also been investigated by
another group. Addy et al. (1982) used hollow dialysis 
tubes containing 20% chlorhexidine in vitro and reported 
that 95% of the drug was released into water during the
first 24 hours. After 3 days the concentration was < 1
(ig/ml. Sealing the 2 ends of the tubings did not change 
the release rate significantly. Coventry and Newman
(1982), used tubes filled with 20% chlorhexidine in the 
periodontal pockets of 11 patients, and reported a marked 
reduction in bleeding on probing and crevicular fluid flow 
after 7 days. Later, Khoo and Newman (1983) used dialysis 
tubing containing 0.5% metronidazole in a parallel design 
study. Three groups of patients received either 
metronidazole tubings or acrylic strips containing 40% 
metronidazole or subgingival irrigation using 0.2% 
chlorhexidine as adjuncts to root planing. Tubings and 
strips were replaced every 7 days for a total period of 28 
days. Irrigation was performed by the patients once daily 
for the same period. Control sites from the same patients 
received only scaling and root planing. Plaque samples 
showed that metronidazole tubings and the metronidazole 
strips both reduced the proportion of spirochaetes. The 
effect of chlorhexidine irrigation was significantly less
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than the other 2 treatments. Root planing alone had the 
least effect. The clinical effect of treatment by 
metronidazole tubes or chlorhexidine subgingival 
irrigation were further compared by wan Yusof et al. 
(1984), where 4 weekly applications of tubes or once daily 
irrigations for 28 days were performed for each patient as 
adjuncts to root planing. At day 84, the pocket depth 
reductions were 1.6 and 1.1 mm for tubing and irrigation 
groups respectively. The results of this study should be 
interpreted cautiously because no control groups were used 
in the study.
1.8.5.2 Acrylic strips
Addy et al. (1982) described the development of 
polymethyl-methacrylate strips containing various
concentrations of chlorhexidine acetate or 40% 
tetracycline or metronidazole. The in vitro release of the 
above mentioned substances from the strips were assessed 
in vitro spectrophotometrically. It was reported that 
both tetracycline and metronidazole strips as well as 30% 
to 50% chlorhexidine strips continued to release the
substance for up to 14 days. However, after initially 
releasing a high concentration on day 1, a marked fall in
release was observed on day 2 with a progressive fall
thereafter. Addy, Alam and Rawle (1984) used acrylic 
strips containing 40% tetracycline in deep periodontal 
pockets for 2 to 3 days. The proportions of motile
organisms and Gram negative rods were reduced. An initial
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reduction in pocket depth was reported in sites treated 
using metronidazole or tetracycline strips but after 3 
months a return toward baseline was observed in the 
tetracycline group (Addy, Langeroudi and Hassan, 1985). 
Addy et al. (1988) in a 3 month parallel design clinical 
study compared the efficacy of acrylic strips filled with 
either metronidazole, tetracycline or chlorhexidine as the 
sole therapy with scaling and root planing alone. After 
14 weeks the metronidazole strips and scaling alone had 
been more effective in improving the clinical parameters 
than the other 2 treatments. Wade et al. (1992) reported 
that the placement of acrylic strips impregnated with 
tetracycline resulted in an increase in the proportion of 
tetracycline resistant bacteria in the treated sites. In 
Other groups using chlorhexidine or metronidazole strips 
or root planing, no such effect was noticed.
1.8.5.3 Ethyl cellulose films
Ethyl cellulose is another substance which has been 
extensively investigated for its potential to act as a 
sustained release system in periodontal pockets. In a 
study by Friedman and Golomb (1982), chloroform or ethanol 
was used to dissolve the ethyl cellulose polymer and allow 
the chlorhexidine to become incorporated into its 
structure. In addition, polyethylene glycol was used to 
modify the release rate. Within 10 days, 95% of the 
chlorhexidine was released in vitro. Soskolne et al.
(1983) reported that 60% of the drug was released within 6
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days in vivo. However, bacteriological sampling indicated 
that, following a transient reduction, the level of 
spirochaetes returned to baseline values after 2 weeks. 
Golomb et al. (1984) incorporated 30% metronidazole in the 
ethyl cellulose films. More than 70% of the drug content 
was released into water in vitro during the first 24 
hours. The in vivo kinetics was found to be similar to 
the in vitro release into water. Stabholz et al. (1986) 
used the ethyl cellulose films containing chlorhexidine 
for 3 consecutive applications, each for 3 days. Until
the end of the 11 week period of the study, pocket depth
and bleeding on probing, as well as microbiological
parameters were reported to be markedly reduced. Stabholz 
et al. (1991) used this system for patients who still had 
pockets > 5 mm, 2 months after root planing. They used a 
split mouth design whereby the contralateral quadrants 
received routine maintenance therapy. The test treatment
included 3 applications of ethyl cellulose films 
containing chlorhexidine which were replaced every 3 days 
without any adjunctive root planing. Both treatments were 
repeated every 3 months for a total period of 2 years. 
The best results in both groups were observed at the 6 and 
the 9 month visits with an average pocket depth reduction 
of 2.3 mm in the test group versus 1 mm reduction in the 
control group. Surprisingly, the amount of attachment 
gain was also 2.3 mm indicating that there was pure 
attachment gain and no recession. This system, whilst
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promising, involves 3 visits every 3 months, a regime 
which normal patients find difficult to comply with.
1.8.5.4 Collagen films
Minabe et al. (1989a) described the development of a local 
drug delivery system consisting of collagen films and 
tetracycline. Atelocollagen was dissolved in water and 
basic tetracycline was added plus HC1 to adjust the 
acidity. Acetone plus glutharaldehyde saturated with 
tetracycline was added to the first preparation to induce 
cross linkage in the molecular structure. The dried 
product was cut into strips. Analysis of GCF showed that
until day 10, tetracycline concentration was above the MIC
\
of tetracycline for the anaerobic bacteria. The authors 
reported that the prolonged release action was due to 
tetracycline being incorporated into the cross linkage of 
the polymer. However, a treatment regime consisting of 
four weekly applications of the tetracycline collagen 
films produced only transient improvements in clinical and 
microbiological outcomes (Minabe et al. 1989b; Minabe et 
al., 1989c). A relatively short lived response to the 
treatment in the above mentioned studies is not 
surprising, and most probably is due to the absence of 
scaling in the study design and the calculus being left 
intact. Realising this concept, Minabe et al. (1991) 
performed a clinical study of treatment of periodontal 
furcation lesions. A split mouth design was implemented 
with the treatment groups including: scaling and root
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planing alone, insertion of tetracycline collagen films 
alone, once a week for 4 weeks, root planing plus collagen 
films and untreated controls. After 8 weeks, in the 
scaling alone group, Ial5% reduction in bleeding on probing 
took place together with a 2 mm reduction in pocket depth 
and a 1.1 mm attachment gain. The result of combination 
therapy was reported to be an 80% reduction in bleeding on 
probing, a 2.7 mm reduction in pocket depth and a 2 mm 
attachment gain. Although the results of this study 
indicate a positive outcome in the short term, the 
evidence of long lasting results is lacking. Moreover, 
the treatment had the disadvantage of several applications 
being necessary.
1.8.5.5 Monolithic fibres
In 1983 Goodson et al. evaluated the physical behaviourj 
of 6 polymers as vehicles to carry tetracycline and slowly 
release it into gingival fluid. The materials included 
polyethylene, polypropylene, polycaprolactone,
polyurethane, cellulose acetate propionate and ethylene 
vinyl acetate. The polymers were melted, mixed with 25% 
tetracycline, spun, extruded and cooled to form 
cylindrical and monolithic fibres with a diameter of 0.5 
mm and containing 322 \ig tetracycline/cm. In vitro and in 
vivo studies showed that all the polymers except for 
ethylene vinyl acetate (EVA) released their tetracycline 
content either too fast or too slowly. Ethylene vinyl 
acetate maintained its release until 9 days with an
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initial concentration of about 600 |ig/ml and a half life 
of 13 hours. Later, Goodson et al. (1985a) reported a 
sustained concentration of 600 |ig/ml throughout the 10 day 
period of the study. This report, in contrast to the 
previous findings of Goodson et al. (1983), indicated that 
the half life was infinite, at least during the 10 day 
period of the study i.e. a zero-order delivery occurred. 
The zero-order kinetics of the monolithic tetracycline 
fibres was later confirmed by Tonetti, Cugini and Goodson 
(1990) , but a sustained GCF concentration of 1590 (ig/ml 
was reported this time, which was more than 2.5 times the 
level of the previous report. Using scanning electron 
microscopy (SEM) they described the presence of the 
tetracycline crystallites on the surface of the carrier 
matrix. Four hours after exposure of the fibres to the 
water, the superficial crystallites were no longer present 
leaving behind narrow channels and niches. The physical 
principles of the rate of release of solid drug dispersed 
in solid matrices has been described several years ago 
(Higuchi, 1963). Once the fibre is placed in the 
subgingival area, the superficial crystallites dissolve 
quickly by simple diffusion. Thereafter, the dissolution 
takes place through narrow channels created and 
progressively elongated by the dissolution of more 
superficial crystallites. This progressive elongation 
causes the solubilisation front i.e. the surface area of 
the drugs under process to remain constantly low. 
Obviously the establishment of such a tortuous structure
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depends on the connectivity of the drug crystallites,
which in turn results from the melted matrix being
impermeable to the drug. After fibre removal, the
concentration of the drug decreases exponentially with a 
half life of 4.5 hours (Tonetti et al., 1990). The drug 
concentration remained above 50 jxg/ml for a total period 
of 11 days. The corresponding time period for 1% and 10% 
tetracycline solutions were 21 hours and 66 hours 
respectively when used to irrigate the pockets (Tonetti et 
al., 1990).
Goodson et al. (1985b) reported a treatment consisting of 
root planing plus tetracycline fibres for adult
periodontitis patients, to be superior to root planing 
alone, and there was approximately 1 mm attachment gain 
after 6 months. It has been reported that the tetracycline 
released from the monolithic fibres could penetrate from 
l-20|im into the soft tissue wall (Ciancio, Cobb and Leung, 
1992) and up to 10 |xm into the cementum and dentinal 
tubules (Morrison et al., 1992). The presence of bacteria 
in the dentinal tubules of the radicular dentine and the 
soft tissues of the pocket has been reported in the 
literature. These micro-organisms might be responsible 
for disease recurrence after mechanical therapy. However 
it is not clear whether a slight penetration of 
tetracycline into the soft and hard tissues could inhibit 
such invading bacteria. In fact the study of Mandel et al.
(1986) suggested that tetracycline fibres failed to
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inhibit A.a.r a micro-organism reportedly capable of 
invading the soft tissues in LJP lesions. They reported 
that monolithic tetracycline fibres when used as the sole 
treatment of the juvenile periodontitis lesions, failed to 
prevent further attachment loss and eradicate A.a. The 
percentage of A.a. positive sites was increased. These 
sites were then successfully treated using surgery plus 
systemic doxycycline therapy for 14 days. Goodson et al. 
(1985b) reported that scaling alone produced less 
reduction in the motile and spirochaete counts as compared 
to treatment with monolithic tetracycline fibres. The 
clinical and microbiological effects of tetracycline 
fibres were further investigated by Goodson et al. 
(1991a,b,c) in a multi-centre trial. Using a split mouth 
design, 107 patients in 5 centres were treated and 
monitored for a period of 60 days. One site in each
quadrant was selected and treated. Treatments consisted 
of scaling and root planing alone, placement of monolithic 
tetracycline fibres for 10 days and placement of placebo 
fibres. One quadrant remained untreated. Ten days prior 
to the baseline, all the sites were treated by supra- 
gingival scaling. Measurements included microbiological 
sampling and recording of pocket depth, attachment levels 
and bleeding on probing. Tetracycline fibre therapy was 
reported to be significantly superior to the other 
treatments. A rather large change in the 2 placebo and 
untreated groups was observed and attributed to all the 
sites being supra-gingivally instrumented before the
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baseline. Microbiological monitoring of sites using DNA 
probes at days 0 and 10 showed that both the scaling and 
tetracycline fibre groups equally, and significantly, 
reduced the proportion of periodontal pathogens (Goodson 
et al., 1991c; Maiden et al., 1991). Goodson and Tanner
(1992) reported that the observed increase in the levels 
of tetracycline resistant bacteria was not due to 
development of plasmid mediated multiple antibiotic 
resistance, but simply due to an increase in the 
proportion of gram positive cocci.
Rapley et al. (1992) reported that after the tetracycline 
fibre treatment of at least 8 teeth per patient, the serum 
levels of tetracycline did not exceed 0.1 ng/ml. They 
reported no serious adverse effects associated with the 
treatment. The use of tetracycline fibres as an adjunct 
to root planing was investigated by Heijl et al. (1991). 
Using a 4 quadrant split mouth design the combination of 
root planing with tetracycline fibre therapy was reported 
to be superior to either of the sole treatments, although 
not significantly. Bacterial sampling of the sites 
confirmed the clinical findings. Newman et al. (1994) 
conducted a multi-centre trial on the efficacy of 
tetracycline fibres as adjunct to root planing on a 
maintenance population. After 6 months, the improvement 
in the clinical parameters of patients who received 
scaling plus tetracycline fibres was significantly higher 
than those treated by scaling alone.
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1.8.5.6 Supragingivally applied anti-plague agents
Chlorhexidine, quaternary ammonium compounds such as cetyl 
pyridinum chloride, phenolic compounds such as triclosan, 
flourides, oxygenating agents, metallic ions such as zinc, 
copper and tin, and enzymes such as amyloglucosidase and 
glucosoxidase have been used in oral rinse and tooth paste 
formulations. Since the efficacy of chlorhexidine in 
plaque control was first demonstrated by Loe and Schiott 
(1970), it is still perhaps the most effective anti-plaque 
agent for oral use. Chlorhexidine is a dicationic 
molecule which can bind onto the oral surfaces, while 
still retaining its bacteriostatic activity. This 
property permits chlorhexidine to retain bacteriostatic 
levels for prolonged periods following application (Rolla 
and Melson, 1975). Oral rinse or supragingival irrigation 
of the gingival margin are not effective ways of 
delivering the irrigants into the pocket (Pitcher, Newman 
and Strahan, 1980; Braun and Ciancio, 1992).
1.8•5.7 Subgingival irrigation
Many studies have been conducted to test the efficacy of 
irrigation of periodontal pockets using antibacterial 
solutions. It is beyond the scope of this thesis to review 
in detail the effect of irrigation on periodontal disease. 
In general, the effect of irrigation as an adjunct to 
conventional therapy has produced transient or 
unremarkable results (Jolkovsky et al., 1990; Lander et 
al., 1986; Wennstrom et al., 1987; Rosling et al., 1986).
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The results of studies on the penetration of the irrigant 
by subgingival irrigation devices are not consistent. 
However, most studies demonstrated that with irrigation 
therapy the antibacterial agent fails to reach the plaque 
front completely (Pitcher, Newman and Strahan, 1980; 
Eakle, Ford and Boyd, 1986; Silverstein et al., 1988; 
Braun and Ciancio, 1992; Boyd, Hollander and Eakle, 1992). 
Antibacterial solutions with high substantivity such as 
tetracycline, in spite of lack of complete penetration, 
could be absorbed into the cementum surface and released 
over time, and so eventually reach the plaque front 
through diffusion into the deeper area of the pocket 
(Stabholz et al. 1993a). Positive results reported by 
some authors who tested this approach supports this theory 
(Christersson, Norderyd and Puchalsky 1993). 
Chlorhexidine, while effective against most subgingival 
organisms in vitro, has less efficacy in vivo, presumably 
due to the absorption by serum proteins in the GCF 
(Hjelford, Rolla and Bonesvoll, 1973), and poor absorption 
of chlorhexidine in deeper layers of plaque.
1.8.5.8 Biodegradable systems and gels (metronidazole 
gel, minocycline gel and other resorbable 
systems)
The main advantage of locally applied gels used as a 
controlled delivery mechanism is their relatively easy 
application and the lack of any need for professional 
removal of the vehicle. Nevertheless, the use of
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antibacterial agents in the form of gels as local delivery 
systems will not necessarily increase the substantivity of 
the drug. Unless the drug itself is a substantive 
material in the subgingival environment or the gel vehicle 
actively contributes to the retention of the drug, the 
drug will simply be washed out. A gel with sufficient 
flow to be syringeable into the pocket is quickly cleared 
from the area. Oosterwaal, Mil^ x and Reaggli (1990) 
reported that when a fluorescein gel was injected into the 
pocket, 50% of it was cleared during the first 12 minutes.
Metronidazole gel: In 1992 Norling et al. introduced a
drug formulation for use in periodontal pockets which 
consisted of 25% metronidazole carried in a vehicle gel. 
The drug is a mixture of sesame oil, glycerol mono-oleate 
(GMO) and metronidazole benzoate. The vehicle materials 
are polar lipids, which are insoluble, but swell in water. 
Contact with water results in the formation of a reverse 
hexagonal form. In this form, the channels for the 
passage of water are closed, resulting in the retardation 
of the solubility of the metronidazole benzoate. When the 
mixture comes into contact with water, the metronidazole 
benzoate on the surface dissolves immediately. As the 
hydration progresses, the remaining metronidazole-free 
vehicle (sol) on the outer surface gradually turns into 
the reverse hexagonal state (gel) which controls 
metronidazole release from within. Stolze and Stellfeld 
(1992) reported that the systemic absorption of
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metronidazole after application of the gel in an average 
of 10 periodontal pockets per patient, was lower than that 
of a single dose of one 250 mg metronidazole tablet. The 
excess amount of gel which is normally swallowed was 
reported to be 60% of the total amount applied. After the 
application of the gel, there is a rapid decrease in GCF 
concentration of the drug after 4 hours (Stoltze, 1992). 
The relatively rapid fall in GCF levels of metronidazole 
after gel application indicates that the system lacks the 
substantivity, even if its concentration in the GCF passes 
the MIC thresholds at the very early stages of treatment 
as reported by Stoltze (1992) . Moreover, it was reported 
that after 24 hours, 50% of the sites still showed 
metronidazole levels greater than 1 (ag/ml (Stoltze 1992) . 
However, care should be taken when interpreting this data. 
Five cartridges were used for each patient, i.e. 1.25 g 
metronidazole per patient. After systemic administration 
of 250 mg of metronidazole a peak plasma concentration of 
5 ng/ml is observed. This is usually seen 4 hours after 
administration. Therefore with a plasma half life of 8 
hours (Neidle, Kroeger and Yagiela, 1985), the serum 
concentration, which is equal to the GCF levels of the 
metronidazole, 24 hours after application of 5 cartridges 
is expected to exceed 3 |ig/ml. Therefore even if no 
controlled release action exists and only systemic 
absorption via direct absorption and swallowing occurs, 
the observation after 24 hours of 50% of sites showing 
levels higher than 1 fig/ml is quite expected. These data
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indicate that sustained release action in the 
metronidazole gel system is minor if there is any at all. 
After the proof of efficacy of metronidazole as a local 
drug using a ligature L induced periodontitis model in 
beagle dogs, (Klinge et al., 1992a), Klinge et al. (1992b) 
evaluated the metronidazole delivery system using varying 
concentrations of metronidazole and varying treatment 
regimes. They reported that the best outcome is achieved 
if it is used at 25% concentration, once a week for 2 
weeks. Metronidazole gel formulation is now commercially 
available as disposable ’intraligamentous type' injection 
syringes containing 1 g of gel which is injected into the 
pocket using a blunt needle (Elyzol, Dumex, Copenhagen, 
Denmark). Pedrazzoli, Kilian and Karring (1992) compared 
the clinical and microbiological effects of 25% 
metronidazole gel alone with root planing alone, using a 
split mouth design. Both treatments i.e. gel therapy and 
root planing were reported to be effective in improving 
the baseline parameters. The gel therapy was found a 
little better, although not significantly, than the 
mechanical therapy. However, the data on bleeding on 
probing indicated that a trend of a return towards the 
baseline appeared in both groups at week 12 until the end 
of the 24 week period of the study. Surprisingly, only 
33% of the pockets showed bleeding on probing at baseline. 
The absence of bleeding on probing is one of the most 
reliable indicators of periodontal health (Lang et al., 
1986; Lang et al., 1990). This indicates that the majority
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of sites in the quoted study were probably not 
periodontally diseased. The inclusion of non diseased 
sites in a study of therapeutic modalities for periodontal 
disease will mask any difference between the groups and 
dilute the treatment effect. A similar clinical design 
but on a larger scale was employed by Ainamo et al. (1992) 
who evaluated 206 patients in a 6 month study in 9 
centres. In contrast to the study of Pedrazzoli et al. 
(1992), the scaling was found to be significantly more 
effective than the metronidazole gel. The pocket depth 
reduction was 1.5 mm and 1.3 mm for scaling and gel 
therapy respectively. The authors considered the
difference clinically unimportant. The patients were 
excluded if they had had periodontal treatment other than 
supra-gingival scaling in the past 6 months. It should be 
mentioned that the application of gel or fibre into the 
pocket is virtually impossible if supra-gingival calculus 
is present at the site, thus making supra-gingival scaling 
inevitable. On the other hand, by inclusion of newly 
supra-gingivally scaled patients in the study, one may 
argue that the pocket depths of these patients might 
continue to improve due to the supragingival scaling, 
after they have been measured at baseline. Such a 
phenomenon was reported by Goodson et al. (1991b). While 
such a design would not induce any imbalance in a study 
which utilises an untreated control group (because any 
change due to pre-baseline treatment would be reflected in 
the untreated control too), it could lead to misconclusion
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if there is no untreated control group in the study 
protocol. Another way round this problem would be 
comparing the effect of supra-gingival scaling plus gel 
therapy with supra- plus sub-gingival scaling.
Minocycline gel: A series of studies in Japan were
conducted to develop an antimicrobial ointment for 
periodontal application. A formulation of 2% minocycline 
in lipid was developed as a viscous gel for application by 
the dentist directly into the crevicular space (Satomi et 
al., 1987; Naora et al., 1987; Kurimoto et al., 1987; 
Isoshima et al., 1987; Ishikawa et al., 1988; Ueda et al., 
1988; Kurimoto et al., 1988; Murayama et al., 1988;
Murayama et al., 1991). Briefly, these studies reported 
that: a) due to a wide range of activity and high
substantivity in the GCF, minocycline was the best 
candidate for use as a local antibacterial agent for 
periodontal therapy; b) the systemic concentration 
following the local application of the ointment was 
minimal; c) a single dose of minocycline ointment only had 
a transient effect on the bacterial population which 
returned to baseline values after 2 weeks; d) to obtain a 
clinical improvement, the ointment had to be applied three 
to four times at one or two weekly intervals. There was 
no difference between the outcomes of three fortnightly 
and four weekly applications.
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The persistence of sublethal levels of wide spectrum 
antibiotics such as minocycline in localized sites of the 
body for long periods may predispose those sites to the 
emergence of resistant bacteria (O'Connor, et al., 1990).
However, no difference was observed between systemic and 
locally applied minocycline on their effect of increasing 
the bacterial resistance to minocycline (Preus et al., 
1995). In 1993 van Steenberghe et al. conducted a clinical 
and microbiological study using the 2% minocycline 
ointment as an adjunct to scaling and root planing. A 
total of 103 patients with at least one periodontal pocket 
were included in a parallel design study. One half of the 
patients received scaling and root planing plus 
minocycline ointment, the other half scaling and root 
planing plus a placebo. The gel application was repeated 
at weeks 2, 4 and 6. Measurements were taken at baseline 
and after 2, 4, 6 and 12 weeks. Both clinical and
microbiological measurements were taken. By week 12, mean 
reductions in probing depth of 1.7 mm and 1.4 mm were 
observed, in test and control groups respectively. The 
attachment gain was 0.8 mm for both groups. The bleeding 
indices were 1.2 and 1 respectively. The minocycline gel 
group showed 13% fewer pockets with detectable 
P.gingivalis, P. intermedia and A.actinomycetemcomitans. 
The reduction in pocket depth and the microbiological 
improvements were significantly different between the 2 
groups. Minocycline ointment is now commercially
available (Dentomycin, Cyanamid, Lederle, U.K.). The
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manufacturer's recommendation is 3 or 4 bi-weekly 
applications of the gel after a single scaling and root 
planing. 500 mg ointment containing 2% minocycline is 
loaded in a disposable polypropylene syringe with a 
plastic contra-angle tip. The material is unstable at 
room temperature and should be kept in the refrigerator. 
Preus et al. (1993) reported that the transmission of 
minocycline resistant bacteria between pockets within the 
same mouth was likely, therefore they recommended that 
after application of the ointment into each pocket, the 
syringe tip should be cleaned with ethanol.
Other drug delivery systems with resorbable vehicles:
Noguchi, Fukuda and Ishikawa (1988) described the 
development of a resorbable delivery system. Tetracycline 
or chlorhexidine were dissolved in ethanol and 
hydroxypropylcellulose powder was added to the solution. 
The end product was formed into strips which could be 
inserted into periodontal pockets. A treatment regime of 
3 applications for one week was advocated. This approach 
was tested in 2 separate split mouth design studies using 
tetracycline as well as chlorhexidine strips. At week 3, 
the pocket depth was only reduced in the sites treated 
with tetracycline strips. However, the pocket reduction 
was transient and a trend towards baseline was observed 2 
weeks after treatment.
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Another antibiotic, ofloxacin, was also used in a similar 
manner by Higashi et al. (1990). Polymethacrylic acid 
particles containing ofloxacin were embedded in a matrix 
of hydroxypropylcellulose which also contained ofloxacin. 
This resulted in a biodegradable system (PT-01) which
carried 10% ofloxacin. The authors reported ofloxacin 
concentrations above 2 jig/ml in the GCF until 7 days after 
insertion of the system. Kimura et al. (1991) tested the 
material on 27 subjects using a split mouth design. The 
treatment was performed weekly for 5 weeks. 
Microbiological samples were taken at weeks 0, 2, 3 and 6. 
In addition to the drug therapy, all test and control 
sites received supragingival scaling during the first 2 
weeks and subgingival root planing thereafter. The 
microbiology results showed that during the first period 
i.e. supragingival scaling plus drug therapy, a
significant reduction of motile rods, spirochaetes and 
black pigmented Bacteroides took place in the test sites 
only, whereas after 2 weeks i.e. following subgingival
scaling plus drug therapy, no significant difference 
between test and control sites was evident. Yamagami et 
al. (1992) used the ofloxacin delivery system in 
periodontal pockets once a week for 4 weeks. No
adjunctive mechanical therapy was used in either the test 
and control sites. It was reported that after 4 weeks, 
probing depth reductions of 1.5 mm vs. 0.6 mm occurred in 
test and control sites respectively. The reductions in 
bleeding on probing were 62% and 10% correspondingly. The
70
usefulness of local treatment of periodontal lesions by- 
ofloxacin had previously been reported by Miyake et al. 
(1988) and Kametaka, et al. (1989).
Okuda et al. (1992) described a biodegradable delivery 
system to release minocycline into periodontal pocket. A 
powder formulation consisting of minocycline HC1 
microencapsulated in a biodegradable polymer, 
poly(glycolide-co-dl-lactide) was placed into the pockets 
using a plastic syringe. Subgingival scaling combined 
with a single dose of the drug was compared to scaling 
alone in a parallel design study. It was reported that 
after 6 months, the microbial flora was more favourable 
for periodontal health in the combined scaling and 
ffiinocycline therapy group as compared to the scaling alone 
group. However, Jones et al. (1994) after a 6 month 
follow-up reported that the system, when used as an 
adjunct to root planing, failed to improve the pocket 
depth significantly over scaling alone. The attachment 
gain in the scaling group was reportedly higher than in 
the group treated with the adjunctive drug.
Eckles et al. (1990) used a 40% mixture of tetracycline in 
petrolatum in a split mouth design study. One quadrant 
received the tetracycline mixture. The other 3 quadrants 
received root planing alone, petrolatum without 
tetracycline and no treatment. At week 12, only the 
pocket depths of sites treated by root planing alone
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showed a significant reduction compared with baseline. 
Bleeding on probing and dark field microscopy data showed 
a transient reduction at week 4 in root planing and 
tetracycline groups, but at week 12 these parameters were 
almost similar between all groups. Unsal, Akkaya and Walsh 
(1994) reported that 40% tetracycline in petrolatum as an 
adjunct to root planing provided significant benefit over 
scaling alone. When the same system was used as an 
adjunct to root planing for the treatment of LJP patients, 
no benefit over scaling alone or scaling plus 
chlorhexidine gel was achieved (Unsal, Walsh and Akkaya, 
1995) .
A system consisting of 5 mm x 5 mm square pieces of type I 
collagen impregnated with 5% metronidazole as an adjunct 
to root planing was reported to produce significantly 
greater improvement in clinical indices compared to root 
planing alone for a period of up to 3 months after 
treatment (Hitzig et al., 1994).
The use of biodegradable materials in local delivery 
systems could facilitate the treatment of periodontal 
lesions by omitting the need for removal of the system 
after the therapeutic period. However, since usually more 
than one visit for the drug application was required, 
there was no advantage over the non-resorbable materials 
which needed a second visit for their removal.
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1.9 A critical conclusion of the literature review
The existing reports in the literature concerning the 
efficacy of using antibiotics in the treatment of 
periodontal disease is controversial. The routine use of 
systemic antibiotics for the treatment of adult 
periodontitis is not justified. Root debridement with or 
without surgical access are usually successful in the 
treatment of adult periodontitis. Some data support the 
use of certain antibiotics for LJP or refractory 
periodontitis. However, reviewing the reports indicative 
of a successful response to mechanical therapy alone in 
these groups of patients (Waerhaug, 1977; Christersson et 
al., 1985; Saxen et al., 1986), it seems reasonable to 
firstly take these patients through mechanical therapy 
alone. A diagnosis of refractory periodontitis should not 
be made unless all the possible causes of failure are 
ruled out. The quality of the patient's oral care as well 
as the professional skills of the operator are principal 
prerequisites for treatment success. Similarly in
considering the treatment of recurrent periodontal disease 
the failure should be weighed against the quality of the 
maintenance programme. If the consequence of an
unsuccessful response is considered so serious that it 
justifies the risk of potential side effects of systemic 
antibiotic therapy, then antibiotic therapy could be 
advocated after confirmation of antibiotic susceptibility.
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The aetiology and pathogenesis of periodontal disease is 
complex. If there are true specific pathogenic bacteria 
among the inhabitants of the subgingival area, then it may 
be assumed that the occasional lack of response to
mechanical therapy is due, in part, to the pathogenic 
bacteria re-populating the root surface from their 
permanent reservoirs in the oral cavity such as the 
tonsils, the dorsum of the tongue, the oral mucosa, 
furcation lesions and dentinal tubules (Adriaens, De
Boever, and Loesche, 1988a; Adriaens et al., 1988b). In
such cases theoretically, the prescription of an
antibiotic may be useful in eliminating the pathogen and 
therefore arresting the progression of the disease.
Two questions arise here. Firstly, the concept of a 
reservoir in the soft tissues is still controversial. If 
it does exist, then naturally adjunctive systemic 
antibiotics are a more effective treatment option than 
root planing or local drug delivery systems. However, if 
the dentinal tubules are a source of re-infect ion of the 
pockets, they appear to be inaccessible to both local and 
systemic antibiotic therapy as well as root planing. In 
this case, surgical pocket elimination seems the only 
logical way of preventing the recurrence of the disease. 
The second question is whether periodontal pathogens are 
indigenous or exogenous. A large amount of evidence 
indicates that some bacteria are strongly associated with 
disease progression while their elimination correlates
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with inhibition of the disease (Newman and Socransky, 
1977; Slots, 1976; Slots, 1977; Spiegel et al., 1979; 
Tanner et al., 1979; White and Mayrand, 1981; Zambon, 
Reynold and Slots, 1981). However, there is also much
evidence indicating that these suspected pathogens can 
also be found at healthy sites. If the suspected pathogens 
are in fact members of the normal flora, they may re- 
populate their natural habitat shortly after the cessation 
of antibiotic therapy. If this occurs, the disease may 
recur as reported by Komman and Karl (1982) .
In an attempt to provide answers to the question of
bacterial specificity in the pathogenesis of periodontal 
disease, Socransky and Haffajee (1992 and 1993) stated 
that several conditions should be met for the initiation 
of a periodontal lesion by pathogenic bacteria. In
addition to the presence of the pathogenic micro-organism, 
the quantity of pathogens should reach a threshold level; 
beneficial micro-organisms should also be absent or few in 
number; the pathogen(s) should be of an appropriate 
virulent clonal type; the host immune response should be 
impaired and finally the environmental conditions such as 
iron concentration, temperature, etc. should be optimal. 
In this context, one could conclude that since the
initiation of the disease is the result of activity of 
specific bacteria, the elimination of these bacteria using 
antimicrobial agents might be justified. On the other 
hand, one may argue that if the prerequisite for the
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initiation of the disease is so complex and dependant on 
several interactive factors, then even slight disruption 
of the ecosystem could stop the pathogenic process. Non­
specific debridement should be enough to stop the disease, 
so long as only one of the above listed conditions are 
altered in favour of a healthy situation. The complexity 
of the aetiopathogenesis of periodontal disease still 
exists and the present literature to date does not provide 
an answer as to whether or not systemic antibiotics should 
be used in the treatment of recurrent and refractory 
periodontitis.
The results of investigations on different local drug 
delivery systems indicate that:
a) The use of these systems as the sole treatment of 
periodontal disease has often been found to be inferior to 
scaling alone. In those studies which reported the 
superiority of the system as the only treatment to scaling 
and root planing alone, the benefit has been either 
transient with a subsequent recurrence of the disease, or 
lacking the evidence of long lasting improvement.
b) The use of these systems as adjuncts to root planing in 
untreated periodontal pockets as a routine treatment 
modality has often brought little or no benefit over 
scaling alone. In the studies in which statistically
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significant advantage over scaling alone were reported, 
the difference has been clinically unimportant.
c) The pharmacokinetic data indicate that very few systems 
are capable of maintaining a high drug concentration in 
the pocket over a sufficient length of time. However, in 
none of the systems is the drug able to penetrate deeply 
into the soft tissue adjacent to the pocket.
d) It seems that in most local delivery systems, the 
systemic uptake of the drug is minimal. Therefore, most 
adverse reactions observed following systemic drug 
therapy, including the chance of development of bacterial 
resistance should remain limited to the periodontium when 
local drug delivery systems are used.
e) If the non-resorbable systems are used, at least 2 
visits are required; one for insertion and another for 
removal of the system. On the other hand, most resorbable 
system should be applied at least twice. Together with 
the price of the systems, these considerations should be 
taken into account when evaluating the cost effectiveness 
of delivery systems for the treatment of patients.
f) Some recently published data indicate that some systems 
may have a potential synergistic effect with scaling and 
root planing, when used in pockets which showed signs of 
recurrence of disease in spite of proper treatment and
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adequate home care and maintenance therapy (Stabholz et 
al., 1991; Newman et al., 1994). However, at present the 
evidence of efficacy of other systems in this population 
of patients is lacking.
g) Due to large variability in the clinical methods of 
measuring the treatment outcome, a comparative evaluation 
of these systems using the existing literature is 
difficult and inconclusive.
Since the first local drug delivery system was developed, 
many clinical trials have been conducted to test the value 
of these systems. A number of these systems are now 
commercially available for use in clinical practice. 
However, to date, no direct controlled comparison of these 
systems has been made. At present, the need for such 
research is more evident than at any other time given the 
widespread marketing and usage of these systems in 
specialist and general practice.
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1.10 Laser
1.10.1 General introduction to lasers
Laser energy has been purported as a further alternative 
or adjunct to scaling and root planing (Midda, 1992; 
Myres, 1991). In theory, laser energy is capable of 
ablating and vaporising microbial plaque and calculus. 
During past few years a number of laser systems have been 
marketed for several dental applications including 
periodontal applications.
1.10.2 Production of laser beam
If a molecule of a material is bombarded by photons of the 
correct size, the molecule will attain a higher energy 
level and the photons are absorbed. If molecules, the 
majority of which are in a higher energy level, are 
bombarded by certain photons some new photons are 
released. These new photons and the original ones will 
strike some other excited molecules and again some new 
photons with the same size and path are emitted and a 
cascade effect occurs. The photons can be accelerated by 
means of a photon resonator which consists of a pair of 
parallel mirrors. If one of the mirrors is semi- 
reflecting, the accelerated photons can ultimately exit 
from the container and a parallel sided collimated beam 
results. Because all the photons are of the same size and 
energy, the beam will be only of one frequency (i.e. 
monochromatic) and since all the photons are in the same 
phase, the beam is coherent and intense. This effect is
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called 'light amplification by stimulated emission of 
radiation1 (LASER).
The primary differentiating characteristic between various 
laser machines is the laser medium which is the original 
source of the excited molecules. The medium may be either 
a solid crystal as used in Nd:YAG lasers or a gas such as 
C02. The wavelengths of the lasers are different, 
depending on the media used to produce the beam. The 
first laser was made using a bar of synthetic ruby 
(Maiman, 1960).
1.10.3 Laser interaction with tissues
The interaction of laser radiation with the target depends 
on a) various properties of the target e.g. chemical 
structure and density and specific absorption; and b) the 
properties of the laser radiation e.g. wavelength, energy 
density and pulse duration. This interaction could be 
either thermal or non-thermal. Thermal effect occurs when 
the absorbed energy causes an increase in the internal
lattice vibration, leading to heat generation. 
Photodisruption occurs if very high energy and short
pulsed radiation is emitted to the tissue. The material 
is ionised by the strong electric field of the beam,
resulting in a hot, electrically charged gas, known as 
plasma. Since, the plasma absorbs all the energy from the 
incident beam, the generated heat would be minimal. The 
temperature in the plasma fluctuates as the result of
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laser beam, resulting in vibration of electrons within 
plasma which leads to generation of audible shock waves. 
This so-called photoacoustic waves are responsible for the 
mechanical breaking apart or shattering of the target 
material (Miserendino, Levy and Miserendino, 1995) .
1.10.4 Types of lasers
There are basically two types of lasers in the medical 
field which are referred to as hard and soft lasers. Hard 
lasers emit a concentrated and high powered radiation for 
use on the tissues. The energy of the photons is much 
higher than that of soft lasers. There are many types of 
hard laser such as Ar-F-excimer, Xe-Cl-excimer, Kr-F- 
excimer, Xe-F-excimer, Nd:YAG, Ho:YAG, Er:YAG, and C02 
lasers of which the two most commonly used in dentistry 
are the C02 and Nd:YAG lasers. Soft lasers emit a low- 
power beam with the wavelength being in the visible or 
near infra-red region of the spectrum. Any biological 
effect occurring after tissue exposure to these types of 
laser are due to the direct effect of radiation rather 
than as a result of heating (photodynamic interaction) .
1.10.2 Nd:YAG Laser
The Nd:YAG laser emits a wavelength of 1064 nm which is 
transmissible through an optic fibre, making it easier to 
handle in the oral cavity. The laser medium in this type
of laser includes a solid crystal of yttrium aluminium
garnet dotted with neodymium. Since 1064 nm is not in the
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visible spectrum, it also needs an accessory He-Ne laser 
as an aiming beam. An Nd:YAG laser beam can penetrate 
water and soft tissues which contain a high percentage of 
water up to a considerable depth, before its energy 
becomes attenuated (Harris and Pick, 1995). This property 
of the Nd:YAG laser makes it more suitable for surgical 
removal of abnormally vascularised lesions which tend to 
bleed during ordinary surgery with a scalpel (Halldorsson 
& Langerholc, 1978).
1.10.3 The effects of lasers on the pulp
The effect of laser energy on the dental pulp has been 
evaluated (Adrian, Bernier and Spraque, 1971; Melcer, 
Chaumette and Melcer 1987; Serebro et al., 1987; Friedman, 
et al. 1991; Leighty et al., 1991; Frentzen, Koort and 
Thiensiri, 1992; Miserendino et al., 1993; White, Fagan 
and Goodis, 1994) . Due to the diversity of the laser 
techniques, energy durations and wavelengths, the results 
are often incomparable. However, it appears that the 
energy of the Nd:YAG laser, due to the absorptive 
characteristics of dental hard tissues, could penetrate 
deeply through enamel and dentine and reach the pulp 
chamber (Launay et al., 1987). Bahchall, et al. (1993) 
reported focal haemorrhage and disruption of odontoblastic 
layer in the dental pulp of dogs when the enamel was 
treated by Nd:YAG laser energy. The pulpal effect of the 
Nd:YAG laser, was studied by White et al. (1994). The 
results indicated that if the thickness of dentine between
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the laser impact and the pulpal tissues was 2 mm, energy 
settings as low as 70 milli-Joules (mJ), at 10 pulses per 
second (pps) for 30 sec could produce a temperature rise 
of 5.8°C in the pulp. If the thickness was 1 mm the 
temperature rise was about 10°C and 17°C after energy 
settings of 70mJ and lOOmJ at lOpps for 30sec 
respectively. It is important to consider that a 
temperature rise of 5.6 °C, causes 15% of the teeth to 
become non-vital as reported by Zach and Cohen (1965). 
The distance between the cementum surface and the root 
canal is often close to 2 mm and it may even be less, 
especially in inter-proximal root concavities and in 
periodontally diseased teeth which have been subjected to 
long-term tooth structure loss due to root planing at 
maintenance visits.
1.10.4 Lasers in periodontics
1.10.4.1 Soft tissue surgery
Lasers have been used for various soft tissue surgery 
techniques in periodontics such as gingivectomy (Pick, 
Pecaro and Silberman 1985; Hylton, 1986; Barak and Kaplan, 
1988), flap incision (Pecaro and Garchume, 1983), sulcus 
deepening (Pogrel, 1989), frenectomy (Pogrel, 1989) and 
gingival curettage (Gold and Vilardi, 1994). Available 
evidence shows that bleeding during laser surgery is less 
than that when using a scalpel to perform surgery (Pogrel, 
1989; Barak and Kaplan, 1988; Pecaro and Gachine, 1983; 
Pick et al., 1985; Frame, 1985a; Frame, 1985b, Horch,
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Gerlack and Schaefer, 1986; Hylton, 1986; Abt et al., 
1987; Frame et al., 1988). This may offer an advantage
over traditional techniques when performing surgery on 
patients with clotting defects or vascular disease (Pick 
and Pecaro, 1987).
There are a number of reports on the healing of laser 
treated wounds compared to scalpel wounds (Hall, Hill and 
Beach, 1971; Fisher et al., 1983; Fisher and Frame, 1984; 
Abergel et al., 1984; Goultschin et al., 1988; White, 
Goodis and Rose, 1991) . Due to the diversity of these 
studies in terms of the type of laser, the duration, and 
the energy settings, the comparison and interpretation of 
the results is difficult and inconclusive. The reported 
results are inconsistent. While most authors reported 
that the scalpel incisions healed more quickly than the 
laser incisions, a few others found little difference 
between the 2 methods. It seems that in interpreting the 
biological effects of lasers on the tissues, each laser 
treatment with its own parameters such as specific 
wavelength, energy, pulsation and duration should be 
specifically and individually considered and assessed. 
The Nd:YAG laser energy has been reported to delay the 
ability of skin fibroblasts to synthesise DNA and collagen 
(Abergel et al., 1984). Most data indicate that re- 
epithelial izat ion of laser wounds is delayed. Some 
authors have suggested that this phenomenon might be 
beneficial in surgical procedures such as sulcus deepening
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(Pogrel, 1989), or in preventing the apical migration of 
the epithelium after periodontal surgery (Midda and
Rent on-Harper, 1991; Gold and Vilardi, 1994) . White et 
al. (1991) reported that the Nd:YAG laser was as effective 
as a scalpel in periodontal soft tissue surgery
techniques. They reported that post-operative pain and 
inflammation were equal in the scalpel treated and laser 
treated groups. Gold and Vilardi (1994) reported that the
Nd:YAG laser was used successfully to remove the pocket 
epithelium without inducing necrosis or carbonisation of 
underlying connective tissue.
1*10.4.2 Treatment of dentinal hypersensitivity
Renton-Harper & Midda (1992) used an Nd:YAG laser for the 
treatment of hypersensitivity and reported less
sensitivity of the exposed roots after application of the 
laser at energies of up to 50 mJ for 2 minutes. The 
sensitivity was assessed by patient tolerance of thermal 
stimuli provided by a cold-air blast. These results were 
confirmed by Gelsky, White and Pruthi (1993).
1.10.4.3 Lasers and the root surface
The number of well controlled studies evaluating the 
behaviour of the periodontal tissues to laser radiation is 
still far from sufficient to provide a proper 
understanding of this subject. In 1992 the Institute for 
Laser Dentistry in a clinical manual (unpublished data) 
claimed that lasers would be capable of enhancing calculus
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removal, killing the pocket bacteria and vaporising the 
necrotic tissues. Research carried out on whether the 
laser has any place in the treatment of diseased root 
surfaces, is briefly reviewed below.
The in vitro effects of the NdrYAG laser on subgingival 
calculus were studied by Tseng et al. (1991a) using the 
scanning electron microscopy (SEM). They used laser 
energies of 2.0W or 2.75W at 20pps for two or three 
minutes, and then tested the lased surfaces for ease of 
calculus removal using a hand curette. They reported heat 
penetration and damage in localized areas of cementum and 
even dentine. However, there was a significant difference 
between the number of curette strokes required to remove 
lased (3.8 strokes) versus non-lased calculus (6.5 
strokes) , and it was concluded that although laser
treatment per se could not remove a significant amount of 
calculus, it enhanced calculus removal.
In an SEM study, Morlock et al. (1992) evaluated the
effect of the NdrYAG laser in vitro either alone, or as an 
adjunct to root planing. They used energies of 1.25W and 
1.50W at 20pps for 20sec on a circular area of 3mm 
diameter. All the treated groups showed changes on the
surface of the cementum including: crater formation,
surface pitting, charring and tracking. They also 
reported that the cementum layer of lased surfaces was
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peeled off in some areas when subjected to hand 
instrumentation.
Trylovich et al. (1992) studied the biocompatibility of 
Nd:YAG laser treated root surfaces. They incubated three 
groups of untreated healthy, lased endotoxin treated, and 
non-lased endotoxin treated root segments in human 
gingival fibroblast cultures. The biocompatibility of the 
surfaces was assessed by the presence of flat fibroblasts 
(which were considered as firmly attached) and the absence 
of round fibroblasts (which were believed to be poorly 
attached) ' on the root segments. They reported
significantly fewer flat fibroblasts in the laser treated 
group compared to both healthy and non-lased endotoxin 
treated groups. Although a relatively low energy level 
(80mJ at lOpps for one minute over a 4x4 mm2 area) was 
used, surface alterations of charring, cratering and 
melting down were observed. Similar results were reported 
by Tewfik et al. (1994) using a modified Nd:YAG laser with 
a wavelength of 532 nm. Thomas et al. (1994) found that 
if the laser treated cementum surface was root planed 
after the laser treatment, the number of well-attached 
fibroblasts increased, but was still below the levels 
observed in unlased controls, whereas the treatment of the 
surface using air-powder abrasive after laser treatment 
resulted in fibroblast attachment almost equal to the 
unlased controls. They concluded that the adverse effect 
of laser on the root surface is a superficial phenomenon.
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Arcoria et al. (1992) used a coaxial C02-Nd:YAG laser for 
irradiation in periodontal surgery on dogs to evaporate 
granulation tissue from osseous defects and re-contour the 
osseous irregularities of the alveolar crest. Two 
different laser treatments were used. The lower energy 
treatment (energy density = 426.6 J/cm2) resulted in no 
improvement when compared to the conventional treatment, 
whereas the higher energy treatment (energy density =
849.3 J/cm2) ended up with significantly more loss of 
attachment and tissue necrosis. This study did not 
determine which type of laser contributed to the adverse 
effects on the periodontal tissues.
Ito, Nishikata and Murai (1993), in an SEM study, reported 
that an NdrYAG laser was capable of removing the smear 
layer from the root surface after root planing. The smear 
layer is a product of root instrumentation and consists of 
mineral and organic remnants of cementum, dentine and 
calculus and deposits of bacterial plaque. This layer is 
thought to act as a barrier between Sharpey's fibres and 
connective tissue fibres in the cementum. The conventional 
treatment for the smear layer removal is the application 
of citric acid. In the above mentioned study, both the 
laser and citric acid were capable of removing the smear 
layer. The laser energy densities ranged from 84.9 to
849.2 J/cm . The openings of the dentinal tubules were 
widened after citric acid treatment whereas the laser
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treatment did not affect the dentinal tubules. It was 
stated that since bacterial invasion into the dentinal 
tubules and inflammation in the pulp tissue are outcomes 
of widened dentinal tubule openings, the laser treatment 
might be superior to citric acid treatment. The data 
obtained from this study would have been more valid if the 
response of the pulpal tissues had been studied. In 
addition, the high energy densities used in this study 
could have affected the biocompatibility of the root 
tissues.
In a study on the chemical characterisation of lased 
surfaces, Spencer, Trylovich and Cobb (1992) used Fourier 
Transform Infrared Spectroscopy. The laser energy
Settings were 80mJ, at lOpps for 1 minute. After 
spectroscopy the protein/mineral ratio had decreased when 
compared to the control sites. They suggested that this 
might have been due to protein denaturation and production 
of ammonia as a result of the laser energy. It was 
pointed out that reattachment might be adversely affected 
by use of the laser. An attempt was made by Arcoria and 
Vitasek (1992) to evaluate the efficacy of lasers in 
calculus removal. Although an Nd:YAG laser was used, the 
laser pulse duration was far more than that of the 
American Dental Laser which is available to the dental 
professions (5 milliseconds versus 150 microseconds). A 
significant difference in calculus removal between lased 
and untreated surfaces was reported. However, hand
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instrumentation was found to be significantly superior to 
laser treatment. It was concluded that the absorption 
characteristics of tissues are most important and that 
research should be carried out to find a wavelength which 
is selectively absorbed by the calculus at the cemento- 
calculus junction. Recently Erbium:YAG laser was
evaluated for its efficacy of calculus removal (Aoki et 
al., 1994). It was reported that the calculus was 
effectively removed, but a rough and chalky surface was 
left behind. The SEM confirmed the presence of a very 
rough surface.
1.10.4.4 The bactericidal effect of lasers
The laser beam is theoretically capable of killing 
bacteria and providing a germ free field of work. Reid 
and Stranc (1991) in an animal Study reported a 
significantly more effective role for a C02 laser in 
sterilizing the artificially infected wounds in rabbits 
when compared with an iodine surgical scrub. However, no 
data is available to show whether the laser energy 
sufficient to kill bacteria/reduce the number of bacteria 
would produce any damage to the host tissues. Further 
research is necessary to determine the susceptibility of 
host tissues to the energy levels effective against 
bacteria. Moreover, longitudinal studies should be 
designed and carried out to elucidate if a laser treated 
tissue in the presence of delayed epithelialization will 
still remain less infected than tissues treated
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conventionally. Tseng et al. (1991b) in an SEM study, 
reported that very few periodontal pathogenic micro­
organisms remained on contaminated root segments when 
lased at 1.5W and lOpps for one minute using an Nd:YAG 
laser in vitro. Cobb, McCawley and Killoy (1992) in an in 
vivo study evaluated the antimicrobial effect of the 
NdrYAG laser. Laser treatment was performed at 1.75W, 
2.25W and 3.00W for one and three minutes either before or 
after hand instrumentation while some teeth were treated 
using the laser alone. Pre-treatment and post-treatment 
samples revealed a marked decrease in the proportion of 
A.a., P.g., and P.i. When two teeth were left in situ for 
seven days, one of them showed an increased number of 
recovered P.i. The authors pointed out that this might be 
due to recolonisation in laser-induced porosities of the 
root surface by the bacteria. Recently, Whitters et al. 
(1994) reported that an Nd:YAG laser energy of 80 mJ at 10 
pps was capable of killing 90% or more oral bacteria 
including several suspected periodontal pathogenic species 
when the laser handpiece was manipulated for 3 minutes in 
50ml microbial suspensions each containing single species.
1.10.5 Concluding remarks from the laser literature
Clearly, it is still too soon to consider the laser as a 
safe and effective tool in the treatment of periodontal 
diseases. It is not clear whether the laser energy has a 
consistent effect on the calculus or other hard tissues. 
If the variation in the absorptive characteristics of
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calculus is large, higher energy settings may be necessary 
to consistently affect calculus. These high settings may 
not be tolerated by the underlying dental tissues. In 
addition, the capability of laser to reduce/eliminate 
pathogenic bacteria from the pocket using moderate and 
high energies (85 mJ at 20 pps and more) in vivo and 
moderate energies (80 mJ and 120 mJ at 10 pps) in vitro 
has been demonstrated (Cobb et al., 1992; Whitters et al., 
1994) . Yet, the bactericidal effect of laser at low 
energies in vivo remains to be elucidated. Moreover, it 
has not been investigated whether the laser bacterial kill 
is followed by a clinical benefit. The bactericidal 
effect, if not associated with destructive effects, may 
eventually have a clinical benefit. Considering all the 
reports reviewed in this chapter indicating the potential 
damage to the biocompatibility of the root surface and 
pulp at higher energies of the dental Nd:YAG laser, it 
seems reasonable to focus research on the efficacy and 
effects of moderate and low laser dosages in periodontal 
treatment.
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1.11 Alms
This thesis attempts to evaluate two of the most recent 
alternative or adjunctive treatment modalities to root 
planing developed for periodontal therapy. These are 
local drug delivery systems and laser therapy.
The main aim of the clinical study of subgingivally 
delivered antimicrobials was to determine the efficacy of 
3 commercially available in the UK locally delivered
systems as adjuncts to scaling and root planing in refractory periodontitis 
sites with a poor response to previous mechanical treatments.
Comparisons were made with scaling and root planing alone 
as the traditional treatment. A further aim was to 
determine the safety and potential side effects of these 
systems. Using multivariate statistical analytical 
methods, the study also sought to investigate the effect 
of cigarette smoking on the periodontal treatment outcome.
The aims of the in vitro study on the Nd:YAG laser were:
1) To determine whether the Nd:YAG laser energy could 
selectively ablate calculus without affecting underlying 
cementum and dentine; 2) To determine whether the ablative 
effect of a given laser energy dosage on the calculus and 
root surface, is repeatable i.e. whether it could be used 
in a predictable manner.
The aim of the clinical laser study was to determine 
whether the low to moderate energy dosages of the Nd: YAG
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laser are capable of killing subgingival bacteria and 
thereby, improving clinical parameters associated with 
periodontal disease. A further aim was to examine the 
effect of these laser settings on the root surfaces in 
vivo using the SEM.
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CHAPTER II
MATERIALS, METHODS & 
PRELIMINARY EXPERIMENTS
2.1 Introduction
The intention of this chapter is to describe the materials 
and methods used in this thesis. The chapter consists of 
2 main parts. The first section of the first part 
describes the measurements of probing pocket depth and 
attachment level. The next 3 sections describe the 
preliminary studies related to the study of subgingival 
antimicrobial systems. These include 1) comparison 
between 2 pressure sensitive probes, 2) determination of 
the intra-examiner variability in the measurement of 
probing pocket depth and attachment levels, and 3) 
estimation of an approximate sample size for the main 
clinical study. The fifth section describes in detail the 
materials and methods used in the clinical study of 
subgingival antimicrobial systems. The second part of the 
chapter deals with the laser studies. The preliminary 
experiments related to the main in vitro laser study are 
described first. These include 1) preliminary evaluation 
of the application of the Nd:YAG laser using an in vitro 
model, 2) determination of a range of laser parameters, 
suitable for use in the main in vitro study, and 3) 
evaluation of cracks observed following SEM examination of 
laser-treated root surface. The materials and methods 
used in the main in vitro laser study are then described 
in detail. The final section of this chapter describes 
the materials and methods used in the clinical laser 
study.
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2.2 The clinical study of subgingival antimicrobial
systems: preliminary studies, materials and 
methods
2.2.1 The Florida probe in measurements of probing
pocket depth and probing attachment level
The Florida probe (Florida Probe Corporation, Florida, 
USA) (Gibbs et al., 1988) was used for measuring the
probing depth and attachment level in this study. This is 
an electronic pressure sensitive probe set at 20 g. The 
Florida probe records the pocket depth and attachment 
level to the nearest 0.2 mm. The system consists of a 
pocket depth handpiece and 2 attachment level handpieces 
(the 'Disk' and the 'Stent' handpieces), a foot switch, 
eomputer interface and personal computer (Figs. 2.1, 2.2). 
The probe tip has a diameter of 0.4 mm, and no visible 
graduation along its length and it reciprocates through a 
sleeve. The edge of the sleeve is the reference from 
which measurements are recorded. A fixed reference point 
is required for attachment level measurements.
Florida probe 'Stent' handpiece: The Florida Probe 'Stent' 
handpiece has a 2 mm diameter disc at the edge of its 
sleeve which, during attachment level measurement, is 
seated on a custom made soft acrylic stent covering the 
crowns of the teeth. These stents were constructed for 
both upper and lower arches for each patient from a 2 mm 
thick silicone layer (Kombiplast, Dreve-Dentamid) using a
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modification of the method described by Isidor, Karring 
and Attstrom (1984a). The stents were made on stone models 
using a vacuum forming machine. The stent was then 
trimmed to cover approximately the coronal one third of 
the crowns of the teeth selected for the study. At other 
teeth, the stent was preserved as much as possible to 
assist location and retention. Using an inverted cone bur 
and a low speed handpiece, grooves approximately 1 mm 
deep, 2 mm wide and 1 mm high were cut, about 1 mm away 
from the apical edge of the stent, at the study sites. The 
grooves were then marked with a permanent pen for 
convenience of identification. The disc of the 'Stent 
probe' handpiece was located in the base of these grooves 
during attachment level measurements. Attachment level 
was assessed relative to the point at which the probe 
handpiece disc was seated on the stent (Fig. 2.3). In 
this way, attachment level measurements do not rely on 
careful location of the cementoenamel junction (CEJ). The 
identification of the CEJ is often complicated by its 
subgingival location or the presence of restorations. The 
grooves on the stent were located at the tooth's maximum 
height of contour for buccal/lingual measurements, and as 
close to the contact point as possible for interproximal 
recordings.
Florida probe 'Disk1 handpiece: The Disk handpiece has a
disk of 10 mm width and 1 mm thickness which seats on the 
occlusal/incisal surface of the tooth. The probe tip was
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placed into the pocket with the probe tip parallel to the 
long axis of the tooth. When the disk was brought in 
contact with the occlusal/incisal point, the foot switch 
was pressed and the value recorded (Fig. 2.4).
Pocket depth Florida probe handpiece: The pocket depth was 
recorded when the probe sleeve was brought into contact 
with the gingival margin without causing blanching of the 
gingiva due to excessive pressure (Fig. 2.5). Probing 
depth was also measured at the same points as attachment 
level recordings i.e., as close as possible to the contact 
point at the interproximal sites, and at the maximum 
height of contour at the buccal/lingual sites. The probe 
tip was kept parallel to the long axis of the tooth during 
the measurements of attachment level and pocket depth.
Pocket depth and attachment level measurements were 
measured electronically, and transferred automatically to 
the computer by pressing the foot switch. Recordings were 
displayed on the computer screen which was hidden from the 
operator in order to allow for 'blind' measurements. The 
measurements were recorded by an assistant.
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Fig.2.1 The Florida probe; the pocket depth handpiece 
(top), the 'Stent' attachment handpiece (middle) and 
the 'Disk' attachment level handpiece (bottom).
FRgg 22. 22 TIfee FEbaniilda ppofofee comppitifeer iimikarffiae  ^, nioamttxirr 
aamid f fxaxfct ss/viticfoh .
Fig.2.3 'Stent' attachment level handpiece in use 
with the occlusal stent.
Fig.2.4 'Disk' attachment level handpiece in use.
Fig.2.5 The 'Pocket depth' handpiece in use.
2.2.2 Preliminary study; Comparison between two
versions of the Florida probe for attachment 
level measurements
2.2.2.1 Introduction
The reproducibility of the 'Stent probe1 and the 'Disk 
probe' has been compared in pockets < 4 mm (Marks et al., 
1991) . In their study, the reproducibility of the 'Disk 
probe' was found to be slightly less than the 'Stent 
probe', however, there have been no reports with regard to 
the reproducibility of these 2 probes in deep pockets. In 
terms of longitudinal attachment level changes, deep 
periodontal pockets are usually of most interest to 
clinical researchers. In view of this fact, the need for 
such a comparison is obvious. Prior to beginning the 
longitudinal study of subgingival antimicrobial treatment 
modalities for periodontal disease, it was decided to 
address the question of which of these 2 probes is 
preferable. The use of the Stent probe requires the 
fabrication of an occlusal acrylic onlay. This is time 
consuming and necessitates some clinical and laboratory 
effort, moreover, an additional appointment is required. 
If the Disk probe shows the same degree of reproducibility 
as the Stent probe, the measurement of attachment level by 
the Disk probe would be preferred. The aim of this pilot 
study was to compare the reproducibility of 2 pressure 
sensitive probes.
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2.2.2.2 Material & methods
The study material consisted of 126 sites in 21 patients 
who were in the maintenance phase of their periodontal 
therapy. It was decided to select a variety of sites with 
regard to the degree of gingival inflammation, pocket 
depth and the state of bleeding on probing. Each patient 
was seen on a screening visit, sites were selected and 
impressions were made for stent fabrication. At the 
second visit, the following parameters were determined by 
a single operator: the Modified Gingival Index (Loebene et 
al., 1986) (described in section 2.2.5.4); the presence or 
absence of bleeding on probing up to 30 seconds after 
probing with the pressure sensitive probe; attachment 
level and probing depth using duplicate measurements.
Attachment levels were measured twice using both the 
'Stent probe' and the 'Disk probe1. The sequence of 
measurements was: 1) Stent probe; 2) Disk probe; 3) Stent 
probe; and 4) Disk probe. The interval between
measurements with the same probe was 20 minutes. The 
difference between the first and the second measurement 
was computed for each probe and the standard deviation of 
the differences were calculated.
2.2.2.3 Results
The standard deviation of 126 differences between the 
first and second measurements of attachment levels using 
the Stent probe and the Disk probe were 0.600 and 0.676
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respectively. Using both probes, the reproducibility of 
the sites with pocket depth of >4mm, sites with bleeding 
on probing, and sites with GI >2 were lower than sites 
with pocket depth <4mm, sites without bleeding on probing 
and sites with GI<2 (Table 2.1).
2.2.2.4 Discussion
In this pilot study, the reproducibility of the Stent 
Florida probe and the Disk Florida probes were compared. 
In the longitudinal studies of periodontal disease, where 
change in attachment levels is a major criteria in 
distinguishing between active sites and inactive sites, or 
successfully treated and unsuccessfully treated sites, it 
is essential to use methods which minimise measurement 
efrors. It was found in this study that the standard 
deviation of Stent probe measurements was narrower than 
the Disk probe measurements. This finding warrants the 
use of the Stent rather than the Disk probe in the 
longitudinal studies of periodontal disease.
One may argue that the acrylic stents may lose their close 
fit to the occlusal plane over time. Nevertheless, the 
personal experience of the author is that if the stents 
are kept on the stone models, warpage will be minimal. 
However, if the teeth move during the 2 measurement 
periods, the stent should be cut to perfectly fit on the 
tooth to be measured. In vitro models should be used to 
precisely evaluate the effect of slight tooth movements on
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able 2.1 The difference between the duplicate recordings 
nd standard deviation obtained using the Disk probe and the 
tent probe.
Sites n Stent probe Disk probe
mean Standard mean Standard
difference deviation difference deviation
11 sites 126 -0.011 0.600 -0.016 0.676
D > 4mm 72 -0.019 0.684 0.022 0.721
D < 4mm 54 - 0.000 0.471 -0.067 0.614
I > 2 70 -0.043 0.613 0.040 0.736
I < 2 56 0.029 0.586 -0.086 0.592
OP ( + ) 62 -0.065 0.644 0.006 0.756
OP (-) 64 0.041 0.555 -0.037 0.594
the reproducibility of the attachment measurements using 
an acrylic flexible stent. Nevertheless, the slight 
changes in the position of teeth may also affect the 
position of the disk of the Disk probe in relation to the 
occlusal surface or incisal edge. The slight superiority 
of the Stent probe to the Disk probe may be explained by 
the fact that the stent could provide a reference point 
for the investigator in both corono-apical and mesio- 
distal dimensions, whereas the disk could provide a 
reference point only in the corono-apical direction and an 
error in the horizontal placement of the probe tip is then 
more likely to occur.
The only previous report on the comparison of the Stent 
and the Disk probes (Marks et al., 1991) was consistent
with the findings of the present study, although in the 
study of Marks et al. the sites had mild periodontal 
problems with shallow pockets.
The findings of higher reproducibility in shallower 
pockets with low gingival inflammation in this study are 
consistent with previous studies (Badersten et al., 1984a, 
Isidor et al., 1984a).
A longitudinal study using both probes is required to draw 
more precise conclusions about the ability of the 2 probes 
to detect attachment level changes.
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2.2.3 Preliminary study; The intra - examiner
reliability of duplicated measurements of 
probing depth and attachment levels.
2.2.3.1 Introduction and methods
In order to improve the reproducibility of the
measurements, it was decided to take duplicate 
measurements rather than single ones. The standard 
deviation of differences between the first and second 
readings would provide a measure of the reproducibility 
and could be used to define a threshold for changes in 
probing pocket depth or attachment levels. Before the 
beginning of the clinical study of subgingival 
antimicrobials, the reproducibility of the examiner for 
the duplicate measurements of pocket depth and attachment 
level was determined.
Forty two sites from 7 patients were selected for the
study. Each patient was examined 4 times by a single 
examiner using the Probing Depth Florida probe and 4 times 
using the Stent Florida probe. There was a 20 minute
interval between each series of duplicate recordings. The
recordings were displayed on a computer monitor which was 
hidden from the examiner and were recorded by an 
assistant. The average of the first and second readings 
was considered as the first duplicate and the average of 
the third and the fourth measurements was considered as 
the second duplicate. The intra-examiner variability of
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these 2 measurements would provide a measure of the 
reproducibility of the duplicate measurements.
2.2.3.2 Results and Discussion
The standard deviations of single and duplicate 
differences for probing depth were 0.60 and 0.42 
respectively and the standard deviations of single and 
duplicate differences for attachment levels were 0.60 and 
0.34 respectively (Table 2.2).
The correlation coefficients between the first and second 
readings are shown in Table 2.3. The coefficients of 
duplicate probings are higher than the coefficients of 
single probings. This held true for both probing depth 
and attachment level measurements.
Both pocket depth measurement and attachment level 
measurements showed a marked improvement in 
reproducibility when duplicate versus single readings were 
taken. This improvement is more pronounced in attachment 
level measurements than pocket depth measurements. This 
finding is in close agreement with Osborn et al., (1990) 
who found marked advantage in duplicate versus single 
measurements of attachment level using the Florida probe, 
but found little advantage in duplicate measurements over 
single measurements of probing depth using the Florida 
probe.
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Table 2.2 Mean and standard deviations of single and 
duplicate differences of probing depth and attachment level 
measurements.
Probing depth: |(mm)
n
(differences)
mean
difference
Standard
deviation
Duplicated 
pair per site
42 -0.16 0.42
Single pair 
per site
42 -0.17 0.60
Attachment level:(mm)
Duplicated 
pair per site
42 -0.01 0.34
Single pair 
per site
42 0.03 0.60
Table 2.3 Correlation coefficients for probing depth and 
attachment level measurements using single and duplicate 
recordings.
Single pairs Duplicate pairs
Pocket depth 0.93 0.96
Attachment level 0.95 0.97
One may argue that the application of 4 consecutive 
probings to one site may lead to bias in the measurements 
or it may have a deteriorating effect on the site. This 
study showed that there is only a minor tendency towards 
deeper measurements in the second readings when compared 
with the first ones (Table 2.2) . Moreover, in view of the 
low pressure applied by the Florida probe compared with 
manual probes, the repeated probing does not seem to 
warrant any concern.
In conclusion, it seems that the reliability of the 
measurements will improve markedly if one uses duplicate 
probing depth and attachment level recordings instead of 
single ones. Therefore, duplicate recording was chosen as 
the method of data collection for these 2 parameters in 
the main study.
2.2.4 Preliminary study; The estimation of sample
size for the study of subgingival antimicrobial 
therapy
2.2.4.1 Introduction
Conducting a clinical trial is often time consuming and 
practical obstacles such as time and finance, force the 
investigators to estimate the minimal size of the required 
sample prior to the start of the study. The results of 
the sample size estimation may also convince the
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investigator not to start the study, if the required size 
is too large. To determine the size of sample in a 
comparative trial, the investigator should have some 
primary information about the data which he will collect. 
If the study aims to compare 2 treatments using a 
quantifiable variable, firstly, the magnitude of the 
difference in the response variable should be known, and 
secondly, the variance of this difference should be known. 
There are only 2 ways to find out these 2 elements:
1) If there has been any previous similar research, the 
obtained mean difference and the standard deviation of the 
differences between 2 groups may be used to estimate the 
sample size. This approach is often too crude and 
impractical because of the large variability in the 
methods of data collection, instruments, patient 
populations and the reproducibility of investigators among 
different centres. Moreover, a previous direct comparison 
between the 2 treatments of interest to the investigator, 
often does not exist.
2) The other approach is to carry out a pilot study of 
exactly the same design as the main study but at a smaller 
scale to estimate the mean difference and standard 
deviation. This approach is also crude due to the use of 
too few samples. The estimated size is, thus, only a crude 
guess based on the few available data. In the absence of 
any similar information about the distribution and the
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magnitude of the real difference between the efficacy of 
the treatments, this would be the only way of estimating 
the size of a sample, with a certain likelihood of 
demonstrating a statistically significant difference 
between the treatments. This latter approach was 
attempted in this pilot study.
2.2.4.2 Material & methods
Nine patients in the maintenance phase of periodontal 
treatment, with 4 pockets were screened, selected and 
randomly assigned to one of the following groups:
1) Scaling and root planing plus application of 25%
tetracycline fibres.
2) Scaling and root planing plus application of 2%
minocycline gel.
3) Scaling and root planing plus application of 25%
metronidazole gel.
Probing pocket depth measurements were obtained at 
baseline and 6 weeks after treatment using duplicate 
recordings with the Florida probe. The detailed clinical 
treatment methods and measurements are described in the 
section 2.2.5.
Based on the mean pocket depth reduction for each 
individual, the sample sizes were determined at 3 
different power levels i.e. 80%, 90% and 95%. P is the
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probability of making a type II error in the statistical 
inference. This is the probability of accepting the null 
hypothesis while it is false. Significance level was set 
at 1%, 5% and 10% levels. The significance level is the 
probability of making a type I error which is the 
probability of rejecting the null hypothesis while it is 
true. The sample size was estimated using the formula 
(Armitage and Berry, 1987):
(Z2a +ZjP)2 c2
N > 2 {  }
So2
When Z2a and Z2p represent the values which are exceeded by 
a standard normal random variable with probability of |a 
and jP respectively. 80 is the mean difference improvement 
between the 2 groups and finally, a is the standard 
deviation of the difference in the response variable i.e. 
pocket depth reduction between the 2 groups.
Since, sites with initially deeper pockets usually show 
higher improvements after treatment as compared with 
shallower pockets, the baseline pocket depth data was used 
as a covariate and the differences were adjusted with the 
covariates. An analysis of covariance was used to 
calculate the covariate-adjusted pocket depth reductions 
in 3 groups. The squared root of the error term mean- 
square in the analysis of covariance output table, was the 
standard deviation (a) of the covariate-adjusted pocket 
depth changes in the sample. The difference between the
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covariate-adjusted changes in the 2 groups with the best 
and second best results is the (80) .
2.2.4.3 Results
The results of the study after 6 weeks are shown in Table 
2.4. The largest reduction in pocket depth was obtained 
in the patients treated with scaling plus tetracycline 
fibres, with a mean pocket depth reduction of 1.80 mm. In 
the other 2 groups the reductions were 0.483 mm and 0.742 
mm for the minocycline gel and the metronidazole gel 
respectively. The 2 highest reductions were obtained with 
the tetracycline fibre and the metronidazole gel 
treatments respectively. The analysis of variance and the 
Tukey multiple comparisons showed that there was no 
Statistically significant difference among the treatments 
with 3 subjects per leg (Tables 2.5 and 2.6). The 
required sample size using the absolute mean values at 
different probabilities of making the type I and type II 
errors are shown in Table 2.7. To demonstrate that the 
tetracycline fibre is superior to both the metronidazole 
gel and the minocycline gel using absolute mean 
differences (Delta = 1.07, SD= 0.717), the size of the
required sample would be 8 subjects per group if 1-p = 80% 
is accepted at probability level of p= 5%. Using the 1-p = 
90% the sample size would be 11 subjects per group.
When the effect of the baseline pocket depths were taken 
into consideration as a covariate, the adjusted pocket
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Table 2.4 Baseline probing depths and their reductions for 
the 3 treatments based on subject means (pilot study).
Treatment n mean PD 
baseline
mean PD 
reduction
SD
Scaling & 
tetracycline fibre
3 5.64 1.81 0.80
Scaling & 
minocycline gel
3 5.02 0.48 0.21
Scaling & 
metronidazole gel
3 5.03 0.74 0.93
Pooled 9 5.23 1.01 0.72
PD, Pocket depth 
SD, Standard deviation
Table 2.5 Analysis of variance for differences between 
treatments.
source S.S. D.F. M.S. F P
Between 2.95 2 2.48 2.88 0.133
groups
Within 3.08 6 0.51
groups
S . S.,Sum of squares 
D.F., Degrees of freedom 
M.S., Mean squares
Table 2.6 Matrix of pair-wise comparison probabilities
using the Tukey test (pilot study).
Scaling &
tetracycline
fibre
Scaling &
minocycline
gel
Scaling &
metronidazole
gel
Scaling & 1.000
tetracycline
fibre
Scaling & 0.138 
minocycline gel
0
Scaling & 0.241
metronidazole
gel
0.900 1.000
Table 2.7 The estimated sample size 
different alpha and beta levels based 
data.
per group using 
on the unadjusted
1-p a=0.01
ino•oIIS a=0.10
0.8 12 8 7
0.9 15 11 9
0.95 17 13 11
Table 2.8 Unadjusted and 
depth reductions among the 3 <
covariate-adjusted mean pocket 
groups.
Treatment Mean PD
reduction
Covariate- Standard 
adjusted mean deviation 
PD reduction
Scaling & 1.81 
tetracycline fibre
1.58 0.80
Scaling & 0.48 
minocycline gel
0.60 0.21
Scaling & 0.74 
metronidazole gel
0.86 0.93
Table 2.9 Matrix of pairwise covariate adjusted mean
differences (pilot study).
Scaling & Scaling & Scaling &
tetracycline minocycline metronidazole
fibre gel gel
Scaling & 
tetracycline 
fibre
Scaling & 
minocycline gel
Scaling & 
metronidazole 
gel
Table 2.10 Analysis of covariance on the mean pocket depth 
reductions with the baseline pocket depths as covariate 
(pilot study).
source S.S. D.F. M.S. F P
Treatment 1.263 2 0.632 1.544 0.300
PDO 1.037 1 1.037 2.535 0.172
Error 2.045 5 0.409
S .S ., Sum of squares 
D.F., Degrees of freedom 
M.S., Mean squares 
PDO, Baseline pocket depth
Table 2.11 The estimated sample size per group to 
demonstrate a significant difference between the 
tetracycline fibre and other treatments at different a and 
(3 levels using the covariate adjusted data.
1-P a=0.01 a=0.05 a=0.10
0.8 19 13 11
0.9 24 18 15
0.95 29 21 18
0.976
0.722 0.254
depth reductions were 1.58 mm, 0.6 mm and 0.86 mm for the
tetracycline fibre, the minocycline gel and the
metronidazole gel treatments respectively (Table 2.8). 
The pooled standard deviation was 0.64. Table 2.9 shows
the matrix of pairwise covariate adjusted mean
differences. Table 2.10 shows the analysis of covariance 
on the effect of the 3 treatments with the baseline pocket 
depth as the covariate. The effect of high baseline
pocket depth was stronger than the treatment effect. The 
sample size required to demonstrate significant
differences between groups at different a and P levels are 
shown in the Table 2.11. At the p-1 = 80% and the a =
5%, the required sample size would be 13 subjects per
group.
2.2.4.4 Discussion
The results of this pilot study should be looked at with 
care because of the relative crudeness of the estimation.
It was the assumption of the pilot study that in the main 
study, pocket depth reductions among the groups would be 
of the same magnitude and variability as were found in 
this study. However, in view of the large variability 
often found between individuals in the response to 
periodontal treatment, it was not known whether the 
results of this study would be repeated in the main study. 
Part of the variability is due to the relatively large 
measurement errors in the clinical examination of pocket 
depth and attachment levels. Another part of the
n o
variation is due to biologic variation in terms of the 
response to the treatment. There is a relatively large 
variation between sites and individuals in their response 
to treatment. The subject was considered as the unit of 
analysis, to take into consideration the 'within- 
individual' biological dependence, under the influence of 
systemic factors. This increased the estimated number of 
required subjects. If the site could have been used as 
the unit of analysis, the sample size requirements would 
be relaxed and a smaller number of subjects would be 
required. In the main study, if a significant difference 
is detected on the subject analysis, most likely a 
significant difference would be detected at a site-based 
analysis too.
In this pilot study it was estimated that a study of 13 
subjects in each group i.e. 52 patients with a total of 
208 diseased sites should provide sufficient power (80%) 
to demonstrate a significant advantage (p<0.05) of 
tetracycline fibre therapy in a 4-leg study, assuming it 
is of the same magnitude as that demonstrated in the pilot 
study. The probability of making a type II error i.e. p
is usually taken as 4 times a. Therefore, at a
significance level of a=0.05, the P=0.20 or 1~P=80% should 
be selected (Armitage and Berry, 1987). Obviously, any
increase in the value of 1-P would further increase the
power of the study to avoid the type II error.
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In this pilot study no control group was used. While no 
published data is available on the combination of 
metronidazole gel and scaling compared to scaling alone, 
some previous studies on the tetracycline fibre and 
minocycline gel indicated that the combination of scaling 
with either of them results in a better response than 
scaling alone (Newman et al., 1994, van Steenberghe et
al., 1993). It was assumed that the effect of scaling and 
root planing alone would not exceed any of the combined 
treatments. If this assumption was not true, then the 
required sample size may have been underestimated.
In this pilot study, the analysis of covariance was used 
to consider the effect of difference in the baseline 
pocket depths on the treatment outcome. The effect of 
baseline pocket depth was larger than the effect of 
treatment. This indicates that to reduce the
heterogeneity among the study population, the inclusion of 
subjects in the study, should result in relatively 
balanced groups in terms of the baseline pocket depth 
(pre-stratification). The post-stratification, using the 
analysis of covariance, will also minimise the remaining 
inevitable minor differences in the baseline pocket 
depths.
In conclusion, the target number of subjects would be at 
least 13 subjects per group i.e. 52 subject. Any excess
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number of subjects in each group would add to the 
statistical power of the study.
2.2.5 Material and methods used in the clinical study 
of the subgingival antimicrobial systems
2.2.5.1 Clinical design
The study protocol was approved by the local ethical 
committee. Subjects were selected from among patients 
attending the Periodontal Unit of the Adult Dental Care 
Department in Glasgow Dental Hospital for their 
periodontal treatment. These patients had finished their 
active phase of therapy and still had periodontal pockets 
> 5 mm with bleeding on probing. The number of subjects 
were estimated by a pilot study (section 2.2.4). The 
minimum target number was 13 patients in each group i.e., 
a total of 52 patients.
Each patient was to be examined at baseline, 6 weeks, 3 
months and 6 months after treatment. After baseline 
measurements patients were allocated randomly to one of 
the 4 treatments including: scaling and root planing plus 
insertion of 25% tetracycline monolithic fibres (Actisite, 
ALZA corporation, Palo Alto, CA) , scaling and root planing 
plus application of 2% minocycline gel (Dentomycin, 
Cyanamide of Great Britain, Lederle, Gosport, Hampshire, 
England), scaling and root planing plus application of 25% 
metronidazole gel (Elyzol, Dumex Ltd, Copenhagen), and
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scaling and root planing alone. The follow-up time points 
were 6 weeks, 3 months and 6 months after the last visit 
of treatment.
2.2.5.1 Patient screening and selection
Selection of sites was carried out on a screening visit, 
consisting of a full-mouth periodontal examination using a 
PC-12 probe. The patients were required to have
periodontal pockets > 5 mm with bleeding on probing or
suppuration in at least 4 non-adjacent teeth which either 
did not respond favourably to the mechanical therapy or 
showed a relapse of disease in spite of transient 
favourable response. Sites with furcation lesions were
not selected due to their unpredictable response to 
treatment. Anterior flat surface sites were preferred to 
the posterior flat sites because of the ease of
measurements and treatment and the higher reproducibility 
in anterior sites (Badersten et al., 1984a; Mullally and 
Linden, 1994). These patients had maintained a relatively 
good oral hygiene throughout previous treatment visits as 
documented in their hospital records.
The patients should not have had any antibiotic treatment 
during the previous 6 months. Patients with a history of 
allergy or adverse reaction following the use of 
tetracycline, minocycline and metronidazole were excluded. 
Patients with systemic disease, pregnancy, lactation, and 
a history of oral candidiasis were not selected. Only
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patients of at least 30 years of age were selected. By 
doing sof subjects with localised juvenile periodontitis 
would not be selected and a more homogenous population 
would be included in the study. If the patient fulfilled 
the inclusion criteria, informed consent was obtained. 
Alginate impressions were made at the same or subsequent 
visit for the fabrication of the measurement stents. Oral 
hygiene instruction was given according to individual 
needs.
2.2 .5 .3 Clinical indices
All the clinical examinations were carried out by a single 
examiner throughout the whole period of study (MR). The
sequence of the measurements was as described below.
2.2.5.4 The Modified Gingival Index
To assess the degree of gingival inflammation at each site 
the modified gingival index (Lobene et al., 1986) was used 
by the examiner. The criteria for the modified gingival 
index are:
Score 0: Absence of inflammation.
Score 1: Mild inflammation; slight change in colour, 
little change in texture of any portion of, but not the 
entire marginal or papillary gingival unit.
Score 2: Mild inflammation; criteria as above but 
involving the entire marginal or papillary gingival unit.
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Score 3: Moderate inflammation; glazing, redness, oedema 
and/or hypertrophy of the marginal or papillary gingival 
unit.
Score 4: Severe inflammation, marked redness, oedema
and/or hypertrophy of the marginal or papillary gingival 
unit, spontaneous bleeding, congestion or ulceration.
In this index, unlike other commonly used gingival
indices, the bleeding on probing component is not
assessed. This allows for a non-invasive assessment of the 
gingival inflammation by visual examination. Since
gingival crevicular fluid (GCF) samples were to be taken 
from the sites to determine the GCF volume, it was
important to use an index with minimal potential for 
disruption of the GCF volume and its biochemical profile.
2.2.5.5 The Plaque Index
The plaque index of (Silness and Loe, 1964) was used to 
score plaque accumulation at each site. Each site was 
dried using a blast of air and a score allocated from a 
range of 0 - 3. The criteria for plaque index includes:
Score 0: No plaque.
Score 1: A film of plaque adhering to the free gingival 
margin and adjacent area of the tooth. Plaque may only be 
recognised by running a probe across the tooth surface.
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Score 2: Moderate accumulation of soft deposits within the 
gingival pocket, on the gingival margin and/or adjacent 
tooth surface, which can be seen by the naked eye.
Score 3: Abundance of soft matter within the gingival
pocket and/or on the gingival margin and adjacent tooth 
surface.
2.2.5.6 Gingival crevicular fluid measurements
Gingival crevicular fluid (GCF) volume was measured as an 
additional index of gingival inflammation. Whatman grade 
4 filter paper (Whatman Labsales Ltd., Maidstone, Kent) 
was cut to 2x13mm strips using a ruler and a scalpel. A 
line was drawn on each strip at 8 mm indicating the length 
of the paper strip to be inserted between the jaws of 
Periotron (Periotron 6000, Harco Electronics, Winnipeg, 
Canada) . Autoclaved paper strips were used for GCF 
sampling. The area was isolated from saliva contamination 
with cotton wool rolls and saliva ejector and the gingival 
site was gently air dried and supragingival plaque 
removed. The sterilised paper strip was introduced into 
the crevice until mild resistance was felt and left for 30 
seconds. The strip was immediately transferred to the 
Periotron and the Periotron reading recorded. The jaws of 
the Periotron were wiped with pure methanol and dried with 
filter paper between readings (Figs. 2.6 and 2.7).
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Fig.2.6 Filter paper strips in situ (top) 
Fig.2.7 Periotron 6000 (bottom).
Periotron 
reading
1.75 + 252.14x
25.
100
0
Volume (ul)
Fig.2.8 Regression lines and equations for the 
Periotron calibration.
2.2.5.7 Calibration of Periotron
Prior to each visit, calibration of the Periotron was 
performed. Known volumes of serum diluted 1:1 with
phosphate buffered saline were introduced onto paper
strips using a Hamilton microsyringe. Volumes included 
0.05, 0.1, 0.2, 0.4, 0.8, 1 fil. Each measurement was
performed three times and the mean values of each volume 
were subjected to regression analysis. Two regression 
lines were constructed: one line for the volumes 0.05-0.20 
jil and another line for the volumes 0.20-1.00 |il. The 
slope and intercept of the regression lines were used to
determine the GCF volume (Fig.2.8). The calibration
reduced any variation in Periotron measurements due to 
changes in atmospheric humidity.
2.2.5.8 The probing pocket depth and probing attachment 
levels
The Florida probe was used for measuring the probing depth 
and attachment level in this study. Based on the results 
of our pilot study (section 2.2.2), the use of 'Stent' 
handpiece was preferred. The Florida probe and the 
methods of measurements were described earlier in detail 
(section 2.2.1).
Both recordings were taken in duplicate. First, the first 
pair of the pocket depth readings was recorded, then the 
stents were placed and the first pair of the attachment 
level readings was taken. After removing the stents and
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changing the position of the patient, the examiner left 
the room and 5 minutes later, the same procedures were 
repeated to record the second pairs of the probing depth 
and attachment level measurements. The average of the 
first and second measurements was calculated as the value 
of the pocket depth and attachment level for that site at 
that time point. The examiner's reliability in these 
procedures was determined and described in section 2.2.3.
2.2.5.9 Bleeding on probing (BOP)
Bleeding on probing was scored dichotomously using the 
Florida Probe (pocket depth handpiece) at the same time as 
the recording of the first measurement of pocket depth. 
The presence or absence of bleeding within 30 seconds of 
probing was recorded.
2.2.5.10 Suppuration
The presence or absence of suppuration was examined by 
gently applying a ball burnisher on the gingival mucosa in 
an apico-coronal direction.
2.2.5.11 Controlled randomisation; criteria for patient 
allocation to treatments
The purpose of patient allocation was to have four groups 
of patients which were balanced in terms of age and 
smoking status. The participants in the study were 
randomly allocated by the therapist to receive one of the 
treatments. Effort was made to prevent serious imbalance
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between groups in terms of the average scores of the above 
mentioned parameters. While pre-stratification by such a 
method is not always perfectly feasible, especially if 
more than one Criterion is used for stratification, it can 
prevent serious imbalance in factors which are known or 
suspected to influence the treatment outcome.
2.2.5.12 Treatments
All the treatments were performed by a single operator 
(NP) who had been trained in the use of the antimicrobial 
systems. In applying the antimicrobial systems, the 
manufacturer's recommendations were strictly adhered to. 
The treatments included:
1) Subgingival scaling and root planing under local 
anaesthesia. All deep pockets within the mouth were 
treated. Each tooth was instrumented for approximately 5 
minutes. Normally, a 60-minute visit was required for 
this purpose. An additional appointment was used if this 
was required.
2) Subgingival scaling and root planing under local 
anaesthesia and the application of 25% tetracycline 
impregnated fibres into the pocket. The fibre delivery 
system was 0.5 mm diameter ethylene vinyl acetate (EVA) 
copolymer fibre loaded 25% by weight with tetracycline 
hydrochloride resulting in a drug concentration of 0.55 
mg/cm fibre. The fibre was wrapped loosely around the
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teeth by passing it through the contact points using 
dental floss, a floss threader or a plastic instrument. 
The pocket was occupied by fibre without creating 
excessive tension in the soft tissues. A cyanoacrylate 
adhesive (Octyldent, Tri-point Medical LP, Raleigh, NC) 
was applied over the gingival crevice to fix the fibre 
into the pocket and a periodontal dressing (Coe-pak, GC 
America INC, Chicago, IL) was placed (Fig. 2.9). The 
fibre was removed 10 days later using periodontal 
curettes.
3) Subgingival scaling and root planing plus the 
application of 2% minocycline dental gel to the pocket 
until it was overfilled. This is a 2% weight by weight 
minocycline hydrochloride preparation which is presented 
in disposable plastic applicators, each containing 0.5 g 
dental gel. The sealed foil packages, each containing one 
applicator were stored in a refrigerator (2-8° C) and were 
allowed to equilibrate to room temperature 15 minutes 
before application. Between application from site to site 
within the patient, the applicator nozzle was cleaned with 
a disposable alcohol impregnated tissue (Azowipe, 
Vemoncarus, England) . Gel application was repeated 14 
days and 28 days after the initial application (Fig. 
2 .10) .
4) Subgingival scaling and root planing plus the 
application of 25% metronidazole dental gel.
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Metronidazole gel is a semisolid suspension containing 
metronidazole benzoate corresponding to 250 mg 
metronidazole per gram of gel. It is presented as 
disposable intraligamentous injection syringes containing 
1 g of gel which is injected into the pocket using a blunt 
needle until it is overfilled. Each package contains 2 
syringes and it should be stored at room temperature 
(20°C). Between applications from site to site, the 
applicator nozzle was cleaned with a disposable alcohol 
impregnated tissue. Gel application was repeated 7 days 
later (Fig. 2.11).
Patients who received gel applications were instructed not 
to eat or drink for 3 hours post application. Moreover, 
they were told not to use interdental cleaning devices in 
the treated sites for the rest of the day. The patients 
who received metronidazole gel were forbidden to take 
alcohol for 24 hours post-treatment to prevent disulfiram 
like reactions (British National Formulary, 1994).
Treatment time was recorded. The length of tetracycline 
fibre used for each site was also recorded. At each post- 
treatment visit, the treated sites were examined for any 
adverse signs related to the treatments and results were 
recorded. Any reported symptoms were also recorded.
During this study, other sites received conventional 
maintenance care according to their individual needs. No
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Fig.2.9 Tetracycline fibre, cyanoacrylate adhesive, 
and the squeezette.
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further treatment was carried out for the study sites 
during the 6 months follow up period unless a site showed 
attachment loss more than 2 mm or developed an abscess.
2.2.5.13 Statistical analysis
Pocket depth and attachment level data were analysed on a 
subject basis, i.e., the values of the 4 sites within each 
patient were averaged at each time point, to produce a 
single figure. The significance of the pocket depth and 
attachment level change from baseline to each follow-up 
time point within each treatment group was tested using 
the paired-t test. An analysis of variance using the 
General Linear Model (GLM) procedures was performed on the 
change in the pocket depth and attachment levels. The 
treatment effect was the main factor with 4 levels/ and 
the baseline pocket depth was a continuous covariate. By 
using this analysis, the effect of baseline pocket depth 
on the treatment outcome is taken into account. 
Hypothesis testing was initiated by including the main 
effect and covariate as well as the interaction between 
these 2 factors. If the interaction was not significant, 
the model was tested again without the interaction term. 
If the p value for the treatment effect was significant, 
post-hoc comparisons were made using the same procedure 
(GLM) , by comparing only 2 treatments at a time, and the 
significance threshold value was divided by the square 
root of the number of comparisons (Brown and Swanson-Beck,
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1988) . Therefore, the significance level was set at 
0.05/V6=0.020.
The significance of change in BOP and suppuration data 
within each treatment group was tested using the Fisher's 
exact test for paired data. The chi-square {%2) test was 
used to test the hypothesis of association between the 
treatments and the improvement in BOP. Since the 
prerequisites of the chi-square test were not met for the 
suppuration data due to the presence of small expected 
counts in too many cells, the Fisher's exact test was 
used. The MGI scores were subjected to the Wilcoxon's test 
to examine the significance of change from baseline to 
each follow-up visit in each treatment group. The 
Kruskal-Wallis test was used to compare the MGI scores and 
the PI scores between treatments. If the test was 
significant, pair-wise comparisons were performed using 
the Mann-Whitney U test and the p value was adjusted for 
multiple comparisons. GCF volume data were analysed using 
the paired-t test for the significance of change within 
each treatment group, and using the one-way analysis of 
variance (ANOVA) to compare the change in the GCF volume 
between groups.
The two sample tj-test was used to compare the change in 
pocket depth and attachment level between smoker subjects 
and subjects who were not smokers, regardless of the 
treatment type. To further elucidate the effect of
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smoking status on the treatment outcome while considering 
other important factors, the GLM procedure was used with 
treatment and smoking status as the main factors with 4 
and 2 levels respectively, and baseline pocket depth as a 
continuous covariate. A backward elimination approach was 
used to eliminate the interaction terms, that is, the 
initial model included all 3-order and 2-order interaction 
terms; the-3-order interaction was eliminated if it was 
not significant, and the model was tested without the 3- 
order interaction. The next insignificant interaction term 
with the largest p value was eliminated and so on. The 
final model consisted of only individual factors and the 
significant interaction terms. Since a significant 
interaction was consistently found between the smoking 
status and the baseline pocket depth, indicative of 
heterogeneity of the covariate slopes, between the smokers 
and non-smokers, linear regression analysis was used for 
the smokers and non-smokers independently, to examine the 
relationship between the baseline pocket depth and 
improvement in pocket depth or attachment level.
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2.3 The laser in vitro studies
This investigation consisted of 3 preliminary studies, and 
a main study. The main in vitro study aimed to evaluate 
the effect of the Nd:YAG laser treatment on the 
subgingival calculus, cementum, and dentine in vitro. 
Prior to the study, 3 pilot studies were performed to 
determine the methodology of the main in vitro study. In 
the following sections the pilot studies are described 
subsequently followed by the methods used in the main in 
vitro study.
2.3.1 Preliminary study; Preliminary evaluation of the 
effect of an Nd:YAG laser on calculus
2.3.1.1 Introduction
This pilot study was used as a preliminary assessment of 
the effect of laser energy on calculus and root surface. 
The information obtained from this study and the 
subsequent pilot studies enabled the investigators to 
design a suitable method of assessing the laser effects in 
a semi-quantifiable fashion for the main in vitro study. 
Here, it was intended to mimic the clinical application of 
the laser using an in vitro model. In this study the 
laser was used either alone or in conjunction with root 
planing and their effects were compared with root planing 
alone and no treatment, as positive and negative controls.
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2.3.1.2 Materials and methods
Six freshly extracted teeth with subgingival calculus were 
selected. The coronal half of the roots was covered with 
dental modelling wax of 2mm diameter. The entire length 
of the roots were then embedded in dental plaster. When 
the plaster had set, the wax was removed with warm water, 
leaving an exposed area of root surface similar to a 
periodontal pocket (Fig. 2.12). Each of the 4 surfaces of 
each tooth was randomly assigned to one of the following 
treatments: A) laser treatment alone, B) root planing
alone, C) laser treatment plus root planing and D) 
untreated control.
One of the following 6 different laser treatments was 
randomly applied to each tooth: 1) 50 milli-Joules (mJ) ,
10 pulses per second (pps) for 1 minute (min) ; 2) 50 mJ, 
10 pps for 2 min; 3) 100 mJ, 15 pps for 1 min; 4) 100 mJ, 
15 pps for 2 min; 5) 125 mJ, 20 pps for 1 min; and 6) 125 
mJ, 20 pps for 2 min. The optical fibre was kept in 
contact with and parallel to the root surface and the tip 
of the probe was moved with overlapping strokes to ensure 
coverage of the entire area being treated.
After treatment, the teeth were gently removed from the 
surrounding plaster and slabs of approximately 2mm in 
thickness containing the treated surfaces were cut from 
the teeth using a handpiece and disc. These were fixed in 
10% neutral buffered formalin for 3 hours, then air dried
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for 48 hours. The specimens were mounted on 32mm diameter 
aluminium stubs with Leit C conductive carbon adhesive, 
sputter coated with gold (Polaron-E 5000) and then 
examined by a scanning electron microscope (SEM) (Jeol- 
T300) operating at an accelerating voltage of 30 kV.
2.3.1.3 Results
It was observed that laser treatment alone at any of the 
pulse energies tested did not remove the calculus from the 
specimens, but areas of black, charred calculus were 
observed on specimens treated with the laser energies 
equal or higher than 100 mJ (Fig. 2.13). At the pulse 
energy of 50 mJ, no change occurred as compared to the 
untreated controls.
At higher magnifications under SEM, scattered areas of 
melted calculus could be seen. However, this pattern was 
the same for all surfaces treated by laser energies of 
equal or higher than 100 mJ (Fig 2.14a) and it was not 
possible to differentiate between the effect of different 
energy settings.
In some of the specimens in the group treated with the 
laser plus root planing, the cementum appeared to have 
peeled away from the root surface, exposing dentinal 
tubules (Figs. 2.14b,c).
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Fig.2.12 Experimental teeth cast in plaster 
(preliminary study).
Fig.2.13 Laser treated calculus (125 mJ, 20 pps, 
minutes). The black coloured area is the charred 
calculus.
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Fig.2.14. SEM micrographs of the laser treated root 
surface (preliminary study).
a: Laser treated calculus (100 mJ, 15 pps, 2 minutes); 
The calculus surface has been melted down. 
b,c: The laser treatment (125 mJ, 20 pps, 1 minute)
followed by root planing on the cementum. The 
cementum layer has been peeled off after root planing, 
exposing the dentinal tubules (c).
d: Surface cracking of the specimen (see the text). 
e: Cementum surface treated with root planing alone;
The surface is covered with a scale like smear layer.
mm
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Many cracks were observed on the surface of the cementum 
and calculus in most of the specimens (Fig. 2.14d). The 
presence of these cracks made a precise evaluation of the 
effects of the treatments on the specimens difficult. On 
surfaces which had only been root planed, a smear layer 
was observed over most of the treated areas on all 
specimens (Fig. 2.14-e). However, the treated area was 
smoother than laser treated surfaces and little measurable 
amount of calculus was observed.
2.3.1.4 Discussion
In previous studies on the effects of laser treatment on 
root surfaces (Cobb et a!., 1992; Morlock et al., 1992;
Trylovich et al., 1992) a protocol similar to the one used 
in this study was employed, i.e. overlapping movements of 
the tip of the laser handpiece parallel to the root 
surface. In view of the fact that the laser beam produced 
only has a diameter of 32o/jUjm, it is likely that during 
the limited treatment time, many areas of the specimens 
may not have been lased, whereas other areas may have been 
treated more than once. Because of this limitation, the 
treatment effects could not always be evaluated precisely.
Although this study showed that treatment with the laser 
beam had a melting effect on the surfaces of the treated 
specimens, it was not possible to differentiate the 
effects of different energies. Therefore, in the main 
experiment, it was decided to keep the fibre stationary 
and perpendicular to the root surface for the duration of
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the treatment period in order to localise the treated 
area.
The presence of surface cracks on the roots was probably 
due in part to the rapid evaporation of water in the 
partial vacuum of the coating chamber. The use of alcohol 
baths to dehydrate the specimens before drying in air may 
decrease the number and severity of the cracks on the 
surface. If the whole tooth was used instead of 2mm thick 
slabs, the greater bulk of dentine present may be less 
prone to cracking than a thin specimen. It was decided 
that the whole tooth should be dehydrated in increasing 
concentrations of ethanol and finally immersed in 
hexamethyldisalazane before air drying (Morlock et al.,
1992) to reduce the likelihood of cracking. Moreover, the 
cracking of specimens was addressed in a pilot study.
2.3.2 Preliminary study; Selection of laser settings
2.3 .2 .1 Introduction and methods
Since the purpose of the main in vitro study was to 
evaluate the effects of different laser settings on 
calculus, cementum and dentine in terms of physical 
damage, this preliminary study was carried out to 
determine which settings appeared to be suitable for SEM 
study. From this information, a range of laser settings 
for the main in vitro study would be selected.
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2 .3 .2.2 Materials and methods
Two calculus covered surfaces were laser treated. Each 
tooth received the following laser settings: 30mJ, 50mJ
and lOOmJ at lOpps; and lOOmJ at 20pps, each for 1 and 5 
seconds. The handpiece was kept stationary, perpendicular 
to the surface using an adjustable jig (Fig. 2.15). The 
specimens were then prepared and examined by SEM. The 
preparation of specimens for SEM have been described in 
sections 2.3.4.7-10.
2.3.2.3 Results
SEM examination showed no change in the specimens treated 
at 30mJ, lOpps for both 1 and 5 seconds. At 50mJ, lOpps 
for l sec, slight changes were noted in one of the 
specimens, the other did not appear to have been damaged.
The same held true for treatment for 1 second at lOOmJ, 
lOpps. Moderate damage was observed on both of the 
specimens treated for 5 sec at 50mJ, lOpps. Treatment at 
lOOmJ, lOpps for 5 sec and lOOmJ, 20pps for both 1 and 5 
sec resulted in severe damage to the calculus. The bottom 
of the pit produced by the laser treatment was hardly 
visible under the SEM, indicating that the underlying hard 
tissues were severely damaged.
2.3.2.4 Discussion and conclusion
Moderate damage was produced by treatment with the laser 
at 50mJ, lOpps for both 1 and 5 sec, and lOOmJ, lOpps for 
1 sec, yet one of the specimens treated at 50mJ, lOpps for
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Fig. 2.15 The jig used to stabilise the laser 
handpiece
1 sec did not appear to be affected. Treatment settings 
other than these values produced either no visible effect 
or very severe damage to the cementum and therefore did 
not seem suitable for further investigation by the SEM. 
From the results of this preliminary study, values of 50mJ 
and lOOmJ for 1 and 5 seconds duration were chosen for 
further investigation. Pulse rate settings of lOpps and 
20pps were also included in the protocol to determine 
their effects on the treatments. The combinations of 
these values resulted in a choice of eight different 
treatment settings to be tested.
2.3.3 Preliminary study; Explanation of cracking of
the laser treated surface
2.3.3.1 Introduction
In previous SEM studies of lased samples, cementum 
specimens showed several cracks. Some studies on
untreated cementum suggested that cracks were produced by 
the coater machine with the vacuum causing the water 
content of the tissue to evaporate very quickly resulting 
in shrinkage and surface crack formation. This study was 
conducted to determine whether cracks on treated surface 
were due to the processing techniques or the impact of the 
laser pulses.
2 .3.3.2 Material and methods
A silicon impression (Xantopren, Bayer, Germany) was 
obtained from one calculus specimen. After laser exposure
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Fig.2.16 Silicon impression from the experimental 
surface (left); epoxy resin impression (right). (See 
the text).
Fig.2.17 SEM micrographs of the replicated untreated 
(top left and top right), and the laser treated 
calculus surface (bottom left and bottom right) 
(preliminary study). No difference in the surface 
cracking is observed.
Fig.2.18 SEM micrograph from the untreated cementum
surface. Cracking of the specimen was due to the
specimen preparation process.
at 100 mJ, 20 pps for 10 sec, another silicon impression 
was taken. Both impressions were poured by epoxy resin 
(Epofix, Struers, England) to obtain replica models of 
tooth before and after laser treatment (Fig. 2.16).
In addition, 2 unlased cementum specimens were fixed and 
dried (as described in the sections 2.3.4.7 and 2.3.4.8). 
The replicas and the untreated cementum specimens were
i
mounted on aluminium stubs and [splutter-coated with gold 
and examined by SEM (sections 2 .3.4.9 and 2.3.4.10).
2 .3 • 3 .3 Results and conclusion
Replicas reproduced the surface details accurately. SEM 
showed no difference in cracking of the two replicas taken 
before and after lasing (Fig. 2.17). The unlased cementum 
specimens showed cracks, similar to previous laser treated 
specimens (Fig. 2.18). Therefore, it was unlikely that 
the laser treatments had a major contribution to the 
surface cracking.
2.3.4 Material and methods used in the main in vitro
laser experiment 
2 .3.4.1 Introduction
The first pilot study (section 2.3.1) demonstrated that 
the study of the effects of laser on the root surface was 
difficult if the laser handpiece was moved on the surface
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during the treatment. The present study describes the 
effect of different laser settings and treatment durations 
on the calculus, cementum and dentine when a stationary 
handpiece is used to deliver the laser energy. The aims 
of this study were: 1) To determine whether there was a 
laser energy dose which could selectively ablate calculus
without affecting cementum. and dentine; 2) To determine whether, the ablative
effect of a given laser energy dosage on the calculus and 
root surface, is repeatable i.e. whether it could be used 
in a predictable manner. This study consisted of 2 
separate experiment; one on subgingival calculus and the 
other on cementum and dentine. The results of these 
experiments have been described in chapter 3.
2.3.4.2 Tooth collection and preparation
Freshly extracted teeth were collected from the Oral 
Surgery Department of Glasgow Dental Hospital.
Calculus experiments For the calculus study, each tooth 
had at least one flat surface with subgingival calculus as 
these are more easily assessed by SEM. Thirty-two teeth 
fulfilling the above criteria were selected.
Cementum and dentine experiment: For the experiment on the 
cementum and dentine, the criteria was to have a flat 
surface with no periodontal disease i.e. the root surface 
should have been exposed only after extraction. Six teeth 
were selected and the remnants of the periodontal ligament
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were removed using forceps. This was confirmed by 
examining the roots at xlO magnification under a 
stereomicroscope. Of these 6 teeth, 3 were randomly 
selected and excessively root planed using a periodontal 
curette until it was judged that the cementum layer was 
removed, and the dentine became exposed. Using a sharp 
scraper, the root surfaces were divided into 8 areas, each 
approximately 2x2 mm. Debris from the scraping and root 
planing were removed gently using a soft brush and 
deionised water. Each area was subjected to one of the 8 
laser treatments as described subsequently. All the teeth 
were kept in a 0.12% thymol solution in a refrigerator 
until the experiment.
2.3.4.3 Study design
Calculus experiments Thirty two teeth were randomly 
divided into 8 groups of 4. Each group was then treated 
by one of the 8 laser protocols as described subsequently.
Each tooth was treated on 2, 3 or 4 sites depending on
the size and extent of calculus.
Cementum and dentine experiments Three cementum covered 
and three root planed teeth were treated. Each of the 8 
small areas described previously was randomly allocated to 
one of the laser treatments.
135
2.3.4.4 The Nd:YAG laser
The laser used in this study was an Nd:YAG laser, 
especially designed for dental practice (American Dental 
Laser, model d.lase-300, Sunrise Technology Inc., Fremont, 
California) (Fig. 2.19). The Nd:YAG laser beam has a 
wavelength of 1064 nm. Since the wavelength is not in the 
visible part of the spectrum, a visible and low energy He- 
Ne laser is used in the instrument as an aiming beam. The 
medium for the laser energy is a crystal rod made of 
yttrium, aluminium and garnet which has been seeded with 
neodymium. A timer is supplied into the energy source and 
gives the laser output a pulse mode, each pulse lasting 
for 150 mp,s. The pulse rate ranges from 10 to 30 pulses 
per second (pps) which is adjustable by the operator. The 
energy ranges from 30 to 150 mJ per pulse. By varying the 
pulse rate and the pulse energy output, a range of average 
power settings from 0.3W to 3W can be achieved. The laser 
energy is transmitted through a flexible optic fibre cable 
which has an inner diameter of 320 urn. The energy is 
transferred to the target area by an adjustable handpiece 
fitted to the end of the cable. The laser is controlled 
by the operator using a foot pedal.
2.3.4.5 Laser usage and safety
Since the high energy NdrYAG laser pulses are readily 
transmitted through the transparent eye tissues, the laser 
operator, assistants and patient wore special protective 
spectacles.
136
Fig.2.19 American Dental laser (Nd:YAG laser)
During application of laser energy to dental tissues, tip 
of the optical fibre may become damaged. When this 
happens, the fibre does not emit a uniform beam. Thus the
beam emitted by the fibre was checked frequently by
examining the integrity of the image of the aiming beam on 
a flat surface (which should be a full circle) . If the
fibre tip was damaged, its first few millimetres were cut
using a special cutter and the handpiece was re-adjusted.
2 • 3.4.6 Laser treatment
The laser treatment settings were chosen from the results 
of a pilot study (section 2.3.2). These were:
Laser energy: 50 and lOOmJ.
Number of pulses per second: 10 and 20pps.
Treatment duration: 1 and 5 sec.
Therefore, 8 laser treatment settings were used in the 
study.
Using an adjustable jig the handpiece tip was held 
stationary, in contact with, and perpendicular to the 
surface to be treated. The use of a stationary handpiece
provides a standardised and repeatable method of applying
the laser beam to the tissue. If the handpiece is moved 
over the entire surface, some areas might be treated more 
than others and some areas might be left untreated,
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because of the small diameter of the laser beam, which is 
only 320 |[im across.
2.3.4.7 Fixation
Immediately after treatment, the specimens were fixed in 
ice-cold 2.5% glutaraldehyde in 0.1M cacodylate buffer at 
pH 7.4 for a minimum of 2 hours.
2.3 « 4.8 Dehydration
After fixation the specimens were washed three times in 
0.1M sodium cacodylate buffer, for 20 minutes each time, 
then dehydrated in increasing concentrations of ethyl 
alcohol as follows: 33% for 4 hours, 50% for 4 hours, 67% 
for 12 hours, 95% for 48 hours and 100% for 72 hours. The 
final dehydration was carried out by immersing the 
specimens in hexamethyldisilazane for 36 hours. The 
specimens were removed from this solution and air dried in 
a dtust-free environment for 24 hours. Long dehydration 
times were required because of the large size of the 
specimens i.e. whole teeth, and also because of the dense, 
highly mineralised nature of the tissue.
The specimens were mounted on 32 mm diameter aluminium 
stubs (Agar Scientific Ltd.) using a conductive carbon 
cement (Leit C, TAAB Laboratories Equipment Ltd.).
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2.3.4.9 jSplutter coating
The specimen was placed in the vacuum chamber of a jsplutter 
coating machine (Polaron E 5000) and the air was evacuated 
until a reading of 0.1 Torr was obtained. At this time 
argon was allowed to bleed slowly into the chamber while 
it was still being pumped down. Argon is
electrochemically neutral and is less likely to interfere 
with the gold coating process than air. A thin film of 
gold was evaporated from a target situated at the top of 
the chamber onto the surface of the specimen at a voltage 
of 1.2 kV. This process was allowed to continue for 5 
minutes.
2.3.4.10 Scanning electron microscopy (SEM)
In this study, a Jeol T 300 scanning electron microscope 
operating at an accelerating voltage of 30KV and
angulation of zero degrees was used. Micrographs were
taken from the laser treated sites at xlOO and x750
magnifications using Kodak TP120 film type 6415 (Kodak 
Ltd. Manchester).
2.3.4.11 Index of laser damage
The evaluation of the surface damage to the tissues 
produced by the laser was carried out as a blind 
examination by the investigator. The following criteria 
were used as an index to quantify the damage produced by 
the laser:
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Fig. 2.2 0 Index for laser damage; Score 0 (see the 
text); magnification = x750.
Fig. 2.21 Index for laser damage; Score 1 (see the 
text); magnification = x750.
Fig. 2.22 Index for laser damage; Score 2 (see the 
text); magnification = xlOO.
?ig. 2.23 Index for laser damage; Score 3 (see the 
:ext); magnification = xlOO.
Score 0: No change (Fig. 2.20) .
Score 1: Slight changes including superficial melting of 
the surface. There is little or no ablated material. 
These changes are not visible at a magnification of xlOO 
(Fig. 2.21) .
Score 2: Moderate changes, i.e. shallow depressions on the 
surface of the tissue caused by the laser. These changes 
are visible at a magnification of XlOO (Fig. 2.22).
Score 3: Severe changes including deep craters caused by 
ablation and dissociation of surface material. These were 
visible on the tooth surface (Fig. 2.23).
2.3.4.12 Statistical analysis
The results from the experiment on cementum and dentine 
indicated that there was large variability between teeth 
in their response to the laser. Thus, in the calculus 
experiment, the tooth rather than the site was used as the 
unit of analysis and the index of damage was averaged over 
sites within a tooth to produce a single measure of damage 
for each tooth. The effect on tooth damage of energy 
setting (50 or lOOmJ), the number of pulses per second (10 
or 2 0), and the time (1 or 5 sec) was assessed by a three- 
way analysis of variance. The total energy input for each 
setting was evaluated by multiplying the energy (mJ) , the 
number of pulses per second and time. The relationship 
between the logarithm of the total energy input and damage 
was assessed by linear regression.
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2.4 The clinical laser study
2.4.1 Introduction; the rationale for the choice of
laser settings
The literature on the laser studies were reviewed in 
details in chapter 1. However, it seems necessary here, 
to highlight the important points of the literature which 
helped determine the laser settings used in this clinical 
study:
Some investigators have suggested that lasers can reduce 
the bacterial population in the pocket and contaminated 
dentine (White et al., 1991; Tseng et al., 1991b; Cobb et 
al., 1992). The main strategy in periodontal therapy is 
the elimination of bacterial plaque from periodontal 
pockets and root surfaces. Laser radiation of various 
wavelengths including Nd:YAG laser has been shown to be 
capable of killing bacteria to various extents (Cobb et 
al., 1992; Stabholz et al., 1993b; Sarkar and Wilson,
1993) and so in theory, could be used to substantially 
reduce the root surface bacterial population. The Nd:YAG 
laser, however, has been shown to alter the physical and 
biological properties of the cementum surface, if used at 
energies in the range commonly used (Cobb et al., 1992; 
Spencer et al., 1992; Trylovich et al., 1992; Morlock et 
al., 1992; Thomas et al., 1992). Root surface damage has 
been reported to be caused by energy level of 80mJ at 
lOpps in vitro using a moving fibre (Trylovich et al.,
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1992). Cobb et al. (1992) used energy settings of 1.75 W
(about 87mJ, 20 pps) and higher in vivo, and reported a
significant reduction in the proportion of 
periodontopathic bacteria. However, the cementum surface 
was damaged by the high levels of laser energy as 
demonstrated by scanning electron microscopy (SEM). 
Moreover, temperature rise beyond the thresholds tolerable 
for the pulp has been observed if the root surface was 
treated with laser energy settings higher than 80mJ, for a 
dentine thickness of 1mm (White et al., 1994). It has 
also been reported that the Nd:YAG laser is capable of 90% 
kills or more for some oral bacteria including several 
periodontopathic species at an energy setting of 80mJ and 
10 pulses per second (pps) for 3 minutes in vitro where 
the fibre was manipulated within 5(j|uL microbial 
suspensions (Whitters et al., 1994). On conclusion, it 
appeared that the 80mJ at lOpps, though low in energy 
level, had some bactericidal effect and thus warranted 
further investigation. Therefore, 80mJ at lOpps was 
included in the protocol. On the other hand, since some 
reports indicated that the laser!-induced alterations may 
happen even at energies as low as 80mJ at lOpps (Trylovich 
et al., 1992), 50mJ at lOpps was also included as a laser 
setting in the study for assessing its efficacy and also 
damage potentials on the root surface.
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2.4.2 Study design; patient and site selection
Eleven patients with untreated chronic adult periodontitis 
who had periodontally affected teeth of poor prognosis and 
scheduled for extraction, took part in this study. In 
total 80 sites were selected, each receiving one of the 
four treatments described subsequently. In each patient, 
four pockets were matched for pocket depth within a 
tolerance of 1 mm. Nine patients provided 8 sites, that 
is two sites for each treatment modality, and two patients 
provided one site for each treatment. An informed consent 
form was signed by each patient.
Clinical measurements were performed for all 4 sites at 
baseline, and 6 weeks after treatment. Microbiological 
samples were taken at baseline, after treatment, and 6 
weeks after treatment. After 6 weeks, test teeth were 
extracted as scheduled. Treated surfaces were examined
using SEM for surface alterations.
2.4.3 Treatments
Treatments included lasing with 50mJ, or 80mJ pulses, or 
scaling; one site was the untreated control.
Pulsed Nd:YAG laser treatments were performed with an 
Nd:YAG laser with a contact fibre optic handpiece, at 
power settings of either 50mJ or 80mJ both at lOpps. The 
optical fibre was kept almost parallel to the root surface 
with the fibre tip in contact with the root surface during
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treatment. The handpiece was moved back and forth by the 
operator to cover the whole surface area of each pocket 
for 3 minutes. Scaling and root planing were performed 
with periodontal hoes and curettes until a smooth surface 
was obtained (on average ten overlapping strokes). Laser 
treatments and scaling were preceded by local anaesthetic 
administration. Control treatment included applying the 
laser handpiece to the root surface of control sites for 3 
minutes with the laser machine switched off, taking into 
account any effect of the fibre in mechanically removing 
bacteria.
2.4.4 Clinical measurements
Baseline measurements included, Plaque Index, Modified 
Gingival Index, subgingival microbiologic sampling, pocket 
depth and presence of bleeding on probing. Immediately 
after treatment microbiologic sampling was repeated. The 
clinical and microbiological measurements were repeated 
after 6 weeks.
2.4.5 The Plaque Index and the Modified Gingival Index
These indices were described in the sections 2 .2.5.4, and 
2.2.5.5.
2.4.6 Pocket depth
Using a pressure sensitive £robe with a standard pressure 
of 25 g, selected sites were measured to the nearest 
millimetre. The probe was inserted immediately
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buccally/lingually at the contact point, being parallel to 
the long axis of the tooth.
2.4.7 Bleeding index
Dichotomous values of bleeding index were obtained. At 
each site, the presence or absence of bleeding up to 30 
seconds after gentle probing at each site was inspected
and recorded at the same time as the pocket depth
measurement.
2.4.8 Microbial sampling and culture
Microbial samples were taken from each site before, 
immediately following, and 6 weeks after treatment. 
Samples were collected by first removing supragingival
plaque, then isolating the site with cotton rolls. A
sterile, medium-size paper point was inserted to the depth 
of the pocket for 10 seconds and transferred into a bottle 
containing Fastidious Anaerobe Broth (FAB) (Lab M. 
England) and immediately transferred to the laboratory for 
total anaerobic count (CFU/ml). Each sample was Vortex 
mixed for 30 sec, serially diluted in FAB from neat to 10"5 
and inoculated with a spiral plater (Don Whitley 
Scientific, Shipley, England) onto Fastidious Anaerobe 
Blood agar containing 7.5% v/v sterile defibrinated horse 
blood. Plates were incubated for 10 days at 37° C in an 
anaerobic incubator (Don Whitley Scientific, Shipley, 
England) at an atmosphere of 5% H2, 10% C02, 85% Nitrogen. 
The total number of colony forming units in each sample
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(CFU/ml) was calculated and converted to logs for 
statistical analysis.
2.4.9 Extraction and SEM
After the 6-week visit, the laser treated teeth were 
extracted and were then fixed in 2.5% glutaraldehyde in 
0.1M cacodylate buffer at pH 7.4. Following fixation, the 
specimens were dehydrated using an ascending series of 
graded ethanol solutions and the final dehydration was 
carried out using hexamethyldisilazane for 36 hours. The 
specimens were (splutter-coated (Polaron E5000) with gold 
and viewed on a Jeol JSM T300 SEM at 30 KV to examine 
whether the laser damage was present on the root surfaces. 
The characteristic features of the laser damaged surface 
include charring, crater formation, cementum melt down, 
with subsequent resolidification of inorganic material 
(Cobb et al., 1992; Trylovich et al., 1992).
2.4.10 statistical analysis
For the analysis of plaque and gingival index data, 
baseline and 6-week visit data were compared using 
Wilcoxon's test and changes in these parameters in the 4 
groups were subjected to Friedman's test. The latter 
compares the mean ranks of treatments i.e. an average of 
every site's score, ranked across the four treatment 
groups within each patient. BOP data of baseline and 6- 
week visit in each treatment group were compared using the 
McNemar's test. Pocket depths were compared using a
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paired t-test on baseline and 6-week visit data for each 
treatment group. Repeated measurement analysis of
variance (ANOVA) was used to compare pocket depth changes 
in 4 groups, and where an overall significant difference 
was detected, Duncan's multiple range test was used to 
uncover the significantly different groups. For the 
microbiology data, differences between the counts in 
samples before and immediately after treatment, as well as 
differences between the counts before treatment and at the 
6-week visit, were subjected to repeated measures ANOVA 
and Duncan's multiple range test.
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CHAPTER III
RESULTS
3.1 The clinical study of local antimicrobial 
delivery systems
3.1.1 Introduction
This study was carried out on maintenance patients who, 
despite previous mechanical therapy, still had sites with 
signs of periodontal disease. The study aimed to 
investigate the clinical effects on the periodontitis 
sites of 3 commercially available locally delivered 
antimicrobial systems as adjuncts to scaling and root 
planing. This section contains the results of the study 
from baseline to the 6 month follow-up. Firstly, subject 
information such as number of participants, subjects 
dropping out, and the demographic characteristics are 
presented. The baseline clinical data will be presented 
in the next section. Then, the probing pocket depth data 
throughout the study is presented together with the 
analysis of the effect of baseline probing depth on 
treatment outcome. This is then followed by the 
attachment level changes and changes in recession. The 
next sections deal with bleeding on probing, suppuration, 
gingival scores, plaque scores, the effect of smoking on 
treatment outcome and GCF volume data. Finally, the 
adverse effects and the time taken for each treatment are 
presented.
3.1.2 Dropped out subjects and excluded sites
A total of 67 patients fulfilled the inclusion criteria 
and agreed to take part in the study. Four suitable sites
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(as described in section 2.2.5.1) were selected within 
each patient, impressions were taken and acrylic occlusal 
stents were fabricated. However, out of 67 subjects, 9 
subjects did not attend for the baseline measurements, one 
patient failed to complete the treatment course on time 
and therefore was excluded, another patient completed the 
treatment but did not attend at the 6 week visit and was 
excluded from the study and finally, two other patients 
discontinued with the study before the 6 month 
measurements, and therefore, the data corresponding to 
them were excluded from the analysis.
Fifty four patients completed the study with the scaling 
alone and the scaling plus tetracycline fibre groups 
having 13 patients each and the scaling plus minocycline 
gel and the scaling plus metronidazole gel groups having 
14 patients each. One patient who received scaling plus 
tetracycline fibre, had one site which had to be excluded 
from the analysis because of accidental early removal of 
the fibre from the pocket. One site in the scaling plus 
metronidazole gel group and one site in the scaling alone 
group were excluded because these sites had been missed 
during examination and the wrong sites measured during one 
of the visits. Therefore, in the scaling plus minocycline 
gel group 56 sites were treated and completely followed 
up, whereas in the scaling plus metronidazole gel group 
this was 55 sites and in the remaining 2 groups 51 sites
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with complete data set were available, resulting in a 
total of 213 sites in the four treatment categories.
3.1.3 Study visits
Patients included in the study were seen in 379 visits
during the course of the study. Fifty four visits were
required for the screening, site selection and impression 
taking; 216 visits were required for the measurements and 
finally 109 visits were required for the treatments
including scaling and root planing under local anaesthesia 
and application of antimicrobial systems, re-application 
of the gels, and removal of the fibres. In addition to 
the 109 visits required for the treatment of the selected 
sites, some additional visits were required for the 
routine maintenance care of the other sites.
3.1.4 Demographic characteristics o£ the patients
Demographic characteristics of the 54 patients who 
completed the study are shown in Table 3.1. Of the 54 
patients, 52 were white Caucasians and 2 were Asians. The 
subject population included 22 male (40.7%) and 32 female 
(59.3%). The average age of participants in the study was
44.6 (ranging from 30 to 67). The average age of the 
subjects in the 4 groups were rather close and no
significant difference existed among them (p=0.370). 
Twenty-eight (51.9%) of the subjects were smoker. The 
distribution of smokers in the 4 treatment groups were
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ile 3.1 Demographic characteristics of the 54 subjects 
4 treatment groups.
Tetracycline
fibre
(n=13)
Minocycline Metronidazole 
gel gel 
(n=14) (n=14)
Scaling
alone
(n=13)
Age
ear)
47.85 
± 1.91
43.57 
± 1.66
44.21 
± 3.11
42.69 
± 1.38
moker
(%)
8
(61.5%)
8
(57.1%)
6
(42.9%)
6
(46.2%)
le (%) 6
(46.2%)
6
(42.9%)
3
(21.4%)
7
(53.8%)
thnic
tegory
13
Caucasians
14
Caucasians
13
Caucasians 
Sc 1 Asian
12
Caucasians 
& 1 Asian
>le 3.2
i mean)
Baseline clinical data (mean 
among the 4 treatment groups
± standard error of 
(n = 54 subjects).
Tetracycline
fibre
(n=13)
Minocycline Metronidazole 
gel gel 
(n=14) (n=14)
Scaling
alone
(n=13)
>cket 5.512 
epth(mm) ± 0.173
5.563 
± 0.186
5.597 
± 0.185
5.471 
± 0.226
BOP 0.916 
± 0.037
0.911 
± 0.050
0.845 
± 0.058
0.961 
± 0.026
Pus 0.115 
± 0.046
0.071 
± 0.031
0.149 
± 0.052
0.160 
± 0.061
MGI 2.288 
± 0.113
1.911 
± 0.188
1.988 
± 0.111
2.282 
± 0.103
PI 0.500 
± 0.133
0.607 
± 0.163
0.613 
± 0.112
0.685 
± 0.103
rather similar (p= 0.35, chi-square=l.268, chi-square 
test) .
3.1.5 Baseline data
Table 3.2 shows the clinical data obtained at the baseline 
visits among the 4 patient groups. There was no 
significant difference between the mean probing pocket 
depth among treatment groups at the baseline (p=0.970, 
one-way ANOVA) . The baseline probing depth (patient 
derived data) ranged from 4.375 mm to 7.25 mm. The 
overall mean probing depth was 5.54 mm with the standard 
error of the mean of 0.09. Although the selected sites 
had to be at least 5 mm in probing depth to be selected at 
the screening visit, when the 'Florida Probe1 was used 
instead of manual probe at the baseline visits, 84 sites 
showed probing depth less than 5 mm, and 4 sites showed 
probing depth less than 4 mm. All the selected sites had 
bleeding on probing or suppuration using manual probe at 
the screening visit, whereas at the baseline visit, when 
the 'Florida Probe1 was used 200 sites were positive for 
either bleeding on probing or suppuration and 13 sites 
showed neither bleeding on probing nor suppuration. There 
was no significant difference between treatment groups 
with regard to bleeding on probing at baseline (p= 0.891). 
The Plaque Index baseline scores were relatively low among 
the treatment groups with an average of 0.60 ± 0.06
indicating a general good oral hygiene level at the 
baseline. There was no significant difference in the
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plaque scores between treatments at the baseline 
(p=0.570) . The Modified Gingival Index (MGI) data had an 
average of 2.11 and a standard error of the mean of 0.07 
at the baseline. No significant difference existed in the 
baseline MGI data between treatment groups (p= 0.122).
3.1.6 Mean reduction in probing pocket depth
Site-based measurements were pooled for each patient at 
each visit to produce a single figure of probing pocket 
depth or attachment level. By doing so, each figure 
represented an 'independent observation'. This would not 
have held true, if a site-based analysis had been 
performed. This particularly seemed important in the 
present study in which antimicrobial drugs were utilised 
and probably a considerable carry-across effect occurred 
between the sites. In addition, since almost all patients 
provided an equal number of sites, each site equally 
contributed to the overall data even after averaging the 
site data within patients.
Table 3.3 shows the probing pocket depth data derived from 
the patients as the unit of analysis. At the 6 week visit 
all 4 treatments resulted in a highly significant 
reduction in the probing pocket depth compared to baseline 
(p<0.001). This significant difference was sustained in 
all groups until the end of study period. Table 3.4 shows 
the reduction of probing pocket depth among the 4 
treatment groups at different follow-up visits. The data
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Le 3.3 Probing depth data (derived from 'patient' as 
unit of analysis) at different visits. Mean ± Standard 
>r of the mean and 95% confidence intervals are shown. 
>ability values are obtained by paired t-tests between 
iline and follow-up visitsjThe unit of measurements is mm.
Time Baseline 6 week 3 month 6 month
ooint
racycline 5.51 4.16 4.06 4.13
fibre ± 0 . 1 7  ± 0. 1 3 ± 0. 1 4 ±0.18
(n=13)
(5.14 , 5.89) (3.88 , 4.45) (3.75 , 4.36) (3.73 , 4.53)
pcO.001 pcO.001 p<0.001
tocycline 5.56 4.81 4.63 4.74
gel
(n-14)
± 0.19 ± 0.23 ± 0.24 ± 0.20
(5.16 , 5.97) (4.21 , 5.18) (4.13 , 5.17) (4.32 , 5.14)
p<0.001 pcO.001 p<0.001
■onidazole 5.60 4.65 4.49 4.58
,ge* ± 0 . 1 9  ± 0 . 2 0  ± 0 .26 ±0.23(n*14)
(5.20 , 6.00) (4.21 , 5.09) (3.93 , 5.05) (4.09 , 5.07)
p<0.001 p<0.001 pcO.001
,ing alone 5 47 4 >87 4<58 4 ^ 73
(n«13)
± 0.23 ± 0.26 ± 0.32 ± 0.33
(4.98, 5.96) (4.29, 5.44) (3.88, 5.27) (4.01, 5.44)
p=0.001 pcO.001 p=0.017
indicated that the major pocket depth reduction took place 
during the first 6 weeks post-treatment. The healing 
response as defined by pocket depth reduction maximised at 
month 3 for all treatments. At the 6 month visit, there 
was a slight relapse towards the initial values in all 
groups. When the baseline pocket depth was taken into 
account as a covariate, the adjusted mean pocket depth 
reductions only slightly varied from the original values 
(Table 3.4).
At the 6 week visit, the pocket depth reduction was the 
greatest in the scaling plus tetracycline fibre group with 
1.35 mm followed by the scaling plus metronidazole gel 
group and the scaling plus minocycline gel group with 0.95 
mm and 0.87 mm respectively. At this time point, the 
lowest pocket depth reduction was observed in the scaling 
alone group with a value of 0.60 mm (Fig. 3.1).
Table 3.5 shows an analysis of variance on the 6 week 
probing depth changes using the 'General Linear Model' 
procedure with the baseline pocket depth as a continuous 
covariate and the treatment as the main effect. Initial 
analysis (Table 3.5a) disclosed that there was no 
interaction between the covariate and the main effect and 
covariate slopes were not heterogeneous across the 
treatment groups. In other words, the effect of baseline 
pocket depth on the magnitude of the change in probing 
depth was fairly similar among the groups. Therefore, the
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Table 3.4 Pocket depth reduction from baseline among the 
4 groups at different follow-up visits. The values in 
parenthesis are covariate adjusted pocket depth reductions 
using baseline pocket depths as a covariate. The values 
in the second row of each cell are 95% confidence 
intervals for unadjusted reductions.
Treatment 6 week 3 month 6 month
Tetracycline 1.35 (1.36) 1.45 (1.46) 1.38 (1.39)
fibre (n=13) 0.97 , 1.73 1.03 , 1.88 0.89 , 1.87
Minocycline 0.87 (0.86) 0.91 (0.91) 0.82 (0.81)
gel (n=14) 0.58 , 1.16 0.54 , 1.29 0.58 , 1.07
Metronidazole 
gel (n=14)
Scaling 
alone (n=13)
0.95 (0.93) 
0.60 , 1.30
0.60 (0.62) 
0.30 , 0.91
1.11 (1.09) 
0.57 , 1.65
0.89 (0.91) 
0.46 , 1.33
1.02 (1 .00) 
0.53 , 1.51
0.74 (0.77) 
0.16 , 1.33
Pocket depth 
(mm)
S c a l i n g  + T e t r a c y c i n g  f i b r e  
S c a l i n g  + M i n o c y c l i n e  g e l  
S c a l i n g  + M e t r o n i d a z o l e  g e l  
S c a l i n g  a l o n e  
9 5 %  c o n f i d e n c e  i n t e r v a l
6  w e e k 3  m o n t h 6 m o n t h
Fig.3.1 Probing pocket depth among the treatment 
groups at the baseline, 6-week, 3-month and 6-month 
visits. Means and 95% confidence intervals are 
displayed.
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Table 3.5 Analysis of variance for pocket depth changes at 
6 week considering the baseline pocket depth as a 
covariate (PDO: baseline pocket depth, Treat: treatment)
a) Including the interaction term:
Source DF Seq SS Adi SS Adi MS F P
TREAT 3 3.7346 1.1954 0.3985 1.42 0.248
PDO 1 1.1326 1.6269 1.6269 5.81 0.020
TREAT*PDO 3 1.7339 1.7339 0.5780 2.06 0.118
Error 46 12.8890 12.8890 0.2802
Total 53 19.4901
b)After removing the insignificant interaction term:
. PF Seq. SS Adi ss Adi ms_______r p
1 1.1845 1.1326 1.1326 3.80 0.057
3 3.6828 3.6828 1.2276 4.11 0.011
49 14.6228 14.6228 0.2984
53 19.4901
c) Post-hoc comparisons*:
Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
p= 0.022
Metronidazole
gel
p=0.045 p=0.726
Scaling
alone
p=0.002 p= 0.268 p=0.146
* After the Bonferroni correction for multiple comparisons, the
threshold for statistical significance was p<0.020
model was tested again without this interaction term 
(Table 3.5b). This analysis disclosed the presence of a 
significant difference among the treatment groups 
(p=0.011). The post-hoc comparisons were performed by 
comparing only 2 treatment groups at a time (Table 3.5c). 
After adjustment of the probability values for multiple 
comparisons, the only significantly different pair was 
found to be the scaling plus tetracycline fibre and the 
scaling alone groups (p=0.002).
At the 3 month visit, the same rank as the 6 week visit 
existed between the treatments with regard to the pocket 
depth reductions. However, the mean reduction in the 
scaling alone group was quite close to the scaling plus 
minocycline gel group. In fact, the covariate adjusted 
mean reductions were exactly the same (0.91 mm). The mean
pocket depth reductions were 1.45 mm, 1.11 mm, 0.91 mm and
0.89 mm for the scaling plus tetracycline fibre, scaling 
plus metronidazole gel, scaling plus minocycline gel and 
scaling alone groups respectively. At the 6 month visit 
the reductions in the pocket depth still had the same rank 
with the reductions as follow; 1.38 mm for the scaling
plus tetracycline fibre group, 1.02 mm for the scaling
plus the metronidazole gel group, 0.82 mm for the scaling 
plus minocycline gel group, and 0.74 mm for the scaling 
alone.
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Table 3.6 Analysis of Variance for pocket depth changes at 
3 month considering the baseline pocket depth as a 
covariate (PDO: baseline pocket depth, Treat: treatment)
a) Including the interaction term:
Source DF Seg SS Adi ss Adi MS F P
TREAT 3 2.6565 2.2040 0.7347 1.36 0.267
PDO 1 1.5319 2.2879 2.2879 4.23 0.045
TREAT*PDOi 3 2.7982 2.7982 0.9327 1.73 0.175
Error 46 24.8641 24.8641 0.5405
Total 53 31.8506
b)After removing the insignificant interaction term:
Source DF Seq SS Adj SS Adj MS F P
PDO 1 1.5260 1.5319 1.5319 2.71 0.106
TREAT 3 2.6623 2.6623 0.8874 1.57 0.208
Error 49 27.6623 27.6623 0.5645
Total 53 31.8506
Table 3.7 Analysis of Variance for pocket depth changes at 
6 month considering the baseline pocket depth as a 
covariate (PDO: baseline pocket depth, Treat: treatment)
a) Including the interaction term:
Adi SS Adi MS
TREAT 3 3.2003 1.1362 0.3787 0.67 0.577
PDO 1 3.1777 3.8311 3.8311 6.75 0.013
TREAT*PDO 3 1.6213 1.6213 0.5404 0.95 0.424
Error 46 26.1206 26.1206 0.5678
Total 53 34.1200
b) After removing the insignificant interaction term:
Source DF Seq SS Adj SS Adi MS F P
PDO 1 3.1965 3.1777 3.1777 5.61 0.022
TREAT 3 3.1815 3.1815 1.0605 1.87 0.146
Error 49 27.7419 27.7419 0.5662
Total 53 34.1200
Tables 3.6 and 3.7 show the analysis of variance 
procedures for the 3 month and 6 month changes in the 
probing pocket depth. Similar to the 6 week data, no 
interaction was found between the baseline pocket depth 
and the treatments and the models had to be tested without 
the interaction terms. There was no significant
difference between the treatments at the 3 month (p=0.208) 
and the 6 month visits (p=0.146).
3.1.7 Mean change in probing attachment level
Table 3.8 shows the mean change in the probing attachment 
levels among the 4 treatment groups during the 6 month 
follow-up after treatment. The same rank as observed in 
the probing depth reductions existed between the treatment 
groups with regard to the attachment level changes. By 
the 6 week visit, a significant attachment gain took place 
in all 4 treatment groups and lasted throughout the study 
period. However, at this time point, the change in the 
scaling alone group was smaller than the other 3 groups. 
In the 3 adjunctive antimicrobial treatment groups, the 
major attachment gain occurred during the first 6 weeks 
post-therapy and the 3 month attachment levels only 
slightly varied from the 6 week visit. However, in the 
scaling alone group the increase in the attachment level 
continued at about the same rate as the first 6 week post- 
treatment. At this time point, the attachment gains were 
0.70 mm in the 2 groups of the scaling plus tetracycline 
fibre and scaling plus metronidazole gel (0.71 and 0.69
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respectively for the covariate adjusted values), 0.50 mm 
for the scaling plus minocycline gel group, closely 
followed by the scaling alone group with 0.46 mm.
While in the scaling plus metronidazole gel group some 
relapse towards the baseline values was observed at the 6 
month visit, the other 3 groups remained almost unchanged 
until the end of study. When the attachment level changes 
were adjusted for small differences in the baseline 
probing pocket depth among the treatment groups, only 
small variation existed between the original values and 
the covariate-adjusted values.
At the 6 month visit, the attachment gain in the 
tetracycline fibre group was still the greatest with 0.70 
mm, followed by the other 3 groups which had relatively 
similar values (0.53, 0.51 and 0.45 mm for the
metronidazole gel, minocycline gel and scaling alone 
groups respectively).
Tables 3.9 to 3.11 show the analysis of variance on the 
attachment level changes at the 6 week, 3 month and 6 
month visits respectively. The General Linear Model 
procedures were used with the baseline probing pocket 
depth as covariate and the treatment as the main factor. 
No significant interaction was found between the treatment 
and the covariate, indicating that the enhancing effect of 
having deeper baseline pocket depth did not vary
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Table 3.8 Attachment level changes from baseline among 
the 4 groups at different follow-up visits. The values in 
() are covariate-adjusted attachment level changes using 
baseline pocket depths as a covariate. The values in the 
second row of each cell are 95% confidence intervals for 
unadjusted reductions .| The unit of measurements is mm.
Treatment 6 week 3 month 6 month
Tetracycline 0.75 (0.75) 0.70 (0.71) 0.70 (0.71)
fibre (n=13) 0.49 , 1.00 0.37 , 1.04 0.28 , 1.12
Minocycline 0.45 (0.44) 0.50 (0.49) 0.51 (0.49)
gel (n=14) 0.16 , 0.74 0.20 , 0.80 0.25 , 0.75
Metronidazole 0.57 (0.56) 0.70 (0.69) 0.53 (0.53)
gel (n=14) 0.26 , 0.90 0.28 , 1.13 0.11 , 1.00
Scaling 
alone (n=13)
0.26 (0.28) 
0.03 , 0.50
0.46 (0.47) 
0.19 , 0.72
0.45 (0.46) 
0.06 , 0.83
Table 3.9 Analysis of Variance for attachment level 
changes at 6 week considering the baseline pocket depth as 
a covariate (PDO: baseline pocket depth, Treat:
treatment).
a) Including the interaction term:
Source PF Seq SS Adj SS Adi MS P P
TREAT 3 1.6372 0.1941 0.0647 0.31 0.816
PDO 1 1.4424 1.5931 1.5931 7.71 0.008
TREAT*PDO 3 0.2951 0.2951 0.0984 0.48 0.701
Error 46 9.5068 9.5068 0.2067
Total 53 12.8814
b)After removing the insignificant interaction term:
Source DF Seq SS Adi SS Adi MS F P
PDO 1 1.5150 1.4424 1.4424 7.21 0.010
TREAT 3 1.5646 1.5646 0.5215 2.61 0.062
Error 49 9.8018 9.8018 0.2000
Total 53 12.8814
Table 3.10 Analysis of Variance for attachment level 
changes at 3 month considering the baseline pocket depth 
as a covariate (PDO: baseline pocket depth, Treat:
treatment)
a) Including the interaction term:
Source PF Seq SS Adj SS Adj MS F P
TREAT 3 0.6937 0.7469 0.2490 0.78 0.511
PDO 1 1.0023 1.2119 1.2119 3.80 0.057
TREAT*PDO 3 0.9266 0.9266 0.3089 0.97 0.415
Error 46 14.6589 14.6589 0.3187
Total 53 17.2815
b)After removing the insignificant interaction term:
Source DF Seq SS Adi SS Adj MS F P
PDO 1 1.0538 1.0023 1.0023 3.15 0.082
TREAT 3 0.6422 0.6422 0.2141 0.67 0.573
Error 49 15.5856 15.5856 0.3181
Total 53 17.2815
Table 3.11 Analysis of Variance for attachment level 
changes at 6 month considering the baseline pocket depth 
as a covariate (PDO: baseline pocket depth, Treat:
treatment)
a) Including the interaction term:
Source DF Seq SS Adj SS Adi MS F P
TREAT 3 0.4707 0.3172 0.1057 0.27 0.843
PDO 1 2.8119 2.6779 2.6779 6.96 0.011
TREAT*PDO 3 0.2985 0.2985 0.0995 0.26 0.855
Error 46 17.6909 17.6909 0.3846
Total 53 21.2720
b)After removing the insignificant interaction term:
Source. DF Seq SS Adj SS Adi MS F P
PDO 1 2.8173 2.8119 2.8119 7.66 0.008
TREAT 3 0.4653 0.4653 0.1551 0.42 0.738
Error 49 17.9894 17.9894 0.3671
Total 53 21.2720
significantly between groups. The null hypothesis
testings were repeated without the interaction term in the 
model. The 6 week difference between the treatments did 
not reach the significance level (p= 0.062). The analysis 
of 3 month and 6 month changes also revealed no 
significant difference in the attachment level changes 
between groups (p= 0.573 and p= 0.784 respectively).
3.1.8 The effect of baseline probing pocket depth on 
the treatment outcome
Since it was found that the baseline probing depth had a 
considerable and often significant effect on the treatment 
outcome i.e. pocket depth reduction and attachment gain 
(Tables 3.5 to 3.7 and 3.9 to 3.11) , in order to further 
highlight this effect, all the sites were divided into 3 
categories according to their initial probing depth values 
and regardless of their treatments. The categories were: 
a) pocket depth < 5 mm; b) 6.5 mm > pocket depth > 5 mm; 
and c) pocket depth > 6.5 mm. Table 3.12 displays the 
changes of pocket depth and attachment level among the 3 
mentioned categories throughout the study period. This 
Table indicates that the sites with deeper initial pocket 
depth generally responded better to the treatment than the 
shallower sites.
3.1.9 Change in the recession
The method used in this study would not allow for 
measurements of initial recession in the study sites
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Table 3.12 Changes in pocket depth and attachment levels 
at different follow-up visits. Sites were broken down by 
their initial pocket depth.
Baseline Pocket depth Attachment
r educ t i on (mm) gain|(mm)
n MEAN SEM Mean SEM
6 week visit:
PD0<5 84 0.57 0.09 0.37 0.08
5<PD0<6.5 91 1.01 0.09 0.46 0.07
PD0>6.5 38 1.48 0.21 0.93 0.19
3 month visit:
PD0<5 84 0.75 0.10 0.41 0.09
5<PD0<6.5 91 1.04 0.10 0.55 0.09
PD0>6.5 38 1.90 0.26 1.08 0.20
6 month visit:
PDO <5 84 0.68 0.11 0.32 0.10
5<PD0<6.5 91 0.92 0.12 0.45 0.09
PD0>6.5 38 1.93 0.28 1.13 0.24
SEM: Standard error of the mean
PDO: baseline pocket depth
Table 3.13 Change in the recession (Mean ± standard error 
of the mean) among the 4 treatment groups at 6 week, 3 
month and 6 month visits.I The unit of measurements is mm.
Time point 6 week 3 month 6 month
Tetracycline 0.60 0.75 0.68
fibre ±0.11 ±0.13 ± 0.21
Minocycline 0.42 0.42 0.32
gel ±0.10 ± 0.08 ±0.10
Metronidazole 0.37 0.41 0.46
gel ±0.14 ±0.15 ±0.13
Scaling alone 0.34 0.44 0.30
±0.15 ± 0.20 ±0.16
One-way ANOVA F=0.86 • F=1.30 F=1.36
p=0.470 psO.286 p=0.266
pocket
depth
reduction
(mm) Rcession change 
A ttachment gain
H  S3 Eh <
pq m  w o
Eh  2  S  CO
E-i S3 H  <
W m  cq o
H S 2 co
H !3 H rtlpq m  w u
Eh S S CO
6 week 3 month 6 month
Fig. 3.2 Mean probing depth reduction, attachment gain, 
and recession changes among the treatment groups at 6 
week, 3 month and 6 month visits (TET: scaling and root 
planing & tetracycline fibre; MIN: scaling and root
planing & minocycline gel; MET: scaling and root planing 
& metronidazole gel; SCA: scaling and root planing
alone).
689610
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because the cemento-enamel junction (CEJ) was not used as 
the reference point but the attachment levels were 
measured from an arbitrarily fixed point on the acrylic 
occlusal stent. The changes in the recession for each 
site was calculated by subtracting the attachment level 
changes from the pocket depth changes. Table 3.13 shows 
the changes in the recession among the treatment groups at 
the follow-up visits. For each follow-up visit, the site 
specific data within each patient was pooled to provide a 
single figure which represented the patient's change in 
the recession from the baseline until that time-point. 
All the treatments resulted in an increase in recession. 
By the end of the 6 month follow-up the greatest recession 
was observed in the scaling plus tetracycline fibre group 
followed by the scaling plus metronidazole gel, scaling 
plus minocycline gel and the scaling alone groups (Fig. 
3.2). There were no significant differences in the 
recession changes between the groups at any time point 
(p=0.470, p=0.286, and p= 0.266 for the 6 week, 3 month and 
the 6 month follow-up visits respectively).
3.1.10 Changes between visits
Between visit changes in the pocket depth and attachment 
levels were analysed by dividing the whole follow-up 
period of the study into 3 phases; the early, intermediate 
and late phases. The early changes were the 6 week 
changes and were presented in the sections 3.1.6 and 
3.1.7. The intermediate changes were the changes which
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occurred between the 6 week visit and the 3 month visit 
and were calculated by subtraction of the 6 week changes 
from the 3 month changes. The late changes were the
changes which took place between the 3 month visit and the 
6 month visit and were calculated by subtraction of the 3 
month changes from the 6 month changes. Tables 3.14 and 
3.15 display the mentioned changes for the pocket depth 
and attachment level respectively. At the early phase of 
the follow-up period, the reduction in the pocket depth 
and increase in the attachment level were the least in the 
scaling alone group. The intermediate changes in the 3
adjunctive antimicrobial groups were small and 
insignificant (p=0.45, p= 0.60 and p=0.41 for the
tetracycline fibre, minocycline gel and metronidazole gel 
groups respectively). However, in the scaling alone 
group, significant pocket depth reduction and attachment 
gain continued to occur during the intermediate phase of 
the follow-up (p=0.047 and p=0.038 for the pocket depth 
reduction and the attachment gain respectively). The 
changes in the late phase i.e. the interval between 3 and 
6 month follow-up visits, were small. All groups showed 
some degree of relapse in the pocket depth with the
greatest relapse in the scaling alone group. None of the 
pocket depth or attachment changes in the late phase of 
the follow-up period were significant.
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Table 3.14 'Between-visit1 changes for pocket depth; The 
early change was the change from baseline until week 6, 
the intermediate change was calculated by subtraction of 
the 3 month pocket depth from the 6 week pocket depth. 
The late change was calculated by subtraction of the 6 
month pocket depth from the 3 month pocket depth. Mean ± 
standard error of the mean are shown. The p values in each 
cell represent paired t-test in changes occurred during 
the interval between the 2 consecutive visits. The data 
are subject derived (patient as the unit of analysis).
Between-visit
change
Between 
baseline & 
week 6 (early 
change)
Between week 
6 & month 3 
(intermediate 
change)
Between month 
3 & month 6 
(late change)
Tetracycline 1.35 0.10 -0.07
fibre ± 0.17 ±0.13 ± 0.20
p<0.001 p= 0.45 p= 0.72
Minocycline 0.87 0.07 -0.13
gel ±0.13 ± 0.09 ± 0.16
p< 0.001 p=0.60 p=0.55
Metronidazole 0.95 0.13 -0.6
gel ±0.16 ± 0.21 ±0.16
p<0.001 p=0.41 p= 0.56
Scaling alone 0.60 0.29 -0.15
±0.14 ±0.13 ±0.19
p=0.001 p=0.047 p= 0.45
One-way ANOVA F=3.95 *1 II o II o o cn
p=0.013* p=0.726 p=0.979
* The only significantly different pair of differences was 
Tetracycline fibre - scaling. The corresponding 95% confidence 
interval for the Tukey test was (0.16 , 1.33).
Table 3.15 'Between-visit’ changes for attachment level; 
The early change was the change from baseline untill week 
6, the intermediate change was calculated by subtraction 
of the 3 month attachment level from the 6 week attachment 
level. The late change was calculated by subtraction of 
the 6 month attachment level from the 3 month attachment 
level. Mean ± standard error of the mean are shown. The p 
values in each cell represent paired t-test in changes 
occurred during the interval between the 2 consecutive 
visits. The data are subject derived (patient as the 
unit of analysis).
Between-visit
change
Between 
baseline & 
week 6 
(early change)
Between week 
6 & month 3 
(intermediate 
change)
Between month 
3 & month 6 
(late change)
Tetracycline 0.75 -0.04 -0.00
fibre ±0.12 ± 0.10 ± 0.21
p<0.001 p=0.65 p=0.99
Minocycline 0.45 0.05 0.00
gel ±0.14 ± 0.08 ±0.14
p=0.006 p=0.56 p=0.98
Metronidazole 0.57 0.13 -0.15
gel ±0.15 ± 0.10 ±0.11
p= 0.002 p=0.21 p=0.19
Scaling alone 0.20 0.19 -0.01
±0.11 ± 0.08 ±0.14
p=0.032 p=0.038 p=0.94
One-way ANOVA F=2.43 F=1.24 II o to U)
p=0.076 p=0.305 p=0.877
3.1.11 The percentage of sites which showed pocket 
depth reduction/attachment gain above 3 x 
standard deviation of measurements
A series of site-specific analysis were performed on the 
pocket depth and attachment level data. For a site to be 
considered as successfully treated, a pre-defined 
threshold had to have been surpassed.
The results of the preliminary study on the intra-examiner 
reproducibility of the measurements of pocket depth and 
attachment level (section 2.2.3) revealed that the 
standard deviation of differences between duplicated 
readings were 0.42 mm for the probing pocket depth and 
0.34 mm for the attachment level measurements using the 
same method and examiner used in the present study. Three 
times standard deviations of the probing depth and 
attachment level measurements i.e. 1.26 mm and 1.02 mm 
respectively were selected as a threshold for treatment 
success. Since the resolution of duplicate readings of 
the Florida Probe is 0.1 mm the thresholds were set at 
least 1.3 mm and 1.1 mm for the pocket depth reductions 
and the attachment level changes.
Table 3.16 shows the chi-square analysis for the 
successfully treated sites as defined above for the pocket 
depth reduction and attachment gain. The analysis of 
pocket depth data indicated that at the 6 week and 3 month 
visits no significant difference existed between the
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groups (chi-square= 7.259, and 4.713 respectively, not 
significant) . At the 6 week visit, the percentage of 
sites with reduced pocket depth > 1.3 mm was 41.2% for the 
scaling plus tetracycline fibre group, 35.7% for the 
scaling plus minocycline gel group, 34.6% for the scaling 
plus metronidazole gel group, and 17.7% for the scaling 
alone group. The corresponding values for the 3 month 
follow-up visit were 49.0%, 30.4%, 45.5% and 37.3%.
However, at the 6 month visit a significant difference was 
found between the groups (chi-square=9.674, p=0.025). The 
follow-up analysis using the 2x2 contingency tables 
revealed the presence of significant difference between 
the scaling plus tetracycline fibre group and the scaling 
plus minocycline gel group (chi-square = 8.84, p<0.001)
and between the scaling plus metronidazole gel group and 
the scaling plus minocycline gel group (chi-square = 4.38, 
p=0.036).
Similar analysis on the attachment level data indicated 
that there was a significant difference between the groups 
at 6 week (chi-square = 13.028, p<0.01). Follow-up
analysis using multiple 2x2 contingency tables indicated 
that there was significant difference between the scaling 
plus tetracycline fibre group and the scaling alone (chi- 
square = 13.028, p<0.001) and between the scaling plus
metronidazole gel group and the scaling alone group (chi- 
square = 10.827, p=0.001). The percentages of 'attachment 
gainer1 sites were 31.4%, 19.6%, 30.9% and 5.9% in the
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Table 3.16 Number and percentage of sites which showed 
pocket depth reduction > 1.26 mm and sites which showed 
attachment gain > 1.02 mm (3x standard deviation of
differences of pocket depth and attachment level
measurements respectively determined in pilot study, 
section 2.2.3) at follow-up visits. N.S: not significant.
Treatment Pocket reduction Attachment gain
> 1.26 mm > 1.02 mm
6 week:
Tetracycline fibre 21 16
41.2% 31.4%
Minocycline gel 20 11
35.7% 19.6%
Metronidazole gel 19 17
34.6% 30.9%
Scaling alone 9 3
17.7% 5.9%
y*= 7.259 N.S y"= 13.028, p<0.or
3 month:
Tetracycline fibre 25 13
49.0% 25.5%
Minocycline gel 17 12
30.4% 21.4%
Metronidazole gel 25 18
45.5% 32.7%
Scaling alone 19 11
37.3% 21.6%
yS 4.713, N.S y> 2.423, N.S
6 month:
Tetracycline fibre 26 18
51.0% 35.3%
Minocycline gel 13 8
23.2% 14.3%
Metronidazole gel 23 17
41.8% 30.9%
Scaling alone 17 15
33.3% 29.4%
T =  9.674, p=0.025' y^ = 6.907, N.S
t Significantly different pairs:
Tetracycline fibre-Minocycline gel, chi-square=8.84, p<0.001. 
Metronidazole gel-Minocycline gel, chi-square= 4.38, p=0.036. 
t Significantly different pairs:
Tetracycline fibre-Scaling alone, chi-square=13.028, p<0.001. 
Metronidazole gel-Scaling alone, chi-square=10.827, p=0.001.
tetracycline fibre, metronidazole gel, minocycline gel and 
the scaling alone groups respectively. However, no 
significant association was found between the treatments 
and the proportion of 'attachment gainer' sites at 3 month 
and 6 month visits-(chi-square=2.423, and 7.127 
respectively, not significant) . The percentage of 
'attachment gainer' sites at the 3 month visit were 25.5%, 
21.4%, 32.7%, and 21.6% for the adjunctive tetracycline
fibre, minocycline gel, metronidazole gel and the scaling 
alone groups respectively. The corresponding figures for 
the 6 month visit were 35.3%, 14.3%, 30.9% and 29.4%
respectively.
3.1.12 Bleeding on probing
Table 3.17 shows the number and percentage of sites within 
each treatment group which showed bleeding on probing at 
baseline, 6 week, 3 month and 6 month visits. Chi-square 
analysis for the baseline data was not possible due to the 
presence of too many small expected frequencies in the 
table. However, the Kruskal-Wallis test revealed no 
significant difference between groups (p=0.891) at the 
baseline.
The Cochran-Q test revealed that within each treatment 
group, there were significant differences between the 
bleeding scores of different time points (p<0.001, Table 
3.18). Follow-up analysis indicated that at the 6 week 
visit post-treatment, the bleeding on probing scores
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Table 3.17 Number and percentage of sites with bleeding on 
probing at baseline, 6 week, 3 month, and 6 month visits 
among the 4 treatment groups.
Time point
Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Scaling
alone
baseline 47 51 48 49
(92.2%) (91.1%) (87.3%) (96.1%)
6 weeks 21 32 29 32
(41.2%) (57.1%) (52.7%) (62.7%)
3 months 18 22 24 30
(35.3%) (39.3%) (43.6%) (58.8%)
6 months 23 31 31 24
(45.1%) (55.4%) (56.4%) (47.1%)
Total 51 56 55 51
Table 3.18 Test for the association of bleeding on probing 
with the time point and probability values obtained by 
comparisons across different time points for each 
treatment group. Probability values in the first row of 
the table were obtained using the Cochran-Q test (baseline 
v.s 6 week v.s 3 month v.s 6 month), and the p values in 
the remaining cells were obtained using the McNemar's 
test. If it was necessary, Fisher's exact probability for
the McNemar's tables were calculated.
Treatment
Te tracyc1ine 
fibre
Minocycline
gel
Metronidazole Scaling 
gel alone
Cochran-Q
test
p< 0.001 p<0.001 p<0.001 p<0.001
Baseline v.s 
6 week
p<0.0Ql* p<0.001* p<0.001* p<0.001*
Baseline v.s 
3 month
p<0.001* p<0.001* p<0.001* p<0.001*
Baseline v.s 
6 month
p< 0.001* p<0.001* p<0.001* p<0.001*
6 week v.s 3 
month
p= 0.648 p= 0.052 p=0.424 p=0.134
6 week v.s 6 
month
p= 0.845
oorHIIQ< p= 0.839 p=0.791
3 month v.s 
6 month
p=0.383 p= 0.078 p=0.189 p= 0.327
* Due to the assumptions of the McNemar test not being held, the p
values marked with (*) were obtained using the Fisher's exact test.
Table 3.19 Chi-square analysis on association of 
improvement in bleeding on probing at the 6 week, 3 month 
and 6 month time points with treatment.
BOP
status
Tetracycline
fibre
n=51
Minocycline Metronidazole 
gel gel 
n=56 n=55
Scaling
alone
n=51
Total
n=213
6 week change:
Improved 26
(51.0%)
22 22 
(39.3%) (40.0%)
18
(35.3%
)
33
64.7%)
88
(41.3%)
Other 25
(49.0%)
34 33 
(60.7%) (60.0%)
125
(58.7%)
Chi-square = 2.826, df = 3 (not significant)
3 month change:
Improved 29
(56.9%)
31 27 
(55.4%) (49.1%)
25
(49.0%)
112
(52.6%)
Other 22
(43.1%)
25 28 
(44.6%) (50.9%)
26
(51.0%)
101
(47.4%)
Chi-square = 1.076, df s 3 (not significant)
6 month change:
Improved 27
(52.9%)
24 20 
(42.9%) (36.4%)
20
(39.2%)
91
(42.7%)
Other 24
(47.1%)
32 35 
(57.1%) (63.6%)
31
(60.8%)
122
(57.3%)
Chi-square = 3.342, df = 3 (not significant)
Table 3.20 Chi-square analysis on association of 
frequency of sites which bled on probing on all the 3 
follow-up occasions with treatment.
Treatment
sites which bled on Other
all 3 follow-up sites
occasions
Tetracycline fibre 6
(11.8%)
45
(88.2%)
Minocycline gel 13
(23.2%)
43
(76.8%)
Metronidazole gel 9
(16.4%)
46
(83.6%)
Scaling alone 13
(25.6%)
38
(74.5%)
Total 41
(19.2%)
172
(80.8%)
Chi-square = 3.977, df = 3 (not significant)
decreased highly significantly in all treatment groups 
(p<0.001, Fisher's exact test for paired data). This 
statistically significant improvement was sustained at 
this level (p<0.001) in all treatment groups until the end 
of 6 month follow-up study. All treatment groups showed 
some further reduction in bleeding on probing at the 3 
month visit compared to the 6 week visit. While in the 
scaling alone group the frequency of bleeding on probing 
continued to decrease until the 6 month visit, all 3 
adjunctive antimicrobial treatment groups showed some 
degrees of relapse in the frequency of bleeding on probing 
at the 6 month visit compared to the 3 month visit. 
However, further follow-up analysis for each treatment 
group indicated that no significant changes took place 
after week 6 in any of the treatment groups (Table 3.18).
Table 3.19 displays the frequency of sites whose bleeding 
on probing improved. There were no statistical
differences between the treatments at any follow-up visit 
(chi-square = 2.826 for the 6 week, 1.076 for the 3 month 
and 3.342 for 6 month visits, not significant). However, 
at any time point the improvement in the scaling plus 
tetracycline fibre group was the greatest with more than 
half of the sites showing improvement, closely followed by 
the other 3 treatments.
Table 3.20 shows the frequency of sites which in spite of 
treatment, bled on probing at all 3 follow-up occasions.
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The scaling alone group showed the highest percentage of 
such sites (25.6%), followed by the scaling plus
minocycline gel group (23.2%), scaling plus metronidazole 
gel group (16.4%), and finally scaling plus tetracycline 
fibre group (11.8%). However, the chi-square analysis
revealed no statistical association between the treatments 
and prevalence of sites with bleeding on probing on 3 
consecutive visits post-treatment (chi-square = 3.977, not 
significant).
3 .1.13 Suppuration
Table 3.21 displays the number and frequency of the sites
which showed suppuration at the baseline, 6 weeks, 3 month
and 6 month visits. All sites showed reduction in the 
frequency of suppurating sites after treatment. In the 
scaling plus tetracycline fibre group the frequency of 
suppurating sites reached zero at 6-week and 3-month 
visits, although 1 site showed suppuration at the 6 month 
visit. This site had no suppuration at the baseline
(Diagram 3.22). At the 3 month visit, the reduction in the 
suppuration remained significant only in the scaling plus 
tetracycline fibre group (p=0.016). In fact, in the
scaling alone group a complete return towards the baseline
value occurred at 3 months. In the scaling plus 
minocycline gel and scaling plus metronidazole gel group 
some degrees of relapse were observed. At the 6 month 
visit, the scores had almost returned to the original
scores in the 2 scaling alone and scaling plus
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Table 3.21 Number and percentage of sites with
suppuration at baseline, 6 week, 3 month, and 6 month 
visits among the 4 treatment groups.
Time point Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Scaling
alone
baseline* 6 4 8 8
11.8% 7.2% 14.5% 15.7%
6 weeks 0 2 1 2
0% 3.6% 1.9% 3.9%
3 months 0 3 4 8
0% 5.4% 7.3% 15.7%
6 months 1 1 7 9
2% 1.8% 12.7% 17.7%
Total number 
of sites
51 56 55 51
Scaling &
tetracycline
fibre
(total n=51)
Scaling &
minocycline
gel
(total n=56)
Scaling &
metronidazole
gel
(total n=55)
Scaling alone 
(total n=51)
Baseline 0900000 ooooooo ooooooooooo ooooooooooooo
6 week ooooooo ooooooo ooooooooooo ooooooooooooo
3 month ooooooo ooooooo ooooooooooo ooooooooooooo
6 month ooooooo ooooooo ooooooooooo ooooooooooooo
Diagram.3.22 Diagram of sites which showed at least one 
episode of suppuration. ®: suppuration, o: no suppuration. 
Symbols on the same vertical position represent the 
suppuration status of a single site throughout the study 
period.
Table 3.23 Matrix of pairwise comparisons to test the 
association of the treatments with the frequency of 
suppuration episodes before and after treatment using the 
Fisher's exact test (p values are given).
Tetracycline Minocycline Metronidazole
fibre gel gel
Minocycline p= 0.076
gel
Metronidazole p= 0.048* p= 0.654
gel
Scaling p= 0.009* p= 0.844 p= 0.686
alone
* significant difference
Table 3.24 Matrix of pairwise comparisons to test the 
association of the treatments with the presence of 
suppuration at 6 week, 3 month and 6 month visit using the 
Fisher's exact test (p values are given).
6 weeks ••
Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
Metronidazole
gel
Scaling
alone
p= 0.272 
p= 0.519 
p= 0.247
p= 0.382 
p= 0.369 p= 0.363
3 month
Te tracycline 
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
Metronidazole
gel
Scaling
alone
p= 0.272
p= 0.068
p= 0.003*
p= 0.278 
p= 0.057 p= 0.099
6 monthi :
Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
Metronidazole
gel
Scaling
alone
p= 0.779 
p= 0.038* 
p= 0.007*
p< 0.001* 
p< 0.001* p> 0.300f
* significant difference
t Chi-square test was indicated, %2 = 0.500, df= 1
metronidazole gel groups. However, in the other 2 groups 
i.e. scaling plus tetracycline fibre and scaling plus 
minocycline gel groups, only one site in each group had 
suppuration.
The number of suppuration episodes throughout the whole 
follow-up period were calculated and compared among the 
groups (Table 3.23). The scaling plus tetracycline fibre 
group (with one episode) was found to have significantly 
less suppuration episodes than the scaling plus 
metronidazole gel group (12 episodes) (p=0.048) and 
scaling alone group (20 episodes) (p= 0.009). The 
difference between the scaling plus tetracycline fibre and 
scaling plus minocycline gel groups (6 episodes) failed to 
reach statistical significance (p=0.076). All other 
comparisons were clearly insignificant.
Since performance of between-treatment comparisons using 
2x4 contingency tables would not be valid due to the 
presence of small expected counts in too many cells, the 
pair-wise 2x2 comparisons between the treatments were 
performed for each follow-up visit (Table 3.24). No 
significant difference between any pair of treatments was 
revealed at week 6. At the 3 month visit, the difference 
between the scaling plus tetracycline fibre and the 
scaling alone groups were statistically significant 
(p=0.003). However, at the 6 month visit, the scaling 
plus tetracycline fibre group was significantly different
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from the scaling alone (p=0.007) and the scaling plus 
metronidazole gel (p=0.038) groups. The scaling plus 
minocycline gel group was also significantly different 
from the scaling alone (p<0.001) and the scaling plus 
metronidazole gel (p<0.001) groups.
3.1.14 The Plaque Index
Table 3.25 shows the frequency distribution of plaque 
scores across the treatment groups at baseline, 6 week, 3 
month and 6 month visits. There was no significant 
difference between the treatment groups at any time point 
(p=0.570, p=0.259, p=0.465, and p=0.739 for the baseline, 
6 week, 3 month and the 6 month visits respectively, 
Kruskal-Wallis test). The mean plaque scores were 
generally low at all time points and was always less than 
1 for any treatment group at any occasion and the majority 
of sites had plaque score of 0 or 1 and very few sites 
showed a plaque score of 3. Nevertheless, a slight 
increase in the plaque scores for all treatment groups was 
observed towards the end of the study.
3.1.15 The Modified Gingival Index
The frequency distribution of the Modified Gingival Index 
(MGI) data is displayed in Table 3.26. There was no 
significant difference between the groups at the baseline 
(p=0.122). The MGI scores decreased significantly at 6 
week in all groups (Table 3.27) and remained significantly 
lower than the baseline scores until the end of study.
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Table 3.25 Frequency distribution of Plaque score data 
among the 4 treatment groups at baseline, 6 week, 3 month 
and 6 month visits. Mean ± standard error of the mean 
(SEM) and medians are shown. Probability values for the 
Kruskal-Wallis test are also displayed.
Time
point
Plaque
score
Tetracycline
fibre
n*51
Minocycline
gel
n»56
Metronidazole
gel
ns55
Scaling
alone
n=51
score 0 30 30 27 21
score 1 16 20 23 25
score 2 5 4 5 5
Baseline score 3 0 2 0 0
mean 0.51 0.61 0.60 0.69
± SuM ± 0.09 ± 0.10 ± 0.09 ± 0.09
median 0 0 1 1
P= 0.570 (Kruskal-Wallis test)
score 0 28 24 31 19
score 1 14 23 16 20
score 2 19 9 7 11
6 week score 3 0 0 1 1
mean 0.63 0.73 0.60 0.88
± SttM ±0.11 ± 0.10 ±0.11 ±0.11
median 0 1 0 1
P= 0.259 (Kruskal-Wallis test)
score 0 16 26 26 24
score 1 27 14 22 20
score 2 7 13 7 7
3 month score 3 1 3 0 0
mean 0.86 0.87 0.65 0.67
± SeM ± 0.10 ±0.13 ± 0.09 ±0.10
median 1 1 1 1
P= 0.465 (Kruskal-Wallis test)
score 0 17 25 21 20
score 1 21 20 22 21
score 2 12 10 11 9
score 3 1 1 1 1
mean 0.94 0.77 0.86 0.82
± SuM ±0.11 ±0.11 ±0.11 ±0.11
median 1 1 1 1
p= 0.739 (Kruskal-Wallis test)
Table 3.26 Frequency distribution of Modified Gingival 
score data among the 4 treatment groups at baseline, 6 
week, 3 month and 6 month visits. Mean ± standard error of 
the mean (SEM) and medians are shown. Probability values 
for Kruskal-Wallis test are also displayed.
Time
point
Plaque
score
Tetracycline Minocycline Metronidazole 
fibre gel gel 
ns51 n=56 n=>55
Scaling
alone
n=51
score 0 0 5 1 0
score 1 5 7 11 5
score 2 27 30 31 28
Baseline score 3 19 12 12 18
score 4 0 2 0 0
mean 2.27 1.98 1.98 2.25
± SEM ± 0.09 ± 0.12 ± 0.10 ± 0.09
median 2 2 2 2
p= 0.122 (Kruskal-Wallis)
score 0 7 4 6 1
score 1 28 22 17 14
score 2 16 30 28 29
6 week score 3 0 0 4 7
score 4 0 0 0 0
mean 1.18 1.46 1.55 1.82
i SEM ± 0.09 ± 0.10 ± 0.10 ±0.10
median 1 2 2 2
p = 0.001(Kruskal-Wallis)
score 0 25 6 4 2
score 1 24 23 20 19
score 2 2 24 26 26
3 month score 3 51 3 5 4
score 4 0 0 0 0
mean 1.55 1.42 1.58 1.63
± SEM ± 0.08 ±0.11 ± 0.10 ±0.10
median 2 1 2 2
p= 0.631(Kruskal-Wallis)
score 0 3 3 5 1
score 1 24 23 15 16
score 2 23 22 26 25
6 month score 3 1 8 9 9
score 4 0 0 0 0
mean 1.43 1.63 1.71 1.82
i SEM ± 0.09 ±0.11 ± 0.12 ±0.10
median 1 2 2 2
p= 0.107 (Kruskal-Wallis)
When the changes in the MGI were tested for between- 
treatment differences, a significant difference was found 
between groups at the 6 week (p=0.002) and 6 month 
(p= 0.012) visits. However, there was no significant 
difference between groups at the 3 month visit (p=0.340). 
The post-hoc comparisons using multiple Mann-Whitney U 
tests (Table 3.28) indicated that at the 6 week visit, the 
scaling plus tetracycline fibre group had a significantly 
greater improvement in MGI scores than the scaling plus 
minocycline gel (p=0.03), scaling plus metronidazole gel 
(p=0.003), and scaling alone (p=0.002) groups. The 
remaining differences were not significant. At the 6 
month visit, similar to 6 week visit, the differences 
between the scaling plus tetracycline fibre group and the 
other 3 groups were significant (p=0.013 for scaling plus 
minocycline gel, p<0.001 for the scaling plus 
metronidazole gel, and p= 0.036 for the scaling alone 
groups). In addition, the improvement in the scaling 
alone group was significantly higher than the scaling plus 
metronidazole gel group (p=0.012). However, when their 
actual scores at the follow-up visits instead of their 
improvement from baseline were compared across the 
treatments, there was no significant difference between 
the groups at the 3 and 6 month visits (p=0.631 and 
p=0.107 respectively) and only the 6 week comparison 
revealed a significant difference (p=0.001).
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Table 3.27 Change in the MGI (modified Gingival Index) data 
from baseline among the 4 treatment groups at 6 week, 3 
months and 6 month visits. Mean and 95% confidence
interval and median of change in MGI are displayed.
Probability values within each cell represent the paired 
comparison between the baseline and the corresponding 
follow-up visit using the Wilcoxon test. Probability 
values in the last row of the table represent between
treatment comparisons at each time point for changes in
MGI using the Kruskal-Wallis test.
Treatment 6 week visit 3 month visit 6 month visit
Tetracycline mean 1.10 0.73 0.84
fibre CI* (0.85 - 1.35) (0.51 - 0.94) (0.59 - 1.10)
med. * 1 1 1
p<0.001 p<0.001 p<0.001
Minocycline mean 0.52 0.55 0.36
gel CI (0.22 - 0.82) (0.30 - 0.81) (0.12 - 0.60)
med. 1 1 0
p=0.003 p<0.001 p=0.011
Metronidazole mean 0.43 0.31 0.27
gel CI (0.20 - 0.56) (0.07 - 0.56) (0.03 - 0.51)
med. 0 0 0
p=0.002 p=0.005 p= 0.036
Scaling mean 0.43 0.63 0.43
alone CI (0.23 - 0.64) (0.39 - 0.87) (0.21 - 0.65)
med. 0 1 1
p=0.001 p<0.001 p=0.002
Kruskal- p=0.002 p= 0.340 p= 0.012
Wallis p
value
t CI : 95% confidence interval 
t med. : median
Table 3.28 Matrix of pair-wise comparisons of 6 week 
improvement and 6 month improvement in the Modified 
Gingival Index (MGI) between treatments using the Mann- 
Witney U test.
A. 6 week change:
Tetracycline
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
p*=0.008
Metronidazole
gel
p=0.001 p=0.624
Scaling
alone
p< 0.001 p=0.613 p=0.942
B. 6 month change:
Te tracyc1ine 
fibre
Minocycline
gel
Metronidazole
gel
Minocycline
gel
p=0.018
Metronidazole
gel
p=0.0018 p=0.438
Scaling
alone
p= 0.049 p= 0.623 p=0.150
* After the Bonferroni correction for the multiple comparisons the
threshold for a significant probability value was p<0.020.
3.1.16 The effect of smoking status on the treatment 
outcome
Table 3.29 shows the improvement in the pocket depth and 
attachment level among the smoker and non-smoker patients, 
regardless of their treatments. At all the follow-up 
occasions the improvement in the non-smoker patients were 
greater than the smoker patients for both probing depth 
and attachment level data. The 2-sample independent t- 
tests showed that for pocket depth reductions, the 6 week 
and 6 month improvements were significantly greater in the 
non-smokers than in the smokers (p=0.019 and p=0.010 
respectively). However, the 3 month comparison did not 
show a significant difference (p=0.090). The changes in
attachment levels were not significantly different at any 
time points (p=0.84, p=0.59 and p=0.095 for the 6 week, 3 
month and the 6 month visits respectively).
At baseline the smokers had a significantly lower GCF 
volume than the non-smokers (p=0.023). In addition, the 
plaque levels of the smokers was not greater than that of 
the non-smokers.
Since the data indicated that smoking may have had an 
influence on the treatment outcome (Table 3.29), it was 
decided to test this effect in a more integrated approach 
together with the other factors i.e. the treatment (which 
was of most interest) and the baseline pocket depth (which 
was shown to have an important effect on outcome).
168
Therefore, the changes in the pocket depth and attachment 
levels were tested in the General linear model (GLM) 
procedures. The smoking status and treatment were the 
main factors with 2 and 4 factor levels respectively and 
the baseline pocket depth was a continuous covariate. The 
initial model testings were performed by including all the 
individual effects together with the 2-order and the 3- 
order interactions. If the 3-order interaction was not 
significant, the model would be tested without the 3-order 
interaction. Similarly, the 2-order interactions were 
removed one by one if they were not significant. 
Therefore, the final model included only the main factors 
and the significant interaction terms (if any). Tables 
3.30 to 3.35 show this analysis for the pocket depth 
reduction and attachment gain data at the 6 week, 3 month 
and the 6 month visits. These series of analysis 
consistently revealed that a significant interaction 
existed between the smoking status and the baseline pocket 
depth at all time points for both the pocket depth 
reduction and the attachment gain. Due to the presence of 
such an interaction the interpretation of either of the 
individual effects of baseline pocket depth and the 
smoking status was not possible. However, since the 
treatment was not a component of a significant interaction 
(except for the 3 month pocket depth reductions) the 
probability values obtained for the treatment were 
interpretable (with one exception) as the significance of 
the treatment effect alone. The treatment effect was
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significant only for the 6 week pocket depth reductions 
and the 6 month pocket depth reductions (p= 0.002 and 
p-0.042 respectively). The presence of interaction
between the smoking and the baseline pocket depth 
indicated that the effect of having deeper pocket depth on 
the treatment outcome was different for the smokers and 
non-smokers. Further inspection of such interaction was 
performed by plotting the changes and the least square 
lines for the smokers and non-smokers against the initial 
pocket depth. Figures 3.3 to 3.8 display the overlaid 
regression lines for the smokers and non-smokers for 
probing depth and attachment level changes. The Figures 
consistently indicated that while in the non-smokers there 
was a linear relationship between the baseline pocket 
depth and the changes in the pocket depth and attachment 
level, in the smoker patients, very weak relationships 
existed between the baseline pocket depth and the changes 
in the pocket depth or attachment level.
Table 3.36 shows the improvements in the pocket depth and 
attachment level for each time point among the treatment 
groups. The results indicated that the probability values 
obtained for between-treatment comparisons are generally 
smaller in the non-smoker sub-group than the smoker sub­
group (with the exception of 6 month pocket depth 
changes) . In other words, in the non-smoker sub-group, 
the treatment effect was often stronger than it was in the 
smoker sub-group.
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Table 3.29 The change in pocket depth (PD) and attachment 
level (AL) , the plaque Index, and the GCF volume in all 
patients broken down by their smoking status (regardless of 
their treatment type) . Mean ± standard error of the mean are 
shown, p values were obtained using 2-sample t-tests between 
smokers and non-smokers data.
a) pocket depth reduction and attachment gain|(mm)
smoking PD 
status change 
6 week
PD 
change 
3 month
PD AL AL 
change change change 
6 month 6 week 3 month
AL 
change 
6 month
Smokers 0.76 
(n=28) ±0.11
0.92
±0.14
0.72 0.50 0.55 
±0.12 ±0.09 ±0.10
0.40
±0.11
Non- 1.14 
smokers ±0.12 
(n=26 )
1.28
±0.15
1.28 0.52 0.63 
±0.17 ±0.10 ±0.12
0.71
±0.13
2-sample p=0.019 
t-test
p=0.090 p=0.010 p= 0.845 p= 0.594 p=0.069
b) Plaque Index :
smoking
status
PI
Baseline
PI PI 
6 week 3 month
PI 
6 month
Smokers
(n=28)
0.55
±0.08
0.65 0.73 
±0.11 ±0.12
0.86
±0.12
Non- smokers 
(n-26)
0.65
±0.10
0.68 0.89 
±0.11 ±0.10
0.83
±0.10
2-sample 
t-test
p=0.44 p=0.84 p=0.31 p=0.85
c) GCF volume |( (J.1)
smoking
status
GCF
Baseline
GCF GCF 
6 week 3 month
GCF 
6 month
Smokers
(n=28)
 ^0.41 
*±0.03
0.41 0.42 
±0.03 ±0.03
0.40 
±0 .03
Non- smokers 
(n=26)
0.51
±0.03
0.44 0.49 
±0.03 ±0.03
0.48
±0.03
2-sample 
t-test
p= 0.023 p=0.48 p=0.088 p=0.055
Table 3.30 Analysis of Variance (GLM) for change in 
pocket depth at 6 week visit. The final model includes 
only the main effects and the significant interaction 
terms (PD0=baseline pocket depth, TREAT=treatment, 
SMOKE=smoking status).
Source DF Seq SS Adi SS Adi MS F P
SMOKE 1 1.9553 0.5585 0.5585 2.44 0.125
TREAT 3 4.3680 3.9084 1.3028 5.70 0.002
PDO 1 1.4883 1.7738 1.7738 7.76 0.008
SMOKE*PD0 1 0.9314 0.9314 0.9314 4.07 0.049
Error 47 10.7472 10.7472 0.2287
Total 53 19.4901
Table 3.31 Analysis of Variance (GLM) for change in 
attachment levels at 6 week visit. The final model 
includes only the main effects and the significant 
interaction terms(PD0=baseline pocket depth,
TREAT=treatment, SMOKE=smoking status).
Source DF Seq SS Adi SS Adi MS F P
SMOKE 1 0.0107 0.8623 0.8623 4.63 0.037
TREAT 3 1.6677 1.3501 0.4500 2.42 0.078
PDO 1 1.5014 1.7913 1.7913 9.62 0.003
SMOKE*PD0 1 0.9502 0.9502 0.9502 5.10 0.029
Error 47 8.7514 8.7514 0.1862
Total 53 12.8814
Table 3.32 Analysis of Variance (GLM) for change in 
pocket depth at 3 month visit. The final model includes 
only the main effects and the significant interaction 
terms(PDO=baseline pocket depth, TREAT=treatment,
SMOKE=smoking status).
Source DF Seq SS Adi SS Adj MS P P
SMOKE 1 1.7375 3.7783 3.7783 10.13 0.003
TREAT 3 3.0439 2.2470 0.7490 2.01 0.127
SMOKE * TREAT 3 4.1079 3.8286 1.2762 3.42 0.025
PDO 1 1.9282 2.7270 2.7270 7.31 0.010
SMOKE*PDO 1 4.6265 4.6265 4.6265 12.41 0.001
Error 44 16.4067 16.4067 0.3729
Total 53 31.8506
Table 3.33 Analysis of Variance (GLM) for change in 
attachment level at 3 month visit. The final model 
includes only the main effects and the significant 
interaction terms (PDO = baseline pocket depth, TREAT = 
treatment, SMOKE = smoking status).
Source DF Seq SS Adj SS Adi MS F P
SMOKE 1 0.0964 2.1881 2.1881 7.89 0.007
TREAT 3 0.7016 0.4356 0.1452 0.52 0.668
PDO 1 1.0730 1.4931 1.4931 5.38 0.025
SMOKE*PD0 1 2.3784 2.3784 2.3784 8.58 0.005
Error 47 13.0322 13.0322 0.2773
Total 53 17.2815
Table 3.34 Analysis of Variance (GLM) for change in 
pocket depth at 6 month visit. The final model includes 
only the main effects and the significant interaction 
terms (PDO = baseline pocket depth, TREAT = treatment, 
SMOKE = smoking status).
Source PF Seq SS Adi SS Adi MS P P
TREAT 3 3.2003 2.9209 0.9736 2.95 0.042
SMOKE 1 4.9117 5.0262 5.0262 15.25 0.000
PDO 1 3.9940 5.3107 5.3107 16.12 0.000
SMOKE*PDO 1 6.5268 6.5268 6.5268 19.81 0.000
Error 47 15.4872 15.4872 0.3295
Total 53 34.1200
Table 3.35 Analysis of Variance (GLM) for change in 
attachment level at 6 month visit. The final model 
includes only the main effects and the significant 
interaction terms (PDO=baseline pocket depth, 
TREAT=treatment, SMOKE=smoking status) r
Source DF Seq SS Adi SS Adi MS P P
TREAT 3 0.4707 0.4577 0.1526 0.51 0.674
SMOKE 1 1.5283 1.5939 1.5939 5.37 0.025
PDO 1 3.2411 3.8732 3.8732 13.06 0.001
SMOKE*PD0 1 2.0881 2.0881 2.0881 7.04 0.011
Error 47 13.9438 13.9438 0.2967
Total 53 21.2720
Table 3.36 The probing pocket depth and attachment 
level changes across the treatment groups at different 
time points, broken down by the smoking status of the 
patients. Probability values in the last column represent 
the analysis of covariance to test the treatment effect 
with the baseline pocket depth as covariate. The data are 
patient derived. Mean and the standard error of the mean 
are displayed.
Smoking Tetracycline Minocycline Metronidazole Scaling P
status fibre gel gel alone value
Pocket
depth 
change (mm) 
(6 week)
N* 1.73 
± 0.27
0.98
±0.17
1.18
±0.12
0.80
±0.22
0.010
Pocket
depth 
change 
(6 week)
S* 1.11 
± 0.19
0.78 
± 0.20
0.63 
± 0.31
0.37
±0.11
0.128
Attachment 0.93 0.43 0.64 0.18 0.035
gain (mm) 
(6 week)
N ± 0.22 ±0.17 ±0.19 ±0.15
Attachment 0.64 0.47 0.48 0.36 0.758
gain 
(6 week)
S ±0.13 ± 0.21 ± 0.25 ±0.17
Pocket
depth 
change 
(3 month)
N 1.60 
± 0.37
0.76
±0.22
1.64 
± 0.28
1.07 
± 0.26
0.030
Pocket S 1.37 1.03 0.40 0.69 0.098
depth
change
± 0.24 ±0.26 ±0.24 ± 0.31
(3 month)
Attachment N 0.82 0.37 0.91 0.42 0.228
gain 
(3 month)
±0.34 ±0.14 ± 0.26 ±0.17
Attachment S 0.63 0.60 0.43 0.50 0.919
gain 
(3 month)
±0.15 ±0.22 ± 0.28 ±0.19
Pocket N 1.67 0.99 1.31 1.22 0.490
depth
change
± 0.41 ± 0.21 ± 0.36 ± 0.37
(6 month)
Pocket S 1.21 0.69 0.64 0.19 0.028
depth
change
± 0.27 ±0.11 ±0.14 ± 0.27
(6 month)
Attachment N 1.06 0.49 0.68 0.73 0.394
gain 
(6 month)
±0.19 ± 0.25 ± 0.31 ± 0.26
Attachment S 0.48 0.53 0.40 0.24 0.798
gain 
(6 month)
± 0.27 ±0.10 ± 0.27 ± 0.20
t N: non-smokers I S: Smokers
Pocket depth
reoucuon i(mm) 
(6 week) -1.66 + 0.51x r‘2 ■ 0.36 ■ Non-smokers
16 + 0.04x r‘2 - 0.00 A Smokers
4 5 6 7 8
Initial pocket 
depth|(mm)
Fig. 3.3 Plot and regression lines of pocket depth
reduction (6-week) against the initial pocket depth
for the smokers and non-smokers.
Pocket depth 
reduction I (mm) 
(3 month)
-3.18 + 0.81x r*2 - 0.49 ■ Non-smokers
* Smokers
4 5 6 7 8
Initial pocket 
depth |(mm)
Fig. 3.4 Plot and regression lines of pocket depth
reduction (3-month) against the initial pocket depth
for the smokers and non-smokers.
Pocket depth 
reductioni (mm) 
(6 month)
non-smokers-4.30 + 1.02x r“2 - 0.61
Smokers
2
4 5 6 7 8
Initial pocket
depthi(mm)
Fig. 3.5 Plot and regression lines of pocket depth
reduction (6-month) against the initial pocket depth
for the smokers and non-smokers.
Attachment gain 
(6 week)
(mm)
2.21 + 0.50x r*2 - 0.41
0.19 + 0.05x r“2 - 0.01
■ Non-smokers 
* Smokers
2
4
Initial pocket 
depthj(mm)
Fig. 3.6 Plot and regression lines of attachment
level changes (6-week) against the initial pocket
depth for the smokers and non-smokers.
Attachment gain |(mm)
(3 month)
rA2 “ 0.38 ■ Non-smokers 
2 - 0.01 4 Smokers
-2.52 + 0.58x 
0.95 - 0.07x
4 5 6 7 8
Initial pocket 
depth |(mm)
Fig. 3.7 Plot and regression lines of attachment
level changes (3-month) against the initial pocket
depth for the smokers and non-smokers.
ttachment gain (mm)
i month)
y “ -3.13 + 0.70x r 2 = 0.47 ■ Non-smokers
SmokersS3
7
Initial pocket 
Depth | (mm)
Fig. 3.8 Plot and regression lines of attachment
level changes (6-month) against the initial pocket
depth for the smokers and non-smokers.
3.1.17 The effect of previous history of periodontal 
surgery on pocket depth reduction
Twenty-three percent of all sites had been previously 
treated by means of periodontal flap surgery. The 
distribution of such sites among the 4 treatment groups 
were similar and ranged from 18% to 24% (chi-square=1.079, 
d.f.=3, not significant). Table 3.37 shows the pocket 
depth reduction at various follow-up time points for sites 
with or without previous surgery. At all 3 follow-up 
visits, the improvement in pocket depth was greater at 
sites which did not have previous surgery. This 
difference almost approached the statistically 
significance level at the 3-month follow-up visit 
(p=0.057) .
3.1.18 The gingival crevicular fluid volume (GCF)
The GCF volumes are shown in Table 3.38. There was no 
difference in the GCF volumes at the baseline between 
treatment groups (p=0.308). After 6 week there was a 
significant reduction in the GCF volume in the scaling 
plus tetracycline fibre group (p=0.031). However, this 
reduction did not remain significant at the 3 month and 6 
month visits. In the remaining 3 groups no significant 
change took place in the GCF volumes after the treatment.
3.1.19 Adverse effects
No serious adverse effect such as toxic or allergic 
reactions was observed or reported by any of the patients.
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Table 3.37 Pocket depth reduction at sites with 
different history of previous periodontal surgery. Mean, 
standard error of the mean, 95% confidence interval for 
difference and the p value for the two-sample t test are 
shown.
Time point Mean + SEM (mm) 95% Cl & 
p value
No Surgery surgery
(n=164) (n=49)
6 -week 0.95 0.82 -0.20 , 0.48
± 0.08 ±0.15 p=0.430
3 -month 1.16 0.81 -0.01 , 0.72
± 0.09 ±0.16 p= 0.057
6 -month 1.08 0.76 -0.03 , 0.69
± 0.10 ±0.15 p=0.076
Table 3.38 Gingival crevicular volumes \{\il) obtained 
at baseline, 6 week, 3 month and 6 month visits among 
the 4 treatment groups. Mean ± standard error of the 
mean are displayed. Probability values were obtained by 
the paired t-tests between the baseline and a follow-up 
time point volumes for each treatment.
Treatment Baseline1 6 week 3 month 6 month
Tetracycline 0.49
fibre ±0.04
Minocycline gel 0.43
±0.04
Metronidazole gel 0.41
±0.04
Scaling alone 0.51
±0.05
0.38 0.46 0.43
±0.04 ±0.04 ± 0.03
p=0.031 p=0.56 p=0.12
0.41 0.49 0.45
±0.04 ±0.04 ±0.04
p=0.62 p=0.28 p=0.73
0.45 0.39 0.42
±0.04 ±0.04 ±0.05
p=0.40 p=0.78 p=0.71
0.46 0.49 0.46
± 0.05 ± 0.05 ±0.04
psO.23 p=0.70 p=0.27
f No difference existed between treatments at baseline (p=0.31).
Table 3.39 Adverse effects in each treatment group
Treatment Symptom Sign
Tetracycline
fibre
Slight pain on 1st day of 
fibre therapy (1 patient)
Slight
redness upon 
fibre removal 
(5 patients)
Minocycline
gel
Bad taste on 1st day of gel 
application (1 patient)
Nil
Gingival tingling on the 
1st day of gel application 
(1 patient)
Metronidazole
gel
Bad taste on 1st day of gel 
application (2 patients)
Nil
Scaling alone Nil Nil
However, mild and transient effects were observed/reported 
(Table 3.39) .
3.1.20 Time taken for the treatments
Each study tooth and their adjacent teeth were scaled and 
root planed under local anaesthesia for approximately 5 
minutes each. In addition, all deep pockets within the 
mouth were scaled and root planed under local anaesthesia. 
A minimum of one 45-60 minute visit was necessary for this 
purpose. An additional visit was used if required. The 
gel therapy normally took 10 minutes per session. The 
average time taken for fibre insertion was 8.2 minutes per 
tooth with a range of 5-20 minutes. The removal of fibres 
took 11.0 minutes per patient.
3.1.21 Sites requiring intervention
At the 3 month visit, one site in the scaling and root 
planing alone group developed an abscess, showed severe 
attachment loss and caused discomfort for the patient.
This tooth was given additional treatment which comprised
scaling and root planing. The 6 month measurements were 
taken for this site. This site showed some further
attachment loss at the 6 month visit. It is normally
recommended to exclude the data of such sites from the 
analysis and instead, to analyse the frequency of excluded 
sites among the treatment groups as an outcome variable 
(Imrey, 1986) . It is most likely that the additional 
treatment at this site has slowed down the attachment loss
172
and therefore, the analysis of data without exclusion of 
this site would have diluted the difference between the 
efficacy of the 4 treatments. On the other hand, since 
the changes in probing depth and attachment level of this 
site at the 6 month visit, i.e., after the additional 
treatment, were still far inferior to the mean of 
remaining sites which received the same treatment, 
exclusion of this site from the 6 month analysis or from 
the entire analysis would have further diluted the real 
differences between the treatments. Therefore,
recognising the slight diluting effect resulting from the 
additional treatment of this site, it was decided to keep 
this site in the analysis.
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3.2 An evaluation of the effect of Nd:YAG laser on
calculus, cementum and dentine, an in vitro 
study
The electron microscopic features of laser treated tissue 
seemed very typical. These features include melting down 
of the tooth material and calculus. The mineral seemed to 
melt and then re-solidify. This resulted in a very porous 
surface. The size of pores ranged from 1 to 20 microns. 
In those specimens where severe damage was evident, a hole 
had been created which was lined with melted material.
Increasing the energy setting and duration of the laser, 
generally resulted in increase in the severity of damage 
to calculus, cementum and dentine, although it was 
observed that cementum and dentine were not affected using 
low energy settings and short durations. On the other 
hand, calculus was more or less affected using all energy 
settings and durations.
3.2.1 Calculus
Table 3.40 shows the degree of damage for each of the 94 
treated sites on 32 teeth, along with the mean damage 
score for each tooth.
Figure 3.9 shows the relationship between the log of the 
total energy input and the mean damage score. The least 
squares linear regression line was:
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mean damage score = 0.925 + 1.54 log10 (total energy input)
The slope of the line was significantly different from 0 
(p<0.001) and r2=66% . A plot of residuals against the
fitted values from this regression indicated that a 
straight line gave an adequate fit to the data. Thus 
there is convincing evidence that higher total energy 
input leads to a greater mean damage score.
The effect of the power setting of the laser, the number 
of pulses per second and the length of time on the mean 
damage score were further investigated by a three-way 
analysis of variance. The results are shown in Table 
3.41. None of the interaction terms are significant. 
However the main effects of power setting, number of 
pulses per second and length of time are contributing 
independently to the mean damage score in an additive way.
A consistent observation was that specimens with complete 
evaporation of calculus also showed some degree of damage 
to the underlying cementum (Fig. 3.10), however, because 
of the variability in calculus thickness which could not 
be controlled, this damage to the underlying cementum was 
not scored in the present study.
3.1.2 Cementum and dentine
Tables 3.42 and 3.43 show the degree of damage to the 
cementum and dentine specimens. Large variability was
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Fig. 3.9 The relationship between the total laser 
energy input (log) and the damage score on 
subgingival calculus.
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Table 3.41 Three-way analysis of variance of the effect of 
power setting, number of pulses per second and length of 
time on the mean damage score.
source_______________ d.f. Sum of squares F___________p
Power 1 3.07 13.3 <0.001
Pulses/sec 1 1.96 8.4 0.008
Time 1 7.91 34.2 <0.001
Power * Pulses 1 0.08 0.3 0.57
Power * Time 1 0.03 0.1 0.74
Pulses * Time 1 0.00 0.0 0.93
Power*Pulses*Time 1 0.52 2.3 0.15
Error 24 5.56
Total 31
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Fig. 3.10 Laser treated subgingival calculus. The 
laser has evaporated not only the calculus but also 
the underlying cementum layer, (top: 50 mJ, 10 pps, 
1 sec; bottom: 100 mJ, 2 0 pps, 1 sec; next page:
100 mJ, 20 pps, 1 sec ) .
Fig. 3.10 (continued)
observed between different teeth, for both cementum and 
dentine specimens. For instance, tooth D was affected by 
none of the laser exposures, whereas tooth F was affected 
by all of the power settings employed.
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3.3 Evaluation of the Nd:YAG laser in periodontal
pocket therapy
3.3.1 Plague Index and Modified Gingival Index
Overall the plaque index scores recorded for all sites 
were relatively low during the study (0.6 at baseline and 
0.37 at 6-weeks). There was a slight reduction in plaque 
scores at the 6-week visit compared to baseline for all 
four groups, although only the control group showed a
significant reduction (p=0.043 Wilcoxon's test).
Friedman's test on changes in plaque scores among the 4 
groups showed no significant differences (p=0.94) (Table 
3.44). The gingival index also was slightly reduced in 
all groups over time with the highest reduction being 
recorded in the scaling group (mean reduction 0.5)
followed by the 50mJ laser, 80mJ laser and control groups 
with mean reductions of 0.26, 0.05 and 0.05 respectively. 
No significant difference was found in changes of gingival 
scores among the 4 groups (p= 0.29) (Table 3.45).
3.3.2 Probing pocket depth
All groups showed a reduction in pocket depth at the 6- 
week visit compared to baseline (Table 3.46), but only the 
scaling group showed a significant reduction (p<0.001, 
paired t-test). Repeated measures analysis of variance on 
differences of the 4 groups proved to be significant 
(p=0.003). In addition, Duncan's multiple range test
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Table 3.44 |Plaque Index at baseline and six-week visits 
among the different treatment groups. Mean ± Standard 
error of the mean are displayed.
Treatment Baseline 6 week Change'
Scaling and 0.65 0.50 0.15
root planing ±0.18 ±0.17 ± 0.21
Laser '50 mJ' 0.80 0.45 0.35
± 0.21 ±0.14 ± 0.23
Laser '80 mJ' 0.50 0.40 0.10
±0.14 ±0.15 ±0.12
Untreated 0.45 0.15’ 0.30
control ±0.15 ±0.11 ±0.13
t p=0.939, Friedman/s test.
| Significantly different from baseline, p=0.043, Wilcoxon's test.
Table 3.45 Modified Gingival Index at baseline and six- 
week visits among the different treatment groups. Mean ± 
Standard error of the mean are displayed.
Treatment Baseline 6 week Change*
Scaling and 1.65 1.15 0.50
root planing ± 0.18 ±0.15 ±0.24
Laser *50 mJ1 2.05 1.80 0.25
± 0.15 ±0.17 ±0.14
Laser *80 mJ1 1.95 1.90 0.05
±0.15 ±0.14 ±0.15
Untreated 1.45 1.40 0.05
control ±0.15 ±0.18 ± 0.22
t P=0.299, Friedman's test.
Table 3.46 Mean ± standard deviation of pocket depth 
results for 4 treatment groups (laser ’50 mCT', laser 
'SOmJ', scaling, and control) .[The unit of measurements is mm.
baseline 6 -week difference
control 6.15 5.90 0.25
± 1.87 ±1.74 ±0.64
laser '50 nU* 6.35 5.90 0.45
± 2.06 ±2.07 ±1.54
laser '80 mJ' 6.65 6.40 0.25
± 1.84 ±1.93 ± 1.19
scaling 5.95 4.55 1.40
± 1.43 ± 1.36’ ± 1.15*
t significantly different from baseline, paired t-test p<0.001.
$ Significantly different from all other groups, Duncan’s multiple 
range test (P<0.05).
revealed that scaling was significantly superior to all 
other groups (p<0.05).
3.3.3 Total anaerobic counts
The total anaerobic counts of subgingival plaque samples 
collected immediately after scaling and 80mJ laser 
treatments showed a significant reduction compared to 
those collected before treatment (p<0.01, paired t-test, 
Table 3.47). However, after 6 weeks, only the scaling 
group still showed a significant reduction compared to 
baseline (p<0.01, paired t-test). The differences in 
counts between the baseline and post-treatment samples and 
between baseline and 6-week samples were subjected to 
repeated measures ANOVA and a significant difference was 
found for the former comparison (p<0.001). Duncan's 
multiple range test elucidated a significant difference 
between scaling and all other groups (p<0.05). However, 
differences between baseline and 6-week visit samples 
among the 4 groups were not significantly different 
(p-0.059).
3.3.4 Bleeding on probing
No improvement was observed in bleeding on probing (BOP) 
for any of the laser treated sites throughout the study 
(Table 3.48), although the control group showed a little 
reduction (10%). The scaling group, however experienced a 
45% reduction (from 95% to 50%) which proved to be 
significant (p=0.0039, McNemar test).
178
Table 3.47 Mean ± standard deviation of log CFU at 
baseline, immediately after treatment and six-week visit 
for 4 groups (laser '50 mJ1 , laser '80 mJ' , scaling, and 
control).
baseline immediately
post.
therapy
six
week
difference
^baseline
-post.
therapy
difference 
=baseline - 
six week
control 4.88 4.97 5.31 -0.09 -0.43
± 1.62 ± 1.46 ± 1.36 ± 0.96 ± 1.57
laser 5.54 5.38 5.72 0.16 -0.18
'50 mJ' ± 1.01 ± 0.69 ± 0.78 ±0.84 ±1.12
laser 5.89 5.36* 5.93 0.53 -0.04
'80 mJ' ± 0.90 ± 0.89 ± 1.02 ±0.71 ± 1.00
scaling 5.72 4.30* 5.09 1.42* 0.63
±0.93 ± 1.51 ±1.11 ± 1.71 ± 1.31
t Significantly different from baseline p<0.01
t Significantly different from all other groups, Duncan's multiple 
range test, p<0.05.
Table 3.48 The number (percentage) of sites with 
bleeding on probing among 4 groups (laser '50 mJ1 , 
laser '80 mJ', scaling, and control).
Treatment Baseline 6 week Change
Laser '50 mJ' 19 (95%) 19 (95%) 0 (0%)
Laser *80 mJ1 20 (100%) 20 (100%) 0 (0%)
Control 20 (100%) 18 (9lo%) 2 (10%)
Scaling 19 (95%) 10 (50%)’ 9 (45%)
t Significantly different from baseline, p=0.0039, McNemar test.
3.3.5 Scanning Electron Microscopy (SEM)
SEM examination of laser treated teeth showed no evidence 
of damage attributable to the laser irradiation. Most 
tooth surfaces were still covered with substantial pieces 
of calculus with surface deposits of bacteria, despite 
laser treatment.
179
CHAPTER IV
DISCUSSION
4.1 Introduction
Therapeutic devices or drugs with potential periodontal 
applications may be used either alone or as adjuncts to 
traditional treatments. However, before it is decided 
whether the device could be used as an adjunctive 
treatment, it is usually essential to test the new device 
or drug alone to evaluate its effect on the biological 
tissues, potential side effects and to investigate the 
efficacy of the device per se.
Up until now, there has been little research on the laser 
application in periodontal therapy. Therefore, before 
investigating or even hypothesising the efficacy of laser 
as an adjunct to scaling and root planing, it would be 
essential to examine the effects of the laser energy per 
se on the dental tissues. This approach was followed in 
this thesis.
On the other hand, considerable research has been done on 
locally applied antibacterial systems in periodontal 
therapy. Several systems have been developed and tested in 
vitro and in clinical studies. A number of these systems 
are now being marketed as adjuncts to scaling and root 
planing. However, to date, the research on subgingivally 
applied antibiotics has been mainly focused on the use of 
these systems as the initial treatment of periodontal 
disease and little work has been done on the efficacy of 
these delivery systems for the treatment of sites with an
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unfavourable response or recurrence of the disease after 
traditional mechanical treatment. In this thesis, the 
effects of subgingival antimicrobial systems as adjunct to 
scaling and root planing on sites with persistent 
pocketing were studied.
4.2 The clinical study of locally delivered
antimicrobial systems
4.2.1 Clinical response
4.2.1.1 Significant improvement after treatments
All treatment modalities used in this study including 
scaling and root planing alone, resulted in a significant 
pocket depth reduction and clinical attachment gain. In 
addition, other clinical parameters including BOP, 
suppuration and the MGI scores were significantly improved 
by all treatments. The results of our investigation 
support the hypothesis that many sites which do not 
respond favourably to initial mechanical periodontal 
therapy, may still benefit from further episodes of 
scaling and root planing. While these results are in 
agreement with previous reports by Listgarten et al. 
(1978) , they are inconsistent with those of Badersten et 
al. (1984b) who found no difference between a single and 3 
courses of scaling and root planing performed every 3 
month.
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4 .2.1.2 Rebound towards baseline
All treatments had improved clinical parameters at the 6 
week visit compared to baseline. The healing response was 
maximised at the 3 month visit. Although the significance 
of pocket depth reduction and attachment gain were 
sustained throughout the 6 month period of the study, a 
rebound towards baseline was observed at the 6 month visit 
in all treatment groups including scaling and root planing 
alone. The study sites did not receive any maintenance 
care throughout the 6 month follow-up period. It could be 
that the 6 month is too long a period for treated sites 
to be left without maintenance care. Nyman, Rosling and 
Lindhe (1975) reported that a programme consisting of 
professional care every 2 weeks was more effective in 
arresting attachment loss than one with every 6 months 
visits.
4.2.1.3 Healing period after root planing alone
The data indicated that the pocket depth and attachment 
level improvement in the scaling alone group was not 
complete at the 6 week visit. Although all groups 
continued to improve between the 6 week and the 3 month 
visits, this was statistically significant only in the 
scaling alone group. Therefore, it can be concluded from 
this study that the optimum time to re-assess the response 
to scaling and root planing should be longer than 6 weeks 
after therapy. While Proye et al. (1982) reported that the 
post-therapy attachment gain was complete within 3 weeks,
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most reports indicated that after scaling and root 
planing, gradual improvement in clinical parameters 
continued to occur up to at least 4 to 5 months post- 
therapy (Badersten, Nilveus and Egelberg, 1981; Kaldahl et 
al., 1988).
4.2.1.4 The effects of locally delivered antimicrobial
systems on probing pocket depth, attachment 
level and recession
Our study revealed that tetracycline fibre therapy as 
adjunct to scaling and root planing, produced the greatest 
reduction in pocket depth. At the 6 week visit, the 
scaling and root planing plus tetracycline fibre was the 
only treatment group which resulted in a significantly 
greater pocket depth reduction than that of the scaling 
and root planing alone group. However, at this time point 
there were no significant differences among the 
antimicrobial treatment groups. At the 3 month and 6 
month visits no significant differences existed between 
any of the treatment groups. When 3x the standard 
deviation of probing pocket depth measurements were used 
as a threshold to assign a site as one with reduced pocket 
depth, at the 6 month visit, the root planing plus 
tetracycline fibre group and the root planing plus 
metronidazole gel group were found to have resulted in a 
significantly greater number of sites with reduced pocket 
depth than the root planing plus minocycline gel group.
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The tetracycline fibres have been reported to provide a 
sustained tetracycline concentration of 1590 iM-g/ml in 
periodontal pockets over a 10 day period (Tonetti et al., 
1990). Metronidazole gel provided a metronidazole 
concentration > 1 |jj,g/ml at 50% of sites 24 hours after 
application, and at 8% of sites 36 hours after application 
(Stoltze, 1992) . Satomi et al. (1987) reported a mean GCF 
concentration of 11.2 ||ng/ml minocycline 24 hours after 
application of 2% minocycline gel into pockets. After 48 
hours the GCF concentration was 5.4!jug/ml. These reports 
indicate that variation exists between the substantivity 
of different drug delivery systems. The results of the 
present study reflects that local delivery systems with 
high substantivity may produce the greatest clinical 
improvement if used as an adjunct to root planing as 
compared with other systems or mechanical treatment alone.
All treatments resulted in a significant gain in clinical 
attachment. The scaling plus tetracycline fibre treatment 
resulted in the greatest improvement in attachment levels. 
However, the study failed to show significant difference 
between groups. Nevertheless, at the 6 week visit, 
scaling plus tetracycline fibre group and scaling plus 
metronidazole gel group resulted in significantly greater 
number of sites with attachment gain (as defined by 3x the 
standard deviation of attachment level measurements) than 
the scaling and root planing alone group.
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All 3 antimicrobial treatments resulted in a greater 
improvement in pocket depth and attachment level than 
scaling and root planing alone. This indicates that all 3 
antimicrobial treatments offered some beneficial effect 
over the scaling alone. However, the difference between 
groups, particularly towards the end of the study, were 
neither clinically nor statistically important.
Treatments do not heal the periodontal lesions permanently 
but have to be repeated. The observation that slight 
rebound towards baseline occurred at the 6 month visit, 
indicate the interval at which treatment must be repeated, 
although, due to the risk of antibiotic resistance, too 
often use of antimicrobial agents is not justified.
The reduction of pocket depth is due to the attachment gain, the
formation of long junctional epithelium and the recession. The
recession occurs mainly as a result of reduction in 
inflammatory infiltrate and therefore, shrinkage of 
tissue. It may also happen as a result of trauma to the 
gingival tissue as a result of instrumentation. The 
slight post-treatment attachment loss at shallow sites has 
been reported in the past and is thought to be in part due 
to the trauma from instrumentation (Claffey et al., 1988 & 
1990) . The amount of recession was the greatest in the 
scaling plus tetracycline fibre group. However, regardless 
of the absolute amount of the recession and the efficacy 
of treatments in reducing pocket depth and increasing
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attachment level, the proportion of recession to 
attachment gain was slightly greater in the tetracycline 
fibre therapy group. In other words, in this group, a 
greater proportion of pocket depth reduction was due to 
recession as compared with other groups. This may, in 
part, be due to some trauma by inevitable tension exerted 
from the tetracycline fibres to the soft tissue wall of 
the pocket. However, the clinical importance of this 
effect, at such a small magnitude, is arguable.
4.2.1.5 Bleeding on probing
It has been demonstrated that the extent of connective 
tissue inflammation is different between bleeding and non­
bleeding sites (Greenstein, et al., 1981; Harper and 
Robinson 1987; Passo et al., 1988). Despite the 
reservation of some authors concerning low reproducibility 
for bleeding on probing scores (Janssen, Faber and van 
Palenstein Helderman, 1986), evidence suggests that the 
bleeding on probing decreases after a successful treatment 
(Caton et al., 1982; Proye et al., 1982) and therefore 
could be used as partjof a diagnostic test to evaluate 
treatment outcome.
Bleeding on probing scores were reduced significantly at 
the 6 week visit in all treatment groups. This 
significant reduction was sustained throughout the whole 
study period. The reduction in the bleeding on probing was 
slightly greater in the scaling plus tetracycline fibre
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group than other groups. This was consistent with the 
probing data. However, no statistically significant 
difference was found between groups at any time point. As 
with the probing pocket depth and attachment level data, 
the majority of change took place within the first 6 week 
period post-therapy.
It has been demonstrated that for a given site, the number 
of bleeding on probing episodes during a longitudinal 
monitoring period, is in correlation with the likelihood 
of attachment loss at that site (Lang et al., 1986 &
1990). Therefore, analysis of sites which show bleeding on 
probing on 3 consecutive follow-up visits, would be a test 
with greater positive predictive value than the assessment 
of bleeding on probing scores for a single visit. In the 
present study, there were no significant differences 
between groups in the frequency of sites which showed 
bleeding on probing on all 3 post-treatment occasions, 
although a trend was observed whereby the scaling plus 
tetracycline fibre group showed a lower frequency of such 
sites compared with the remaining groups.
4.2.1.6 Suppuration
The suppuration decreased dramatically after all 
treatments at the 6 week visit. This reduction was 
statistically significant in all but the scaling plus 
minocycline gel group. However, this lack of statistical 
significance was most probably due to a lower proportion
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of suppurative sites in this group at the baseline, 
resulting in a greater likelihood of a type II error, and 
thus, a less powerful statistical test for this group. 
The suppuration reached zero at the scaling plus 
tetracycline fibre group at the 6 week visit and it 
remained zero at the 3 month visit. However, in other 
groups the scores showed a rebound towards baseline. 
Notably, in the scaling and root planing alone group a 
full rebound was observed at this time point. At the 6 
month visit, in addition to the scaling alone group, the 
scaling plus metronidazole gel group also showed an almost 
full rebound. Interestingly, this was in contrast to the 
other 2 groups namely the scaling plus tetracycline fibre 
and the scaling plus minocycline gel groups each having 
only one suppurating site at this time point.
The rebound in suppuration scores was observed at the 3 
month visit, whereas the rebound in other clinical 
parameters such as probing depth, attachment level, and 
bleeding on probing was not observed before the 6 month 
visit. This may indicate that the suppurative sites may 
be more prone to disease recurrence after the treatment 
than the nonsuppurative sites.
The notable difference in reduction of suppuration between 
the root planing alone and the remaining treatments 
observed at the 3 month visit may indicate that the 
locally applied antimicrobial systems might have a
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particular benefit over the scaling and root planing alone 
in the treatment of sites which show suppuration despite 
previous mechanical treatments. The scaling plus
tetracycline fibre treatment may be particularly useful in 
predictably treating such sites. Extremely high
concentration of tetracycline over a 10 day period could 
possibly be effective in suppressing the putative 
organisms in the pocket. However, care should be taken 
when applying the tetracycline fibres in sites with a high 
rate of pus drainage. Tightly inserted fibres in such 
sites may exacerbate the situation by blocking the 
drainage route. No such complication occurred in our 
study. This was presumably due to, as recommended by the 
manufacturer, deliberately loose placement of fibres at 
these sites.
4.2.1.7 The Plaque Index, the Modified Gingival Index, 
and the GCF volumes
The patients' plaque control was generally satisfactory 
throughout the study, and at all time points the mean PI 
was lower than 1 for any group. Nevertheless, there was a 
trend towards a slight increase in the PI in all groups 
towards the end of the study. It is generally believed 
that after initial mechanical therapy the PI decreases. 
However, it should be noted that the subjects in the 
present study had been previously treated mechanically and 
their plaque retentive factors had been corrected. 
Moreover, they all had a satisfactory oral hygiene
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awareness and had been practising a high standard of oral 
hygiene before they were selected for the study. 
Therefore, the study population was different from an 
'untreated' population with low oral hygiene awareness and 
intact plaque retentive factors and therefore little 
further improvement in the level of plaque control could 
be expected from the present study population.
It is generally believed that subjects who participate in 
a study, may demonstrate an improved oral hygiene, which 
may result in some improvement on their periodontal 
disease status eve'n if they have received no active 
treatment. This, so-called Hawthorne effect, was not 
evident in our study. It should be noted that the change 
in the oral hygiene behaviour of patients as a result of 
the Hawthorne effect could be only a short-term phenomenon 
as such change would naturally return to normal once the 
subjects become accustomed to their new treatment. In the 
present study, the subjects were first seen at a screening 
visit. It was at this visit when they were first informed 
of the study. Thus, the Hawthorne effect might have 
started at the screening visit, and the baseline plaque 
scores may, therefore, represent an improved PI status 
compared to the screening visit. However, since no data 
recording were performed at the screening visit, it was 
not possible to demonstrate its possible role on the 
patients!1 plaque scores. It is possible that once the 
patients were treated and finished the active phase of the
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study, i.e. the treatment phase, they gradually returned 
back to their routine level of plaque control which was 
slightly inferior to the baseline scores.
The MGI scores were improved significantly after all 
treatments and remained significantly different from 
baseline throughout the entire study period. However, the 
improvement in MGI in the scaling plus tetracycline fibre 
treatment group was greater than the other treatment 
groups. While at the 6 week and the 6 month visits, the 
improvement in this group was significantly greater than 
all other groups, there were no significant differences 
among the remaining groups. However, the difference 
between groups did not reach the statistically significant 
level at the 3 month visit.
The advantageous effect of tetracycline fibre therapy in 
reducing the MGI scores was most likely due to the 
elimination of pathogenic bacteria by the constant high 
level of tetracycline in the periodontal pocket. However, 
the tetracycline family have been reported to have 
biologic effects other than antibacterial activity on the 
inflamed tissues, which may ultimately result in the 
resolution of the inflammation. It has been reported that 
the tetracyclines could inhibit collagenase activity via 
binding to metallic ions on matrix metalloproteinase 
molecules (Golub et al., 1984), inhibit parathyroid 
hormone-induced bone resorption (Gomes, Golub and
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Ramamurthy, 1984) , bind to and demineralise the root 
surface and increase the binding of fibronectin and 
decrease the binding of laminin (Terranova et al., 1986), 
and promote fibroblast attachment and spreading on the 
root surface (Somerman et al., 1988; Rompen et al., 1993). 
Therefore, the greater resolution of inflammation at sites 
treated by tetracycline fibres could be in part due to 
anticollagenolytic activity. Minocycline gel on the other 
hand might have had a more limited effect than the 
tetracycline fibres due to lower substantivity of the gel 
delivery system.
The GCF volume reduction at the 6 week visit was 
significant only at sites treated by scaling and root 
planing plus tetracycline fibres. The GCF volumes at 
subsequent follow-up time points were not significantly 
different from baseline at any time point. This could be 
a reflection of rebound to pre-treatment values as well as 
sampling error and biological variation.
4.2.2 Methodological considerations 
4.2.2.1 Screening of the sites
In the present study the selection of sites was based on 
cross-sectional screening. At the screening visit 4 sites 
with probing depth > 5 mm and bleeding on probing despite 
previous treatments were selected. One might question the 
method of screening in this study as to whether this 
method was able to pick up the disease active sites. Some
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authors have suggested that the inclusion of sites in a 
longitudinal study of therapeutic modalities for
periodontitis should be based on the longitudinal 
screening of sites, and that only those sites which would
show an attachment loss exceeding a predetermined
threshold over the screening period should be selected for 
the study (Page and De Rouen, 1992) . In reply to this 
question it should be noted that firstly, a study with
longitudinal screening would require much more time and
manpower than a study with cross sectional screening such 
as the present study (Goodson, 1992). In addition, a
pragmatic consideration is that in practice,
antimicrobials would be used on sites which appeared 
resistant to treatment based on residual pocketing and 
BOP.
Furthermore, if the concept of disease activity and the
random burst model is true, some active sites could be
selected by longitudinal screening over a period. 
However, there would not be any certainty as to whether 
all of the selected sites would have continued to remain 
active. The activity of some of them could have been 
limited to a short time coinciding with the screening 
period, followed by a period of quiescence before the end 
of screening period, resulting in the inclusion of some 
false positives in the study. Therefore, if the concept 
of disease activity is accepted, even by monitoring sites
193
for disease activity before site selection, the study 
would not be immune from inclusion of quiescent sites.
Finally, the true distribution and model for periodontal 
disease progression is as yet unknown and the effort of 
clinical scientists and statisticians to disclose the true 
model is hampered by the large measurement errors of the 
available diagnostic tools. Until more advanced
technology allows for the error free detection of 
attachment level changes over time, the true model will 
remain unknown (Sterne, 1988) . In fact when the most 
reproducible technique using an automated electronic probe 
was used, the regression analysis revealed that 76% of the 
sites showed attachment loss which is consistent with a 
continuous model and only a small subset of sites showed 
either bursts of activity or remission of the disease 
(Jeffcoat and Reddy, 1991b).
4.2•2•2 Patient population
The subjects of the present study were selected among 
patients which responded poorly to previous mechanical 
treatments or showed recurrence of the disease after 
transient improvement. Although a significant improvement 
was achieved as a result of scaling alone, this was lower 
than would be expected if carried out as the initial 
treatment on an 'untreated' periodontitis population. 
Usually, following the initial treatment, a marked pocket 
reduction and shrinkage occurs due to the elimination of
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subgingival plaque, calculus and other plaque retentive 
factors. Therefore, somewhat less improvement could be 
expected from the scaling and root planing alone if some 
of these factors have already been reduced by initial 
therapy.
In practice, it is not feasible to use antibiotics as the 
initial treatment of untreated periodontal disease. In 
fact, the only justified use of chemical treatment in 
periodontal therapy is the treatment of sites with 
persistent disease despite previous mechanical treatment.
4.2.2.3 Parallel design
This was a parallel-designed study. Such a design is more 
likely to disclose true differences between treatment 
modalities which may be associated with a considerable- 
carry-over effect. If a split mouth design was used, the 
wash-out of antimicrobial agents through saliva could 
affect the microbial flora in study sites which received 
other treatments. This, in addition to boosting the 
systemic response due to removal of antigenic challenge or 
the inoculation effect following mechanical 
instrumentation, could mask true differences between 
groups if a split mouth design was used (Imrey, 1986).
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4.2.2.4 Sample size estimation
Estimation of sample size was carried out in a pilot study 
with the same measurement techniques. Nine patients were 
treated, each by scaling and root planing plus one of the 
3 local delivery antimicrobial systems. It was estimated 
that 13 patients in each group would provide enough 
statistical power (with a probability of 80%) to disclose 
a significant difference (p<0.05) in the 6-week pocket 
depth reduction between the scaling and tetracycline fibre 
therapy and the remaining treatments. The assumption was 
that the standard deviation and the mean difference of 
pocket depth reductions would be exactly repeated in the 
main study. However, the final analysis revealed that the 
difference between the scaling plus tetracycline fibre and 
the scaling plus metronidazole gel or minocycline gel 
groups did not reach the statistical significance. 
However, the difference between the scaling and root 
planing plus tetracycline fibre group, and the scaling and 
root planing alone proved to be significant at the 6 week 
visit. The mean difference between treatments was greater 
in the pilot study than it was in the final analysis of 
the full study. This inconsistency could be attributed to 
the small number of subjects used in the pilot study. A 
parallel design was selected for the study to prevent the 
so-called carry-over effects between treatments. However, 
by using this design the variation among individuals in 
terms of treatment response could have had a greater role 
than if a split mouth design was used, especially when the
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number of subjects were too small in the pilot study. 
Therefore, while a pilot study could provide a rough 
estimation of approximate sample size, it could not be 
entirely reflective of the final study results.
4.2.2.5 Measurements of attachment level and pocket 
depth
In the present study, an electronic pressure sensitive 
probe was used to measure attachment levels and probing 
pocket depth. The measurements were taken in duplicate 
and a single examiner was used for the measurements 
throughout the study. The reliability of clinical 
measurements is often expressed as the standard deviation 
of differences between repeated measurements. In this 
study, the standard deviation of attachment levels using 
the Stent Florida Probe was 0.60 mm. When duplicate 
measurements were used instead of single ones, the 
standard deviation reached 0.34 mm for attachment levels 
and 0.42 mm for pocket depth measurements. The overall 
small measurement error obtained in this study might also 
have been due, in part, to the position of sites in this 
study, the majority of which were the anterior flat 
surfaces. It has been reported that anterior sites are 
measured more reproducibly than molar flat surfaces or 
molar furcation sites (Loos, Kiger and Egelberg, 1987).
The reproducibility of attachment level recordings was 
greater than that of pocket depth recordings as indicated
197
by a smaller standard deviation for the former. Moreover, 
the results indicated that the standard error of the mean 
of attachment gain was consistently smaller than that of 
the pocket depth reduction across the treatment groups and 
at any time point. The greater reproducibility of the 
attachment level measurements over the pocket depth 
measurements could be attributed to the use of the acrylic 
stents with reference points (grooves) for attachment 
level measurements which served as reference points both 
at the apico-coronal, and the mesio-distal directions. On 
the other hand, the pocket depth measurements relied on 
the placement of the probe tip as close as possible to the 
contact point by the examiner, a factor which did not have 
a role in the attachment level measurements. Moreover, 
the vertical rest seat for the edge of the probe sleeve 
differed for the pocket depth and attachment level Florida 
Probes. While the acrylic stent provided a rather firm
seat for the attachment handpiece, the gingival margin was 
a more resilient seat for the pocket depth handpiece
sleeve. Previous report on the reproducibility of the
Florida probes (Gibbs et al. 1988) is in agreement with 
our finding of slightly higher reproducibility of the
attachment level over pocket depth measurements.
4.2.3 The effect of baseline pocket depth on the
response to treatment
Many investigators have postulated that sites with an 
initially greater pocket depth may show a greater pocket
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depth reduction and attachment gain following non-surgical 
therapy (Badersten et al., 1984b; Badersten, Nilveus and 
Egelberg, 1987; Claffey et al., 1988 & 1990; Claffey,
1991) . This phenomenon was also clearly demonstrated in 
the present study. More pocket depth reduction in deeper 
sites is to be expected, as the shrinkage (and thus pocket 
depth reduction) is in proportion to the initial bulk of 
inflamed tissue. More attachment gain in deeper sites may 
indicate that the amount of re-adaptation of tissues at 
the apical aspect of the pocket may be related to the 
height of the soft tissues initially. Deeper sites may 
heal with a greater amount of adaptation of the pocket 
lining to the root surface or with a less penetrable 
junctional epithelium (Egelberg and Claffey, 1994). The 
analysis of pocket depth or attachment gain data should 
therefore, take into account this important variation in 
treatment response among the study sites. In the present 
study, the General Linear Model analysis was used, which 
allowed simultaneous assessment of the significance of 
baseline probing pocket depth effect on the pocket depth 
reduction (or attachment gain) together with the 
assessment of the significance of the main effect i.e., 
the treatment type. This analysis revealed that the 
baseline pocket depth had a strong and often significant 
effect on the pocket depth reduction and attachment gain. 
Moreover, this effect was often stronger than the effect 
of treatment type. The analysis consistently revealed 
that there was no significant interaction between the
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effect of baseline pocket depth and the effect of 
treatment type. This indicates that the effect of having 
deeper baseline pocket depth resulting in a greater 
improvement, did not depend on the treatment type. This 
lack of interaction is a prerequisite for validly 
interpreting the effect of individual terms in the 
analysis.
Finally, it has been reported that a small proportion of 
the effect of initial pocket depth on the magnitude of 
pocket depth reduction and attachment gain may be due to a 
statistical artefact known as 1 regression towards the 
mean1 (Blomqvist, 1987; Egelberg, 1989) . Due to this 
phenomenon, the measurement error causes some sites to be 
recorded deeper (or shallower) than their real depth at 
baseline. Therefore, even if no treatment is performed, in 
the next data recordings, the majority of such sites would 
probably be recorded closer to their actual depth. Thus, 
in the absence of any real change, this would falsely 
indicate that the site has become shallower (or deeper) . 
The greater the measurement error, the greater would be 
the 'regression towards the mean1 (Blomqvist, 1987). In 
the present study, while the regression towards the mean 
might have played a role, its effect must have been 
reduced by the use of electronic pressure sensitive probes 
and duplicate measurements.
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4.2.4 The effect of smoking
During the past few years, there has been an explosion of 
evidence concerning the effects of smoking on periodontal 
tissues. It has been found that smokers are more 
susceptible to periodontal disease than non-smokers 
(Ismail, Burt and Eklund, 1983; Linden and Mullally, 
1994). A significant association exists between the
current smoking status and advanced periodontitis and bone 
loss (Bergstrom, Eliasson and Preber, 1991; Horning, Hatch 
and Cohen, 1992; Locker and Leake 1993). MacFarlane et 
al. (1992) reported that 90% of patients responding poorly 
to periodontal treatment were smokers. Stoltenberg et al. 
(1993) reported that cigarette smoking is a stronger risk 
indicator than any of the putative periodontal pathogenic 
micro-organisms. Preber and Bergstrom (1986 & 1990) and Ah 
et al. (1994) reported that smokers present a less 
favourable response to surgical and non-surgical 
periodontal treatment. Tonetti, Pini-Prato and Cortellini 
(1995) reported a significantly less attachment gain 
following guided tissue regeneration procedures in smoker 
as compared with non-smoker subjects. Moreover, they 
reported that smoking was a significant risk marker for 
treatment failure at 1 year follow-up after an initial 
success.
The results of the present study |are in agreement with 
previous studies which found an important role for 
cigarette smoking in periodontal disease. Regardless of
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the treatment type, the pocket depth reduction and 
attachment gain were consistently greater among non- 
smokers as compared with smokers. When the effects of 
smoking status together with the baseline pocket depth on 
the treatment outcome were assessed using a multivariate 
analysis (GLM), the effect of smoking was found to be 
significant at the 3 month and 6 month pocket depth 
reductions. Moreover, the effect of smoking on attachment 
gain was found to be significant at all 3 follow-up 
occasions. These findings are in agreement with previous 
reports (quoted earlier) on the role of smoking in 
periodontal disease.
An important consistent finding was the presence of a 
significant interaction between the smoking effect and 
baseline pocket depth effect at all follow-up visits for 
both pocket depth reduction and attachment gain. This 
indicates that the inhibitory effect of smoking on 
treatment response is more pronounced at initially deeper 
sites. These findings are in agreement with those 
reported recently by Ah et al. (1994) who found that the 
unfavourable response in smoking subjects was more 
pronounced and significant at the initially deeper sites. 
These findings may have important prognostic implications 
in the treatment of periodontal disease. This phenomenon 
might be related to the reportedly impaired function of 
fibroblasts in smokers (Raulin et al., 1988). Fibroblast): 
have been shown to bind and internalise nicotine (Hanes,
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Schuster and Lubas, 1991). The clinical attachment gain 
observed after non-surgical periodontal therapy is mainly 
due to an increase in density of the connective tissue 
fibres. A deep pocket represents a pocket with a soft 
tissue wall which is less resistant to probe penetration 
due to a less dense collagen component in the connective 
tissue. After treatment and elimination of inflammation, 
in a non-smoking subject with a presumably normal 
fibroblast function, the density of functional collagen 
fibres will be largely recovered and the amount of 
expected attachment gain is proportional to the initial 
degree of inflammation i.e., the initial degree of probe- 
penetrability of the tissues as well as the initial bulk 
of soft tissue wall of the pocket which contained 
disintegrated connective tissue fibres. In other words, 
the deeper the initial pocket depth, the greater the post- 
treatment attachment gain (and thus, pocket depth 
reduction) . On the other hand, in a subject with a 
presumably impaired fibroblast function, the amount of 
tissue adaptation is reduced as a result of fibroblasts 
failing to increase the density of collagen fibres. The 
data of the present study suggests that in smoking 
subjects the amount of tissue adaptation after therapy: a) 
is lower than seen in non-smoking subjects; and b) has a 
weak relationship with the initial degree of tissue 
resistance to probe. The mechanisms of healing among the 
smokers may, therefore,, be somewhat different from the 
non-smokers. Other important biological effects of
203
nicotine on the periodontium includes decreased 
phagocytosis, chemotaxis and viability of neutrophils from 
oral tissues (Kenney et al., 1977; Kraal et al., 1977), 
and impaired production of IgA, IgG, and IgM (Holt, 1987; 
Johnson et al., 1990) which all could be potentially 
important factors in protecting the host tissues from re­
infection during the healing process.
Our data also indicated that the rebound in pocket depth 
reduction and attachment gain observed at the 6 month 
visit, was, on average, entirely limited to the smoking 
subjects. This is in close agreement with MacFarlane et 
al. (1992) who reported a prevalence of 90% smokers among 
refractory periodontitis patients.
It has been reported that smokers generally have a poorer 
oral hygiene (Ismail et al., 1983; Ah et al., 1994) and 
thus, it has been speculated that this difference in 
plaque level might be responsible, in part, for less 
favourable treatment response in the smoker subjects. In 
the present study, most subjects were highly motivated and 
had little plaque retentive factors. The plaque scores in 
non-smokers were not lower than those of smokers. This
i
allowed for a comparison between 2 categories matched for
their plaque levels. Therefore, the less favourable
healing in smokers could not be attributable to the plaque
control level. This is in agreement with the studies of
Ismail et al. (1983), and Tonetti et al. (1995) who after
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controlling for plaque levels, still found a higher 
periodontal disease score or a less favourable response to 
periodontal therapy among the smokers.
Nicotine may cause a vasoconstriction in the peripheral 
blood vessels (Kardachi and Clarke, 1974; Clarke, Shephard 
and Hirsch, 1981; Shields, 1977) . In our study, one of 
the criteria for site selection was the presence of 
bleeding on probing, thus it was not possible to assess 
the difference in baseline bleeding tendency between 
smokers and non-smokers. However, the results indicated 
that the baseline GCF volumes were significantly lower
among smokers than non-smokers. After treatments, the 
decrease in the GCF volume of smokers was less than non- 
smokers. However, their actual mean GCF volumes still
remained lower than non-smokers. These findings are 
consistent with both a diminished peripheral blood flow 
(leading to a diminished GCF flow) and a reduced response 
to periodontal therapy among the smoker subjects.
One limitation of the present study is that the number of 
cigarettes smoked per day | was not taken into
consideration. While this would have provided a stronger 
and more conclusive analysis, it might also have
necessitated the inclusion of a greater number of subjects 
due to the presence of a greater number of cells in the 
multivariate analysis.
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4.2.5 The effect of previous surgery
It was observed that the sites which had been treated by 
means of periodontal flap surgery, generally showed less 
improvement after treatments as compared with those which 
had not been treated surgically. Sites with previous 
surgery may have greater recession, so smaller pocket 
depth reduction due to this element is likely.
4.2.6 Safety
No serious adverse effect was observed as a result of 
treatment with locally applied antimicrobial systems. 
This could be a potentially important advantage over the 
systemic usage of antibiotics. Systemic antibiotic 
therapy is occasionally associated with side effects (see 
chapter 1) which may complicate the decision making as to 
when to prescribe a systemic antibiotic for a chronic and 
non-fatal disease such as periodontitis. Nevertheless, 
the chance of occurrence of antibiotic resistant bacteria 
at the site of treatment should not be entirely ruled out 
if local delivery systems are used. Metronidazole 
antibiotic resistance is not common. It has been reported 
that the occurrence of minocycline resistant bacteria 
after minocycline gel therapy is not more than that 
observed following the systemic use of minocycline (Preus 
et al., 1995). Goodson and Tanner (1992) reported that 
the increase in the proportion of tetracycline resistant 
bacteria after tetracycline fibre therapy was mainly due 
to an increase in the proportion of Gram positive coccal
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micro-organisms which were assumed to be associated with 
periodontal health rather than disease. They also 
reported that this increase in tetracycline resistance was 
not associated with increase in penicillin resistance, and 
therefore, they considered the risk of development of 
plasmid mediated tetracycline resistance low. While, it 
appears that the use of local antimicrobial systems may 
involve less risk for patients, further research on this 
area is indicated due to increase in the use of local 
antimicrobial systems. It should also be determined how 
often antimicrobial systems could be used without taking 
the risk of inducing a non-responsive antibiotic resistant 
micro-flora, if these systems are going to be used as 
adjunctive tools in maintenance therapy.
4.2.7 Treatment time and cost-effectiveness
Tetracycline fibre therapy was quite time-consuming. It 
took, on average, 8.2 minute to treat each pocket by 
tetracycline fibres. Considering the time needed to apply 
the adhesive and periodontal dressing, normally a one-hour 
appointment was required to complete the tetracycline 
fibre therapy for 4 sites. Moreover, an additional visit 
was required to remove the fibres. On the other hand, 
although gel therapy per se did not take much time, 
minocycline gel therapy required 3 separate visits, each 2 
weeks apart, and metronidazole gel therapy required 2 
visits with a one week interval. These complicated 
treatment disciplines may affect the cost of the treatment
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by dental practitioners. In this way, it may also affect 
the patient acceptance of the treatments. Together with 
the rather expensive price of the systems, these 
considerations should be taken into account when one is 
weighing the potential benefits of the local antimicrobial 
systems over the traditional treatment strategies.
4.3 The in vitro laser study
Increasing the energy setting and duration of the laser, 
generally resulted in increase in the severity of damage 
to calculus, cement urn and dentine, although it was 
observed that cementum and dentine were not affected using 
low energy settings and short durations. On the other 
hand, calculus was more or less affected using all energy 
settings and durations. It seems that regardless of the 
energy and duration of the laser irradiation, there were 
more severe physical changes to calculus compared to 
either dentine or cementum. One of the reasons may be 
that subgingival calculus is usually darker than the 
dental tissues, and therefore absorbs more laser energy 
than the other tissues. The wavelength of the Nd:YAG 
laser beam (1064nm) is not in the visible spectrum, but it 
is quite near the visible spectrum. Visible light is 
highly absorbed to the subgingival calculus and thus, the 
laser wavelength would also be expected to be highly 
absorbed by the subgingival calculus. Even with very low 
energy and duration (50mJ, lOpps, lsec) , the laser could
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cause some physical changes to calculus, whereas it did 
not affect any of the cementum specimens using 50mJ, lOpps 
for either 1 or 5 sec. On the other hand, using lOOmJ, 
20pps for 5 sec the laser caused severe destruction of 
calculus, dentine and cementum.
Interestingly, when the laser energy was strong enough and 
calculus was thin enough to be evaporated completely, some 
parts of the underlying dental tissues were affected too. 
It seems that none of the laser settings could 
differentiate calculus and dental tissues and all were 
affected (e.g. Fig. 3.11). Perhaps calculus causes more 
laser power absorption to the area, thus more heat is 
generated. This heat may affect not only the calculus 
itself but also the adjacent tissues. SEM showed that 
there were no distinct boundaries between cementum and 
calculus on the internal wall of the laser lesions. No 
specimen was found in which the laser could evaporate 
calculus completely without evaporating cementum. This 
inability to differentiate foreign and host material may 
limit the clinical application of the laser for calculus 
removal in periodontal pockets.
Results showed that the value of power setting, number of 
pulses per second and radiation duration have an additive 
contribution to the damage score. However, the study has 
low power to distinguish between different models of the 
effect of power setting, number of pulses per second and
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length of time on the mean damage score in view of the
small overall sample size and the arbitrary nature of the
mean damage score.
This study has attempted to quantify the effects caused by 
the laser on the root surface. In previous studies, the 
laser handpiece was moved on the root surfaces with an 
almost parallel angulation to the root surface, where the 
whole surface was exposed using an overlapping movement of 
the laser tip. As stated previously it may be possible 
that some points on the root surface had multiple 
treatments because of the overlapping movement. On the 
other hand, viewing the small size of optic fibre diameter 
in relation to the whole treatment area, there was a 
possibility of undertreating some parts. It was not 
clear, therefore, which part of the treated surface could 
be attributed to the particular laser settings. In
addition, the degree of damage might have been influenced
partly by the speed of movements, a factor which was not
controlled in previous studies. To reduce the
methodological variability, it was decided to lase only
one point for a specific period of time without moving the 
fibre. This protocol appears to have been highly 
successful.
Results have indicated that specific dentine and cementum 
specimens appear to have different degrees of
susceptibility to the laser. The variability of this
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susceptibility was evidenced by the two following 
extremes, one of the dentine specimens was not affected by 
any of the eight laser settings, whereas another was more 
or less affected by all 8 settings. Others fell somewhere 
between the two. This phenomenon may be the result of 
variability in colour, texture, percentage of water 
content, or some other inherent host or site factors which 
may influence the degree of energy absorption. Such 
unpredictable variation may limit the clinical application 
of lasers in periodontal pockets. Moreover, in most 
teeth, different sites of the same calculus specimen 
showed different susceptibility to laser exposure. Out of 
32 teeth only 11 teeth showed equal damage scores for all 
treated sites. This is probably due to variation in the 
colour, thickness, composition, and other characteristics 
of calculus in the same tooth.
To date there is no study on the effect of Nd:YAG lasers 
on the periodontal ligament. Trylovich et al. (1992) 
reported a decreased compatibility of fibroblasts on the 
laser treated root surface. Moreover, in a study with 
cultured human skin fibroblasts, Abergel et al. (1984) 
reported collagen production and DNA synthesis to be 
delayed by Nd:YAG laser exposure. It is likely that 
periodontal fibroblasts show similar response after laser 
exposure.
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Further work is necessary to clarify root tissue behaviour 
to the laser irradiation. In conclusion, the laser can 
cause physical changes on calculus under laboratory 
conditions, even if used with low energies and short 
durations. However, calculus free dental tissues were not 
affected by low energies of laser (50mJ-10pps-lsec). In 
addition, there was variability in the degree of 
susceptibility of different teeth and different parts of 
the same tooth to the laser.
4.4 The clinical laser study
Most treatment modalities used in periodontal therapy aim 
to reduce the bacterial plaque on the root surface and 
periodontal tissues to levels compatible with the host 
response such that the disease will be controlled. The 
effectiveness of scaling and root planing in the treatment 
of periodontal disease is universally accepted (Axelsson 
and Lindhe, 1981; Kaldahl et al., 1988; Morrison, Ramfjord 
and Hill, 1980; Badersten et al., 1984b). In theory, the 
ability of laser energy to kill and ablate bacteria might 
be useful in eliminating bacterial plaque and thereby 
reducing probing depth and bleeding on probing. The 
purpose of the present study was to determine whether the 
relatively low level laser pulse energies were sufficient 
to reduce microbial numbers, and improve the clinical 
parameters of periodontal disease and to determine whether
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these energy levels had any detrimental effect on the root 
surface in vivo.
All groups (including the untreated control) showed some 
reduction in pocket depth at the re-assessment visit 
compared to baseline. The slight reduction in pocket 
depth in all groups may be explained by the improved oral 
hygiene of the patients. Three weeks before baseline, 
they received a full oral hygiene instruction. 
Furthermore, after baseline, there was still a slight 
improvement in the plaque scores for all groups, however, 
supragingival plaque control has been shown to have a 
minor effect on pocket depth (Beltrami, Bickel and Baehni, 
1987).
The patients had a relatively low gingival index at the 
baseline (mean= 1.77) and the scaling group showed the 
highest reduction in gingival index (0.5) and bleeding on 
probing, whereas the reduction in the gingival index of 
the other groups was minimal and could be attributed to 
improved oral hygiene.
While the gingival index may reflect the presence of 
inflammation at the periphery of the periodontium, the 
absence of bleeding on probing may provide a better 
assessment of health for the whole periodontium. Only the 
scaling group showed a significant reduction in the 
incidence of bleeding on probing, suggesting that the
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laser treatments used in this study were not capable of 
reducing the level of inflammation within the pockets.
The post-therapy reduction in anaerobic counts in the 
scaling group was significantly greater than all other 
groups; 80mJ laser treatment produced only a 3 fold 
reduction in bacterial numbers which failed to change 
significantly the clinical parameters during the course of 
the study.
Tseng et al. (1991b) in an SEM study, reported that very 
few periodontopathogenic microorganisms were observed on 
contaminated root segments when lased at 1.5W and lOpps 
for one minute using a Nd:YAG laser in vitro. Cobb et al. 
(1992) in an in vivo study evaluated the antimicrobial 
effect of the Nd:YAG laser. Laser treatment was performed 
at 1.75W, 2.25W and 3.00W for 1 and 3 minutes either
before or after hand instrumentation while some teeth were 
treated using the laser alone. They reported a 
significant decrease in the proportion of A.a., P.g., and 
P.i. in samples collected pre and post treatment. When 
two teeth were sampled seven days after laser treatment, 
one showed an increase in the numbers of recovered P.i. 
that was credited to recolonisation of bacteria in laser- 
induced porosities of the root surface. In this study, 
lower pulse energies than those used by Tseng et al. 
(1991b) and Cobb et al. (1992) were used. This was done 
to limit any thermal effect which laser treatment may have
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on the cementum and to test whether 80mJ pulses (3 mins 
exposure) which yielded 99.9% kills for some species 
(Whitters et al., 1994) were as successful in inhibiting 
bacteria in vivo. In previous studies (Tseng et al., 
1991b; Cobb et al., 1992; Whitters et al., 1994), 
different methods and microbial volumes have been 
investigated making determination of the energy dose per 
microbial cell difficult. This also makes determination 
of the optimal laser parameter for bacterial killing 
difficult.
SEM examination of the laser treated surfaces in this 
investigation revealed no sign of physical damage due to 
laser energy. This observation is contrary to that 
reported by Trylovich et al. (1992) who used an energy 
setting of 80mJ and lOpps for 1 minute in vitro and 
observed by SEM physical damage on the root surface. This 
difference may be due to lasing technique since the 
handpiece was held perpendicular to the root surface by 
Trylovich et al. but almost parallel to the surface in the 
present study. The laser energy delivered to the root 
surface is higher if the fibre is held perpendicular to 
the root surface. Moreover, the presence of biological 
fluid in the pocket could have a cooling effect on the 
root surface and might prevent root damage. The root 
surface adjacent to the pocket is located subgingivally 
and in order for the laser energy to have access to the
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surface, the handpiece has to be kept almost parallel to 
the surface.
In the present study, teeth with a poor prognosis were 
used because there was no certainty as to whether the 
laser energy would have a permanent detrimental effect on 
the root surface, pulp or periodontium. The Nd:YAG laser 
energy has a wavelength of 1064nm and is capable of 
penetrating through tissues into a considerable depth 
before its energy becomes attenuated.
Trylovich et al. (1992) evaluated the biocompatibility of 
root surfaces treated by pulsed Nd:YAG laser at energy 
levels of 80mJ, lOpps and higher and reported a decreased 
degree of fibroblast attachment on the root segments 
following the laser treatment. Similar findings were 
reported by Thomas et al. (1994). They also observed that 
subsequent root planing of the laser treated root reversed 
only some of the impaired surface biocompatibility of the 
root. Spencer et al. (1992) characterized the chemical 
structure of lased root surfaces using Fourier transform 
infrared photoacoustic spectroscopy. They reported a 
decrease in the protein/mineral ratio on the cementum 
surfaces lased at energy level of 80mJ and lOpps and 
suggested that the ammonium ion content was increased as a 
result of protein denaturation. Clearly, further research 
is required to determine a clinically effective and yet
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safe method for applying laser energy in the treatment of 
periodontally diseased tissues.
4.5 Conclusion and further studies
Of the therapeutic systems investigated in this thesis, 
subgingivally applied antimicrobial systems appeared to be 
potentially useful adjuncts to scaling and root planing.
Laser therapy, on the other hand, did not appear to be a
(
beneficial and safe alternative to scaling and root 
planing. The clinical study of locally delivered ' 
antimicrobial systems revealed that the use of these 
systems as adjunct to scaling and root planing may offer 
some benefit over the scaling and root planing alone at 
sites which appeared to have an unfavourable response to 
previous mechanical therapy. Scaling plus tetracycline 
fibre offered the greatest advantage especially in the 
treatment of suppurative sites. It is recommended to use 
these systems as adjunct to scaling and root planing. 
Furthermore, since the scaling and root planing either 
with or without surgical access is often quite effective 
in arresting untreated periodontal lesions, and in view of 
the tetracycline fibre insertion being time consuming, it 
is recommended to use these systems only for selected 
sites i.e. sites with a poor response to initial therapy. 
In this study, tetracycline fibre, a system with a non- 
resorbable vehicle produced a greater improvement than the 
other 2 systems with resorbable vehicles. Further research 
could possibly focus on the development of bioresorbable
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vehicles with improved substantivity. Furthermore, if 
longer-lasting resorbable vehicles can be developed, the 
need for repeated application of the systems will be 
eliminated.
The results of studies on Nd:YAG laser revealed that when 
ablating subgingival calculus using the Nd:YAG laser, the 
cementum and dentine are damaged. Moreover, there is a
large variability on the absorption of laser energy on 
calculus or dental hard tissues. This makes the Nd:YAG 
laser an instrument with unpredictable outcome. When the 
Nd:YAG laser energy was used at lower energy levels in a 
clinical study, although no physical damage and melting 
down was observed on the root surface, it did not result 
in a significant bacterial kill or improvement of clinical 
parameters as compared with scaling and root planing. Our 
conclusion is that the Nd:YAG laser has little application 
in the treatment of plaque associated periodontal disease. 
Before introducing lasers into routine periodontal
therapy, further research should be directed towards the 
development of laser energy wavelengths with selective 
absorption for calculus and subgingival bacteria and 
little absorption for cementum, dentine and soft tissues.
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setting, n u m b er o f  p u lse s  per sec o n d  and  th e  d u ra t io n  o f  ex p o su r e  co n tr ib u te d  
independently to  th e  m ea n  d a m a g e  score  in an  a d d itiv e  way. C em en tu m  sp e c im e n s  
"ere not a ffec ted  by trea tm en t 1 (50  m J. 10 p p s . 1 s). trea tm en t 2 (50  m J. 10 p p s.
5 s). and trea tm en t 5 (5 0  m J. 20  p p s. 1 s). D e n t in e  sp ec im en s  were n o t a ffec te d  by 
treatment 1 (50  m J. 10 p p s. 1 s). T h e  resu lts a ls o  sh o w ed  th at there w as v a r ia b ility  
>n susceptib ility  o f  d ifferen t teeth  and  d ifferen t p a r ts  o f  ea ch  to o th  w h ich  w as  
true for c a lc u lu s , c em en tu m  an d  d en tin e .
Certain m a n u fa c tu rer s  an d  research ers  
have su ggested  th at th e  N d :Y A G  laser  
c°uld be u sed  to  fa c ilita te  r o o t p la n in g  
•A m erican D e n ta l L a ser  C o m p an y . 
Product m a n u a l, T se n g  et a l. 1991a). 
W e  stu d ies  h ave r ep o rted  th at the  
kser co u ld  p o te n t ia lly  red u ce  th e  n u m ­
ber o f  cu rette  stro k es  n e c essa ry  for re­
moving ca lcu lu s  (T sen g  et a l. 1991a). 
^he laser m igh t a lso  red u ce  th e  su b -g in -  
?lval b acte ira l flora  in v itro  (T sen g  et 
al- 1991b. W h ite  et a l. 1991). C o b b  et 
*)• (1992) have ex a m in e d  th e  b a cter i­
cidal effect o f  N d :Y A G  laser  in vivo, 
co n c lu d ed  th a t la ser  ex p o su re  o f
th e  ro o t su rfa ce  can  s ig n ifica n tly  d e ­
crea se  th e  n u m b er o f  p e r io d o n ta l  
p a th o g e n s .
M o r lo c k  et al. (1 9 9 2 ) e x a m in e d  la ser  
e ffe c ts  u sin g  S E M  and  d escr ib ed  th e  e f ­
fe c ts  ca u sed  by th e laser en erg y  o n  th e  
r o o t su r fa ce  in v itro . T rv lo v ich  et al. 
(1 9 9 2 ) r ep o rted  th at th e la ser  d e crea sed  
th e  b io c o m p a tib l ity  o f  th e  ro o t su r fa ce  
fo r  f ib ro b la st a tta ch m en t. U s in g  F o u r ­
ier tr a n s fo r m  p h o to  a c o u s tic  in fra -red  
sp ectro sc o p y . S p en cer  et a l. (1 9 9 2 )  
sh o w ed  th a t th e  laser red u ced  th e  p r o ­
te in /m in e r a l r a tio  and  in d u c ed  c h e m ic a l  
ch a n g e s  o n  th e  root surface.
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P rev io u s  s tu d ies  have u sed  o v e r la p ­
p in g  m o v e m e n ts  in an a ttem p t to  m im ic  
th e  c lin ica l th era p eu tic  use. th e  la ser  
h an d  p iece  tip  b e in g  kept in c o n ta c t  
w ith  th e ro o t su rface, w ith  an  a lm o s t  
p a ra lle l a n g u la tio n  to  th e  surface. O v er ­
la p p in g  m o v e m e n ts  a ttem p t to  en su re  
th at th e  w h o le  su rface  is trea ted . It is 
p o ss ib le , how ever, th at so m e  areas w ere  
over trea ted  by th is  o v er la p p in g  te c h ­
n iq u e. O n  th e  o th er  h a n d , v ie w in g  th e  
sm all d ia m eter  o f  th e  laser h a n d p ie c e  
(3 2 0  //m ), so m e  areas m igh t n o t  have  
b een  trea ted  at a ll. M oreover , th ere w as  
n o  co n tr o l on  th e  sp eed  o f  th e  m o v e ­
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m en ts. To d o  a c o m p a ra tiv e  ev a lu a tio n  
o f  laser e ffec ts  on  d ifferen t tissu es  at 
d ifferen t pow er settin g s  and d u ra tio n s , 
it is n ecessa ry  to  sta n d a rd ize  th e e x p e r i­
m en ta l m e th o d . In th is s tu d ) a laser  
beam  held in a fixed p o s it io n , p e r p e n ­
d icu lar  to  th e  su rface  has been  used . 
T h is  stu d y  a im ed  to  ex a m in e  th e effect 
o f  laser on ca lc u lu s  and  root tissu es. A  
fu rther ob jec tiv e  w as to  d e ter m in e  if  
there w as any  d ifferen ce  in th e su scep ti-  
bility o f  c a lcu lu s , cem en tu m . and  d e n ­
tin e  to  laser e x p o su re . T h is  s tu d ) in ­
clu d ed  tw o  sep a ra te  e x p er im en ts  th e re­
su lts  o f  w h ich  w ere co m p a red  and  
d iscu ssed  togeth er .
Material and Methods 
Experimental design and specimen 
preparation
First experim ent, calculus 
32 freshly ex tra cted  teeth  w ith  s u b g in g i­
val ca lcu lu s  w ere selec ted . U sin g  tw ee z ­
ers. rem a in in g  ta g s  o f  p er io d o n ta l lig a ­
m en t w ere rem oved  and  th is  w as c o n ­
firm ed u sin g  a light m icro sco p e  ( Xl O  
m a g n ifica tio n ). T h e  teeth  were kept in 
"..0.12 th y m o l s o lu tio n  until the tim e o f  
the e x p erim en t. C a lcu lu s  covered  teeth  
w ere ra n d o m !) d iv id ed  in to  S d ifferen t 
trea tm en t g r o u p s  o f  4. T h e  laser trea t­
m ent w as carried  out using an N d :Y A G  
laser (A m e r ica n  D en ta l Laser, m o d el 
d .la se -3 0 0 . S u n r ise  T ech n o lo g y  Inc.. 
F re m o n t. C a lifo r n ia ) . Lach g ro u p  were 
su b jec ted  to  th e laser treatm en t using  
p red eterm in ed  se ttin g s  and d u ra tio n s . 
L aser settin g s  in c lu d ed : 50 m J -1 0  pps 
(p u lse 's ). 5(1 m J -2 0  p p s. 100 m J -1 0  pp s. 
100 m J -2 0  pp s. E ach  settin g  w as used  
for  1 and 5 s. th u s  p rov id in g  8 v a r io u s  
settin g s  and  d u r a t io n s . D e p e n d in g  on  
th e  ex ten t o f  c a lc u lu s , each  to o th  w as  
treated  on  e ith er  2. 3 or 4 p arts o f  the  
ca lc u lu s  u sin g  th e sam e pow er settin g  
a n d  d u ra tio n . D u r in g  the ex p erim en t.
Fig. 1. U nlased calcuius (original m agnifi­
cation  X750; b a r= l( ) / /m ) .
Fig. 2. (a) Lased calculus (using 50 mJ. 20 pps. 1 s) "score 0". There is no  laser induced 
change (original m agnification. x?50 : bar=  10 //m ). (b) Lased calculus (using 50 mJ. 10 pps. 
1 s) "score 1". Superficial bacteria have been destroyed in the m iddle (orig inal m agnification  
>'750: bar=  10 //m i. ic) Lased calculus (using 50 mJ. 10 pps. 1 s) "score 2". (orig inal m agnifi­
cation  x  100: ba r=  100 //m l. id) Lased calculus (using 50 mJ. 20 pps. 1 s) "score 3". (original 
m agnification > 100: b a r=  100 //mi.
the laser h an d p iece  w as held p e rp en ­
d icu la r ly  in c o n ta c t w ith  the ca lcu lu s  
su rfa ce  using a ca lib ra ted  jig  to  prevent 
m o v em en t.
Second experim ent, cem entum  and den­
tine
3 ca lcu lu s-free  teeth  w-ere root p lan ed  
until it w as ju d ged  that the cem en tu m  
layer had been rem oved . T h is  w as c o n ­
firm ed  b) m icro sco p ic  ex a m in a tio n  
u sin g  X lO  m a g n ifica tio n . 1 su rface  on  
ea ch  o f  three cem en tu m  covered  and 3 
r o o t-p la n e d  teeth  w ere d iv id ed  in to  8 
areas usin g  a sh a rp  scraper. E ach  area  
w as su b jected  to  the laser treatm ent in 
th e sam e m an n er  as d escr ib ed  for c a lcu ­
lus. 2 hea lth ) cem en tu m  covered  teeth  
w ere selected  at ran d om  and rem ained  
u n treated  as co n tr o ls . T h e  exact lo c a ­
t io n  o f  treated site s  in rela tion  to  the  
c a lcu lu s  sh ap e w as record ed , to  en ab le  
e a sy  lo c a liza tio n  o f  th e treated sites  
u sin g  th e SE M  even if  there w'ere no  
ch an ge .
Scanning electron microscopy
Im m ed ia te ly  a fter  c o m p le tio n  o f  the 
laser treatm ent the sp ec im en s w'ere im ­
m ersed  in ice -co ld  2.5%  g lu tara ld eh yd e  
in 0.1 M c a co d y la te  bu ffer  at pH  7 .4  for
2 h. F o llo w in g  fix a tio n , th e sp ec im en s  
w ere deh yd rated  u sin g  a series o f  
g ra d ed  e th a n o l s o lu t io n s  for th e fo llo w ­
ing d u ra tio n s: 33%  for  4 h: 50"n for 4 
h; 67%  for  12 h: 95%  for 4S h: and  
100%  for 72 h. T h e  final d eh yd ration  
w as carried  ou t using  h cx a m eth y ld is ila -  
za n e  for 36  h.
In p rev io u s  SE M  s tu d ies , cem en tu m  
sp e c im en s  sh ow ed  several crack s. S o m e  
s tu d ies  su g g e sted  that th ese  crack s were 
p ro d u ced  by the c o a le r  m a ch in e . T h e  
v a cu u m  in th e m a ch in e  c a u ses  th e  w ater  
c o n te n t o f  th e tissu e  to  e v a p o ra te  very  
q u ick ly , w-ith a ten d en cy  for  sh r in k age  
and  cra ck s to  occu r. In th is  s tu d ) , it w as 
d ec id e d  to  put the sp e c im en ts  th rou gh  
c o n sec u t iv e  c o n c en tr a tio n s  o f  a lc o h o l  
b ath s over lo n g  p er io d s  o f  tim e, and the  
final d eh y d ra tio n  w as carr ied  ou t u sin g  
h e x a m th v ld isa la sa n e . to  rem ove the  
w ater c o n te n t c o m p le te ly  b e fore  c o a l ­
ing . M o reover , to  d ifferen tia te  the laser  
in d u ced  cra ck s ( if  a n y ) an d  v a c u u m  in ­
d u ced  cra ck s the fo llo w in g  p relim in ary  
ex p er im en t w as p er fo rm e d . A  s ilico n  
im p ress io n  w as o b ta in ed  from  on e  c a l­
c u lu s  sp ec im en . A fter  laser e x p o su re  at 
100 m J. 20  p p s for 10 s. a n o th e r  s ilicon  
im p ressio n  w as tak en . B oth  im p ressio n s  
w'ere p o u red  by e p o x y  resin  to  o b ta in  
rep lica  m o d e ls  o f  to o th  b efo re  and  after
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Fig. 3. Plot o f  log to ta l energy versus, m ean dam age score.
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laser trea tm en t. R esin  rep licas w'ere 
ex a m in ed  by S E M .
A fter  c lea n in g  w ith  a lc o h o l the sp e c i­
m en s were m o u n te d  o n  a lu m in u m  
s tu b s, and  sp u tter -c o a te d  (P o la ro n -  
E 5 0 0 0 ) w ith  g o ld  a n d  ex a m in ed  by  
S E M  (J eo l-T 3 0 0 ) M icro g r a p h s  w'ere 
tak en  from  each  treated  area usin g  
X I 00  and X 7 5 0  m a g n if ic a tio n s .
Index for laser damage
To q u a n tify  the e ffe c ts  o f  th e  laser on  
treated  sites, the fo llo w in g  criteria  were 
used as an ind ex .
S core  0. n o  ch a n g e  (F ig s . 1. 2a).
Scare 1. S light ch a n g e s  in c lu d in g  su p er­
fic ia l m eltin g . T h e  d ep th  o f 'e v a p o r a te d '  
(d isa p p ea red ) m a ter ia l is less  th an  20  
pm .  T h ese  c h a n g es  are n o t v is ib le  u sin g  
X 1 0 0  m a g n ifica tio n  (F ig . 2b ).
Score 2. M o d era te  c h a n g e s , v isib le  
usin g  X 1 0 0  m a g n if ic a tio n , sha llow  d e ­
p ress ion  (less th an  50 p m )  ca u sed  by the  
la ser  (F ig . 2c).
Score 3. Severe ch a n g e s , in c lu d in g  d eep
cra ters  w ith  severe e v a p o r a tio n  (F ig . 
2d ). A ll the sp e c im en s  w ere ex a m in ed  
b lin d ly  and  scored  u sin g  th e ab ove  
in d ex .
Statistical analysis
T h e  resu lts  from  ex p er im en t no. 2 
sh o w ed  th at there w as large v a r ia b ility  
b etw een  teeth  in th eir r esp o n ses  to  the  
laser. T h u s , in ex p erim en t no. 1. the  
to o th  rather th an  th e site w as used  as 
th e un it o f  a n a ly s is  and th e  in d ex  o f  
d a m a g e  w as averaged  over s ite s  w ith in  
a to o th  to  p ro d u ce  a s in g le  m ea su re  o f  
d a m a g e  for each  to o th .
T h e  e ffec t on  to o th  d a m a g e  o f  pow-er 
se tt in g  (50  or  100 m J). th e n u m b er o f  
p u lse s  per sec o n d  (10  or 2 0 ). and  the  
tim e (1 or 5 s) w as a ssessed  by th ree- 
w'av a n a ly s is  o f  var ian ce .
T h e  to ta l en ergy  in p u t fo r  each  se t­
tin g  w as ev a lu a ted  by m u ltip ly in g  the  
p ow er, th e n u m b er o f  p u lses  an d  tim e. 
T h e  r e la tio n sh ip  b etw een  th e  lo g a r ith m
o f  th e to ta l en erg y  in p u t and d a m a g e  
w as a ssessed  by lin ear regress ion .
Results
T h e e lectro n  m ic r o sc o p ic  fea tu res  o f  
laser treated  tissu e  seem ed  very  ty p ica l.  
T h ese  fea tu res in c lu d e  m e ltin g  d o w n  o f  
the to o th  m ater ia l and  ca lcu lu s . T h e  
m in era l seem ed  to  m elt and  th en  r eso l­
idify. T h is  resu lted  in a very  p o r o u s  su r­
face. T h e  size  o f  p ores ranged  from  1 to  
20 pm . In th o se  sp e c im en s  w h ere  severe  
d a m a g e  w as ev id en t, a h o le  had  been  
created  w h ich  w as lin ed  w ith  m elted  
m ateria l.
In crea sin g  the en erg y  se ttin g  and  
d u ra tio n  o f  the laser, g en era lly  resu lted  
in in crease  in the sev er ity  o f  d a m a g e  to  
ca lcu lu s , c em en tu m  an d  d en tin e , a l­
th o u g h  it w as o b serv ed  th at c em en tu m  
and d e n tin e  w ere n o t a ffec ted  u s in g  low  
en ergy  se ttin g s  and  sh o rt d u ra t io n s . On  
the o th er  h an d , c a lcu lu s  w as m o re  or  
less a ffec te d  u sin g  all en erg y  se ttin g s  
and d u ra tio n s .
Calculus
Table 1 show's th e d egree  o f  d a m a g e  for  
each o f  th e 94  treated  s ite s  on  32 tee th , 
a lo n g  w ith  the m ean  d a m a g e  sco re  for  
each to o th .
F ig . 3 show ’s th e r e la tio n sh ip  betw-een 
the lo g  o f  the to ta l en erg y  in p u t an d  the  
m ean d a m a g e  score. T h e  least sq u ares  
linear regress ion  line w as: 
m ean d a m a g e  score  =  0 .9 2 5  +  1.54 lo g 10 
(to ta l en erg y  in p u t)
T h e  s lo p e  o f  th e  lin e w as s ig n ifica n tly  
d ifferen t from  0 ( p < 0 .0 0 1 )  an d  n  =  
66% . A  p lo t o f  res id u a ls  a g a in st th e  fit­
ted v a lu es  from  th is  r eg ress io n , in d i­
cated  th at a stra igh t lin e gave  an a d e ­
q u ate  fit to  th e d a ta . T h u s  th ere is c o n ­
Fig. 4. Lased calculus, (a) 50 mJ, 10 pps, 1 s. (b) and  (c) 100 mJ. 20 pps. 1 s. T he laser has evaporated n o t only the calculus (CA) but also 
underlying cem entum  (C E) layer (orig inal m agnifications (a) and  (b) X100. b a r= 1 0 0  p m . (c) x750 . b a r= 7 5 0  //m).
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Table 1. D istribution  o f degree o f physical changes on calculus for each site and  the  m ean dam age score for each too th
Laser setting
50 mJ 
10 pps 
1 s 
(group 1)
50 mJ 
10 pps 
5 s 
(group 2)
100 mJ 
10 pps 
1 s 
(g roup  3)
100 mJ 
10 pps 
5 s 
(group 4)
Specim en no. 1 9 17 25 T 10 18 26 T 3 11 19 27 T 4 12 20 28 T
Degree o f  physical change
0 ** * 3 + * 2 * 1 0
1 * »* ** 5 * * 2 •* * * *** 7 0
** * * 4 * * * ** 5 * * 2 • * *** 5
3 0 • • * 3 * 1 *** ** ** 7
No. treatm ents 3 3 3 3 3 3 3 3 3 2 3 3 3 3 3
M ean o f  dam age 1.67 1.33 0.67 0.67 2.67 2.0 1.0 1.33 1.67 1.0 1.5 1.0 3.0 2.67 2.67 2.0
50 mJ 50 mJ 100 mJ 100 mJ
20 pps 20 pps 20 pps 20 pps
1 s 5 s 1 s 5 s
Laser selling (group 5) (group  6) (g roup  7) (g roup  8)
Specim en no. 5 13 21 29 T 6 14 22 30 T 7 15 23 31 T 8 16 24 32 T
Degree o f physical change
0 * *« 3 * 1 • 1 0
1 ** • 3 0 - 0 0
*> * * *** 5 * **• 4 • • • •  *** • 8 * 1
3 0 ** • *** « 7 *• • 3 *** *** **» ** 11
No. treatm ents 3 2 3 3 3 3 3 3 4 3 3 ' ’ 3 4 3 2
M ean o f  dam age 0.67 1.5 0.67 2.0 2.67 2.0 3.0 2.0 2.0 2.0 2.0 2.5 3.0 3.0 2.75 3.0
Table 2. Three-way analysis o f  variance o f  the effect o f  power setting, num ber o f  pulses per 
second and  length o f lime on the mean dam age score
Source d.f. Sum  o f squares F P
power 1 3.07 13.3 < 0 .0 0 1
pulses/s 1 1.96 8.4 0.008
time 1 7.91 34.2 < 0 .0 0 1
power x  pulses 1 0.08 0.3 0.5"
power x  time 1 0.03 0.1 0.74
pulses x  time 1 0 .0 0 0 .0 0.93
power x  pulses x  time 1 0.52 2.3 0.15
error 24 5.56
total 31
vincing evidence that higher total 
energy input leads to a greater mean 
damage score.
The effect o f  the power setting o f  the 
laser, the number of pulses per second 
and the length of time on the mean 
damage score were further investigated 
by a three-way analysis o f  variance. The 
results are shown in Table 2. N one o f  
the interaction terms are significant. 
However the main effects o f power set­
ting. number o f pulses per second and 
length o f  time are contributing indepen­
dently to the mean damage score in an 
additive way.
A consistent observation was that 
specimens with complete evaporation 
o f calculus also showed some degree o f  
damage to the underlying cementum  
(Fig. 4). however, because o f the vari­
ability in calculus thickness which could 
not be controlled, this damage to the
underlying cementum was not scored in 
the present study.
Cementum and dentine
Figs. 5. 6 show the degree o f damage to 
the cementum and dentine specimens. 
Large variability was observed between 
different teeth, for both cementum and 
dentine specimens. For instance, tooth 
D  was affected by none o f the laser ex­
posures, whereas tooth F was affected 
by all o f the power settings employed.
Replica models
Replicas reproduced the surface details 
accurately. SEM showed no difference 
in cracking o f the two replicas (Figs. 7, 
8). Therefore, the cracking could not be 
attributed to the laser treatment.
Discussion
It seems that regardless o f  the energy 
and duration o f the laser irradiation, 
there were more severe physical changes 
to calculus compared to either dentine 
or cementum. This may be due to calcu­
lus absorbing the NdYAG laser wave­
length (1064 nm) more readily than the 
dental tissues. Although the calculus is 
darker in colour than dentine or ce­
mentum. greater absorption at this 
infra-red wavelength cannot be as­
sumed. Even with very low energy and 
duration (50 mJ. 10 pps, 1 s), the laser 
could cause some physical changes to 
calculus (Fig. 2b). whereas it did not af­
fect any o f  the cementum specimens 
using 50 mJ. 10 pps for either 1 or 5 s. 
On the other hand, using 100 mJ. 20 
pps for 5 s the laser caused severe de­
struction o f calculus, dentine and ce­
mentum.
Interestingly, when the laser energy 
was strong enough and calculus was 
thin enough to be evaporated com ­
pletely, some parts o f  the underlying 
dental tissues were affected too. It 
seems that none o f  the laser settings 
could differentiate calculus and dental 
tissues and all were affected (e.g.. Figs. 
4a-c). Perhaps calculus causes more 
laser power absorption to the area, thus 
more heat is generated. This heat may 
affect not only the calculus itself but 
also the adjacent tissues. Figs. 4a. b
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%• ~ Replica m odel o f  calculus before the laser trea tm en t. A few cracks are visible on the 
l0°th surface (orig inal m agnifications: (a) X15. b a r= 1 0 0 0  /rm; (b) X150. b a r= 1 0 0  /rm).
show th at th ere  w ere n o  d is tin ct b o u n d ­
aries b etw een  c em en tu m  an d  ca lcu lu s  
0n the in tern a l w all o f  th e  laser le sio n s.
sp ec im en  w as fo u n d  in w h ich  the  
*aser c o u ld  e v a p o ra te  ca lc u lu s  c o m ­
pletely w ith o u t e v a p o r a tin g  cem en tu m . 
Jhis in a b ility  to  d ifferen tia te  fore ign  
and h o st m a ter ia l m a y  lim it th e  c lin ica l
a p p lic a tio n  o f  the laser fo r  c a lc u lu s  re­
m o va l in p er io d o n ta l p o ck e ts .
R esu lts  sh ow ed  th a t th e  v a lu e  o f  
p ow er se tt in g , n u m ber o f  p u lse s  per s ec ­
o n d  an d  r a d ia tio n  d u ra tio n  h ave an  a d ­
d itive  c o n tr ib u tio n  to  th e d a m a g e  score . 
H ow ever , th e  stu d y  h as low p o w er  to  
d is tin g u ish  b etw een  d ifferen t m o d e ls  o f
th e e ffect o f  p ow er  settin g , n u m b er  o f  
p u lses  per seco n d  an d  length  o f  tim e on  
th e m ean  d a m a g e  score  in view  o f  the  
sm all overall sa m p le  size and  th e  a rb i­
trary n atu re o f  th e  m ean  d a m a g e  score.
T h is  stu d y  h as a ttem p ted  to  q u a n tify  
th e e ffe c ts  ca u sed  by the laser o n  the  
roo t su rface. In p rev iou s stu d ies , the  
laser h a n d p iece  w as m oved  on  th e  r o o t  
su rfa ces  w-ith an  a lm o st  p ara lle l a n g u ­
la tio n  to  the ro o t surface, w h ere  the  
w h o le  su rface  w as e x p o sed  u s in g  an  
ov erla p p in g  m o v em en t o f  the la ser  tip. 
A s sta ted  p rev iou sly , it m ay be p o ss ib le  
th at so m e  p o in ts  on  th e root su rface  
had  m u ltip le  trea tm en ts  b ecau se  o f  the  
ov erla p p in g  m o v em en t. O n th e o th er  
han d , v iew in g  th e  sm all size o f  o p tic  
fibre d ia m eter  in  rela tion  to  th e  w'hole  
trea tm en t area, th ere w as a p o ss ib ility  
o f  u n d ertrea tin g  so m e  parts. It w as not  
clear, th erefore, w h ich  part o f  the  
treated  su rface  c o u ld  be a ttr ib u ted  to  
th e p articu lar  laser settin gs . In a d ­
d it io n . th e d egree o f  d am age  m ig h t have  
been  in flu en ced  p artly  by th e sp eed  o f  
m o v e m e n ts, a fa c to r  w h ich  w as n o t  
co n tr o lled  in p rev io u s s tu d ies . To re­
d u ce  th e  m e th o d o lo g ic a l var iab ility , it 
w as d ec id ed  to  lase  o n ly  o n e  p o in t for  
a sp ecific  p er io d  o f  tim e w ith o u t m ov ­
in g  th e  fibre. T h e  p ro to co l a p p ea rs  to  
have been  h ig h ly  su ccessfu l.
R esu lts  have in d ica ted  th at sp ecific  
d e n tin e  and cem en tu m  sp e c im en s  a p ­
pear  to  have d ifferen t degrees o f  s u sc e p ­
tib ility  to  th e laser. T h e  va r ia b ility  o f  
th is  su scep tib ility  w as ev id en ced  by the  
tw o  fo llo w in g  ex trem es, o n e  o f  th e  d e n ­
tin e  sp ec im en s  w as n o t a ffec ted  by any  
o f  th e  e igh t la ser  settin g s , w h erea s  a n ­
o th er  w as m o re  or less a ffec ted  by all 8 
settin g s . O th ers  fell so m ew h ere  betw een  
th e  tw o. T h is  p h en o m e n o n  m a y  be the  
result o f  v a r ia b ility  in co lo u r , textu re. %  
o f  w ater c o n te n t , or  so m e  o th er  in ­
heren t h o st or  site  fa c to r s  w h ich  m ay  
in flu en ce  th e d egree  o f  en ergy  a b s o r p ­
tio n . Su ch  u n p red ictab le  v a r ia tio n  m ay  
lim it th e c lin ica l a p p lica tio n  o f  la sers  in 
p er io d o n ta l p o ck e ts . M oreover , in m o st  
te e th , d ifferen t site s  o f  the sa m e c a lc u ­
lu s  sp ecim en  show'ed d ifferen t su sc e p ti­
b ility  to  laser ex p o su re. O ut o f  32  teeth  
o n ly  11 tee th  sh ow ed  eq u a l d am age  
sco res  for  all treated  sites. T h is  is p r o b ­
a b ly  d u e  to  v a r ia tio n  in th e  co lo u r , 
th ick n ess , c o m p o s it io n , an d  oth er  
ch a ra cter istic s  o f  ca lcu lu s  in th e  sam e  
to o th .
I f  la sers  are to  be used fo r  an y  p er i­
o d o n ta l trea tm en t, th ey  sh o u ld  be 
h a rm less  to  p u lp  tissu es. A d r ia n  (1 9 7 7 )
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Fig. S. Replica m odel o f  the specim en on Fig. 7 a fte r the laser treatm ent. N o difference in 
surface crack ing  is observed, (orig inal m agnifications: (a) x  15. b a r=  1000 //m; (b) x  150. b a r=  
100 um).
rep orted  th a t e n e rg y  d e n s itie s  su ffic ien t  
to  p rod u ce  c ra ter in g  o n  the to o th  su r­
face c o u ld  be u sed  w ith o u t p ro d u cin g  
n ecrosis  w h en  an  N d :Y A G  laser w as  
used . In a s tu d y  o f  laser  e ffe c ts  on  the  
pulp. W h ite  e t a l. (1 9 9 0 ) lased  teeth  im ­
m ed ia tely  a fter  e x tr a c t io n . T h ey  re­
p orted  no s ig n ifica n t ch a n g e s  in the  
pulp  if  the d e n t in e  th ick n ess  b etw een  
p u lp  and the la sed  s ite  w as m ore th an  
I m m . F u rth er  in v e s tig a tio n  sh o u ld  be 
carried  o u t to  e x a m in e  th e p o ten tia l e f ­
fects o f  laser on  th e d en ta l pulp.
To d ate  th ere  is n o  s tu d y  o n  the e ffec t  
o f  N d :Y A G  lasers  o n  th e p er io d o n ta l 
ligam en t. T rv lo v ich  et al. (1 9 9 2 ) re­
p orted  a d ec rea sed  c o m p a tib ility  o f  
fib rob lasts  o n  th e  la ser  treated  root su r­
face. M oreover , in a s tu d y  w ith  cu ltu red  
h u m an skin  fib ro b la sts . A b ergel et al. 
(1 9 8 4 ) rep o rted  c o lla g e n  p ro d u ctio n  
and D N A  s y n th e s is  to  be tle la y ed  by 
N d :Y A G  laser e x p o su re . It is likely th at 
p e r io d o n ta l fib ro b la sts  sh o w  sim ilar  re­
sp o n se  a fter  la ser  ex p o su r e .
F u rth er w ork  is n ecessa ry  to  c lar ify  
root tissue b e h a v io u r  to  th e laser ir­
r a d ia tion . In c o n c lu s io n , the laser can  
ca u se  p h ysica l c h a n g e s  o n  ca lcu lu s  
under la b o r a to r y  c o n d it io n s , even  if  
used w ith  low  e n e rg ie s  an d  sh o r t d u r­
a tio n s. H ow ever , ca lc u lu s  free d en ta l 
tissues were n o t a ffec te d  by low  en erg ies  
o f  laser (5 0  m j- lO p p s- lse c ) .  In a d d itio n ,  
there w as v a r ia b ility  in th e degree  o f  
s u scep tib ility  o f  d iffe ren t teeth  and  d if­
ferent parts o f  th e sa m e to o th  to the  
laser.
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Zusammenfassung
Fine Beurteilung der EfJ'ekte vines Sd : Yug 
Lasers aid subgingivalen ZaJinstein. Dentin 
and Zement. Fine in Vitro Studie  
Das Ziel der vorliegenden A rbeit besiand 
darin . die Effckte der Nd:YAG Laserbe- 
handlung a u f  den subgingivalen Zahnstein. 
den Zem ent und das D entin  bei verschiede- 
nen Einstellungen der Energiezul'iihrung und 
der D auer der L asercxpositioncn der Prtipa- 
rate. in Vitro zu untersuchen. Die U ntersu- 
chung  besiand aus zwei Versuchen. 1m R ah- 
men des ersten Versuchs wurden 32 Zdhne 
mit Z ahnste inanlagerungen in 8 Laserbe- 
h and lungsgruppen  eingeteilt. Jeder Z ahn 
w urde an 2. 3 oder 4 Stellen behandelt. Fur 
den zweiten Versuch w urden 3 extrahierte  
Ziihnc mit W urzelzem entschicht und 3. mit 
W urzelgiiittung behandeltc. ex trah ierte  Ziih- 
ne m it cntbloBtem  D entin uusgewahlt. Eine 
Oberfiiiche an jedem  Z ahn  w urde 8 verschie- 
denartigen  Laserbehandlungen ausgesetzt. 
Bei beiden Versuchen w urden ullc P n iparate  
m it R asterelektronenm ikroskopie  unter- 
sucht. Von jeder behandelten  Stelle w urden 
V likroradiogram m e in 100- und 750facher 
VergroBerung angefertig t. Um das AusmaB 
des Laserschadens zu bew erten. w urde eine 
w illkurliche Skala (von 0 -3 ) angew andt. Im 
allgem einen beschadigte der Laser den Z ah n ­
stein m ehr als den Z em ent oder das D entin. 
Die lineare Regressionsanalyse ergab. daB 
hohere E nergiezufuhr den groBercn m ittleren 
Schaden am  Z ahnstein  verursachte {Rz = 
66%. /7<0.001). Was den Z ahnstein anbe- 
langt. zeigte die 3-Wege Varianzanalvse. daB 
die Einstellung der Energiezul'iihrung. die 
Zahl der Im pulse pro Sekunde und die D auer 
der Exposition, unabhiingig von einander 
und additiv. zu der H ohe des m ittleren Scha- 
dens-Seore beitrugen. Die Z em entprapara te  
w urden durch die B ehandlung 1 (50 mJ. 10 
pps. I Sek). die B ehandlung 2 (50 mJ. 10 pps. 
5 Sek) und die B ehandlung 5 (50 mJ. 20 pps. 
I Sek). nicht beeintiuBt. Die D en tinp rapara te  
w urden durch die B ehandlung 1 (50 mJ. 10 
pps. 1 Sek) nicht beschiidigt. Die Resultate 
zeigten weiterhin. daB. sowohl beim Z ahn­
stein, beim Zem ent oder am  D entin . Schwan- 
kungen der Suszeptivitat der einzelnen Ziihne 
und der verschiedenen A bschn itte  eines jeden 
Z ahns vorhanden waren.
Resume
Une evaluation des effe ts d im  laser Nd: YAG  
sur le tart re sous-gingival, la dentine et le ce­
m ent: une etude in vitro 
Le but de cette etude a ete d ’evaluer les effets 
du  tra item ent au laser N d:Y A G  sur le ta rtre  
sous-gingival. le cem ent, la dentine, in vitro 
et a divers niveaux de puissance et de duree. 
C ette  etude com prenait deux experiences. 
D ans la premiere. 32 den ts  avulsees avec 
ta rtre  on t ete reparties en 8 groupes de tra ite ­
m ent au laser. C haque dent a ete traitee au 
niveau de 2. 3 ou 4 sites. D ans la seconde 
experience. 3 dents avulsees recouvertcs de 
cem ent et 3 dents avulsees avec racines lissees 
et den tine  exposee ont ete selectionnees. Une 
surface de chaque dent a fait I'objet de huit 
tra item ents differents au laser. D ans les 2 ex­
periences. tous les echantillons on t ete analy ­
ses au  m icroscope electronique a balavage. 
Des m icrographies on t ete realisees de cha­
que site traite . a une am plification  de I0 0 x  
et 750x .  Une echeile a rb itra ire  (de 0 a 3) a 
ete utilisee pour estim er le niveau des lesions 
causees par le laser. G eneralem ent. le laser 
e n tra in a it plus de degats au niveau du  ta rtre  
q u 'a u  niveau du cem ent ou de la dentine. 
L 'analvse de regression lineaire a dem ontre  
q u 'u n  dux energetique eleve provoque au ni­
veau du ta rtre  un degre moyen de lesion 
(/? -= 66% . /><0.00l). L 'analvse de variance a 
trois voies a m ontre que p o u r le ta rtre  la 
puissance, la frequence et la duree de I’e.xpo- 
sition ont con tribue  independam m ent au de­
gre moyen de lesion, et ce. de m aniere add iti­
ve. Des echantillons de cem ent n 'o n t pas ete 
affectes par le tra item ent I (50 mJ. 10 pps. 
1 s). le tra item ent 2 (50 mJ. 10 pps. 5 s) et le 
tra item en t 5 (50 mJ. 20 pps. Is). Les echan til­
lons de dentine n 'o n t pas ete endom m ages 
pa r le tra item ent 1 (50 mJ. 10 pps. 1 s). Les 
resu lta ts  dem ontren t egalem ent une variabili­
ty de sensibilite au  niveau des differentes 
den ts  et des differents sites p o u r chaque  dent, 
ceci e tan t aussi bien valable p o u r le ta rtre  et 
le cem ent que pou r la dentine.
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The aim of this study was to  determine whether the NdrYAG laser 
energies of 50 and 8C MJ at 10 pulses per second (pps) were capable 
of im proving the clinical parameters associated with periodontal 
disease. These energy settings were chosen as previous work indi­
cated that higher values would damage root surfaces and that 80 MJ 
had an in-vitro bactericidal effect. Eighty periodontally affected sites 
in teeth scheduled for extraction from 11 patients w ith  adult 
periodontitis were randomly placed in one of the follow ing j  treat­
m ent groups: 1 .laser treatm ent at 50 MJ, 10 pps for 3 minutes; 2.1aser 
treatm ent at 80 MJ, 10 pps for 3 m inutes;3. scaling and 4. untreated  
control. Probing depth, bleeding on probing (BOP), plaque index, 
gingival index and gingival crevicular fluid (GCF) volum e were 
measured at baseline and week 6. Baseline subgingival m icrobiologi­
cal samples were collected, then repeated immediately after treatm ent 
and at week 6 to assess the total anaerobic colony form ing units 
(CFU). Only the scaling group showed a significant reduction in 
pocket depth and BOP (P < 0.001). The microbial samples taken 
immediately after scaling and laser at 80 MJ and 10 pps treatm ents 
showed a significant reduction in total CFU compared to the  
baseline (P < 0.01), which was sustained only in the scaling group  
until week 6 .Electron microscopy did not reveal any heat damage on  
the root surfaces. This study demonstrated that application of 
Nd:YAG laser pulses of50M J and 80 MJ failed to improve theclinical 
and microbiological parameters of periodontal disease.
R e c e n t ly ,  extens ive  c laim s have been  m ade  for 
th e  p u lsed  N d : Y A G  laser w h ic h  inc lude  efficacy 
in  calculus rem ov a l ,  p o c k e t  cure t tage ,  po ck e t  
d e p th  re d u c t io n  an d  t r e a tm e n t  o f  den t in a l  h y ­
p e rs e n s i t iv i ty.1"4 In  ad d i t io n ,  so m e  inves tiga tors  
have  sugges ted  th a t  lasers can reduce  the  b ac te ­
rial p o p u la t io n  in the  p e r io d o n ta l  p o c k e t.5
T h e  m ain  s tra tegy in p er iodon ta l  th e rapy  is the 
e lim ination  o f  bacterial p laque from  periodonta l 
pockets  and ro o t  surfaces. Laser radiation o f  vari­
ous w avelengths inc lu d ing  N d :Y A G  laser has 
been sh o w n  to be capable  o t kil ling bacteria5"'5 and
so in theory, could be used to render the root 
surface free of bacterial plaque and deposits. The 
Nd:YAG laser, however, has been shown to alter 
the physical and biological properties of the 
cementum surface, if used at energies in the range 
recommended by the manufacturer.5,9-12Our group 
has examined the in-vitro effect of this laser on 
calculus (fixed fibre, few seconds exposure) and 
found that there was a wide variability among the 
specimens in terms of the degree of physical 
changes on calculus following laser application.15
R oot surface damage has been reported to be 
caused by energy level of 80 MJ at 10 ppsm vitro 
using a moving fibre.10 Cobb et al.5 used energy 
settings of 1.75 W (about 87 MJ, 20 pps) and 
higher in vivo, and reported a significant reduc­
tion in the proportion of periodontopathic 
bacteria. However, the cementum surface was 
damaged by the high levels of laser energy as 
demonstrated by scanning electron microscopy 
(SEM). It has also been reported that the Nd:YAG  
laser is capable of 90% kills or more for some 
oral bacteria including several periodontopathic 
species at an energy setting of 80 MJ and 10 
pulses per second (pps) for 3 minutes in vitro 
where the fibre was manipulated within 50 yil 
microbial suspensions containing 10s C FU /m l.14
The aims of this study were: 1. to determine 
whether the Nd:YAG laser energy settings of 50 
and 80 MJ at 10 pps could change the clinical 
parameters associated with chronic periodontitis; 
2. to check if these laser energy levels damaged 
the cementum surface in vivo; and 3. to deter­
mine the effect of the laser on the total viable 
anaerobic counts in the periodontal pocket.
Materials and methods
Subjects
Eleven patients with untreated chronic adult 
periodontitis who had periodontally affected 
teeth of poor prognosis scheduled for extraction 
took part in this study. In total 80 sites were 
selected, each receiving one of the four treat­
ments described subsequently. In each patient 
four pockets were matched for pocket depth 
within a tolerance of 1 mm. N ine patients pro­
vided eight sites, that is two sites for each 
treatment modality, and two patients provided 
one site for each treatment.
Study design
The study design is shown in figure 1. The 
following clinical parameters were recorded for 
each site before treatment and 6 weeks after 
treatment^'plaque index,15 modified gingival in­
d e x ,16 g ingival crevicular fluid volum e  
determination using filter paper strips and 
Periotron 6000,17 bacterial sampling, pocket
depth using a pressure sensitive probe with a 
force of 25 g and the presence or absence of 
bleeding on probing.
Treatments
Treatments included laser treatments of 50 MJ, 
or 80 MJ, or scaling; one site was the untreated 
control. The NdrYAG laser used has a wave­
length of 1064 nm. In this study the laser energy 
was delivered in a pulsed mode with a pulse 
duration of 150 ps via an optical fibre of 320 pm 
diameter. Laser treatments were performed with 
a Nd:YAG laser (American dental laser, model 
d.lase-300, Sunrise Technology Inc., Fremont, 
California) with a contact handpiece, at power 
settings of either 50 MJ or 80 MJ both at 10 pulses 
per second (pps). The energy density was 62.9 
J/cm2 and 99.5 J/cm2 for the two laser settings 
used in the study respectively. The optical fibre 
was kept almost parallel to the root surface with 
the fibre tip in contact with the root surface 
during treatment. This means that a diverging 
beam was incident on the root surface. The 
handpiece was moved back and forth by the 
operator to cover the whole surface area of each 
pocket for 3 minutes. The total energy dose 
delivered to the root surface were 90 J and 144 J 
for the two laser settings respectively. Scaling 
and root planing were performed with peri­
odontal hoes and curettes until a smooth surface 
was obtained (average often overlapping strokes). 
Laser treatments and scaling were preceded by 
local anaesthetic administration. Control treat­
ment included applying the laser handpiece to 
the root surface of control sites for 3 minutes 
with the laser machine switched off, taking into 
account any effect of the fibre mechanically 
removing bacteria.
Bacteriology
Microbial samples were taken from each site 
before, immediately following and 6 weeks after 
treatment. Samples were collected by first re­
moving supragingival plaque, then isolating the 
site with cotton rolls. A sterile, medium-size 
paper point was inserted to the depth of the 
pocket for 10 seconds and transferred into a 
bottle containing Fastidious Anaerobe Broth 
(FAB) (Lab M, England) and immediately trans­
ferred to the laboratory for total anaerobic count 
(CFU/m l). Each sample was Vortex mixed for 
30 seconds, serially diluted in FAB from neat to 
10'5 and inoculated with a spiral plater (Don  
W hitley Scientific, Shipley, England) onto Fas­
tidious Anaerobe Blood agar containing 7.5% 
v/v sterile defibrinated horse blood. Plates were 
incubated for 10 days at 37°C in an anaerobic 
incubator (Don Whitley Scientific,Shipley, Eng­
land) at an atmosphere of 5% H,, 10% C 0 2, 
85% Nitrogen. The total number of colony
forming units in each sample (CFU/ml) was 
calculated and converted to logs for statistical 
analysis.
Scanning electron microscopy (SEM)
After the 6-week visit, laser treated teeth were 
extracted to complete the patient’s treatment 
plan. The extracted teeth were then fixed in 
2.5% glutaraldehyde in 0.1 M cacodylate buffer 
at pH 7.4. Following fixation, the specimens 
were dehydrated using a ascending series of 
graded ethanol solutions and the final dehydra­
tion was carried out using hexamethyldisilazane 
for 36 hours. The specimens were sputter-coated 
(Polaron E5000) with gold and viewed on a Jeol 
JSM T300 SEM at 30 kV to examine whether the 
laser damage was present on the root surfaces. 
The characteristic features of the laser damaged 
surface include charring, crater formation, 
cem entum  m eltd ow n  w ith  subsequent 
resolidification of inorganic material.5’10,15
Statistical analysis
For the analysis o f plaque and gingival index 
data, baseline and 6-week visit data were com­
pared using W ilcoxon’s test and changes in these 
parameters in the four groups were subjected to 
Friedman’s test. The latter compares the mean 
ranks of treatments ie an average of every site’s 
score, ranked across the four treatment groups 
within each patient. BOP data of baseline and 
6-week visit in each treatment group were com­
pared using the McNemar test. Pocket depths 
were compared using a paired t-test on baseline 
and 6-week visit data for each treatment group. 
Repeated measurements analysis of variance 
(A N O V A ) was used to compare pocket depth 
changes in four groups, and where an overall 
significant difference was detected, Duncan’js 
multiple range test was used to uncover the 
significantly different groups. For the micro­
biology data, differences between the counts in 
samples before and immediately after treatment, 
as well as differences between the counts before 
treatment and at the 6-week visit, were subjected 
to repeated measures A N O V A  and Duncan’s 
multiple range test.
Results
Overall the plaque index scores recorded for all 
sites were relatively low during the study (0.6 at 
baseline and 0.37 at 6-weeks). There was a slight 
reduction in plaque scores at the 6-week visit 
compared to baseline for all four groups, although 
only the control group showed a significant 
reduction (P -  0.043, W ilcoxon’s test). Fried­
man’s test on changes in plaque scores among the 
four groups showed no significant differences (P 
-  0.94) (Table I). The gingival index also was
slightly reduced in all groups over time with the 
highest reduction being recorded in the scaling 
group (mean reduction 0.5) followed by the laser 
(50 MJ), laser (80 MJ) and control groups with  
mean reductions of 0.26, 0.05 and 0.05 respec­
tively. N o significant difference was found in 
changes of gingival scores among the four groups 
(P = 0.29) (Table II).
All groups showed a reduction in pocket 
depth at the 6-week visit compared to baseline 
(fig. 2), but only the scaling group showed a 
significant reduction (P < 0.001, paired t-test). 
Repeated measures analysis of variance on dif­
ferences of the four groups proved to be 
significant (P = 0.003). In addition, Duncan’s 
multiple range test revealed that scaling was 
significantly superior to all other groups (P < 
0.05).
The total anaerobic counts of subgingival 
plaque samples collected immediately after scal­
ing and laser (80 MJ) treatments showed a 
significant reduction compared to those collected 
before treatment (P < 0.01, paired t-test; fig. 3). 
However, after 6 weeks only the scaling group 
still showed a significant reduction compared to 
baseline (P < 0.01, paired t-test). The differences 
in counts between the baseline and post-treatment 
samples and between baseline and 6-week sam­
ples were subjected to repeated measures 
A N O V A  and a significant difference was found 
for the former comparison (P< 0.001). Duncan’s 
multiple range test elucidated a significant dif­
ference between scaling and all other groups (P  
< 0.05). However, differences between baseline 
and 6-week visit samples among the four groups 
were not significantly different (P = 0.059).
N o  improvement was observed in bleeding 
on probing (BOP) for any of the laser treated 
sites throughout the study (fig. 4), although the 
control group showed a little reduction (10%). 
The scaling group, however experienced a 45% 
reduction (from 95% to 50%) which proved to 
be significant (P = 0.0039, McNemar test). In 
both of the laser treated groups, the gingival 
crevicular fluid (GCF) volume was slightly in­
creased at 6-week compared to baseline, whereas 
the scaling group showed a reduction and the 
control group remained almost unchanged (fig. 
5). N one of these changes, however, reached 
statistical significance (P < 0.05).
Scanning electron microscopy 
SEM examination of laser treated teeth showed 
no evidence of damage attributable to the laser 
irradiation.
Sensitivity
Five patients presented with mild hyper­
sensitivity to hot and cold drinks on treated teeth 
one week after treatment. O f these, three pa­
tients had hypersensitivity related to scaling, 
laser (50 MJ) and laser (80 MJ). One patient had 
sensitivity on scaling teeth and laser (80 MJ) 
treated teeth, and in another patient the laser (50 
MJ) and laser (80 MJ) treated teeth were sensi­
tive.
Discussion
M ost treatment modalities used in periodontal 
therapy aim to reduce the bacterial plaque on the 
root surface and periodontal tissues to levels 
compatible with the host response such that the 
disease will be controlled. The effectiveness of 
scaling and root planing in the treatment of 
periodontal disease is universally accepted.18,19 
Adjunctive therapy aimed at reducing or elimi­
nating bacteria such as loca lly  delivered  
antibacterial agents has proved useful in peri­
odontal treatment.25"22 In theory, the ability of 
laser energy to kill and ablate bacteria might be 
useful in eliminating bacterial plaque and thereby 
reducing probing depth and bleeding on prob­
ing. The purpose of the present study was to 
determine whether the relatively low level laser 
pulse energies were sufficient to reduce micro­
bial numbers, and improve the clinical parameters 
of periodontal disease and to determine whether 
these energy levels had any detrimental effect on 
the root surface in vivo.
All groups (including the untreated control) 
showed some reduction in pocket depth at the 
re-assessment visit compared to baseline. The 
slight reduction in pocket depth in all groups 
may be explained by the improved oral hygiene 
of the patients. Three weeks before baseline, 
they received a full oral hygiene instruction. 
Furthermore, after baseline, there was still a 
slight improvement in the plaque scores for all 
groups, however, supragingival plaque control 
has been shown to have a minor effect on pocket 
depth.23
The patients had a relatively low gingival 
index at the baseline (mean = 1.77) and the 
scaling group showed the highest reduction in 
gingival index (0.5) and bleeding on probing, 
whereas the reduction in the gingival index of 
the other groups was minimal and could be 
attributed to improved oral hygiene. While the 
gingival index may reflect the presence of in­
flammation at the periphery of the periodontium, 
the absence of bleeding on probing may provide 
a better assessment of health for the whole 
periodontium. O nly the scaling group showed a 
significant reduction in the incidence of bleed­
ing on probing, suggesting that the laser 
treatments used in this study were not capable of 
reducing the level of inflammation within the 
pockets.
The post-therapy reduction in anaerobic 
counts in the scaling group was significantly 
greater than all other groups; laser (80 MJ) treat­
ment produced only a three-fold reduction in 
bacterial numbers which failed to change signifi­
cantly the clinical parameters during the course 
of the study.
In this study, lower pulse energies than those 
used by Cobb et al.5 were used. This was done to 
limit any thermal effect which laser treatment 
may have on the cementum and to test whether 
80 MJ pulses (3 min exposure) which yielded 
99.9% kills for some species14 were as successful 
in inhibiting bacteria in v ivo. In previous studies, 
different methods and microbial volumes have 
been investigated,5,14 making determination of 
the energy dose per microbial cell difficult. This 
also makes determination o f the optimal laser 
parameter for bacterial killing difficult.
SEM examination of the laser treated sur­
faces in this investigation revealed no sign of 
physical damage due to laser energy. This obser­
vation is contrary to that reported by Trylovich 
et al.10 who used an energy setting of 80 MJ and 
10 pps for 1 minute in vitro and observed by 
SEM physical damage on the root surface. This 
difference may be due to lasing technique since 
the handpiece was held perpendicular to the root 
surface by Trylovich er al.l° but almost parallel 
to the surface in the present study. The laser 
energy delivered to the root surface is higher if 
the fibre is held perpendicular to the root sur­
face. Moreover, the presence of biological fluid 
in the pocket could have a cooling effect on the 
root surface and might prevent root damage.The 
root surface adjacent to the pocket is located 
subgingivally and in order for the laser energy to 
have access to the surface, the handpiece has to 
be kept almost parallel to the surface.
In the present study, teeth with a poor prog­
nosis were used because there was no certainty as 
to whether the laser energy would have a perma­
nent detrimental effect on the root surface, pulp 
or periodontium. The observation of tooth  
hypersensitivity to cold and heat in some of the 
laser treated teeth may be due to either damage 
to the cementum and exposure of dentinal tu­
bules or damage to the pulpal tissues because of 
laser radiation penetrating through the cementum 
and dentine, SEM examination did not show  
cemenmm surface damage, and this may raise 
concern about the pulpal effect of the laser 
energy. The Nd'.YAG laser energy has a wave­
length of 1064 nm and is capable of penetrating 
through tissues to a considerable depth. Clearly, 
further research is required to determine a clini­
cally effective and yet safe method for applying 
laser energy in the treatment of periodontallv 
diseased tissues.
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Table I Plaaue index at baseline and 6-week visits 
among the different treatment groups (mean ± stand­
ard error of the mean are displayed)
Treatment Baseline 6 week Change*
Scaling and 0.65 0.50 0.15
root planing ± 0.18 ± 0.17 ± 0.21
Laser (50 MJ) 0.80 0.45 0.35
± 0.21 ± 0.14 ± 0.23
Laser (80 MJ) 0.50 0.40 0.10
± 0.14 ± 0.15 ± 0.12
Untreated 0.45 0.15** 0.30
control ± 0.15 ± 0.11 ± 0.13
*P = 0.939, Friedman’s test.
^^Significantly differentfrom baseline^3=0.043, Wilcoxon’s 
test.
Table II Modified gingival index at baseline and 
six-week visits among the different treatment groups 
(mean ± standard error of the mean are displayed)
Treatment Baseline 6 week Change*
Scaling and 1.65 1.15 0.50
root planing ± 0.18 ± 0.15 ± 0.24
Laser (50 MJ) 2.05 1.80 0.25
± 0.15 ± 0.17 ± 0.14
Laser (80 MJ) 1.95 1.90 0.05
± 0.15 ± 0.14 ± 0.15
Untreated 1.45 1.40 0.05
control ± 0.15 ± 0.18 ± 0.22
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Fig. 1 Study design.
Fig. 2 Pocket depth at the baseline and 6-week visits 
among the treatment groups (mean and 95% confi­
dence intervals are displayed).
Fig. 3 Total anaerobic count (log) at baseline, imme­
diately after treatment and 6-w eek visit among the 
treatment groups (mean and 95% confidence inter­
vals are displayed).
Fig. 4 Percentage of sites w ith  bleeding on probing at 
baseline and 6-w eek visit among the treatment groups.
Fig. 5 Change in the gingival crevicular fluid volume 
after treatment among the treatment groups (mean 
and 95% confidence intervals are displayed).
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Abstract
The aim of this study was to evaluate the efficacy of 3 commercially available 
locally delivered antimicrobial systems as adjuncts to scaling and root planing 
in treatment of sites with persistent periodontal lesions following a course of 
scaling and root planing. Fifty-four patients with 4 pockets > 5 mm and 
bleeding on probing and/or suppuration were randomised in 4 treatment 
groups including: scaling and root planing plus application of 25% 
tetracycline fibre (S+Tet) (13 patients), scaling and root planing plus 
application of 2% minocycline gel (S+Min) (14 patients), scaling and root 
planing plus application of 25% metronidazole gel (S+Met) (14 patients) and 
one group received scaling and root planing alone (S) (13 patients). Clinical 
measurements were taken at baseline and 6 weeks after treatments. All 
treatments were applied using the distributors recommended protocols and 
resulted in significant improvement in pocket depth, attachment level, 
bleeding on probing and the Modified Gingival Index (MGI) scores. The 
improvements in clinical parameters were greater in all 3 adjunctive treatment 
groups than scaling and root planing alone. The mean pocket depth 
reductions were: S+Tet=1.35mm, S+Met=0.95mm, S+Min=0.87mm and 
S=0.60mm. The pocket depth reduction was significantly greater in scaling 
plus tetracycline fibre group than scaling and root planing alone group 
(p=0.002). The difference between groups in improvement of attachment 
level or bleeding on probing was not significant. Scaling plus tetracycline 
fibre treatment resulted in the greatest reduction in the MGI scores which was 
significantly greater than all other groups. While the frequency of sites with 
suppuration was markedly reduced following all treatments, it reached zero in 
the scaling plus tetracycline fibre group. No serious adverse effect was 
observed or reported in any treatment group. While all 3 locally applied 
antimicrobial systems seem to offer some benefit over scaling and root 
planing alone, a treatment regime of scaling and root planing plus tetracycline 
fibre placement gave the greatest advantage in the treatment of persistent 
periodontal lesions at least during the 6 week period following treatment.
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Introduction
Currently, the primary objective of periodontal treatment is to stop disease 
progression. The results of several clinical trials indicate that meticulous 
scaling and root planing in conjunction with patient’s proper plaque control, 
can arrest periodontitis.1'5 Nevertheless, scaling and root planing may not 
always result in a complete elimination of the disease. Poor access to the 
bottom of deep pockets, and anatomical complexity may occasionally limit the 
efficacy of root planing.6,7 It has also been suggested that repopulation of 
scaled teeth from the bacterial reservoirs in dentinal tubules may be 
responsible for recurrence of the disease.8 Moreover, some suspected 
periodontal pathogens have been shown to invade the soft tissue adjacent to 
pockets,9 an area which may not be debrided by root planing.
The recognition of bacterial plaque as the main etiologic factor in the 
pathogenesis of periodontal disease, encouraged many investigators to use 
antibiotics as adjuncts to mechanical treatment of periodontitis (reviewed by 
Slots and Rams).10 The results of clinical trials on the use of antibiotics as 
the sole treatment or adjunct to mechanical therapy for untreated periodontitis 
are controversial.11"14 Moreover, the well known unwanted effects associated 
with the systemic use of antibiotics preclude the use of these agents as the 
sole or adjunctive treatment for untreated periodontal lesions as a routine 
procedure.
To overcome the considerable disadvantages of systemic antibiotic therapy, 
local delivery of antibacterial agents into periodontal pockets has been 
extensively developed and investigated since the late 70’s. Many systems 
were designed to maintain high levels of antimicrobial agents in the crevicular 
fluid with minimal systemic uptake.15"20 Many clinical studies have been 
conducted to assess the value of these systems as adjuncts to root planing or 
the sole treatment for untreated periodontal lesions.21'26 If these systems are 
used as adjuncts to scaling and root planing, studies suggest that there is a
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slight advantage over scaling and root planing alone, although this difference 
has often been clinically minimal or statistically insignificant. This may be 
because scaling and root planing alone is usually quite effective in producing 
clinically obvious and statistically significant improvements. On the other 
hand, few studies have evaluated the effects of local drug delivery systems 
on sites which responded poorly or showed recurrence of disease after 
scaling and root planing.27,28 However, to date, there has been no report 
assessing the comparative efficacy of a number of currently marketed 
systems using the distributors recommended protocols, on sites with 
previously unsuccessful mechanical therapy. We report here the baseline to 
six week results of an investigation into the effect of 3 commercially available 
local drug delivery systems on the clinical parameters of sites with persistent 
periodontal lesions following a course of scaling and root planing.
Materials and Methods
Study Design
This was a parallel designed study. Patients with persistent pockets which 
did not respond favourably to scaling and root planing, were randomised in 4 
treatment groups. One group received scaling and root planing only whereas 
the other three groups received scaling and root planing plus one of the 3 
locally delivered antimicrobial systems adjunctively as described 
subsequently. The patients were examined for the clinical parameters at 
baseline and 6 weeks after the last treatment.
Subjects and sites
The subjects comprised of 67 patients who had been attending the 
Periodontal Department of the Glasgow Dental Hospital for chronic 
periodontitis therapy. Of the 67 participants included in the study, 54 
completed the course of study and 13 excluded themselves by failing to 
attend either treatment or examination visits. Of the 13 excluded subjects, 9 
had not been allocated to any treatment yet, one was in the S group, one was
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in S+Min group and 2 were in the S+Met group. The participants had 
previously received quadrant scaling and root planing under local 
anaesthetic, and in the spite of mechanical treatment and good oral hygiene, 
still had deep pockets with bleeding on probing. Patients inclusion criteria 
was that they had at least 4 non-adjacent teeth with probing pocket depth > 5 
mm with bleeding on probing or suppuration. Sites with furcation lesions 
were not selected. Patients with a systemic disease, or with a history of 
systemic antibiotic therapy over the past 6 months were excluded. The 
patients fulfilling the inclusion criteria were informed of the study and having 
given consent, alginate impressions were taken and soft occlusal acrylic 
stents were fabricated for the measurements of attachment levels.
Clinical Measurements
At the baseline visit and 6 weeks after the last treatment, the following clinical 
parameters were measured by a single examiner (MR). The Plaque Index29, 
the Modified Gingival Index 30, duplicated probing pocket depth using the 
Florida Probe 31 (Florida Probe Corporation, Florida, USA) with a controlled 
force of 20 g, duplicated attachment level recordings using the Florida Probe 
and occlusal stents. The examiner was blind with respect to the readings 
which appeared on a computer monitor hidden from the examiner and 
recorded by an assistant. The presence of suppuration was assessed using 
a ball burnisher. Bleeding on probing was assessed using the Florida Probe 
and the presence or absence of bleeding up to 30 seconds after probing were 
recorded.
Treatments
The 4 study sites in each patient received one of the 4 treatments. Moreover, 
full-mouth scaling and root planing was performed under local anaesthesia 
for all patients. For each antibiotic treatment the manufacturer’s/distributors 
recommendations were rigidly adhered to. These included: 1) Scaling and 
root planing alone. Each tooth with deep pocketing was root planed under
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local anaesthesia for approximately 5 minutes. 2) Scaling and root planing 
plus application of 2% minocycline gel (Dentomycin, Cyanamid, Lederle, 
U.K). After scaling and root planing as described above, the minocycline gel 
was directly applied into the pockets using a disposable applicator until it was 
overfilled. The gel application took a few seconds per tooth. The gel 
application was repeated 2 weeks and 4 weeks after the first application. 3) 
Scaling and root planing plus application of 25% tetracycline ethylene vinyl 
acetate fibres (Actisite, Alza Corporation, Palo Alto, CA.). After full-mouth 
scaling and root planing as described above, the fibres were inserted into the 
pockets using dental floss and a plastic instrument. On average, 11.51 cm of 
fibre was required to fill each pocket. This was equivalent to a dosage of 
5.75 mg tetracycline per pocket. The fibre placement took on average, 8.2 
minute per tooth. Then the fibres were secured using a cyanoacrylate 
adhesive (Octyldent, Tri-point Medical LP. Raleigh NC) and a periodontal 
dressing (Coe-pak, GC America INC, Chicago, IL). After 10 days the patient 
was recalled and the fibres were removed. 4) Scaling and root planing as 
described above plus application of 25% metronidazole gel (Elyzol, Dumex, 
Denmark). After root planing, the metronidazole gel was applied into the 
pockets using a disposable applicator until it was overfilled. The gel 
application took a few seconds per tooth. The application was repeated 7 
days later. All the treatments were performed by a single operator (NP). At 
the first post-operative visit, the patients were examined for any adverse 
signs or symptoms related to these treatments.
Statistical analysis
For each visit, duplicated recordings of pocket depth and attachment level 
measurements were averaged for each site. For pocket depth and 
attachment level data, the subject-based analysis was performed, i.e., the site 
values within each patient were averaged for each visit producing a single 
figure for each patient. For each treatment group, the baseline and 6 week 
pocket depth and attachment level data were subjected to a paired-t test.
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The changes in the pocket depth and attachment level were subjected to 
General Linear Model (GLM) procedures with the baseline probing depth as a 
continuous covariate. This took into account the effect of baseline probing 
pocket depth on the treatment outcome. The chi-square (%2) test was then 
used to examine the association between the treatment and the cessation of 
bleeding on probing after treatment. Since prerequisites for the chi-square 
test were not met for the suppuration data, the Fisher’s exact test was used to 
compare 2 treatments at a time. The Plaque index and the Modified Gingival 
Index data were analysed by the Wilcoxon’s test for each treatment. The 
change in the indices were compared across the treatment groups using the 
Kruskal-Wallis test. Where there were significant differences, post-hoc 
comparisons were performed using multiple Mann-Whitney-U tests and the 
significance level was corrected using the Bonferroni adjustment for multiple 
comparisons. All the statistical procedures were performed using one 
software package (Minitab, release 9.2).
Results
In all 4 treatment groups pocket depth decreased significantly at week 6 
compared to baseline (Table 1). Mean reduction in pocket depth at week 6 
was greatest in patients who received scaling plus tetracycline fibre treatment 
and was followed by the scaling plus metronidazole gel, scaling plus 
minocycline gel, and scaling alone groups respectively. A primary analysis 
revealed that there was no significant interaction between the covariate 
(baseline pocket depth) and the treatment effect. Analysis of variance (GLM) 
showed that there was a significant difference among the treatments 
(p=0.011). Pair-wise comparisons revealed that pocket depth reduction was 
significantly greater in the scaling plus tetracycline fibre group than scaling 
alone (p=0.002). The remaining comparisons were not significant.
Table 2 shows the results of attachment level changes. Since the attachment 
levels were measured from an arbitrary reference point on the occlusal
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stents, only the actual changes would be meaningful and are presented here. 
All treatments resulted in a significant attachment gain compared to baseline. 
Primary analysis showed no indication of significant interaction between the 
treatment type effect and the baseline pocket depth. The difference between 
the treatment groups did not reach statistical significance (p=0.062).
The bleeding on probing decreased significantly in all treatment groups 
(p<0.001, Fisher’s exact test for paired data). The greatest reduction
occurred in the scaling plus tetracycline group. However, no significant 
difference existed between treatments (%2= 2.83, d.f.=3) (Table 3).
All treatments reduced the frequency of sites with suppuration (Table 4). 
With the scaling plus tetracycline fibre treatment the frequency of suppuration 
reached zero at the reassessment visit. However, pair-wise comparisons 
between treatments revealed no significant difference between groups.
The study population maintained a relatively good oral hygiene and the mean 
PI scores remained below 1 in all treatment groups throughout the study 
period. The PI scores did not differ significantly after the various treatments. 
There was no significant difference in the PI scores among the treatment 
groups at baseline (p=0.570) and after 6 weeks (p=0.259).
The Modified Gingival Index (MGI) scores decreased significantly after all 
treatments (Table 5). The greatest reduction occurred in the scaling plus 
tetracycline group. The change in the MGI scores in the scaling and 
tetracycline group was significantly greater than the other groups. The 
remaining pair-wise comparisons were not significant.
No serious adverse effect was noted throughout the study. However, in some 
cases gingival redness was observed upon the fibre removal (5 patients), 
slight pain on the first day of fibre therapy was reported (1 patient), as was
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bad taste on the first day of gel therapy (1 patient in the minocycline gel and 
2 patients in the metronidazole gel groups) and gingival tingling on the first 
day of gel therapy (1 patient in the minocycline gel group).
Discussion
This study evaluated the clinical response to 3 locally delivered antimicrobial 
systems as adjuncts to scaling and root planing. The participants in this 
study had already been treated for their chronic periodontal disease using 
quadrant scaling and root planing under local anaesthesia and still had 
pocketings > 5 mm with bleeding on probing or suppuration.
All treatment modalities used in this study including scaling and root planing 
alone, resulted in a significant pocket depth reduction and clinical attachment 
gain. In addition, other clinical parameters including BOP, suppuration and 
the MGI scores were significantly improved by all the treatments. The results 
of our investigation support the hypothesis that many sites which do not 
respond favourably to initial mechanical periodontal therapy, may still benefit 
from further episodes of scaling and root planing. These results are 
consistent with previous reports by Listgarten et al,32 and Magnusson et al.33 
Scaling plus tetracycline fibre treatment produced the greatest improvement 
in the study sites. Pocket depth reduction was significantly greater in the 
scaling plus tetracycline group compared to scaling alone. Heijl et al.25 
reported that scaling plus tetracycline fibre produced a greater pocket depth 
reduction than the scaling alone, however, the difference between groups 
were not significant in that study. On the other hand, Newman et al.26 
reported an advantage in combined scaling and tetracycline fibre therapy 
over scaling alone on a maintenance population, which was significant 6 
months after treatment.
All adjunctive antimicrobial treatments in this study produced greater mean 
improvements in all clinical parameters than scaling alone. This suggests
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that at sites with persistent periodontal disease despite previous mechanical 
therapy, adjunctive local antimicrobial treatment is effective. While this is the 
first report which describes the effect of adjunctive use of metronidazole gel 
vs. scaling and root planing alone, previous studies indicated that the 
metronidazole formulation alone may produce improvements comparable with 
those of scaling and root planing alone in probing depth and bleeding on 
probing.22,34 The combined treatment of scaling and root planing and 
minocycline gel has previously been reported to have a significant benefit 
over the scaling and root planing alone in the treatment of untreated 
periodontal lesions.23
The treatments resulted in a marked reduction in the frequency of 
suppuration among the sites. However, only in the scaling plus tetracycline 
fibre group did it virtually reach zero. The sustained concentration of 
tetracycline at very high levels 35 for 10 days could explain the superiority of 
this treatment modality over other locally delivered antimicrobials in the 
treatment of suppuration and chronic abscesses.
This was a parallel-designed study in order to disclose true differences 
between treatment modalities which may be associated with a considerable 
carry-over effect. If a split mouth design was used, the wash-out of 
antimicrobial agents through saliva could affect the microbial flora in study 
sites which received other treatments. This, in addition to boosting the 
systemic response due to removal of antigenic challenge or the inoculation 
effect following mechanical instrumentation, could mask true differences 
between groups if a split mouth design was used.36
The treatments did not result in any serious adverse effects and were all well 
tolerated by the patients. The adverse effects of any therapeutic agent may 
be reduced if delivered directly to the site of action. Adverse effects may 
follow systemic antibiotic therapy such as pseudomembranous colitis or
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allergic reactions and tend to question the justification for systemic antibiotic 
therapy for a chronic and non-lethal infection such as periodontal disease. 
These concerns would be markedly reduced if local antimicrobial agents 
could be used effectively. Nevertheless, the chance of unwanted effects such 
as gastro-intestinal disturbances, allergic reactions and development of 
antibiotic resistance could not be ruled out.
The application of tetracycline fibres required 8.2 minute per tooth on 
average in addition to scaling time and was markedly more time consuming 
than other treatments. In addition, all 3 antimicrobial treatments required 2-3 
visits. These factors need to be considered in the cost-benefit analysis of 
antimicrobial treatments over traditional approaches.
Although a significant improvement was achieved as a result of scaling alone, 
this was lower than would be expected if performed on an ‘untreated’ 
periodontitis population. Usually, following the initial treatment, a marked 
pocket reduction and shrinkage occurs due to the elimination of subgingival 
plaque, calculus and other plaque retentive factors. Therefore, somewhat 
less improvement could be expected from the scaling and root planing alone 
if some of these factors have already been reduced by initial therapy. 
Accordingly, if a true difference exists between the efficacy of combined root 
planing plus antimicrobial treatment and scaling alone, the possibility of 
detecting this difference is greater if the study subjects are selected from a 
population which have little gingival inflammation, excellent oral hygiene, and 
still some pocketing, i.e., a population which scaling and root planing could 
do only little to further improve their gingival condition. In fact, viewing the 
time and cost which is involved in using different locally delivered 
antimicrobial systems, the use of these agents do not seem to be justified as 
a part of initial periodontal therapy. Instead, a scenario is suggested whereby 
following initial phase therapy, tetracycline fibre could be used for local sites
li
with remaining severe disease, in place of surgery, whereas the other 
systems might be applicable in less severe cases.
This report represents the initial 6-week results of our investigation on the 
efficacy of locally applied antimicrobial agents for the treatment of persistent 
periodontitis. While these short-term results suggest that antimicrobial 
agents may be beneficial in the treatment of periodontal lesions, the evidence 
is needed for longer term benefits over 3 and 6 months to determine the full 
efficacy of these treatment modalities.
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Tables
Table. 1 Pocket depth analysis:
a) Baseline and 6-week pocket depth and reduction in pocket depth. Means 
expressed in mm and (SEM) are shown._____________________
Treatment groups Baseline 6- week pocket 
pocket depth depth
Pocket depth 
reduction
PT
Scaling alone 
(n=13)
5.47
(0.23)
4.87
(0.26)
0.60
(0.14)
0.001
Scaling & 
minocycline gel 
(n=14)
5.56
(0.19)
4.81
(0.23)
0.87
(0.13)
<0.001
Scaling & 
tetracycline fibre 
(n=13)
5.51
(0.17)
4.16
(0.13)
1.35
(0.17)
<0.001
Scaling & 
metronidazole gel 
(n=14)
5.60
(0.19)
4.65
(0.20)
0.95
(0.16)
<0.001
b) Analysis of variance (GLM) on Docket depth reductions:
Source DF Sea SS Adi SS Adi MS F P
Baseline pocket depth 1 1.18 
Treatment 3 3.68 
Error 49 14.62 
Total 53 19.49
1.13
3.68
14.62
1.13 3.80 
1.23 4.11 
0.30
0.057
0.011
c) Post-hoc comparisons:
Scaling & 
tetracycline fibre
Scaling & Scaling & 
minocycline gel metronidazole gel
Scaling & 
minocycline gel
p=0.022
(not significant)
Scaling & 
metronidazole gel
p=0.045 
(not significant)
p=0.726 
(not significant)
Scaling alone p=0.002 p=0.268 p=0.146 
(not significant) (not significant)
t  Paired-t test (baseline vs. 6-week)
N.B. The Bonferroni correction for multiple comparisons, produces a threshold for
statistical significance of p<0.020.
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Table.2 Attachment level analysis:
a) change in attachment levels among the treatment groups. Means 
expressed in mm and (SEM) are shown.________________ ______
Treatment groups Attachment gain PT
Scaling alone 
(n=13)
0.26
(0.11)
0.032
Scaling & minocycline gel 
(n=14)
0.45
(0.14)
0.0056
Scaling & tetracycline fibre 
(n=13)
0.75
(0.12)
<0.001
Scaling & metronidazole gel 
_ (n=14)
0.57
(0.15)
0.0018
b) Analvsis of variance (GLM) on attachment level chanaes:
Source DF Sea SS Adi SS Adi MS F P
Baseline pocket depth 1 
Treatment 3 
Error 49 
Total 53
1.52 1.44 
1.56 1.56 
9.80 9.80 
12.88
1.44
0.52
0.20
7.21
2.61
0.010
0.062
t  Paired-t test (baseline vs. 6-week)
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Table 3. Frequency and percentage of sites with improved bleeding on 
probing among the 4 treatment groups at the baseline and 6 week visits with 
the chi-square analysis on association of improvement in bleeding on probing 
with treatment.
Treatment Sites which stopped 
bleeding on probing
Scaling alone (n=51) 18 (35.3%)
Minocycline gel (n=56) 22 (39.3%)
Tetracycline fibre (n=51) 26 (51.0%)
Metronidazole gel (n=55) 22 (40.0%)
Total (n=213) 88 (41.3%)
%2= 2.826, df = 3 (not significant)
Table 4. Suppuration data:
a) Frequency and percentage of sites with suppuration at the baseline and 6- 
week visits.
Treatment Suppuration 
at baseline
Suppuration 
at week 6
Scaling alone (n=51) 8(15.7%) 2 (3.9%)
Scaling & minocycline gel (n=56) 4 (7.2%) 2 (3.6%)
Scaling & tetracycline fibre (n=51) 6(11.8%) 0 (0%)
Scaling & metronidazole gel (n=55) 8 (14.5%) 1 (1.9%)
b) Matrix of pair-wise comparisons to test the association of treatment with the 
presence of suppuration at the 6 week visit using the Fisher’s exact test (p values 
are given).___________________________________________
Scaling & Scaling & Scaling &
tetracycline fibre minocycline gel metronidazole gel
Scaling & p= 0.272
minocycline gel
Scaling & p= 0.519 p= 0.382
metronidazole gel
Scaling alone p= 0.247 p= 0.369 p= 0.363
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Table 5. a) The mean (SEM) baseline, 6-week scores and change in 
Modified Gingival Index (MGI) scores among the treatment groups._______
Treatment Baseline 6 week Change
Scaling alone 2.25 (0.09) 1.82 (0.10) 0.43(0.10)
p=0.001f
Scaling & 
minocycline gel
1.98(0.12) 1.46(0.10) 0.52(0.15)
p=0.003
Scaling & 
tetracycline fibre
2.27 (0.09) 1.18(0.09) 1.10(0.13)
p<0.001
Scaling & 
metronidazole gel
1.98(0.10) 1.55 (0.10) 0.44 (0.12)
p=0.002
p value 
(Kruskal-Wallis test)
0.122 0.001 0.002
b) Matrix of pair-wise comparisons using the Mann-Whitney U test:
Scaling & 
tetracycline fibre
Scaling & 
minocycline gel
Scaling & 
metronidazole gel
Scaling & 
minocycline gel
p=0.008*
Scaling & 
metronidazole gel
p=0.001 p=0.624
Scaling
alone
p<0.001 p=0.613 p=0.942
t  Wilcoxon’s test (Baseline vs. 6-week)
t  After the Bonferroni correction for multiple comparisons, the threshold for significance
level was p=0.020.
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Abstract
Recent investigations imply that a key mechanism in the pathogenesis of 
periodontal disease may be the ability of oral micro-organisms to induce 
production and /or activation of matrix metalloproteinases (MMPs) in the host 
tissues. It has been suggested that the pharmacologic inhibition of MMP
activity could play an important role in achieving a desirable outcome in
periodontal therapy. The efficacy of locally delivered antibiotics on the level of 
gingival crevicular fluid (GCF) stromelysin (SL) and tissue inhibitor of
metalloproteinases (TIMP) on sites with a history of a poor response to
mechanical treatment was studied. 52 patients with 4 periodontal pockets >5 
mm and bleeding on probing were randomised into four groups of 13 patients. 
One group received scaling and root planing alone and the other three groups 
received scaling and root planing plus a locally delivered antimicrobial system. 
These included 25% tetracycline fibre, 2% minocycline gel, and 25% 
metronidazole gel. The GCF samples taken at baseline and 6 weeks after 
treatments were analysed using an enzyme linked immunosorbent assay 
(ELISA). All treatments resulted in significant improvement in clinical 
parameters. The pocket depth reduction was significantly greater in the scaling 
plus tetracycline fibre group than the scaling alone group (p=0.003). GCF SL 
levels significantly decreased after adjunctive tetracycline fibre (paired t-test, 
p=0.020) and minocycline gel (paired t-test, p=0.023) treatments whereas it 
remained almost unchanged in the other two groups. While the GCF TIMP 
level did not change significantly in the scaling and root planing alone group, it 
significantly increased for all three adjunctive antimicrobial treatments (for 
tetracycline fibre p<0.001, minocycline gel p=0.005, metronidazole gel 
p<0.001). The use of adjunctive locally delivered antimicrobial systems, 
particularly, the tetracycline family, may offer an advantage in changing the
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metalloproteinase profile of the GCF to a one more compatible with periodontal 
health.
INTRODUCTION
Recent investigations imply that a key mechanism in the pathogenesis of 
periodontal disease may be the ability of oral micro-organisms to induce 
production and /or activation of matrix metalloproteinases in the host tissues.1^3 
Stromelysin (SL) is a member of the matrix metalloproteinase family which may 
play a role in chronic inflammatory periodontitis.4 Extracellular control of these 
enzymes is performed by tissue inhibitor of metalloproteinases (TIMP)5 and during 
normal tissue turnover, inflammation and healing, levels of MMPs and TIMP will 
change.6 The effect of treatment on the levels of MMPs and inhibitors has been to 
decrease collagenase activity, 7 9 to decrease the amount of collagenase and 
stromelysin (SL) produced, and to increase the level of TIMP.10'11 
It has been suggested that the pharmacologic inhibition of MMP activity could 
play an important role in achieving a desirable outcome in periodontal 
therapy.12'16 In addition to antimicrobial effects, tetracyclines have been shown 
to be able to inhibit metalloproteinases (MMPs). However, recent results 
indicate that the inhibition of MMPs by systemic tetracycline depends on the 
drug concentration and type2 as well as the origin of the MMP. 13 Therefore, 
theoretically a great inhibitory effect on MMPs would be expected if higher 
concentrations of drug could be delivered to the site of action. Recently, there 
has been increasing interest in the use of locally delivered antibiotics in order 
to obtain a high concentration of the drug at the target site and to minimise 
potential systemic adverse effects. We therefore sought to investigate the effects 
of locally delivered antibiotics on the amount of fibroblast derived SL and TIMP in 
GCF of sites with advanced periodontal breakdown.
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Materials and Methods 
Selection of subjects and test sites:
52 subjects with adult periodontitis ( 62% Female; mean age 45 ; range 30-67) 
who had previously been treated with subgingival scaling and root planing, 
were recruited from patients in the Periodontology Unit of Glasgow Dental 
Hospital and School. All study subjects signed an informed consent form and a 
full medical history was recorded. Inclusion criteria required that subjects had 
no history of systemic disease which could influence the course of periodontal 
treatment, and that they were not on any medications such as antibiotic 
therapy, which could influence the manifestations of periodontal disease, within 
the previous 6 months.
Patients selected to take part in the study had at least four periodontal pockets 
equal to or deeper than 5 mm with bleeding on probing. The patients were 
randomly allocated into four groups of 13 patients each, three of which 
received scaling followed by a locally delivered antibiotic. A total of 208 sites 
with recurrent periodontitis were examined and treated. Two diseased sites 
were excluded for technical reasons, one site lost its tetracycline fibre before 
the 10 day placement period finished and in the scaling group a further site 
could not be measured. In order to increase the accuracy of the 
measurements taken and to simplify the harvesting of GCF, the buccal, mesial 
and anterior sites were preferred to the lingual, distal and posterior sites.
Study Visits
Site selection was carried out at the screening visit after a full periodontal 
examination using a PCP-12 probe (Ash, Densply, UK). If the patient fulfilled 
the criteria, an impression was taken, and an acrylic stent fabricated for 
attachment level measurements using the Florida probe (Florida Probe 
Corporation, Florida, USA).
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Oral hygiene instruction was given according to individual needs, but no 
periodontal instrumentation was carried out at the screening visit. 10 days after 
the screening visit baseline measurements were taken. The plaque index (PI) 
of Silness & Loe (1964) 17 was recorded to assess the patient’s oral hygiene, 
the severity of gingival inflammation was measured using the gingival index of 
Lobene et al (1986). 18 GCF sampling, volume measurements, bleeding on 
probing (BOP) and suppuration were registered. Duplicate measurements of 
pocket depth and attachment level with an acrylic stent were carried out, using 
the electronic pressure sensitive Florida probe, with a constant force of 20 
grams.
At the treatment visits each group received one of the following treatments:
1) Subgingival scaling and root planing under local anaesthesia and the 
application of tetracycline impregnated fibre (Actisite®, ALZA, corporation, Palo 
Alto, CA), into the pocket. The fibre was wrapped loosely around the teeth by 
passing it through the contact points using dental floss or a plastic instrument. 
The pocket was occupied by fibre without creating excessive tension in the soft 
tissues. Cyanoacrylate adhesive was applied to the site and a dressing (Coe- 
Pak, GC America INC. Chicago, IL) was placed. The fibre was removed 10 
days later.
2) Subgingival scaling and root planing plus the application of minocycline 
dental gel (Dentomycin®, Lederle Dental Division, Gosport, Hampshire, 
England), to the pocket until it was overfilled. The excess was removed using 
cotton wool pellets. This application was repeated 14 days and 28 days after 
the initial application.
3) Subgingival scaling and root planing plus the application of metronidazole 
dental gel (Elyzol®, Dumex, Denmark), to the pocket until it was overfilled. The 
excess was removed using cotton wool pellets. The application was repeated 7 
days later.
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4) The control group received subgingival scaling and root planing alone.
42 days post treatment all the baseline measurements were repeated for each 
patient.
During this study other sites received conventional periodontal maintenance 
care.
Sampling method
The site to be sampled was isolated with cotton wool rolls and supragingival 
plaque was carefully removed. The region was dried with a gentle air stream 
and 30s later GCF was collected. A Whatman grade 4 paper strip (2 x13 mm) 
was inserted into the crevice until mild resistance was felt and left in situ for 
30s. 19 The sampling method is reliable and causes no significant disturbances 
of the gingival blood vessels20. The fluid volume on the strip was measured 
immediately after sampling with a Periotron 6000 (Harco Electronic, Winnipeg, 
Canada). The jaws of the Periotron were wiped with pure ethanol and then 
dried between readings. Strips were placed in individual sterile micro­
centrifuge tubes and stored at -30° C until further processing was carried out. 
Strips were eluted into 500 pi of incubation buffer at room temperature using a 
rotary mixer. The strips were then discarded and the eluate aliquoted and 
stored at -30° C. These aliquots were subsequently analysed for the 
quantification of SL and TIMP.
Calibration of the Periotron 6000
In order to transform the Periotron digital readings for each paper strip into 
volumes, and also to verify the accuracy of the instrument, the following 
procedure was carried out. Known volumes of PBS plus serum (in equivalent 
volume) were delivered to Whatman grade 4 paper strip with a Hamilton 
microsyringe at a range of volumes (0.05-1 pi) then Periotron readings taken.
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Each measurement was performed 3 times. The mean value for each volume 
was used in a linear regression analysis, from which the slope and intercept 
were used to determine the volumes of GCF collected .
GCF Analysis
All constituents were assayed by means of sandwich enzyme linked 
immunosorbent assays (ELISA), based on a modification of the method of 
Cooksley et al. (1991J. 21 The first antibody, Mac 78 anti-stromelysin for SL 
and Mac 19 anti-TIMP was coated onto a 96-well polystyrene microplate 
(Immulon 4, Dynatech Laboratories, Billinghurst, Sussex, U.K). The 
experimental sample was then added and any antigen present was captured by 
the immobilised antibody. The plate was then incubated with the second 
antibody. Biotinylated Mac 15 antibody and rabbit polyclonal antibody were 
used to reveal TIMP and SL, respectively followed by, in the latter case 
horseradish peroxide (HRP)-conjugated anti-rabbit IgG (donkey) (Jackson). 
The polyclonal and monoclonal antibodies were against both proenzyme, and 
active forms of the enzymes under investigation. The ELISA for TIMP can only 
detect free TIMP. 21 All the antibodies were donated by Cell Tech. Ltd. Slough, 
UK. Finally the plate was incubated with Extravidin-Peroxidase (Sigma). 
Visualisation was achieved by incubation with tetramethylbenzidine (TMB) 
(KPL-Dynatech) substrate, and the reaction stopped with 2.5% NaF. The plate 
was read at 630 nm, on a Dynatech MR 5000 plate reader. Serial dilutions of 
standard were run for each individual plate and their optical density (ODs) used 
in a linear regression analysis from which the slope and intercept were used to 
determine the sample concentration of SL and TIMP. Results were expressed 
as pg/30s sample.
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Statistical Analysis
In order to identify the distribution characteristics of the data, it was inspected 
using histograms and it was noted that the data exhibited a markedly skewed 
distribution. Log transformation was successful in producing a normal 
distribution of data within the different groups. The differences in stromelysin 
levels of each subject, between before and after treatment, for each treatment 
group, was subjected to paired t-test. The analysis of covariance (ANCOVA) 
was used on changes of SL and TIMP with the baseline SL or TIMP levels as 
continuous covariates. If a significant difference was found between 
treatments, then the post-hoc comparisons were performed by comparing two 
groups at a time and the probability threshold for statistical significance was 
adjusted to 0.02 using Bonferroni correction22. The Mann-Whitney U test and 
Two sample t-test were used to analyse the baseline levels of SL and TIMP 
respectively between bleeding and non-bleeding sites, and between 
suppurating and non-suppurating sites. Comparisons of SL and TIMP levels at 
sites with different MGI were performed using the Kruskal-Wallis test. Data 
were analysed using Minitab statistical package version 9.2.
RESULTS
Clinical response following the treatments has been reported in a further 
manuscript (Radvar et ai, in press). Briefly, a significant improvement in 
pocket depth, attachment level, bleeding on probing (BOP) and the MGI scores 
occurred in all treatment groups. The tetracycline fibre treatment resulted in a 
significantly greater change in pocket depth than the scaling alone group 
(p=0.003) (Table 1). In addition, the scaling plus tetracycline fibre treatment 
resulted in a greater improvement in the MGI scores than the scaling plus 
minocycline gel treatment (p=0.002), the scaling plus metronidazole gel 
treatment (p=0.007), and the scaling alone treatment (p=0.001). No significant
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difference existed in the MGI scores between other groups. There were no 
significant difference in attachment level changes and BOP changes between 
treatment groups. The GCF volume was reduced siginificantly only the scaling 
plus tetracycline fibre groups. There was no significant changes in the GCF 
volume after other treatments.
The mean GCF level of SL decreased in all antibiotic treated groups and this 
decrease was significant in the tetracycline fibre group (paired t-test, p=0.020) 
and the minocycline gel group (paired t-test, p=0.023) (Table 1). Paired t-test 
demonstrated that the level of GCF TIMP significantly increased in all antibiotic 
treated groups, whereas it decreased in the scaling groups, although not 
significantly (p=0.49) (Table 1). The analysis of covariance (ANCOVA) on the 
baseline SL was used to reduce the error resulting from the variation in the 
baseline. The level of SL at baseline had a significant effect on the SL change 
following treatment (p<0.001), and this effect was positive i.e. the higher the 
baseline SL, the higher the reduction of SL. Treatment also had a significant 
effect on the reduction of SL (p=0.001). Follow-up analysis showed significant 
differences between; i) tetracycline fibre and scaling alone groups (p=0.004); 
and ii) minocycline gel and scaling alone groups (p=0.002) (Table 2).
There was a significant difference in TIMP levels between treatment groups 
(p=0.007). Furthermore, the analysis of TIMP levels revealed that a significant 
difference existed between the minocycline gel and the scaling alone group 
(p=0.018), and also between the metronidazole gel and scaling alone group 
(p=0.001) (Table 3).
The level of SL significantly increased with increasing gingival inflammation 
(p=0.028). No such relationship was observed between gingival inflammation 
and GCF TIMP (p=0.395) (Table 4). The level of SL was higher in sites with 
bleeding on probing (Mean=20.59 pg/pl), than sites with no bleeding on
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probing (Mean=18.57 pg/pl), however the difference was not statistically 
significant (Mann-Whitney U test, p=0.47). TIMP levels were lower in bleeding 
sites (Mean=291.2 pg/pl) when compared with non-bleeding (Mean=322 pg/pl) 
sites, however this was not statistically significant (p=0.395). The level of SL 
was lower in sites with suppuration (Mean=15.69 pg/pl), than sites without 
suppuration (Mean=21.09 pg/pl) but the difference was not significant (Mann- 
Whitney U test, p=0.36). The TIMP level was higher in suppurating sites 
(Mean=381.9 pg/pl) compared with the sites which did not show suppuration 
(Mean=281.1 pg/pl), but this difference was not significant (p=0.12).
DISCUSSION
This paper reports the effects of the local delivery of antibiotics, as an adjunct 
to periodontal treatment, on GCF levels of SL, and TIMP, in patients who had 
previously received periodontal treatment. The clinical results of this 
investigation have been reported by Radvar etal. (1995).23 
Golub et al. (1987) 24 demonstrated that tetracyclines inhibit MMP activity by a 
mechanism independent of their antimicrobial activity. It was shown that the 
systemically administrated tetracycline could inhibit collagenases derived from 
inflammatory sources but inhibition of fibroblast collagenase activity needed 
higher concentrations than could be achieved by this method of delivery.24_25-12' 
13 Therefore, it is hypothesised that locally delivered tetracyclines, due to their 
high local concentrations can inhibit collagenase from both origins. 
Metronidazole appears to reduce the prevalence of Porphyromanas gingivalis 
and spirochetes at active sites in recurrent periodontitis subjects26. In addition, 
the results of Teng et al. (1992) 27 suggest that metronidazole treatment can 
cause the reduction of both active and latent forms of gelatinase. The 
reduction of gelatinase activity is best explained by the antimicrobial effect of
10
metronidazole which appears to blunt destructive host immune and 
inflammatory responses.
It has been suggested that SL may act as a marker of stromal cell involvement in 
the process of tissue degradation.6 Our observation that the mean level of SL 
decreased after antibiotic treatment could be explained by the fact that local 
delivery antibiotics plus scaling and root planing may change the microbial 
flora. This may cause a larger decrease of SL than scaling and root planing 
alone. However, the greatest decrease was observed in the sites treated by 
tetracycline or minocycline delivery systems.
Previous studies have also shown that tetracyclines, in addition to decreasing 
the level of periodontal bacteria, resulting in decrease of MMP activity in the 
gingiva, could decrease the synthesis of pro-MMPs 28-29 and also protect the 
endogenous MMP inhibitors (TIMP-1) and other proteinase inhibitors (a1- 
antitrypsin) 30 from degradation and inactivation by direct and indirect 
mechanisms. However, it cannot be established from this study whether the 
effect of the tetracyclines on the level of SL is direct, or indirect through the 
reduction in microbial challenge which could reduce the microbial proteases 
and inflammatory mediators such as cytokines, both of which could reduce the 
levels of human MMP.
After treatment the level of free TIMP increased. This might be due to a 
reduction in MMPs which would bind to free TIMP. 31^ 3 The elevation of GCF 
TIMP was higher in the metronidazole group than in the other groups. This 
indicates that the regulation of TIMP is not solely dependent on the MMPs. 
The level of GCF TIMP was significantly elevated in the patients who were 
treated with antimicrobial agents. However it did not significantly change in the 
scaling group. The observation of a greater clinical improvement in all three 
adjunctive antimicrobial treatment groups compared with the scaling and root 
planing alone supports our biochemical findings and suggests that the extent of
li
healing in the patients who received local delivery antibiotics was greater than 
the group who only received scaling and root planing.
It has been suggested that MMP and TIMP may be regulated independently.34 
In conclusion, adjunctive treatment of locally delivered antibiotics, particularly, 
tetracycline fibre and minocycline gel, is able to decrease the production of SL 
in the GCF, although whether this is through direct or indirected mechanisms 
remains unclear. However the correlation between reduced SL and improved 
clinical parameters is confirmatory (Harian et al. 1995) that SL is a marker of 
periodontal health.
12
References
1. Birkedal-Hansen H. Role of Matrix Metalloproteinases in Human Periodontal 
Diseases. Journal of Periodontology, 1993; 64:474-484.
2. Lee W, Aitken S, Kulkarni G, Birek P, Overall CM, Sodek J, McCulloch 
CA. Collagenase activity in recurrent periodontitis: relationship to disease 
progression and doxacycline therapy. Journal of Periodotal Research, 1991; 
26: 479-485.
3. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival 
fibroblasts degrade type I collagen films when stimulated with tumour necrosis 
factor and interlukin 1: Evidence that breakdown is mediated by 
metalloproteinases. Journal of periodontal Research, 1989; 24: 207-213.
4. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Matrix metalloproteinases- 
1, -3, -8 in adult periodontitis in situ. Annals of the Newyork Academy of 
Sciences, 1994;732:459-461.
5. Murphy G, Koklitis P, Carne AF. Dissociation of tissue inhibitor of 
Metalloproteinases (TIMP) from enzyme complex yields fully active inhibitor. 
Biochemical Journal, 1989; 261: 1031-1034.
6. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal- 
Hansen B, Decario A, Engler JA. Matrix Metalloproteinases: A Review. 
Critical review in oral Biology and Medicine, 1993; 4: 197-250.
7. Larivee L, Sodek J, Ferrier JM. Collagenase and collagenase inhibitor 
activities in crevicular fluid of patients receiving treatment for localised juvenile 
periodontitis. Journal periodontal Research, 1986; 21: 702-715.
8. Hakkarainen K, Uitto V-J, Ainano J. Collagenase activity and protein 
content of sulcular fluid after scaling and occlusal adjustment of teeth with deep 
periodontal pockets. Journal of periodontal Research, 1988; 23: 204-210.
13
9. Yanagimura M, Koike F, Hara K. Collagenase activity in gingival 
crevicular fluid and inhibition by tetracyclines. Journal of Dental Research, 
1989; 68: (Spec Iss), 1691-1693.
10. Haerian A, Adonogianaki E, Mooney J, Manos A, Kinane DF. Effect of 
treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of 
metalloproteinases and their ability to predict response to treatment. Journal of 
Clinical Periodontology, 1995; In press.
11. Haerian A, Adonogianaki E, Mooney J, Docherty JP, Kinane DF. 
Gingival crevicular stromelysin, collagenase and tissue inhibitor of 
metalloproteinases levels in healthy and diseased sites. Journal of Clinical 
Periodontology, 1995; 22: 505-509.
12. Golub LM, Wolff M, Lee H-M, et al. Further evidence that tetracyclines 
inhibit collagenase activity in human crevicular fluid and from other mammalian 
sources. Journal of Periodontal Research, 1985; 20: 12-23.
13. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. 
Tetracyclines inhibit connective tissue breakdown: new therapeutic implications 
for an old family of drugs. Critical Reviews in Oral Biology of Medicine, 1991; 
2: 297-322.
14. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. Anon- 
antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone 
loss in prophyromonas gingivalis-induced periodontitis in rats. Annals of the 
Newyork Academy of Sciences, 1994; 732: 96-111.
15. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, Othani H, 
Andoh N, Takeha S, Konttinen YT. Effects of tetracyclines in neutrophil, 
gingival, and salivary collagenases: A function and Western-Blot assessment 
with special reference to their cellular sources in periodontal diseases. Annals 
of the NewYork Academy of Sciences, 1994; 732: 112-131.
14
16. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee H-M, UittoV-J, 
Saari H, Konttinen YT. Specificity of the anticollagenase action of 
tetracyclines: Relevance to their anti-inflammatory potential. Antimicrobial 
agents and chemotherapy, 1992; 36: 227-229.
17. Silness J, Loe H. Periodontal disease in pregnancy. I. correlation 
between oral hygine and periodontal condition. Acta Odontologica 
Scandinavica, 1964; 22: 112-135.
18. Lobene RR, Weatherford T, Ross NM, Lamm RA, Manaker L. A 
modified gingival index for use in clinical trials. Clinical Preventive Dentistry, 
1986; 8: 3-6.
19. Griffith GS, Curtis MA. Wilton JMA. Selection of a filter paper with 
optimum properties for the collection of gingival crevicular fluid. Journal of 
periodontal Research, 1988; 23: 33-38.
20. Gustafsson A, Asman B, Bergstrom K, Soder P-O. Granulocyte elastase 
in gingival crevicular fluid. A possible discriminator between gingivitis and 
periodontitis. Journal of Clinical Periodontology, 1992; 19: 535-540.
21. Cooksley S, Hipkiss JB, Tickle SP, Holmes-Levers E, Docherty AJ, 
Murphy G, Lowson AD. Immunoassay for the detection of human 
collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and 
enzyme-inhibitor complex. Matix, 1991; 10: 285-291.
22. Brown RA, Swanson Beck J. A non-algebraic to their appropriate use in 
biomedical research and pathology practice. 3 Analysis of variance and 
distribution-free methods. Journal of Pathology, 1988; 41: 1256-1262.
23. Radvar M, Pourtaghi N, Kinane DF. A comparative evaluation of 3 
locally delivered antimicrobial systems used in conjunction with scaling and 
root planing in persistent periodontal pockets. Journal of Periodontology 1995. 
submitted for publication.
15
24. Golub LM, McNamara TF, D’Angelo GD, Greenwald, Ramamurthy NS. 
A non-antibacterial chemically-modified tetracycline inhibitors mammalian 
collagenase activity. Journal of Dental Research, 1987; 66: 1310-1314.
25. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF. Effect 
on gingival and crevicular fluid collagenase activity in humans. Journal of 
Periodontal Research, 1990; 25: 321-330.
26. Loesche WJ, Syed SA, Morrision EO, Kerry GA, Higgins T, Stoll J. 
Metronidazole in periodontitis I. clinical and bacteriological result after 15 to 30 
weeks. Journal of Periodontology, 1984; 55: 325-335.
27. Teng YT, Sodek J, McCuttoch CAG. Gingival crevicular fluid gelatinase 
and its relationship to periodontal disease in human subjects. Journal of 
Periodontal Research, 1992; 27: 544-552.
28. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease 
progression by inhibiting tissue-destructive enzyme: a potential therapy role for 
tetracycline and their chemically-modified analysis. Journal of periodontology, 
1993; 64: (suppl.): 819-827.
29. Uitto VJ, Firth JD, Pan YM, Nip L, Golub LM. Doxacycline and 
chemically modified tetracyclines inhibit gelatinase A (MMP-2) gen expression 
in human skin keratinocytes. Annals of the NewYork Academy of Sciences, 
1994; 732: 140-151.
30. Sorsa T, Lindy O, Konttinen TY, Suomalinen K, Ingman T, Saari H, 
Halinen H, Lee HM, Golub LM, Hall J, Simon S. Doxacycline in the 
production of serum alpha-1-antitrypsin from human meutrophil collagenase 
and gelatinase. Antimicrobial Agents and Chemotherapy, 1993; 37: 592-594.
31. Cawston TE, Murphy G, Mercer E, Calloway WA, Hazieman BL, 
Reynolds JJ. The interaction of purified rabbit bone collagenase with purified 
rabbit bone metalloproteinase inhibitions. Biochemical Journal, 1983; 211: 
313-318.
16
32. Murphy G, Willenbrock F, Crabbe T, O’Shea M, Ward R, Atkinson S, 
O’Connell J, Docherty A. Regulation of Matrix Metalloproteinase Activity. 
Annals of the NewYork Academy of Sciences, 1994; 732: 31-41.
33. Howard. E.W., Bullen, E. C., Banda. M. J. Preferential inhibition of 72 and 
92-KDa gelatinases by tissue inhibitor of Metalloproteinases.2. Journal of 
Biological Chemistry, 1991; 266: 13070-13075.
34. Overall CM. Regulation of tissue inhibitor of matrix metalloproteinase 
expression. Annals of the NewYork Academy of Sciences, 1994; 732: 51-65.
17
Table 1. Mean differences (baseline - after treatment) of biochemical and 
clinical parameters after therapy in four treatment groups.
Treatment ASL ATIMP Attachment
gain
Pocket depth 
reduction*
S &TC Fibre
n
51
mean
(SEM)
0.11
(0.05)
P*
0.020
mean
(SEM)
-0.32
(0.07)
P*
<0.001
mean
(SEM)
0.75
(0.12)
P*
<0.001
mean
(SEM)
1.35
(0.17)
P*
<0.001
S & Min Gel 52 0.13
(0.06)
0.023 -0.22
(0.08)
0.005 0.40
(0.14)
0.013 0.813
(0.13)
<0.001
S & Met Gel 52 0.01
(0.30)
0.730 -0.38
(0.07)
<0.001 0.59
(0.14)
0.001 0.965
(0.18)
<0.001
S 51 -0.01
(0.06)
0.940 +0.05
(0.07)
0.490 0.26
(0.11)
0.032 0.604
(0.14)
<0.001
* The S & TC showed a significantly greater pocket depth reduction than the S (p= 0.003).
* Paired t-test, baseline and post-therapy for each treatment 
S & TC Fibre= Scaling and Tetracycline fibre
S & MIN Gel= Scaling and Minocycline gel 
S & Met Gel= Scaling and Metronidazole gel 
S= Scaling alone
Table 2. Statistical analysis of changes of GCF level of Stromelysin between 
test groups (n=206).
A. Analysis of covariance
Source DF SS MS F P
Baseline SL 1 14.59 14.59 291.03 <0.001
Treatments 3 0.897 0.30 5.97 0.001
Error 47 10.07 0.05
Total 51 25.38
B. Significance
Scaling & TC
Scaling & Min Gel
0.658
Scaling & Met Gel
0.509
Scaling alone
0.004
Fibre
Scaling & Min Gel 0.377 0.002
Scaling & Met Gel 0.035
TC Fibre= Tetracycline fibre DF= Degree of freedom
MIN Gel= Minocycline gel SS= sum of square
Met Gel= Metronidazole gel MS= Mean of square
* Adjusted for baseline level
** After Bonferroni correction the significant threshould was <0.020
18
Table 3. Statistical analysis of changes of GCF level of TIMP between test 
groups (n=206).
A. Analysis of covariance
Source DF s s MS F P
Baseline TIMP 1 20.53 20.53 119.25 <0.001
Treatments 3 2.13 0.71 4.13 0.007
Error 201 34.61 0.17
Total 205 60.73
B. Significance
Scaling & Min Gel Scaling & Met Gel Scaling alone 
Scaling &TC 0.503 0.170 0.036
Fibre
Scaling & Min 0.400 0.018
Gel
Scaling & Met 0.001
Gel___________________________________________________________
TC Fibre=Tetracycline fibre DF= Degree of freedom
Min Gel= Minocycline gel SS= Sum of square
Met Gel= Metronidazole gel MS= Mean of square
* Adjusted for baseline level
** After Bonferroni correction the significant threshould was <0.020
Table 4. Comparison mean (SEM) of GCF SL and TIMP levels for different 
gingival inflammation scores at baseline, using Kruskal-wallis test.
n Stromelysin(pg/30s) TIMP(pg/30s)
MGI=0 6 16.70 (4.12) 295.0 (115)
MGI=1 29 11.50 (1.03) 234.0 (53.2)
MGI=2 112 18.64 (2.28) 326.1 (38.9)
MGI=3 59 28.45 (6.53) 263.4 (38.1)
p value 0.028 0.395
MGI= Modified gingival index
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